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Abstract 
Mucus is the first point of contact between the gut microbiota and the host. Here we 
used the gut symbiont Lactobacillus reuteri to investigate the molecular mechanisms 
underlying the interactions between gut bacteria and mucus. 
 
Firstly, the mucus binding ability of a collection of L. reuteri strains from different 
vertebrate hosts was assessed in vitro against mucus extracted from mouse and 
porcine gastrointestinal tracts. The adhesion profile was strain-specific showing the 
highest binding phenotype for strain ATCC 53608 (a pig isolate) and binding ability for 
a number of L. reuteri human isolates. Genome sequencing of the ATCC 53608 strain 
and comparative genomics was carried out to gain novel insights in the strain-specific 
determinants of L. reuteri adhesion to mucus. 
 
The second part of this work investigated the occurrence at the genetic and protein 
level of two specific cell surface proteins, MUB and Lar_0958, expressed by the ATCC 
53608 strain and human strains, respectively and their role in mediating mucus binding 
and autoaggregation ability of L. reuteri strains, as determined by flow-cytometry and in 
vitro mucus binding assays with recombinant and native proteins. 
 
Finally a quantitative proteomic approach, stable isotope labelling with amino acids in 
cell culture (SILAC), was used to identify novel mucus binding protein candidates. This 
was achieved through detection of increased cell surface protein expression when L. 
reuteri was grown in presence of mucins, resulting in induced mucus binding 
phenotype. Collectively, these results shed new light on the nature and distribution of 
strain-specific surface proteins mediating L. reuteri adhesion to mucus. 
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1 Introduction 
1.1 Physiology of the Vertebrate Gastrointestinal (GI) Tract 
The vertebrate gastrointestinal (GI) tract has a large surface (~400 m2 in human adults 
[1]) covered in mucus which is colonised by bacteria after birth/hatching. These 
mucosal surfaces become the focal point of host-bacterial interactions, providing not 
only the first line of defence against invading pathogens, but also a habitat for 
mutualistic bacteria [2]. There are seven classes of extant vertebrates, mammals, 
birds, reptiles, amphibians, jawless fish, cartilaginous fish and bony fish [3]. The GI 
tract of vertebrates can be grouped into three fundamental variations, ruminant, cecal 
or straight tube (also called simple gut). In ruminants, the stomach is enlarged and 
compartmentalised and acts as a fermentation vat, whereas in the cecal adaptation, 
there are blind sacs extending from the intestinal canal at the end of the small 
intestine/beginning of large intestine [4]. Both of the adaptations functionally delay the 
transit of fibrous food in order to expose it to microbial degradation for longer. 
Chickens, rats and mice show cecal adaptations (Figure 1.1). Birds have a relatively 
short midgut and hindgut with a straight colon and paired ceca with the highest cecal 
length to total intestinal length ratio, whereas in rodents the single cecum is large and 
highly developed [3]. For pigs and humans with their straight tube variation, a 
haustrated colon (pouches), enables maximal surface area exposure for water 
absorption (Figure 1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Anatomy of vertebrate GI tracts. Chicken and rat with cecal adaptations, pig and 
human with straight tube physiology. The colon of pigs and humans is haustrated throughout its 
entire length [3]. 
Chicken 
(Gallus domesticus) 
Body length: 46 cm 
Rat 
(Rattus norvegicus) 
Body length: 17 cm 
Pig 
(Sus scrofa) 
Body length: 125 cm 
Adult Human 
(Homo sapiens) 
Body length: 180 cm 
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The anatomy of the human GI tract can be described in terms of foregut, (esophagus 
and stomach), midgut (small intestine, comprising of duodenum, jejunum and ileum) 
and hindgut (cecum and large intestine/colon) (Figure 1.2). The function of the foregut 
is to degrade large food particles, the midgut to absorb nutrients from the food and the 
hindgut to absorb water. 
 
 
Figure 1.2 Anatomy of the human GI tract. 
 
The GI tract is a highly dynamic environment including, food digestion, immune 
secretions (including mucus and anti-microbials), epithelial cell shedding, along with 
complex interactions between the host and the collection of resident microbes called 
the microbiota. However, some parameters remain relatively consistent such as body 
temperature, the normal range for the human body is 36.4 - 37.5 °C, while it is 37.5 – 
38.5 °C in rats, 38 - 40 °C in pigs and 40.6 – 41.7 °C in chickens.  
 
Other consistent parameters within the GI tract may be more regional, for example 
peristaltic movements, pH and microbial biomass (Figure 1.3). Peristaltic movements in 
the small intestine are continuous, creating a significantly different environment to the 
large intestine where transit time is greatly reduced. In the human stomach the pH is 
highly acidic (1.0-2.5), whereas it rises to 6.6 in the proximal intestine, and 7.5 in the 
terminal ileum, before a drop to 6.4 in the cecum, then rising progressively in the colon 
from right to left to 7.0 [5-7]. As a consequence, the microbial biomass is low (102-3 
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cells ml-1 of luminal contents) in the stomach, before rising in the small intestine to 103-8 
cells ml-1 with the highest concentration of microbes found in the colon with up to 
1011cells ml-1 (Figure 1.3) [8]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Schematic representation of pH and microbial biomass along the length of human GI 
tract [8]. 
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1.2 Mammalian GI Mucus 
The epithelium in the GI tract is covered by a layer of mucus which protects the host 
from the luminal contents and provides a habitat for the microbiota. Mucus is secreted 
by goblet cells which are one of the four main types of cells constituting the intestinal 
mucosal epithelium, the others being, absorptive enterocytes, Paneth cells and 
enteroendocrine cells. The proportion of goblet cells increases from 4 % in the 
duodenum to 16 % in the distal colon [9], correlating to the variation in mucus thickness 
along the length of the GI tract (Figure 1.4) [10]. Mucus plays an important role in the 
stomach (corpus and antrum) where it protects the underlying epithelium from harsh 
acidic digestion processes. However, the colon is the location of the greatest depth of 
mucus [10], which also corresponds to the highest number of permanent bacterial 
residents [11, 12]. Colonic mucus exists in two distinct layers, a firm and a loose layer, 
as shown in rats (Figure 1.4) [10] mice [13], and humans [14]. 
 
The firm mucus layer (50 µm thick in the mouse colon) is well organised, stratified in 
appearance and impenetrable to bacteria, thereby excluding direct contact between the 
gut microbiota and the colonic epithelium [15]. The loose mucus layer (100 µm thick in 
the mouse colon) which is easily aspirated and has a less defined outer border, is an 
expansion (4-5 fold in volume) of the firm layer due to endogenous proteolytic activity 
[13], and provides the habitat for the resident microbiota. The situation is thought to be 
equivalent in the human colon, however only the thickness of the firm mucus layer has 
been measured using histological methods with results varying from 70 to 155 µm [16, 
17]. 
 
 
Figure 1.4 Mucus thickness varies along the length of the rat GI tract [10]. 
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The conditions in the small intestine are different to those in the colon (Figure 1.5). 
Since the primary function of the small intestine is the absorption of nutrients, the 
structure of the epithelium reflects this with villi and crypts to enlarge the surface area 
and only one, thinner, loosely adherent mucus layer [18]. Although the bacterial load is 
greatly reduced in the small intestine, there is a need to manage the proximity of the 
bacteria to the epithelium. This is believed to be controlled by the host secreting 
antimicrobial peptides into the mucus, for example the secretion of RegIIIγ, by multiple 
cell types including enterocytes and Paneth cells, controls the proximity of Gram-
positive bacteria to the epithelium [19]. 
 
 
Figure 1.5 Structure of human small intestine and colon [20]. 
 
The principal constituents of mucus are large, highly glycosylated proteins called 
mucins [21, 22]. The protein backbone (apomucin) is highly decorated with mainly O-
glycan structures. Mucins can be classified as either secreted or membrane bound 
(Figure 1.6), and it is the secreted gel-forming mucins which make up the bulk of the 
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mucus and provide its viscous properties [18]. The secreted mucins form homo-
oligomers via the cysteine rich domains found at the amino and carboxyl termini, which 
form disulphide bonds with other mucin molecules creating a stable structure.  
 
 
Figure 1.6 Schematic of mucin structures both secreted and membrane bound [23]. Cys S-S 
Cys represents the disulphide bonds of the cysteine rich apomucin. 
 
In humans 17 different mucin genes (MUC), have been identified, however the 
predominant mucin expressed in the small intestine and colon, is the secreted gel-
forming mucin MUC2 [24-26]. The mammalian homologue of human MUC2 is 
designated Muc2, and is also the predominant mucin expressed in small intestine and 
colon of mice, rats and pigs, while lower expression of the membrane bound mucins 
occur (Table 1.1) [27-29].  
 
Mammal Stomach Small Intestine Cecum & Colon 
Human 
MUC5AC, MUC6, 
MUC5B, MUC1, 
MUC13, MUC16 
MUC2, MUC1, 
MUC3, MUC4, 
MUC5B, MUC6, 
MUC12, MUC13, 
MUC15, MUC17 
MUC2, MUC1, 
MUC3, MUC4, 
MUC12,  MUC13, 
MUC15, MUC17, 
MUC19, MUC20,  
Mouse/Rat Muc5ac 
Muc2, Muc1, 
Muc3(17), 
Muc2, Muc1, 
Muc3(17),  
Pig Muc6 
Muc2, Muc4, Muc12, 
Muc13, Muc20  
Muc2,  
Table 1.1 Mucin expression in human, rodent and pig GI tract [30-32]. 
 
MUC2 forms large multimeric net-like structures, by first forming dimers in its C-
terminus in the endoplasmic reticulum (ER) (Figure 1.7A), and then in the Golgi 
apparatus, the apomucin backbones are decorated with O-glycan structures before N-
terminal oligomerisation and being tightly packed into secretory vesicles. During 
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secretion, these multimeric mucin structures combine to form large sheets (Figure 
1.7B), which are further stabilised by crosslinking by both covalent and non-covalent 
mechanisms (Figure 1.7C) [25, 33]. 
 
 
Figure 1.7 Schematic representation of MUC2 multimeric structures, A) dimerization, B) 
trimerisation forming net, C) stabilisation of the large sheets [23]. 
 
Glycosylation accounts for between 50-90 % of the mass of the mucin molecule 
(ranging from 200 - 40,000 kDa) and each glycan chain can consist of up to 12 
monosaccharides, the exact oligosaccharide structure of which is influenced by specific 
glycosyltransferases, blood group of individual, diet, and bacteria [32, 34, 35]. The 
carbohydrates commonly found in mucins are N-acetylgalactosamine (GalNAc), N-
acetylglucosamine (GlcNAc), fucose, galactose and sialic acid with traces of mannose 
and sulphate [36]. The mucin O-glycan chain is initiated with a GalNAc attachment to 
serine or threonine residue and consists of three structural regions, the core, the 
backbone and the peripheral region (Figure 1.8).  
 
 
Figure 1.8 Schematic of mucin O-glycan structure, with core, backbone and peripheral regions 
[37]. 
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There are eight reported core structures (Figure 1.9) [38], and in the human colon the 
mucin glycans are mainly built on core 3 structures [39], although core 1, 2, 4 and 5 are 
also present [40]. Core structures 1, 2, 3 and 4 have also been found on mucins in rat 
small and large intestines [41], pig stomach [42]. 
 
 
Figure 1.9 The eight core structures of mucin O-glycans. Linkage positions are illustrated by the 
line connecting the monosaccharides with α linkages labelled and β-anomers unlabelled [38]. 
 
The continued addition of glycans to the core structures gives rise to a large number of 
possible glycan structures. Over 100 different O-glycan structures, both linear and 
branched, are associated with colonic mucin in humans. Grouped in terms of acidity, 
10 different neutral structures were described, 19 monosialylated, and 11 
monosulphated structures, while the vast majority of structures present multiple acidic 
residues [39]. 
 
Analysis of the O-glycan structures associated with Muc2 in small and large intestines 
of rats, showed that the large intestine was enriched for sulphated residues whereas 
the small intestine was enriched in sialylated residues [41]. This region specific 
glycosylation was found to also occur in humans with a decreasing gradient of fucose 
from ileum to rectum and a corresponding increased gradient of sialic acid [43]. The 
acidic gradient was shown to be acquired after birth, perhaps due to bacterial 
colonisation or initiation of digestive and absorptive functions of GI tract [44]. 
 
These terminal mucin O-glycans have been proposed to serve as preferential binding 
sites for gut bacteria [45], which in the case of mouse colonic Muc2 were shown to 
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include fucose, GalNAc, GlcNAc, galactose, sialic acid and sulphated residues [46] 
whereas pig gastric mucin includes fucose, GlcNAc, GalNAc, galactose and sialic acid 
[47]. Furthermore, early work by Hoskins et al showed ~1 % of the fecal flora could 
degrade mucin [48], often viewed as a harmful bacterial activity it has become clearer 
more recently that commensal bacteria engage in mucin degradation and mucin could 
be designated as endogenous prebiotic [49]. Complete mucin degradation requires 
proteases which are produced by both bacteria and the host and a combination of 
saccharolytic enzymes including sialidases, α-glycosidases, β-D-galactosidases and β-
N-acetylglucosaminidases [50], which are only produced by bacteria. Multiple genera 
have members which produce one or more mucin degrading enzymes, including, 
Streptococcus, Akkermansia, Bacteroides, Bifidobacterium and Ruminococcus [51, 52]. 
The mechanisms of mucin degradation in the human GI tract has recently reviewed in 
Derrien et al [49]. 
 
Mucins are not the sole constituents of mucus, a detailed proteomic analysis of the two 
mucus layers from mouse colon reported 1057 proteins identified within this complex 
mixture [53]. A large proportion of the proteins identified were predicted to be of cellular 
origin as a result of epithelial cells shedding into the mucus layer. Plasma proteins 
were also identified, although it is unclear whether these are normally found within the 
mucus or due to contamination during experimental manipulation of the tissue. 
 
There are a wide variety of non-mucin proteins specifically secreted into the mucus, for 
example lysozyme, secretory immunoglobulin A (IgA), growth factors, defensins and β-
galectins which all have well defined roles in the defence of the host. A number of 
proteins secreted by goblet cells are thought to interact with mucins to support the 
maintenance of the gel and/or contribute to the defensive functions of the mucosal 
barrier. These include Fc gamma binding protein (FCGBP), which may help stabilise 
and crosslink the net-like structure of the Muc2 mucin [53], calcyclin, a calcium binding 
protein which may have a role in mucus secretion [54], and intestinal trefoil factor, 
which may have a role in altering physiochemical properties of mucin through 
crosslinking [55]. Other proteins secreted into mucus include PEC-60 an inhibitor of 
insulin secretion [56] and Gob5 with sequence similarity to an epithelial chloride 
channel [57]. However the interactions of these proteins with mucin have not been well 
defined. 
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1.3 Human Gut Microbiota 
1.3.1 Establishment of the microbial community 
Vertebrates evolved around 500 million years ago from the multicellular eukaryotes 
which have existed for at least 1.2 billion years, which were preceded by the evolution 
of microbial communities. The co-evolution of vertebrates with associated microbial 
communities has shaped host biology [3, 58].  
 
Defined as, “the community of microbes that lives in an individual’s GI tract” [59], the 
gut microbiota is composed of bacteria, archaea, eukarya and viruses. Metagenomics 
of 22 human fecal samples indicated that the archaea constitute 0.8 %, eukarya 0.5 % 
and viruses 5.8 %, while the vast majority (92.9 %) are of bacterial origin [60]. 
 
It is generally understood that from the sterile environment of the womb, the process of 
microbial colonisation begins at birth [61], although recent studies showed the 
presence of bacteria (Enterococcus and Staphylococcus) in the meconium of healthy 
new born infants [62], indicating interactions with microbes prior to birth. Studies 
suggest that colonisation in mammals is influenced by the type of delivery (vaginal vs. 
caesarean section) [63] and diet (formula vs. breast) [64].  
 
The colonisation process in humans begins with aerobes and facultative anaerobes as 
they have the capability for oxidative metabolism, which is necessary in an 
environment which starts with a positive oxidation reduction potential. The colonisation 
is therefore initiated by Escherichia coli and other enterobacteriaceae (Klebsiella, 
Enterobacter and Citrobacter species), Enterococci and Staphylococci species. Other 
groups of aerobes such as Aeromonas, Pseudomonas, Acinetobacter may be found 
transiently in the first few weeks of life but disappear rapidly as the oxygen and redox 
potential is reduced to negative values, leading the way for anaerobes, Bacteroides, 
Bifidobacteria and Clostridia to colonise (Table 1.2) [4, 65, 66]. 
 
Age 1 week 1 month 6 months 1-4 yrs. Adult 
Ratio 
Anaerobe:Aerobe 
1:1 10:1 100:1 100:1 500:1 
Table 1.2 Colonisation of human GI tract ratios of anaerobe: aerobe corresponding to age. 
 
The complexity of the microbiota increases gradually through childhood [67], until the 
community found in human adults reaches a relatively stable climax. The highest 
microbial load is found in the large intestine of the GI tract, where the flow rate of the 
contents does not exceed the doubling rate of the microbial populations [4], and where 
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commensals are found to inhabit the thick outer mucus layer. Changes to both the 
microbiota and to gut health generally occur in elderly adults, due to an increased 
frequency of antibiotic usage and changes in the diet [68, 69]. The stability of the adult 
microbiota is under question, for example the degree to which the unique bacterial 
communities of an individual are re-established after antibiotic treatment is unclear [70]. 
 
1.3.2 Composition and ecology of the human gut microbiota 
The microbial composition of the human GI tract shows geographical distribution both 
along the length and cross-sectionally between lumen, mucus and epithelial layers [71]. 
The microbial composition in the small intestine of adult humans includes 
Bacteroidetes and members of Clostridiales clusters XIV and IV and 
Enterobacteriaceae [72-74]. Whereas the colonic microbiota achieves the highest cell 
densities recorded for any ecosystem [12, 75] and is made up of ~ 800 different 
species corresponding to >7000 different strains (Table 1.3). Bacteria from the 
Cytophaga-Flavobacterium-Bacteroides and the Firmicutes [75] divisions account for 
>98 % of all 16S rRNA [61], although bacteria have been identified from 9 of the 55 
known bacterial divisions.  
 
Table 1.3 Comparison of microbial composition and load of small intestine vs. colon. 
 
Recently, phylogenetic composition analysis of human fecal samples using 
metagenomic techniques revealed three clusters referred to as enterotypes, 
Bacteroidetes, Prevotella and Ruminococcus based on abundance, indicating that 
variability between humans is stratified rather than continuous [60]. Long term diet has 
been linked to enterotype partitioning [76]. However, at the species and strain level the 
microbiota is as individual as a fingerprint which has shifted the focus of some research 
from which strains are present to what they are doing functionally, since metabolic 
pathways are found to be evenly distributed and prevalent across individuals [77]. The 
stability of the system in terms of functionality can be achieved with fluctuating 
populations of bacteria [61] adapting as necessary to the stochastic factors, meaning 
that complex communities of quite different composition can have similar functional 
Small Intestine Colon 
10
8
 cells ml
-1
  10
11
 cells ml
-1 
Escherichia coli, Klebsiella, Enterococcus, 
Bacteroides, Ruminococcus, Dorea, 
Clostridium, Coprococcus, Weissella, 
Lactobacillus, Granulicatella, Streptococcus, 
Veillonella. 
Five major phyla: Firmicutes, Bacteroidetes, 
Actinobacteria, Verrucomicrobio and 
Proteobacteria – Hundreds of species. 
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characteristics. The microbial variability indicates that not all factors influencing the 
composition are predictable and that gut microbial communities are governed by a 
different set of ecological rules than free living communities [58].  
 
Stochastic niche theory [78], which was first applied to the microbiota by Dethlefsen et 
al 2006 [79], combines the concepts that both predictable factors (e.g. genome of host 
and diet), and random factors (e.g. microbial exposure and disease), influence the 
composition of the microbiota, suggesting that the colonisation patterns outlined above 
are probabilistic rather than predictable. Predictable factors for vertebrate microbial 
community composition have been well studied for example, it was shown that the 
microbiota associated with hindgut and foregut herbivores form two distinct groups, 
confirming the importance of diet and/or gut physiology [58]. The random factors are 
less well understood and include historical contingencies occurring during the 
community assembly and temporal dynamics from complex microbe-microbe and 
microbe-host interactions [79].  
 
Microbe-microbe interactions may involve multiple species and strains in complex food 
webs, where the metabolic product from one microbial strain becomes the substrate for 
another. These metabolic webs have the potential to be inconceivably complex and 
changeable when made of >7000 different strains of bacteria, able to adjust 
transcriptome and metabolomes to the variations in substrate availability [61]. As well 
as these positive interactions, the microbes may also compete and produce 
antimicrobials such as bacteriocins in order to gain competitive advantage. 
Microorganisms can compete and cooperate simultaneously, for example Bacteroides 
thetaiotaomicron and Methanobrevibacter smithii facilitate each other’s growth by 
complementary energy metabolism, while competing for nitrogen [80]. 
 
Microbe-host interactions may also involve more than one microbial partner, for 
example lactate released by some Bifidobacterium species, is used by lactate 
fermenters such as Eubacterium hallii, to produce butyrate, which can then be 
metabolised by the host to maintain gut health [81]. Another example of these complex 
relationships is the one between mucin degrading bacteria e.g. Bacteroides fragilis 
which degrade sulpho-mucins present on the host, to release sulphate which is used 
by sulphate reducing bacteria (e.g. Desulfovibrio desulfuricans) to reduce to the highly 
toxic hydrogen sulphide [82]. 
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The profound importance of the gut microbiota to host health was first revealed by 
germ free mice models, which provided evidence that intestinal bacteria are involved in 
a number of key physiological functions including nutrient absorption [83, 84], epithelial 
renewal [85], angiogenesis [83, 86], energy harvest, use and storage [87], 
development, expansion and function of the immune system [88], and the development 
of neural systems [89].  
 
The increasing prevalence of chronic and degenerative diseases in industrialised 
countries has been linked to the disruption of the co-evolved mutualism between 
humans and their microbiota [59]. Some diseases are associated with a specific gut 
microbe for example peptic ulcer disease and Helicobacter pylori and Streptococcus 
gallolyticus (previously named Streptococcus bovis), has a well-known association with 
the pathology of colorectal cancer [90-92]. Whereas changes in composition of 
microbiota have been associated with obesity, with a lower proportion of Bacteroidetes 
and a higher proportion of Actinobacteria found when comparing obese to lean 
individuals [93]. The aetiologies of the inflammatory bowel diseases (IBD), (which 
include Crohn’s disease and ulcerative colitis) are not associated with a specific 
species of gut microbe but chronic microbial infections are implicated in the pathology 
[94-96]. With antibiotic and probiotic use for the treatment of pouchitis [97, 98], an 
increase in bacterial translocation in Crohn’s disease [99] and a colitogenic microbial 
flora has been described which can induce colitis in a mouse model [100]. 
 
Colonising gut microbes can be defined as either specialists, bacteria which show host 
specific evolutionary genetic adaptations such as Lactobacillus reuteri [101, 102] or 
generalists, with larger genomes and therefore the ability to adapt to variations in the 
environment, for example the ability to utilise a wide range of host and dietary 
carbohydrate moieties in Bacteroides thetaiotaomicron, B. vulgatus and 
Parabacteroides distasonis with their extensive array of carbohydrate active enzymes 
[8, 103]. 
 
1.3.3 Lactobacillus reuteri in the vertebrate GI tract 
Gram-positive lactobacilli which belong to the Firmicutes phylum are natural mutualistic 
inhabitants of the GI tract of mammals [104, 105]. Within the genus Lactobacillus, there 
are 145 recognised species, although many members of which form part of the 
ecosystem in the GI tract, lactobacilli are also found in many other niches which may 
impact the GI environment, including plant, dairy, meat products and sourdough bread 
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[106]. L reuteri belongs to the Bacilli class, a major group in the Firmicutes, one of the 
two dominant phyla of the GI microbiota (Figure 1.10). 
 
  Phylum : Firmicutes 
  Class : Bacilli 
  Order : Lactobacillales 
  Family : Lactobacillaceae 
  Genus : Lactobacillus 
  Species : L. reuteri 
Figure 1.10 Phylogenetic classification of L. reuteri. 
 
L. reuteri strains are ideal candidates for studying the adaptation of bacteria to their 
host due to the evidence of host-driven diversification with host specific clades. This 
was determined using phylogenetic analysis, consisting of principle component 
analysis using multi-locus sequence analysis of house-keeping genes. This is 
supported not only by their ubiquitous nature, inhabiting many species of mammals and 
birds including, human, pig, chicken, turkey, mouse and rat. but also by rodent isolates 
preferentially colonising Lactobacillus free mice in vivo [101]. 
 
L. reuteri strains are found in stomach, duodenum, jejunum, ileum, cecum and recto-
sigmoidal colon of humans [72, 107]. The type strain DSM 20016 was detected in a 
human subject over several months and is considered autochthonous [108, 109], 
however the organism is not detected in every human subject [110]. In contrast, L. 
reuteri strains are commonly found in GI tract of pigs [111-113], rodents [114, 115] and 
chickens [116]. It is well documented that Lactobacillus species are able to adhere 
directly to the squamous epithelium in the forestomach of rodents, the stomach of pigs 
and the crops of chicken [116], however this does not exclude their colonisation of the 
lower GI tract. 
 
A number of L. reuteri strains have had their genomes sequenced, a complete genome 
sequence is available for DSM 20016 (Genbank accession number CP000705.1), and 
JCM 1112 (Genbank accession number AP007281.1). Both strains have been 
considered as the type strains and are derived from the same original human faecal 
isolate, L. reuteri F275 [117]. Their genome sequences are very similar apart from the 
presence of two large unique regions in L. reuteri JCM 1112 that result in a 40-kb 
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difference between the strains. The draft genomes of seven other L. reuteri strains are 
also available (see www.ncbi.nlm.nih.gov/genome/438), including MM4-1a (human 
isolate), 100-23 (rat isolate), CF48-3A (human isolate), SD2112 (human isolate), MM2-
3 (human isolate), lpuph (rodent isolate) and mlc3 (rodent isolate). 
 
Colonisation is a multifactorial process linked to cell surface properties and the ability of 
the bacteria to adapt to its environment. Persistence is often used as a measurement 
of colonisation and is reported to be strain specific [118]. Additionally, binding to the 
intestinal mucosa is considered a prerequisite for successful colonisation [119]. The 
ability of L. reuteri to colonise the GI tract has been attributed to a number of 
colonisation factors, including adherence to epithelial cells [120], binding of fibronectin 
[121], collagen binding ability [122, 123], ability to bind to mucus [124], autoaggregation 
[125], production of antimicrobial substances [126], presence of lipoteichoic acids 
(LTA) on the bacterial cell surface [127] along with extracellular polymeric substances 
(EPS) [128].  
 
Probiotics are defined by the World Health Organisation (WHO) as, “Live 
microorganisms which when administered in adequate amounts confer a health benefit 
on the host” [129]. The criteria for selecting probiotic micro-organisms include the 
ability to adhere mucus and/or human epithelial cells and cell lines. Some L. reuteri 
strains are considered as probiotics especially since the discovery of their ability to 
produce an antimicrobial substance called reuterin [130]. However, a recent literature 
review on the subject reported that only one L. reuteri strain (human isolate ATCC 
55730) presented substantial evidence for its probiotics properties in humans (Table 
1.4) [131]. L. reuteri ATCC 55730 is used in humans for the prevention and cure of 
colitis, diarrhoea, gastroenteritis, rotavirus, and is also noted for its 
hypocholesterolemic effects [96, 132-138]. Other L. reuteri strains are effective in 
animal models and are widely used in livestock industries [112, 139, 140] . 
 
Other health related properties of L. reuteri strains are yet to be fully exploited, 
including the production of vitamin colbalamin (vitamin B12) by L. reuteri DSM 20016, a 
lack of this vitamin is characterised by anaemia and macrocytosis of red blood cells 
[141]. Furthermore, L. reuteri ATCC 53608 has the potential to be used to produce D-
Mannitol (important in food, pharmaceuticals, medicine and chemistry) through the 
action of a mannitol-2-dehydrogenase [142].  
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Strain of L. reuteri Probiotic action Reference(s) 
ATCC 55730 Prevention of diarrhoea and treatment of 
gastroenteritis in humans 
[133, 134, 136, 143] 
ATCC 55730 Reduction of colicky symptoms in 95% of 
human infants 
[144, 145] 
ATCC 55730 Reduction of IgE associated eczema in 2 
yr old humans 
[146] 
ATCC 55730 Immune stimulation in humans – CD4 
lymphocytes 
[107] 
SD2112 Tolerated in humans with HIV [147] 
DSM 12246 
R2LC 
JCM 5869 
ATCC PTA 4659 
ATCC 55730 
6798  
Prevention of experimental colitis using 
animal models 
[138, 148-151] 
100-23 Immune stimulation and regulation in 
mice 
[152, 153] 
Table 1.4 Strains of L. reuteri with reported probiotic actions. 
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1.4 Bacterial mechanisms of adhesion 
General mechanisms used by bacteria to adhere within the GI tract (including to 
mucus) involve biofilms, aggregation and mucosal recognition mediated by both 
specific and non-specific bacterial cell surface factors. 
 
1.4.1 Biofilm formation, aggregation and mucosal recognition 
Biofilms are mono or polymicrobial aggregates surrounded by a mixture of 
polysaccharides, proteins and nucleic acids which form a matrix, creating localised 
conditions and a lifestyle entirely different to the planktonic state. The matrix protects 
bacteria from desiccation, oxidising agents, antibiotics, ultraviolet radiation and in the 
GI tract against host immune defences [154]. The bacteria within the biofilm may 
express a different metabolic phenotype when compared to free-living counterparts 
[155]. Biofilms have been characterised in the squamous epithelium in the stomach of 
mice [156], however the situation in the rest of the GI tract is less well understood [157, 
158]. The formation of biofilms requires adhesion and aggregation of bacterial cells. 
Bacterial aggregation to self (autoaggregation), or between mixed bacterial strains 
(coaggregation) is the initiation step for numerous functions to occur including conjugal 
pairing, biofilm formation, colonisation of the GI tract, and clearance of pathogens [159-
162].  
 
The classical theory of adhesion between bacteria and a solid substrate involves five 
types of forces with three stages in the process; at a distance > 50 nm van der Waals’ 
attractive forces are at work, at 10-20 nm there is an addition of electrostatic 
interactions, salvation (hydration) and steric forces and at less than 1.5 nm, specific 
interactions become involved [163] (Figure 1.11). Both bacteria and the biological 
surfaces to which they adhere usually have a negative zeta potential. The liquid layer 
surrounding the bacteria exists as two parts, an inner region where ions are strongly 
bound and an outer region where they are less firmly associated. The potential at the 
boundary of inner and outer regions is the zeta potential (Figure 1.12). When the 
bacteria have a large negative zeta potential they will tend to repel each other. 
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Figure 1.11 Schematic representation of the interactions involved in bacterial adhesion to solid 
substrate [163]. 
 
During the second stage of the interaction, hydrophobicity and hydrophobic surface 
components on bacteria (e.g. S-layers) probably have a dehydrating effect on the water 
film, enabling the third stage of direct contact of specific interactions between 
protuberant parts of the cell surface and the substratum to occur [163, 164]. Some 
Lactobacillus strains (L. acidophilus ATCC 4356 and L. casei ATCC 393), can alter 
their hydrophobicity in response to increasing ionic strength in the surrounding liquid 
[165], giving them an advantage in adhesion/ colonisation, although this is yet to be 
confirmed.  
 
 
Figure 1.12 Zeta potential surrounding negatively charged bacteria. 
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1.4.2 Bacterial cell surface structures 
Cell surface structures are used by bacteria to interact with their environment. Gram-
positive and Gram-negative bacteria have different cell wall structures (Figure 1.13 and 
Figure 1.14).  
 
 
Figure 1.13 Schematic representation of the cell surface architecture of Gram-negative bacteria. 
Components include; slime and capsular polysaccharides (CPS), lipopolysaccharides (LPS), 
outer membrane, periplasm, peptidoglycan (PG), and cytoplasmic membrane [166]. 
 
The primary difference is the outer membrane which is present in Gram-negative 
bacteria but absent in Gram-positive bacteria. The peptidoglycan (PG) layer is thinner 
in Gram-negative bacteria and usually represent <10 % dry weight of the cell wall, 
whereas for Gram-positive bacteria the PG layer is thicker usually representing 10 % 
dry weight of the cell wall. Lipid content of the cell walls shows the reverse trend with 
higher values between 11-22 % in Gram-negative bacteria compared to 4 % in Gram-
positive bacteria. In Gram-negative bacteria, the outer membrane contains 
lipopolysaccharides whereas unique to Gram-positive bacteria are the teichoic acid and 
lipoteichoic acid structures [167]. 
 
In certain species of both Gram-positive and Gram-negative bacteria, the cell is 
surrounded by an outer shell of proteins packed in a paracrystalline surface layer (S 
layer). The attachment site of the S-layer is the outer membrane in Gram-negative 
bacteria and the PG layer for Gram-positive bacteria. S-layers are generally 
monomolecular crystalline arrays exhibiting a morphologically similar, oblique lattice 
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structure and representing 10–15 % of the total protein of the bacterial cell wall [168-
170]. However, the biological functions of most of these S-layer proteins remain to be 
defined [171]. 
 
 
Figure 1.14 Schematic representation of the cell surface architecture of Gram-positive bacteria. 
Components include; peptidoglycan (PG), lipoteichoic acids (LTA), wall teichoic acids (WTA), 
extracellular polymeric substances (EPS), sortase dependent proteins (SDP), surface layer 
proteins (S-layer proteins) and secreted proteins [33].  
 
Another possible feature of both Gram-positive and Gram-negative bacteria is a thick 
shell composed of capsular polysaccharides, often a characteristic of pathogenic 
bacteria thought to help mask the bacteria from an immune response [172]. 
Extracellular appendages such as pili/fimbriae and flagella are found in both Gram-
positive and Gram-negative bacteria and are well studied in pathogens, although pili 
have recently been identified on the surface of probiotic L. rhamnosus GG [173]. The 
proteinaceous pilus fibre is composed of one major pilin that forms the pilus backbone 
and two minor pilin subunits [174-177]. These slender, elongated, surface appendages 
often mediate adherence between microbes and their host cell targets [178]. Flagella 
are substantially larger than pili and are composed of several thousand copies of 
flagellin subunits. Although the primary role of flagella is locomotion, they also have a 
role in adhesion [179]. 
 
EPS were previously known as exopolysaccharides, defined as long-chain 
polysaccharides composed of branched, repeating units of sugars loosely attached to 
the cell surface or secreted into the environment by certain Gram-positive bacteria 
[180]. They were later re-named as extracellular polymeric substances, when it 
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became clear that the matrix also contained proteins, nucleic acids, lipids and other 
biopolymers such as humic substances [154, 181, 182]. EPS form the bulk of many 
biofilms and can also play a role in adhesion via non-specific interactions by 
contributing to the physico-chemical properties of the cell surface. Being negatively 
charged, they have the potential to interfere electrostatically with the binding of the 
bacteria to the receptor on the mucus. For example, EPS extracted from 
Bifidobacterium longum NB667, reduced binding of L. rhamnosis GG to mucus in a 
dose dependent manner [183]. 
 
Bacterial adhesins are often large proteins consisting of repeating modules, anchored 
to the cell surface of Gram-positive and Gram-negative bacteria by various different 
mechanisms [184], such as single N- or C-terminal transmembrane anchors, 
lipoprotein anchors, LPxTG-type anchors, or other repeated cell wall-binding domains 
including Lysine Motif (LysM) domains or glycine-tryptophan dipeptide motifs [185, 
186]. Other proteins are secreted in the surroundings, some of which have been shown 
to re-associate with the cell surface by electrostatic interactions [170, 185].  
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1.5 Specific interactions between lactobacilli and mucus 
Many of the bacterial-mucus adhesion studies have been carried out with Lactobacillus 
species, since mucus binding is often studied in potential probiotic bacterial strains, 
with the aim to select probiotics based on their ability to persist in the gut [178, 187-
201]. Bacterial adhesion to mucus has also been studied in pathogenic bacteria, as 
part of the infection process, Helicobacter pylori for example, has been shown to have 
at least four mechanisms of mucin adhesion [202]. Furthermore, mucus binding has 
been studied in the context of competitive exclusion, the preferential adhesion of 
probiotic bacteria, thereby reducing the virulence of pathogens [105, 111, 203-205]. 
The biochemical mechanisms for sensing host environments, interacting with host 
surfaces and even communicating with the host are often the same in human 
pathogenic, commensal and mutualistic organisms [70]. 
 
The majority of studies on Lactobacillus adhesion to mucus have been carried out 
using in vitro methods, where mucus is immobilised on microtitre plate wells and the 
adhesion of bacteria detected in a variety of ways, predominantly radioactive labelling 
or cell counting. Recently, more sensitive techniques have begun to be developed, 
surface plasmon resonance (SPR) has been used to determine binding of lactobacilli to 
mucin [195, 196], flow cytometry (FCM) used to determine the binding of Bacteroides 
fragilis to mucin [206] and atomic force microscopy (AFM) was used to determine the 
binding of Lactococcus lactis to mucin [207], these more sensitive techniques give 
further information on the kinetics of the interactions and can provide insights on the 
contributions of specific and non-specific interactions. However these labour intensive 
and costly methodologies are not generally used for screening. 
 
Mucus glycoproteins are generally postulated to act as the molecular receptors of 
bacterial binding. The mucus and mucins used in these assays are from a variety of 
sources; extracted from intestines, faeces, from mucus-secreting cell lines such as 
HT29-MTX or from a commercial source, which may have an impact, since the 
identification of region-specific glycosylation [40, 43]. However only indirect evidence 
has been gathered for adhesion to mucin glycans in Lactobacillus species [208, 209], 
and further work is needed to confirm the role of mucin carbohydrates in adhesion.  
 
Although EPS [118, 183, 210-212], LTA [213], S-layer proteins [168, 179, 214-217], 
undefined secreted factors [111, 218, 219], autoaggregation ability, and hydrophobicity 
[220] have been suggested as potential bacterial adhesion factors, little biochemical 
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evidence supporting their role in adhesion is available. In contrast, several bacterial cell 
surface proteins have been shown to act as mediators of specific Lactobacillus 
adhesion to mucus [124, 190, 216, 218, 219, 221, 222]. At present only a few mucus 
adhesins have been functionally and structurally characterised (Table 1.5).  
 
Bacterial Strain Bacterial Adhesin Mucus Receptor Reference 
L. reuteri 1063 
Mucus binding 
protein (MUB) 
(GenBank AF120104) 
Sigma porcine gastric mucin, 
mucus from pig or hen 
intestines, fractionated mucus 
from pig or hen intestines. 
Immunoglobulin (non-immune 
Fab-dependent) 
[124, 223] 
L. reuteri 104R 
(previously named L. 
fermentum 104R) 
Mucus adhesion-
promoting protein 
(Map A) 
(Previously MAPP) 
(GenBank AJ293860) 
None identified 
Binds to purified Sigma porcine 
gastric mucin, small intestinal 
porcine mucus. Also binds to 
epithelial cells, specifically 
ANXA13 and PALM from 
Caco2 cells 
[203, 222, 
224-227] 
L. johnsonii La1 NCC 
533 
Elongation Factor Tu 
(La1 - EF-Tu) 
(GenBank NP 
964043) 
None identified, binds to 
purified mucus from HT-
29MTX cells containing MUC 
5AC and human colonic mucus 
extract containing MUC2, also 
binds epithelial cells 
[228] 
L. johnsonii La1 NCC 
533 
Heat shock protein of 
GroEL class (La1 - 
GroEL) 
(GenBank NP 
964487) 
None identified, binds to 
purified mucus from HT-
29MTX cells containing MUC 
5AC, also binds epithelial cells 
[229] 
L. plantarum LA 318 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
(GAPDH) 
(GenBank AL935254) 
Binds to human colonic mucus. 
 
[230] 
L. rhamnosus GG 
Pilin subunits 
SpaC, SpaF, SpaB 
(GenBank 
YP003170190, 
YP003172118, 
YP003170189) 
Binds to human colonic mucus, 
SpaC and SpaF specific. SpaB 
non-specific electrostatic 
interactions 
[173, 174] 
Table 1.5 Functionally characterised mucus adhesins from Lactobacillus species. 
 
Mucus binding protein (MUB), a 358 kDa protein from L. reuteri 1063, was the first 
functionally and structurally characterised mucus adhesion in commensals [124]. MUB, 
shows the typical structure of many Gram-positive cell surface proteins, with a YSIRK 
signal peptide for translocation across the cytoplasmic membrane and a C-terminal 
LPxTG anchor motif, recognised by a family of enzymes called sortases, which 
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covalently attach the protein to the PG. The 14 Mub repeats found in MUB, can be 
divided into six type 1 and eight type 2 domains based on sequence homology. The six 
type 1 repeats show 15-85% amino acid (aa) sequence identity, whereas the eight type 
2 domains show higher conservation with >91% aa sequence identity [124] (Figure 
1.15).  
 
 
 
 
 
 
Figure 1.15 Structure of mucus binding protein MUB, with YSIRK signal sequence, Mub repeats 
(type 1 in orange and type 2 in white) and LPXTG cell wall anchor.  
 
Mub repeats are believed to mediate binding to mucus, since fusion proteins consisting 
of different Mub repeats and the maltose-binding protein (MBP) were shown to adhere 
to pig mucus components, pig gastric mucin and hen intestinal mucus. The binding of 
Mub-MBP to mucus components could be partly inhibited by the glycoprotein fetuin, 
which suggests that the receptor of Mub adhesion is a sialylated glycan structure, 
possibly those attached to mucins.  
 
By searching protein databases, Boekhorst et al [231], identified 48 proteins with at 
least one Mub domain in nine different lactic acid bacterial species, mostly lactobacilli 
from GI tract. More recently an in silico analysis of extracellular proteomes of 
lactobacilli revealed 47 proteins from six Lactobacillus genomes contained mucus 
binding domain(s) [232], strongly suggesting that the Mub repeat is a functional unit 
that could play an important role in host-microbe interactions. Many of these proteins 
contain multiple Mub repeats which raises interesting questions about the role and 
requirement of each repeat unit.  
 
Furthermore, each Mub repeat, approximately 200 aa in length, consists of two 
domains B1 and B2. The B1 domain of Mub repeat 5 (MubR5), has structural similarity 
to repeat unit of Protein L, an immunoglobulin (Ig) binding protein from 
Peptostreptococcus magnus, and was shown to bind to mammalian Igs including 
secretory IgA [223]. Further work by Coic et al [233] showed that the chemically 
synthesised MUB70 which corresponds to the B1 domain has binding affinity for colonic 
mucus from humans, guinea pig and rabbits but not mice or rabbit ileal mucus, and 
specific recognition of Muc2. 
Signal sequence 
LPXTG 
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A distinction needs to be made between MUB domains which have been characterised 
at both biochemical and structural level and the putative mucus binding MucBP 
domains found in the Pfam database (PF06458 http://pfam.sanger.ac.uk/). The MucBP 
domains are predicted to be smaller than the Mub domains and roughly correspond to 
the B2 domain, but show a much wider phylogenetic distribution than the Mub domains 
(Figure 1.16) [231, 234]. Spr1345 from Streptococcus pneumonia is one of the few 
MucBP domains to have been functionally characterised [235], binding to mucin and 
polysaccharides hyaluronan and chondroitin sulphate, suggesting specificity for the 
carbohydrate moiety of mucins [236]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.16 Crystal structures of Mub repeats, MucBP domains and related proteins. a) L. 
reuteri MubR5 (PDB 3I57); b) Spr1345 from Streptococcus pneumonia (PDB 3NZ3); c) 
LBA1460 from L. acidophilus (PDB 3O69); d) PEPE_0118 from Pediococcus pentosaceus 
(PDB 3LYY); e) Imo 0835 from Listeria monocytogenes (PDB 2KT7); f) related adhesion protein 
from P. pentosaceous (PDB 2KYW) and g) InlB B repeat from L. monocytogenes (PDB 3NZ3) 
[234]. 
 
Another L. reuteri mucus adhesion protein (Map A) was purified, identified, and 
characterised (Table 1.2.2) from strain 104R [224]. After lithium chloride (LiCl) 
extraction from the cell surface, proteins were purified by either gel filtration or mucin 
affinity purification, and MapA was detected in the fractions by dot blot assays with 
horseradish peroxidase-labelled porcine intestinal mucus and commercial porcine 
gastric mucin. Map A was also found to inhibit adhesion of L. reuteri 104R to porcine 
MubR5 
MucBP Imo0835 
MucBP Spr1345 
MucBP LBA1460 
MucBP PEPE_0118 
Q03HU7 
InlB B-repeat  
(a) 
(b) 
(c) 
(e) 
(d) 
(f) 
(g) 
B1 B2 
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intestinal mucus. Identification was performed by, sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), and Western blotting. Map A is part 
of the ATP-binding cassette (ABC) transporter family, which include adhesins specific 
to other GI tract receptors e.g. collagen, and epithelial cells. 
 
Some of these adhesins are multifunctional molecules with at least two independent 
functions for example, in the cytoplasm protein elongation factor thermo unstable (EF-
Tu) is part of the mechanism to synthesise new proteins as part of the ribosomal 
complex whereas on the cell surface EF-Tu binds to mucus and epithelial cells [228]. 
EF-Tu and a heat shock protein from Hsp60 class (GroEL), were recently identified as 
surface molecules and functionally characterised as mucus binding proteins in L. 
johnsonii NCC533 La1 (Table 1.2.2) [228, 229]. L. johnsonii NCC533 La1 EF-Tu was 
identified from cell surface proteins extracted with LiCl. Proteins which adhered to 
epithelial cells, were run on SDS-PAGE, transferred to nitrocellulose membrane, and 
identified using antibodies against cell surface proteins whereas the presence of GroEL 
at the bacterial surface was demonstrated using a whole-cell enzyme-linked 
immunosorbent assay. Recombinant proteins of both EF-Tu and GroEL were produced 
and shown to bind to mucins extracted from human colon and HT29-MTX cells. 
Although present at the cell surface, EF-Tu and GroEL, do not contain a signal 
sequence, LPxTG peptidoglycan anchor motif or lipoprotein motif and are considered 
as intracellular proteins. Interestingly the GroEL of Salmonella typhimurium induced 
aggregation of bacteria in the presence of mucus [229].  
 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) isolated from the cell surface of 
L. plantarum LA 318 has also been functionally characterised as a mucus binding 
protein [230] (Table 1.2.2). L. plantarum LA 318 cells washed in PBS had reduced 
ability to bind to human colonic mucin as detected by SPR and GAPDH was identified 
as a protein in the PBS wash fraction, by SDS-PAGE followed by N-terminal aa 
sequencing. Purified with a two-step chromatographic procedure GAPDH was then 
shown to bind to human colonic mucin. GAPDH is common on the surface of many 
pathogenic bacteria, and the presence of adhesins on both pathogenic and mutualistic 
bacteria reinforces the theory of competitive exclusion. 
 
L. rhamnosus GG has recently been shown to possess pilin structures [173]. 
Prototypically, the pilus fibre is composed of 3 pilin subunits only one of which shows 
adhesive ability, the other two contribute to structural integrity [174-177]. L. rhamnosus 
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GG has two pilus gene clusters, spaCBA and spaFED and the pilus subunits SpaC, 
SpaF and SpaB bind in vitro to human intestinal mucus [173, 174] (Table 1.2.2). Using 
recombinant proteins, the two adhesive pilin subunits SpaC and SpaF, showed specific 
mucus binding ability, whereas the binding between pilin subunit SpaB and mucus was 
shown to be mediated by electrostatic interactions.  
 
Adhesion exhibited by these mucus binding proteins is not solely restricted to mucus, 
Map A, EF-Tu and GroEL also bind to epithelial cells whereas GAPDH from L. 
crispatus ST1 binds to plasminogen [237] and MUB to Igs [223]. 
 
Other functionally characterised adhesins are considered as mucus binding proteins 
(Table 1.6), although a careful inspection of the literature shows that these have been 
tested either indirectly, against epithelial cells or in a denatured form so no direct 
biochemical evidence of binding to mucus is available. 
 
Bacterial Strain Bacterial Adhesin Receptor Reference 
L. reuteri NCIB11951 Collagen binding protein 
(CnBP) 
Collagen [123] 
L. plantarum WCFS1 
L. plantarum 299v 
Mannose specific adhesin 
(Msa) 
Mannose [221, 238-240] 
L. acidophilus NCFM La-MUB None stated [216] 
L. reuteri JCM 1081 29 kDa protein 
(Lr W1) 
Porcine gastric 
mucin and 
epithelial cells 
[241] 
Table 1.6 Functionally characterised adhesins of Lactobacillus, with putative mucus binding 
function. 
 
The adhesion of Collagen binding protein (CnBP) isolated from L. reuteri NCIB11951 to 
collagen was inhibited by both porcine intestinal mucin and by a lectin with specificity 
for α-D-galactose [123], indicating a possible lectin-like adhesion to mucus although 
this has not been studied further. CnBP is a MapA homologue and part of the ABC 
transporter family, which include other types of adhesins. 
 
Mannose specific adhesin (Msa) proteins from both L. plantarum WCFS1 and L. 
plantarum 299v show similar structure to MUB proteins, with N-terminal signal peptide, 
sortase dependent LPxTG anchor motif and the presence of Mub repeats [216, 221, 
242]. Msa contributes to L. plantarum to bind to mannose but no experimental work has 
been carried out to assess its binding to mucus.  
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One of the MUB homologues from L. acidophilus NCFM (La-MUB), was shown to be 
involved in adhesion to epithelial cells as observed by the 65% reduction in binding 
with a MUB mutant strain, however no binding experiments to mucus were carried out 
[216]. 
 
A 29 kDa protein (named Lr W1) isolated from L. reuteri JCM 108 and separated on an 
SDS-PAGE was shown to bind to mucus and epithelial cells [241]. However the protein 
was in a denaturated form and no experiment was performed using the native form of 
the protein. Lr W1 shows 71.1% sequence similarity to protein Lr0793 from L. reuteri 
ATCC 55730 which is a CnBP homologue. Lr W1 N-terminal aa sequence shows 
similarity to CnBP and like Map A and CnBP, Lr W1 is part of the ABC transporter 
family [122, 241, 243]. Together this information indicates that the role played by Map 
A, CnBP and Lr W1 in mucus adhesion may be similar. 
 
A review on the extracellular biology of lactobacilli by Kleerebezem et al highlighted the 
prediction of 2451 putative extracellular proteins from 13 lactobacilli genomes. The 
largest exoproteomes were found in L. casei (306 proteins representing 11.1% of all 
proteins encoded in genome) and L. plantarum (313 proteins 10.4 %), whereas the 
smallest exoproteomes were found in L. fermentum (128 proteins 6.9 %) and L. reuteri 
(117 proteins 6.1 %). On average the function of up to 60 % of these exoproteins are 
unknown [232], revealing large numbers of potential cell surface proteins for the 
interaction of bacteria with the GI tract. 
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1.6 Aims and objectives of the research project 
 
1.6.1 Aim 
The overall aim of the project is to investigate the mechanisms by which mutualistic 
gastrointestinal (GI) microbes bind to intestinal mucus, assessing the contributions of 
specific molecular interactions involved in the adhesion process. 
 
1.6.2 Objectives 
The first objective is to screen mutualistic Lactobacillus reuteri strains from different 
host origin for mucus adhesion and autoaggregation properties, using in vitro adhesion 
and autoaggregation assays. 
 
The second objective is to investigate the role played by specific mucus binding 
proteins of representative L. reuteri strains, in bacterial autoaggregation and mucus 
adhesion. 
 
The third objective is to identify novel L. reuteri cell surface factors potentially involved 
in binding to mucus using a quantitative proteomics approach 
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2 Materials and Methods 
2.1 General Materials 
The water used in this study was deionised and ultrapure to resistance 18.2 MΩ cm-1, 
(Barnstead Nanopure Diamond, Barnstead Thermolyne Corporation, New Hampshire, 
USA). All chemicals used in this study were from Sigma-Aldrich (Poole, Dorset, UK) 
unless otherwise specified. Phosphate buffered saline (PBS) with the following 
composition, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, 2.7 mM Kill, 137 mM NaCl (pH 7.4) 
was used throughout the study. 
 
Porcine gastric mucin (PGM) from Orthana (Biofac A/S, Kastrup, Denmark), was used 
for the standard curve in protein concentration assays, and type III porcine gastric 
mucin (PGMIII) from Sigma (Sigma-Aldrich, Poole, Dorset, UK) was used for media 
supplementation and as a control throughout the optimisation of the mucus 
characterisation methods. 
 
Blocking Buffer used in this study was Protein Free Blocking Buffer in PBS (Thermo 
Scientific, Waltham, USA). Fluorescein labelled lectins, Wheat germ agglutinin (WGA), 
succinylated wheat germ agglutinin (SWGA), Sambucus nigra agglutinin (SNA), Ricinis 
communis agglutinin I (RCA), concanavalin A (ConA), Lotus tetragonobolus lectin 
(LTL) and Ulex europaeus agglutinin (UEA) were all from Vector Labs (Peterborough, 
UK).  
 
Rabbit polyclonal antibodies used in Western blotting, flow cytometry (FCM), 
immunogold labelling, competition assays, purification of native proteins and protein 
adhesion assays were produced by BioGenes (Berlin, Germany) to titres of > 200 000 
(Table 2.1). Preimmune serum (PIS) was provided for each rabbit.  
 
Antibody Raised against AA sequence* 
Anti-MubR5 Recombinant type 2 Mub repeat 5 G2105……D2289 
Anti-MubRI Recombinant type 1 Mub repeat I V550…….T742 
Anti-Lar Recombinant Lar repeat 1 K577…….D672 
Table 2.1 Polyclonal antibodies used throughout study. * The aa positions given are those on 
the full-length protein before removal of the secretion signal. 
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2.2 Microbiology 
2.2.1 Bacterial strains, media and culture conditions 
L. reuteri strains used in this study are listed in Table 2.2. Bacterial culture media, de 
Man, Rogosa and Sharpe (MRS) and two variations of Lactobacillus defined media 
(LDM) were used in this study. The MRS is composed of 10 mg ml-1 peptone, 8 mg ml-1 
“Lab-Lemco”, 4 mg ml-1 yeast extract, 20 mg ml-1 glucose, 2 mg ml-1 dipotassium 
hydrogen phosphate, 5 mg ml-1 sodium acetate 3H2O, 2 mg ml
-1 triammonium citrate, 
0.2 mg ml-1 magnesium sulphate 7H2O, 0.05 mg ml
-1 Manganese sulphate 4H2O and 1 
ml sorbitan mono-oleate. The composition of LDM II and LDM III is reported in 
Appendix 1. 
 
The cultures were maintained as frozen stocks held at -80 °C in MRS with 20-50 % 
(v/v) glycerol. L. reuteri strains were grown from frozen stocks to stationary phase in 
MRS broth at 37 °C for 20 h. Cells were subcultured to 0.2 % by volume (20 µl into 10 
ml) in MRS or prewarmed (37 °C) LDM II and grown at 37 °C to exponential phase (9.5 
h) or to early stationary phase (16 h). For the induction assay, bacterial cells were 
grown from frozen stocks as above then subcultured to 0.2 % by volume (20 µl into 10 
ml) in either MRS or prewarmed (37 °C) LDM II, supplemented with 0.1 % (w/v) Type III 
porcine gastric mucin (PGMIII) and grown at 37 °C to early stationary phase (16 h). For 
growth curves, OD600 values were measured every hour for ~80 h. Three biological 
replicates were performed. 
 
2.2.2 Carboxyfluorescein (cF) labelling of bacteria 
L. reuteri strains were grown to early stationary phase in MRS, cells were collected by 
centrifugation (1342 xg, 5 min, 15 °C), washed twice with PBS and resuspended in 
PBS. Cell suspensions were adjusted to an optical density at 600 nm (OD600) of 0.5, 
representing approximately 2 x 108 cells ml-1. The bacterial cells were then labelled by 
incubation with 10 μM carboxyfluorescein diacetate (cFDA) (Sigma-Aldrich, Poole, 
Dorset, UK) at 37 °C for 40 min. Carboxyfluorescein (cF) labelled cells were then 
centrifuged, washed and resuspended in PBS. 
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Strain Source Comments 
ATCC 53608 Pig 
Purchased from the American Type Culture Collection (ATCC; Lab of 
the Government Chemist, LGC Standards, Teddington, UK), derived 
from strain 1063 
DSM 20016 Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
MM4-1a Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
MF2-3 Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
CF4-6g Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
FJ1 Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
MF14-C Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
LMS11-3 Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
sr11 Human Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
JW2015 Pig Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
Lp167-67 Pig Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
20-2 Pig Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
3c6 Pig Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
CR Rat Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
One-One Rat Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
ATCC 55739 Rat Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
DSM 17509 Rat Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
N2D Rat Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
R2LC Rat Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
ML1 Mouse Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
#20 Mouse Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
r13 Mouse Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
Lr4020 Mouse Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
LB54 Chicken Kindly supplied by Jens Walter, University of Nebraska, Lincoln, USA 
MM4KO Human 
Full name MM4-1a Lar_0958 K/O was kindly provided by Stefan 
Roos, University of Agriculture Science (SLU), Uppsala, Sweden. 
1063N Pig 
Isolated by Donald MacKenzie at the Institute of Food Research 
(IFR), Norwich, UK, was a spontaneous mutant derived from strain 
1063 (isolated from pig) supplied by Jens Walter. 
Table 2.2 L. reuteri strains used in this study. 
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2.3 Biochemistry 
2.3.1 Mucus preparation 
For preparation of the solublised mouse colonic mucus (MCM-S), mouse large 
intestines (from wild type C57BL/6 mice) were washed with cold sterile PBS 
additionally containing a cOmplete Mini Protease Inhibitor Cocktail Tablet per 10 ml 
PBS (Roche, Basel, Switzerland). The mucosal surface was scraped with a glass slide 
to remove the mucus layer. Mucus scrapings were collected into 1 ml of ice-cold, PBS 
containing 4 M guanidine hydrochloride and protease inhibitors. The tissue was kept on 
ice and homogenised with both an Ultra-Turrax polytron (IKA, Staufen, Germany) and a 
Status 70 ultrasonicator set to 3 x 30 s pulses at 45 % power (Philip Harris Scientific, 
Lichfield, UK), with intermediate incubation steps on ice for 30 s, then the sample was 
centrifuged (17 000 xg, 1 h, 4 °C) to remove cell debris. The sample was stored at -20 
°C. For preparation of the crude mouse colonic mucus (MCM-C), mouse small 
intestinal mucus (MSIM) and pig small intestinal mucus (PSIM), mouse small and large 
intestines (from wild type C57BL/6 mice) were rinsed with ice cold sterile PBS + 0.05 % 
(w/v) Tween 20 (PBST 0.05 %). The mucosal surface was scraped with a scalpel and 
the mucus layer placed into ~1 ml ice cold PBST 0.05 %. The tissue was rinsed using 
ice cold PBST 0.05 %, and material collected in the solution was combined with the 
scraped material. Fresh porcine small intestine, obtained from the local 
slaughterhouse, was rinsed with 67 mM phosphate buffer (pH 6.7) containing 0.02 % 
w/v sodium azide and a mix of protease inhibitors (Roche Diagnostics GmbH, 
Mannheim, Germany; 1 tablet per 50 mL buffer). Mucus was removed by scraping the 
epithelial surface of the jejeunal segment of the intestine with a plastic scraper 
(Corning, NY). After mixing by vortex (Genius 3- IKA, Staufen, Germany) the mucus 
extracts were centrifuged (17 000 xg, 1 min at room temperature (RT)). The 
supernatant was stored, 1 ml of fresh ice cold PBST 0.05 % was added to the pellet 
and mixed. The samples were sonicated (Branson 2110, Danbury, Connecticut, USA) 
for 15 min at RT then centrifuged (17 000 xg, 1 min at RT). The supernatant was 
combined with the saved supernatant and the sample was stored at -20 °C. Mucin 
concentrations were estimated using the bicinchoninic acid (BCA) assay (see section 
2.5.1) with PGM for the standard curve. 
 
2.3.2 Mucus characterisation: agarose/polyacrylamide composite gel electrophoresis 
(AgPAGE) and Western blot 
Composite gels were made by mixing two heated solutions, solution A (1.2 % agarose, 
0.375 M Tris-HCl (pH 8.1), 12 % glycerol, 7 % acrylamide/bis-acrylamide w/w ratio 
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19:1) and solution B (0.5 % agarose, 0.375 M Tris-HCl (pH 8.1)). The 0.5-1.2 % 
agarose gradient, 0-7 % polyacrylamide gradient, 0-12 % glycerol gradient gels were 
cast in the mini-Protean gel casting apparatus (Bio Rad, Hertfordshire, UK), at 60 °C, 
after adding tetramethylethylenediamine (TEMED) 0.03 % and ammonium persulphate 
0.01 % to both solutions. The gel was allowed to set for 3 h at RT, then kept at 4 °C 
overnight in a humidified environment.  
 
Samples were reduced and alkylated in sample loading buffer to a final concentration 
0.23 M Tris-HCl (pH 8.1),18 % glycerol, 0.003 % bromophenyl blue, 0.6 % SDS, 200 
mM dithiothreitol (DTT), for 3 h at 37 °C, and stored at -20 °C until needed. 
Immediately prior to loading on the gel, samples were boiled at 92 °C for 5 min. Gels 
were run at 300 V for 3 h at 4 °C in 192 mM Tris-borate (pH7.6), 1 mM 
ethylenediaminetetraacetic acid (EDTA), 0.1 % SDS. Gels were stained using Alcian 
Blue following the protocol in Schulz et al [244] and Colloidal Blue (Life Technologies, 
Ltd., Paisley, UK), following manufacturer’s instructions.  
 
Prior to Western Blotting, Colloidal Blue stained gels were destained with 10 % acetic 
acid overnight, incubated in 50 mM Tris-HCl pH 7.5, 1 % SDS for 1 h. Proteins were 
transferred at 150 V for 4 h at 4 °C to HybondP 0.45 µm polyvinylidene difluoride 
(PVDF) membrane (GE Healthcare, New Jersey, USA) using 3 mm filter paper 
(Whatman, Maidstone, UK), and following the procedure from Life Technologies 
blotting handbook (Life Technologies, Ltd., Paisley, UK), with blotting buffer 25 mM 
Tris-HCl, 192 mM glycine, 0.04 % SDS, 20 % methanol. Membranes were blocked with 
Blocking Buffer, incubated overnight with 1/1000 dilution in PBS of fluorescein labelled 
lectins. Membranes were washed twice in PBS before fluorescent signals were 
detected using a Pharos-FX Plus Molecular Imager (BioRad, Hemel Hempstead, UK). 
 
2.3.3 Adhesion (Bacterial, Protein and Induction assays) 
2.3.3.1 Bacterial Adhesion Assay 
Bacteria were grown to early stationary phase and cF labelled as above (section 2.2.2), 
mucus prepared as above (section 2.3.1) was diluted in PBS (1 mg ml-1 for adhesion to 
MCM-S, or 0.1 mg ml-1 for adhesion to PSIM and MSIM) and 200 µl of the solution was 
loaded into high binding, black, polystyrene microtitre plate wells (Greiner Bio-One Ltd., 
Stonehouse, UK) and incubated for 20 h at 4 °C. The wells were washed three times 
with 200 µl PBST 0.05 % using a plate washer (Applied Quality Systems, Tonbridge, 
UK). Then, 200 µl of Blocking Buffer was added to each well and the plates incubated 
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at RT for 1 h. The wells were washed as above, before cF-labelled bacteria (200 µl) 
were added to each well and incubated at 37 °C for 4 h. The wells were washed as 
above and adhered bacteria were lysed by incubation at 37 °C for 1 h with 200 μl of 1 
% (w/v) SDS in 0.1 M NaOH. The released cF fluorescence was measured in a 
FLUOstar OPTIMA plate reader (BMG Labtech, Offenburg, Germany) at 485 and 520 
nm as excitation and emission wavelengths, respectively. Negative controls of bovine 
serum albumin (BSA) coated wells were included. Each assay was performed in 
triplicate and on at least three separate occasions. Standards were included on each 
occasion also in triplicate consisting of 200 µl of SDS lysed cF-labelled bacteria in 
order to evaluate the % adhesion.  
 
Competitive bacterial binding assays were performed as described above but with the 
following modifications, prior to addition of 200 μl of labelled bacterial suspension to 
each well, the bacterial suspensions were incubated at 37 °C for 1 h with 1 % (v/v) of 
one of the following, anti-Mub-R5, anti-Mub-RI, anti-MubR5 and anti-MubRI combined, 
0.5 % (v/v) of anti-Lar or the preimmune serum from each corresponding rabbit as a 
negative control.  
 
2.3.3.2 Protein adhesion assay 
Mucus prepared as above (section 2.3.1) was diluted in PBS to 0.1 mg ml-1 and 200 µl 
of the obtained solution was loaded into high binding polystyrene microtitre plate wells 
(Greiner Bio-One Ltd., Stonehouse, UK) and incubated for 20 h at 4 °C. In order to 
remove unbound mucus components, the wells were washed three times with 200 µl 
PBST 0.05 % using a plate washer (Applied Quality Systems, Tonbridge, UK). Then, 
200 µl of Blocking Buffer was added to each well and the plates incubated at RT for 1 
h. The wells were washed as above, then, 100 µl of protein (native MUB, recombinant 
MubR5, recombinant MubRI-II-III or recombinant Lar repeat) at a concentration of 0.1 
mg ml-1 was added per well and the plates incubated at RT for 2 h. The wells were 
washed as above to remove unbound protein. Primary antibody either anti-MubR5, 
anti-MubRI or anti-Lar or negative control PIS from the appropriate rabbit was added to 
the wells, (100 µl at 1/20 000 dilution in PBS) and incubated at RT for 1.5 h. The wells 
were washed as above. Secondary antibody anti-rabbit IgG alkaline phosphatase (AP) 
(100 µl at 1/30 000 dilution in PBS) was added to the wells and incubated at RT for 1.5 
h. Substrate SIGMAFAST p-nitrophenol phosphate (pNPP) (100 µl of 1 mg ml-1 pNPP 
in 0.2 M Tris 5 mM MgCl2, pH 9.6-10.5; Sigma) was added to the wells and absorbance 
was measured at 405 nm after overnight incubation at RT. Each assay was performed 
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in triplicate and the data were analysed in Excel (Microsoft, Washington, USA) see 
section 2.3.5. 
 
2.3.3.3 Induction assay 
Following the method by Jonsson et al 2001 [191], L. reuteri strains were grown to 
early stationary phase in MRS or LDM II broth either in the presence or absence of 
mucin supplementation at 0.1 % (w/v) PGMIII. Bacterial cells were collected by 
centrifugation (9000 xg, 6 min, RT), washed once with PBST 0.05 % and resuspended 
in PBST 0.05 % to an OD600 of 0.5.  
Mucus samples prepared as described in section 2.3.1 were diluted to 0.1 mg ml-1 in 
PBS and 100 µl was loaded into sterile, flat bottom, 96-well microtitre plates (Greiner 
Bio-one, Stonehouse, UK) and incubated for 20 h, at 4 °C. In order to remove unbound 
mucus components, the wells were washed with 200 µl PBST 0.05%. Then, in order to 
block the wells, 200 µl of PBST 1 % was added per well and the plates incubated at RT 
for 1 h. The wells were washed twice as above with PBST 0.05 %. Then, 100 µl of 
PBST 0.05 %-washed bacteria was added per well and the plates incubated at RT for 2 
h. The wells were washed four times with PBST 0.05 % to remove unbound bacteria, 
and 100 µl PBST 0.05 % was added to the wells before adhered bacteria were 
examined under an inverted microscope with an Olympus U-PMTVC 1514899 UC30 
camera (Olympus, Southend on Sea, UK) to capture images. The PBST was removed 
from the plate, the wells allowed to dry for 20 h at RT and the dry plate was read at 460 
nm using the FLUOstar OPTIMA plate reader (BMG Labtech, Offenburg, Germany). 
Each assay was performed in triplicate and on at least three separate occasions. 
Negative controls of BSA coated wells were included on each occasion also in 
triplicate. Data were analysed in Excel (Microsoft, Washington, USA), see section 
2.3.5. 
 
For the protease treatment of bacterial cells, the induction assays were performed as 
outlined above with the following changes, the PBST washed bacteria were diluted to 
OD600 1 and incubated for 1 h at 37 °C with 1 ml of either PBS, shaving buffer (20 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 1 M D-arabinose, 10 mM CaCl2), or 1.7 µg ml-1 trypsin 
in shaving buffer. After the incubation cells were washed once (5000 xg for 5 min) and 
then resuspended to OD600 0.5 in PBST 0.05 % and 100 µl of cell suspensions were 
added to the coated wells. 
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2.3.4 Spectrophotometry autoaggregation assay 
L. reuteri strains were grown to early stationary phase in MRS broth, cells were 
collected by centrifugation (1342 xg, 5 min, 15 °C), washed twice with PBS and 
resuspended in PBS to an OD600 of 0.5. Samples (1 ml) were analysed by 
spectrophotometry using a U-3010 Spectrophotometer (Hitachi, Tokyo, Japan) by 
recording OD600 values every 10 min for 5 h at 37 °C.  
 
2.3.5 Statistical Analysis 
For bacterial adhesion assay (section 2.3.3.1), protein adhesion assay (section 
2.3.3.2), and induction assay (section 2.3.3.3) the data were analysed in Excel 
(Microsoft, Washington, USA), statistical analysis using Student’s t-test.  
 
For the spectrophotometric autoaggregation assay (section 2.3.4), the data were 
analysed using Excel and One-way ANOVA statistical analysis was performed using 
Statistical Package for the Social Sciences (SPSS) (IBM, New York, USA) on 
normalised data (inversed). 
 
2.3.6 Flow cytometry (FCM) 
FCM was carried out using bacteria were grown in filtered (0.2 µm) MRS broth to early 
stationary phase. Aliquots (1 ml) were harvested (17 000 xg, 2 min 4 °C) and washed 
once with filtered (0.2 µm) PBS buffer and the OD600 value was adjusted to 2.5 with 
PBS. Bacterial cells were analysed in a FC500 flow cytometer using CXP software 
(Beckman Coulter, High Wycombe, UK). At least 20,000 events per sample were 
acquired at low flow rate.  
 
To determine bacterial cell numbers, the number of events (corresponding to cells) was 
counted for 1 min at a constant flow rate of 10 µl min-1. To determine bacterial 
autoaggregation ability, the forward scatter (FS) and side scatter (SS) signals of PBS-
washed cells were recorded. To determine the cell surface expression of the MUB and 
Lar_0958 proteins, the following additions to the above method were made. Prior to 
FCM analysis, aliquots (50 µl) of PBS-washed cells were incubated with polyclonal 
anti-MubR5 or anti-Lar antibody (1:100 final dilution in PBS) in the dark on ice for 30 
min. Following a wash with 1 ml PBS, the cells were resuspended in 25 µl PBS 
containing goat anti-rabbit IgG (whole molecule)-fluorescein conjugated antibody (1:26 
final dilution in PBS) and incubated in the dark at RT for 15 min. Finally, 20 µl of this 
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treated cell suspension was diluted in 0.6 ml PBS, (for ATCC 53608) or 1 ml (all other 
strains). The level of protein on the cell surface was quantified by measuring the green 
fluorescent signal in FL1 channel (530/30 nm). Data were analysed using FlowJo (Tree 
Star Inc., Ashland, USA), Excel (Microsoft, Washington, USA) and SPSS (IBM, New 
York, USA). 
 
2.3.7 Immunogold scanning electron microscopy (SEM) 
In order to visualise MUB and Lar_0958 proteins on the surface of whole bacteria by 
immunogold SEM, bacteria were grown to stationary phase in MRS broth (16 h 
incubation at 37 °C), washed once with PBS and resuspended in PBS to OD600 3.0 (~ 1 
 109 cells ml-1). The PBS-washed bacteria were air dried on to carbon-coated nickel 
grids and fixed by exposure to 25 % (v/v) glutaraldehyde vapour. Residual free 
aldehydes were blocked with PBS buffer (pH 7.4) containing 50 mM glycine for 15 min. 
The grids were incubated in goat blocking solution (Aurion, Wageningen, The 
Netherlands) for 1 h, washed for 3  5 min with incubation buffer (PBS buffer 
containing 0.1 % (w/v) BSA-c™ (Aurion, Wageningen, The Netherlands)), then 
incubated overnight at 4 °C with anti-MubR5/anti-MubRI combined or singly, or anti-Lar 
polyclonal antibody (1:1000) in incubation buffer. Grids were washed 6  10 min with 
incubation buffer and then incubated for 2 h at RT with goat anti-rabbit IgG-15 nm gold 
particle conjugated antibody GAR-15 (Aurion, Wageningen, The Netherlands), 1:50 in 
incubation buffer). Following 6  5 min washes with incubation buffer and 3  5 min 
washes with PBS, the bacteria were re-fixed in PBS containing 2 % (v/v) 
glutaraldehyde. After 1  5 min wash with PBS and finally 2  5 min washes with 
ultrapure water, the grids were examined and photographed in a FEI Tecnai G2 20 
Twin transmission electron microscope. Control grids treated with preimmune serum 
(PIS) or treated only with the secondary antibody were included.  
 
 
2.4 Molecular Biology 
2.4.1 Genomic DNA extraction 
Bacteria were grown to early stationary phase in MRS (37 °C, 16 h) and the equivalent 
of 1.5 ml of an OD600 value of 3 (approximately 2 x 10
9 bacteria) was used for 
extraction. Genomic DNA was extracted using the Qiagen DNeasy Blood and Tissue 
Kit (Qiagen, Crawley, West Sussex, UK) following the manufacturer’s instructions for 
Gram-positive bacteria and increasing the lysis incubation time at 37 °C to 1 h. DNA 
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was eluted in buffer “AE” (200 µl per extraction) (Qiagen, Crawley, West Sussex, UK) 
was stored frozen at -20 °C.  
 
2.4.2 General bioinformatics tools 
SignalP v4.0 was used for the prediction of secretion signals [245] 
(www.cbs.dtu.dk/services/SignalP/). Protein domain predictions were performed using 
the Conserved Domain search tool from the National Centre for Biotechnology 
Information (NCBI) website, (www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi).  
 
2.4.3 Polymerase chain reaction (PCR) of mub and lar_0958 genes  
Bacteria were grown to early stationary phase in MRS broth, cells were collected by 
centrifugation (1342 xg, 5 min, 15 °C), washed twice in ultrapure water, resuspended to 
OD600 5.5 in ultrapure water. Whole cell PCR was performed in 50 µl reaction volumes 
consisting of 10 pmol each primer, 125 U HotStarTaq (Qiagen, Crawley, West Sussex, 
UK), and 10 µl of washed bacterial cell suspension. For detection of the mub gene, 
primers MucB1-RVIf and MucB2-RVIr were used and for the lar_0958 gene, primers 
lar0958-f1 and lar0958-r1 were used (see Table 2.3). The reactions were carried out in 
a thermocycler (Veriti 96 well - Applied Biosystems, Carlsbad, California USA) with the 
following programme: 15 min of initial denaturation and Taq activation at 95 °C, 
followed by 35 cycles of 30 s at 94 °C, 30 s at either 50 °C (mub) or 58 °C (lar_0958) 
and either 60 s (mub) or 40 s (lar_0958) at 72 °C and a final extension step for 10 min 
at 72 °C. The resulting PCR products were analysed by agarose electrophoresis gel 
(section 2.4.4) and DNA sequencing. 
 
Primer Sequence Tm 
MucB1-RVIf 5’-ATGCAAGAAGCTCAAGCCATC-3’ 66 °C 
MucB2-RVIr 5’-TTAATCAAGCTTCTTGTAGGT-3’ 55 °C 
lar0958-f1 5’-AAAGTTACCTATAGTGGTAGTG-3 60 °C  
lar0958-r1 5’-AATCCCTAGTGGATTAATCGTG-3 62 °C  
Table 2.3 Primers used for mub and lar_0958 gene detection by PCR. 
 
2.4.4 Agarose gel electrophoresis 
Agarose gels (1.5 %) were used for the separation of PCR amplification products. All 
gels were prepared using TAE buffer (20 mM Tris-base, 10 mM acetic acid, 5 mM 
EDTA, pH8). Samples were loaded into the gel after addition of the Orange G loading 
dye (New England BioLabs Inc., Massachusetts, USA) according to manufacturer’s 
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instructions. Electrophoresis was carried out using the Horizon58 system from 
Biometra (Goettingen, Germany) with a constant voltage of 100 V. The gels were 
incubated in 0.5-1 µg ml-1 ethidium bromide solution for 30 min before PCR products 
were visualised on a shortwave UV transilluminator. Gel images were taken using the 
Alphaimager (Protein Simple, Santa Clara, California, USA). 
 
2.4.5 Random amplified polymorphic DNA (RAPD) analysis  
RAPD analysis was performed in 50 µl reaction volumes consisting of 100 pmol primer, 
(see Table 2.4) 125 U HotStarTaq in x1 PCR buffer and approximately 40 ng of 
genomic DNA (see section 2.4.1 for genomic DNA extraction method).  
 
Primer Sequence 5'-3' Tm °C GC% Reference 
BF2 CGGCCCCTGT 29 80 [246] 
1247 AAGAGCCCGT 25 60 [246] 
1254 CCGCAGCCAA 27 70 [246] 
XD8 CAAGGCCATCC 29 63.6 [246] 
XD9 GAAGTCGTCC 25 54.5 [246] 
M13 GAGGGTGGCGGTTCT 60 66.7 [246] 
M14 GAGGGTGGGGCCGTT 65 73.3 [246] 
Coc AGCAGCGTGG 27 70 [246] 
OPL-04 GACTGCACAC 25 60 [247] 
Table 2.4 List of primers tested in RAPD-PCR analysis 
 
The reactions were carried out in a thermocycler (Veriti 96 well - Applied Biosystems, 
Carlsbad, California USA) with the following programme: 15 min of initial denaturation 
and Taq activation at 95 °C, followed by 45 cycles of 30 s at 94 °C, 30 s at either 33 °C 
(primers BF2, 1247,1254, XD8, XD9, Coc, and OPL-04) or 45 °C (primers M13 and 
M14) and 1 min at 72 °C and the final extension step for 10 min at 72 °C. The 
amplification products were analysed by agarose gel electrophoresis (see section 
2.4.4). 
 
2.5 Proteomics 
2.5.1 Protein Quantitation Assays 
Protein concentrations were estimated either using the BCA assay (Sigma-Aldrich, 
Poole, Dorset, UK) according to manufacturer’s instructions, or by NanoDrop ND-1000 
(Thermo Scientific, Waltham, USA), when an absorbance value of 1 at 280 nm was 
equivalent to 1 mg ml-1 unless otherwise specified. 
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2.5.2 Preparation of cell wall extracts, soluble cytoplasmic extracts and spent media 
extracts 
The bacteria were grown to early stationary phase in MRS broth, cells were harvested 
by centrifugation at 1342 xg for 10 min. The spent growth media (2 ml) was retained 
and concentrated using Vivaspin-2 ultrafiltration spin columns with a 100,000 Da 
molecular weight cut off (MWCO) (Sartorius Stedim Biotech, Aubagne Cedex, France) 
at 4 °C, following the manufacturer’s instructions. The concentrated samples were then 
buffer-exchanged with PBS and centrifuged to give approximately 50-70 fold 
concentration, this sample was named spent media (SM) extract. Soluble cytoplasmic 
extracts (SCE) and cell wall extracts (CWE) were prepared from PBS-washed bacteria 
following the method described in [173] with modifications. Briefly, cell pellets from 
each 20 ml culture were weighed and the cells were disrupted by vortexing with an 
equal volume of 425-600 µm diameter glass beads (Sigma-Aldrich, Poole, Dorset, UK) 
and 17 ml PBS g-1 wet weight of cells for 3  2 min pulses at full speed with 2 min 
intervals on ice between pulses. Undisrupted cells were removed by centrifugation at 
1000 xg for 1 min, the supernatant was recovered and recentrifuged at 16 000 x g for 
30 min at 4 °C to pellet the cell wall material. The supernatant from the latter spin was 
kept as the SCE. The cell walls were resuspended in 50 µl of digestion buffer (50 mM 
Tris-HCl, 5 mM MgCl2, 5 mM CaCl2, 10 mg ml
-1 hen egg white lysozyme (HEWL) and 
150 U ml-1 mutanolysin) and incubated for 3 h at 37 °C, to release the cell wall proteins. 
The CWE was clarified by centrifugation at 17 000 xg for 30 min at 4 °C, and the 
supernatant was recovered and stored at -20 °C. 
 
2.5.3 SDS-PAGE and Western Blotting 
NuPAGE® 4-12 % Bis-Tris gels were used with 3-(N-morpholino)propanesulphonic acid 
(MOPS) SDS running buffer (50 min at 200 V constant voltage) and HiMarkTM 
Unstained High Molecular Weight Protein Standard as marker. Samples were prepared 
for SDS-PAGE by adding lithium dodecyl sulphate (LDS) and Reducing Agent, all 
according to manufacturer’s instructions (Invitrogen, Life Technologies Ltd., Paisley, 
UK). 
 
Gels were stained with the Colloidal Blue staining kit (Life Technologies Ltd., Paisley, 
UK) and scanned in a GS-800 calibrated densitometer (Bio-Rad, Hertfordshire, UK). 
The software TL120 v2006e from Nonlinear Dynamics Ltd (Newcastle-upon-Tyne, UK) 
was used for analysis of apparent molecular weight (MW). 
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For Western Blot, proteins were transferred electroblotted onto ImmobilonTM-P 
membrane with 0.45 µm pore size, (Millipore, Watford, UK) using the XCell II blot 
module and NuPAGE transfer buffer (Life Technologies Ltd., Paisley, UK), following the 
manufacturer’s instructions. Membranes were blocked with Blocking Buffer for 1 h and 
proteins detected with either anti-MubR5 or anti-Lar polyclonal antibody (1:1000 
dilution in PBS), followed by goat anti-rabbit IgG (whole molecule)-alkaline 
phosphatase conjugate (1:30,000 dilution in PBS) and incubated with 100 µg ml-1 
Nitroblue tetrazolium, 50 µg ml-1 5-bromo-4-chloro-3-indolyl phosphate-toluidine in 4 
mM MgCl2, 100 mM Tris-HCl (pH 9.6) as alkaline phosphatase substrate for 20 min. All 
washing steps between incubations were performed in PBST 0.05 %. 
 
2.5.4 Cell surface proteome extraction 
Bacteria were grown to early stationary phase in MRS broth, cells (50 ml) were 
harvested at 12 000 xg, 15 min, 4 °C and washed with shaving buffer (20 mM Tris-HCl, 
150 mM NaCl pH 7.4). Cell pellets were resuspended in 0.5 ml of trypsin solution (10 
µg ml-1 trypsin, 1 M D-arabinose, 10 mM CaCl2, 20 mM Tris-HCl, 150 mM NaCl pH 7.4) 
and incubated in at 37 °C for 30 min with gentle shaking (10 rpm, Innova 44, New 
Brunswick Scientific, Enfield, Connecticut, USA). Control samples were incubated in 
the solution without trypsin. Cells were then centrifuged at 17 000 xg, 20 min at RT, 
and the supernatant collected, filtered (0.2 µm), quick frozen on dry ice and stored at -
20 °C. The protein concentration of samples was estimated using the standard BCA 
assay (see section 2.5.1) using BSA for the standard curve.  
 
Shaved protein extracts were further digested with trypsin or chymotrypsin as follows, 
samples (50 µg) were diluted in digestion buffer 1 (DB1: 8 M Urea 100 mM Tris, pH 8, 
5 mM DTT) to a volume of 50 µl and incubated at RT for 2 h before 389 µg 
iodoacetamide (IAA) was added to each sample, followed by an incubation in the dark 
at RT for 20 min. Ammonium bicarbonate (50 mM) was added to reduce the urea 
concentration to 1 M, and trypsin or chymotrypsin was added to the samples to make 
an enzyme: protein ratio of 1:50. Samples were incubated at 28 °C, 16 h and then 
adjusted to 0.1 % (w/v) with trifluoracetic acid using a 2.5 % stock solution. The 
solution was filtered by OMIX Varian c18 tips (Walnut Creek, California, USA) following 
the manufacturer’s instructions. The samples were dried using a speed vac (Thermo 
Scientific, Waltham, USA) and frozen at -80 °C. Samples were reconstituted with 80 µl, 
0.5 % (v/v) formic acid, sonicated for 5 min, then 45 µl loaded into the LTQ-Orbitrap 
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plate (to enable two injections of 20 µl), with blanks of 50 % (v/v) acetonitrile in 
between each sample.  
 
Samples were analysed by LTQ-Orbitrap, the resulting RAW files were converted to 
Mascot generic files using Proteome Discover version 1.1.0.263 (Thermo Scientific, 
Waltham, USA) prior to protein identification using the MS/MS ion search with an in-
house version of Mascot search engine (Matrix Science Ltd., London, UK) against an 
in-house L. reuteri ATCC 53608 proteomic database.  
 
2.5.5 Purification of MUB and Lar_0958 proteins 
Bacteria (L. reuteri ATCC 53608 or MM4-1a) were grown to early stationary phase in 
LDM II media, cells were removed from the spent medium by centrifugation at 10 458 
xg for 15 min at 4 °C. The medium was then filtered through a 0.22 µm filter before 
concentration using the Vivaflow tangential flow filtration system at 4 °C, with 50 and 
200 cassettes run in parallel (Vivascience AG, Hannover, Germany). The concentrated 
medium extract was then dialysed in PBS using Spectra/Por membrane MWCO 2500 
Da, before a final filtration step using 0.45 µm PVDF membrane spin columns (Millipore 
Ultrafree-CL Centrifugal devices). The proteins in the medium extract were then 
separated using a prepacked gel filtration Superpose 6 PC 3.2/30 column on an AKTA 
Fast Protein Liquid Chromatography (FPLC) system (GE Healthcare, New Jersey, 
USA), with PBS as the eluent, detecting protein content of the fractions at 280 nm. The 
fractions were analysed by SDS-PAGE and Western Blot (see section 2.5.3). 
 
2.5.6 Preparation of stable isotope labelling with amino acids in cell culture (SILAC) 
samples 
Bacterial cells were grown from frozen stocks overnight in MRS, then spun at 1342 xg 
for 6 min at RT, spent MRS was removed and cells were resuspended in LDM III 
without arginine or mucin then subcultured to 2 % by volume (3 ml into 150 ml) in LDM 
III, with one of four variations, a) heavy arginine b) heavy arginine supplemented with 
0.1 % (w/v) PGMIII c) light arginine or d) light arginine supplemented with 0.1 % (w/v) 
PGMIII and grown at 37 °C to early stationary phase (16 h), the bacteria were 
subcultured again into the same media, grown at 37 °C to an OD600 0.4. The heavy 
arginine and light arginine pairs of cultures, 100 ml each (one with mucin, the other 
without) and the reciprocal pair were mixed in equal amounts to give 200 ml at OD600 
0.4. Three biological replicates were performed. 
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Cells were harvested using the Avanti J-26XP (Beckman Coulter, High Wycombe, UK) 
high performance centrifuge at 10 000 xg, for 30 min, at 4 °C. The spent media 
supernatant was concentrated x8-fold through an Amicon Ultra 4 3000 Da MWCO 
cellulose spin column (Millipore, Watford, UK), as described in 2.4.6 and the sample 
was designated secreted proteome (SP). 
 
Cells were treated with shaving buffer as described in section 2.3.8, but with 2.7 µg ml-1 
trypsin. Samples were centrifuged at 17 000 xg, 20 min at RT, and the supernatant 
collected, filtered (0.2 µm), quick frozen on dry ice and stored at -20 °C. This sample 
was designated cell surface proteome (CSP). 
 
Cell pellets were further processed to extract cell wall proteins. Samples were re-
suspended in 1 ml PBS and ultrasonicated on ice (Status 70 ultrasonicator 6 x 30 s at 
55 % power with 30 s cooling intervals) (Philip Harris Scientific, Lichfield, UK). Samples 
were centrifuged at 17 000 xg, 30 min, 4 °C, and the supernatant discarded. The cell 
wall pellets were incubated with 1.8 ml g-1 wet weight pellet of digestion buffer (50 mM 
Tris-HCl, pH 9.6, 5 mM MgCl2, 5 mM CaCl2, 10 mg ml
-1 HEWL at 93 000 U mg-1, 150 U 
ml-1 mutanolysin) for 3 h at 37 °C. The extract was clarified with centrifugation at 17 
000 xg, 4 °C, 30 min, after which the cell wall proteome (CWP), was removed carefully 
and stored at – 80 °C until use. 
 
The protein concentration of samples was estimated using the NanoDrop (see section 
2.5.1). All samples were further digested with trypsin, following the digest protocol 
described in section 2.5.4 for the CSP samples while the SP and CWP samples were 
first separated by SDS-PAGE, (as described in section 2.5.3) and the lanes cut into five 
sections before an in-gel digestion as described below. 
 
Gel slices were cut into ~1 mm3 pieces and washed twice with 1 ml Solution A (0.2 M 
ammonium bicarbonate in 50 % (v/v) acetonitrile) with 15 min incubations in the 
solution before removal with a pastette. Then gel pieces were washed with 100 % (v/v) 
acetonitrile, before a 10 min incubation in 100 % (v/v) acetonitrile, the liquid was 
removed by pastette and samples air-dried. DTT solution (1 ml of 10 mM DTT in 50 
mM ammonium bicarbonate) was added to the samples and they were incubated for 30 
min at 60 °C. DTT solution was removed by pastette before 1 ml IAA solution (100 mM 
IAA in 50 mM ammonium bicarbonate) was added and samples incubated for 30 min at 
RT in the dark. IAA solution was removed with a pastette and gel pieces washed twice 
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with Solution A, with 15 min incubations in between washes. Gel pieces were then 
treated with 100 % (v/v) acetonitrile, as described above and air-dried for 16 h. Trypsin 
solution (30 µl of 10 µg ml-1 trypsin in 10 mM ammonium bicarbonate) was added to all 
samples. After the trypsin solution was fully absorbed, ammonium bicarbonate (10 mM) 
was added to cover the gel pieces. Samples were incubated at 37 °C for 3 h. An equal 
volume of 1 % (v/v) formic acid was added to the tubes which were vortexed then 
allowed to stand for 10 min. Samples containing the digested proteins were then 
recovered from the tubes by pastette, the gel pieces were incubated for a further 3 min 
with a further equal volume of 50 % (v/v) acetonitrile. Both samples were pooled 
together, dried using a speed vac (Thermo Scientific, Waltham, USA) and frozen at -80 
°C.  
 
2.5.7 Mass spectrometry of SILAC samples and data analysis 
Prior to analysis, 90 µl 0.5 % (v/v) formic acid was added to the SILAC samples above 
(section 2.5.6), samples were sonicated for 5 min, then 22 µl loaded onto the LTQ-
Orbitrap plate in duplicate with blanks of 50 % (v/v) acetonitrile in between samples 
from each lane of the gel.  
 
All samples were analysed by LC-MS/MS, performed on an Nanoflow-HPLC system 
(NanoAQUITY) (Waters, Manchester, UK), coupled to the LTQ-Orbitrap MS (Thermo 
Scientific, Waltham, USA) using the following settings. Samples (20µl) of the digested 
peptides were trapped off-line to a Symmetry C18 Trap (5 µm 180 µm x 20 mm) which 
was then switched on-line to a UPLC BEH C18 column (1.7 µm 75 µm x 250 mm) and 
held at 45 °C. Peptides were eluted by a gradient of 0-80 % acetonitrile in 0.1 % formic 
acid over 80 min at a flow rate of 250nl min-1. The MS was operated in positive ion 
mode with nano spray source at a capillary temperature of 200 °C. The LTQ-Orbitrap 
was run with a resolution of 60 000 over the mass range m/z 300-2000 and an MS 
target of 106 and 1 s max scan time. The MS/MS was triggered by a minimal signal of 
2000 with an automatic gain control target of 30000 ions and max scan time of 150 ms. 
For MS/MS events selection, a charge state of 2+ and 3+ was used. Dynamic 
exclusion was set to 1 count and 30 s exclusion time with an exclusion mass window of 
± 20 ppm. 
 
Raw MS spectra were processed using MaxQuant software suite v 1.2.2.5 [248] 
(consisting of MaxQuant, Andromeda and Perseus programs from Max Planck 
Institute, Martinsried, Germany) and peak lists were searched using the Andromeda 
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search engine [249], for identification of proteins against forward and reversed protein 
database of L. reuteri downloaded from NCBI 
(http://www.ncbi.nlm.nih.gov/protein/?term=lactobacillus%20reuteri) containing 37,307 
protein sequences. The default database search criteria were used, which included 
carbamidomethylation as a fixed modification, heavy arginine Arg 10 and oxidation (M) 
as variable modifications, two missed cleavages were allowed, mass tolerance was 0.5 
Da at the fragment ion level. Search results were parsed at FDR 1 % at both the 
peptide and the protein level. The following modifications were made: under the 
modification and labels tab, Lys8 was removed from the heavy labels, the enzyme was 
changed to trypsin and the main search ppm to 5; under the identifications and 
quantification tab, the box for kept low-scoring versions of identified peptides was 
ticked and also the between parameter groups and match between runs boxes with a 
time window of 2 min. In Perseus, for SILAC ratios to be considered significantly 
different, there must be a ratio present in at least three out of the five samples, all going 
in the same direction (i.e. all positive or all negative), and at least one shown to be 
significantly different using the Significance B test with Benjamini Hochberg FDR set to 
0.05. 
 
For comparison, data were also analysed in Mascot Distiller v 2.4.3.1 (Matrix Science 
Ltd., London, UK). For quantification purposes the proteins had a minimum of two 
peptides, with ion score significance threshold of <0.05, a correlation threshold of >0.9 
and a standard error threshold of <0.05. For SILAC ratio analysis, Scaffold Q + S 
v3.4.3 (Proteome Software, Portland, USA) [250] was used to distinguish protein up- or 
down-regulation displaying a log2 fold change. These proteins were investigated for 
subcellular localisation using a combination of bioinformatics tools, SignalP v4.0 
(http://www.cbs.dtu.dk/services/SignalP/) [245] for secretion signal prediction, 
SecretomeP v2.0 (http://www.cbs.dtu.dk/services/SecretomeP/) [251] for non-classical 
secretion pathway prediction, TMHMM v2.0 (http://www.cbs.dtu.dk/services/TMHMM-
2.0/) [252] for transmembrane helix prediction, LipoP v1.0 
(http://www.cbs.dtu.dk/services/LipoP/) [253] for lipoprotein prediction, and PSORTb 
(http://www.psort.org/psortb) [254] for subcellular localisation prediction. 
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3 L. reuteri adhesion to mucus  
Gastrointestinal (GI) mucus is the first point of contact between the gut microbiota and 
the host, providing the host with defence against pathogens and also a habitat for 
mutualistic bacteria. It is likely that bacteria which have evolved to reside in the 
mucosal niche will have developed mechanisms to specifically interact with mucus. 
Here we investigated autochthonous bacteria-host interactions, by testing the mucus 
binding ability of a large collection of strains of the model gut symbiont L. reuteri, 
isolated from different vertebrate species, (human, pig, rat, mouse and chicken). 
 
3.1 Extraction and characterisation of GI mucus  
Mucus was chosen in this study rather than commercially available mucin, as it 
represents a more native substrate for binding. Mucus was extracted from mouse 
colons (MCM), mouse small intestines (MSIM), and pig small intestines (PSIM). Crude 
mucus extracts were prepared using the method described in Roos et al 2000 [255], for 
PSIM, MSIM and MCM (referred to as MCM-C), resulting in material in a native form. 
For comparison, solubilised mucus extracts of MCM were also prepared using a GuHCl 
based extraction method (referred to as MCM-S). 
 
A basic characterisation of the mucus samples was carried out using the agarose/ 
polyacrylamide composite gel system based on the work of Schulz et al 2002 [256], 
with modifications (see Materials and Methods section 2.3.2). The use of AgPAGE 
composite gels allows the electrophoretic separation of very high molecular mass 
mucin glycoproteins, the nature of which make mucus samples unsuitable for 
traditional electrophoresis and analysis techniques. Commercially available type III pig 
gastric mucin (PGMIII) was used as a positive control during the optimisation of the 
method. 
 
The BCA assay was first used to provide an approximate value of the protein 
concentration in mucus. The loading of the mucus samples onto the AgPAGE gel was 
further adjusted in order to obtain comparable Colloidal Blue signals from all samples, 
corresponding to 0.31 mg of MCM-S, 1.12 mg of MCM-C, 0.38 mg PSIM and 2.36 mg 
MSIM as estimated by BCA assay, using PGM for the standard curve. Mucus samples 
in the gel were initially probed with Alcian Blue stain (Figure 3.1A). Alcian Blue (copper 
phthalocyanine), stains acid mucopolysaccharides and glycosaminoglycans, through 
electrostatic forces with the negatively charged macromolecules.  
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Figure 3.1 Electrophoresis of mucus samples using composite gel stained with A) Alcian Blue 
and B) Alcian Blue and Colloidal Blue. Lane 1, Hi MW markers; lane 2, MCM-S; lane 3, MCM-C; 
lane 4, PSIM; lane 5 MSIM and lane 6, mucin control. 
 
At high apparent molecular mass > 500 kDa, strong Alcian Blue staining was observed 
for the MCM-C mucus sample, with fainter staining for the MCM-S and MSIM samples, 
indicating the presence of acidic mucins in these samples. The commercial mucin 
preparation showed strong Alcian Blue staining with a smeared appearance. 
Subsequent Colloidal Blue staining confirmed the presence of other proteins in the 
samples (Figure 3.1B), with discrete bands corresponding to apparent molecular mass 
between 40 and 66 kDa were observed across all samples. The small intestinal mucus 
samples showed discrete bands between 66 – 290 kDa, whilst bands above 500 kDa 
were observed across all samples. In order to further characterise the mucus samples 
with regard to their carbohydrate moieties, the proteins separated on AgPAGE were 
transferred onto a PVDF membrane and probed with fluorescently labelled lectins 
specific to mucin sugars (Table 3.1). 
 
Lectin Abbreviation Sugar recognition 
Wheat germ agglutinin WGA 
N-acetylglucosamine (GlcNAc) 
Neuraminic (sialic) acid 
Succinylated wheat germ agglutinin SWGA N-acetylglucosamine (GlcNAc) 
Sambucus nigra lectin SNA Neuraminic (sialic) acid 
Ricinis communis agglutinin I RCA 
Galactose 
N-acetylglucosamine (GlcNAc) 
N-acetylgalactosamine (GalNAc) 
Concanavalin A Con A Mannose 
Lotus tetragonobolus lectin LTL Fucose 
Ulex europaeus agglutinin UEA Fucose 
Table 3.1 Specificity of lectins used in this study 
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Figure 3.2 Western blot analysis of mucus samples separated by AgPAGE and probed with f-lectins (as indicated). Positive signals indicated with white stars. 
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Wheat germ agglutinin (WGA) recognises N-acetylglucosamine (GlcNAc) and has also 
been reported to interact with glycoproteins via sialic acid residues, whereas 
succinylated WGA (SWGA) does not recognise sialic acid (Table 3.1). All mucus 
samples tested were positive for WGA but negative for SWGA (Figure 3.2) indicating 
the presence of sialic acid in all samples. In order to further investigate the sialylated 
structure present in the mucus samples, the blots were probed with Sambucus nigra 
lectin (SNA), which binds preferentially to sialic acid attached to terminal galactose via 
an (α-2,6), and to a lesser degree, (α-2,3), linkage. There was a difference between the 
binding of WGA and SNA in all samples, indicating variation in the sialic acid forms 
present.  
 
Ricinis communis agglutinin I (RCA) recognises galactose, GlcNAc and N-
acetylgalactcosamine (GalNAc) (Table 3.1). All samples apart from PSIM were positive 
for RCA (Figure 3.2). Since there was no SWGA signal, which may indicate a lack of 
GlcNAc, the RCA recognition may be attributed to presence of galactose or GalNAc. 
Concanavalin A (ConA) recognises mannose and showed positive signals for all 
samples although with a weaker signal for MCM-C, indicating mannose content across 
the mucus samples, which is present in low amounts in mucin, and along with other 
contaminating sugars may come from shed epithelial cells present in the native mucus 
extracts. 
 
Ulex europaeus agglutinin (UEA) recognises α-linked fucose, whereas Lotus 
tetragonobulus lectin (LTL) recognises fucose linked to the C-2 of the galactose of 
βDGal(1-4)DGlcNAc, but not on βDGal(1-3)DGlcNAc [257]. There was positive 
recognition by UEA of bands in PSIM, MCM-C and MCM-S samples (Figure 3.2), but 
there was no recognition in any mucus sample by LTL, which suggests that fucose in 
the mucus samples is α-linked or on C-2 of βDGal(1-3)DGlcNAc. The PGMIII positive 
control, showed positive bands for all lectins tested. 
 
Taken together these results showed that although different profiles were observed 
between colonic mucus and small intestinal mucus extracts, all mucus samples 
displayed similar responses to lectin probing, indicating the presence of expected 
sugar residues. 
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3.2 Development, optimisation and standardisation of the mucus adhesion 
assay 
An adhesion assay was developed for assessment of bacterial adhesion to mucus. 
Briefly, carboxyfluorescein (cF) labelled bacteria [258] were incubated on mucus 
coated wells, non-adhering bacteria washed off and the bound cells were lysed before 
the fluorescence signal was measured at 520 nm using a plate reader. The use of cell 
permeant cF diacetate (cFDA) to label the bacterial cells was chosen over a range of 
alternatives due to its mechanism of action. Upon entering the cells, cFDA undergoes 
hydrolysis by intracellular esterases, releasing cF which is retained in the cell by an 
intact membrane. The two advantages of this method are that, only viable cells are 
labelled and furthermore since cF is internalised in the cells, the surface of the bacteria 
and therefore the cell surface proteins potentially involved in adhesion remain 
unaffected by labelling. However in order to measure fluorescence the bacterial cells 
need to be lysed (see Materials and Methods section 2.3.3.1). 
 
Immobilised BSA was used as a control, as it was found to give minimum signal 
compared to casein, β-lactoglobulin, ovalbumin and an equivalent signal to PBS (data 
not shown). The adhesion assay was optimised and standardised both in terms of 
mucus coating and preparation and bacterial cell numbers, viability and growth phase 
(see section 3.2.1-3.2.2 below). 
 
3.2.1 Saturation of mucus coating and mucus preparation comparison 
In order to ensure that the microtitre plate wells were saturated with immobilised 
mucus, to avoid non-specific binding of the bacteria to the wells, the binding of cF 
labelled L. reuteri strain ATCC 53608 was tested against wells coated with a serial 
dilution of MCM-S ranging from 2 mg ml-1 to 0.24 µg ml-1 (Figure 3.3). Binding is 
represented by the level of fluorescence detected after non-adhered bacteria were 
washed off and bound cells lysed to release the fluorescence. Immobilised BSA was 
included as a control. 
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Figure 3.3 Binding of strain ATCC 53608 to varying concentrations of MCM-S (blue bars) 
immobilised on microtitre wells. Control BSA (green bar). 
 
No significant variation was observed within the range of mucus tested, indicating that 
the concentrations used were above the saturation level. A value of 1 mg ml-1 was used 
for MCM-S and 0.1 mg ml-1 for further MSIM and PSIM adhesion studies. 
 
Since two different methods were used for the MCM extraction, resulting in the 
samples MCM-C and MCM-S, the adhesion of strain ATCC 53608 was tested at two 
concentrations of both mucus preparations. 
 
 
Figure 3.4 Effect of MCM preparation and concentration 1 mg ml
-1
 (blue bars), 0.1 mg ml
-1
 (blue 
and white bars) on binding ability of L. reuteri ATCC 53608. 
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There was no significant difference in the binding ability of strain ATCC 53608 to MCM 
prepared using the two different methods or at the two concentrations used (Figure 
3.4), indicating that the method of extraction did not have an impact on the 
reproducibility of the assay. 
 
3.2.2 Adhesion assay optimisation and standardisation; bacterial cell numbers, 
viability, labelling and growth phase 
Adhesion assays generally rely on OD600 values of bacterial suspensions to normalise 
the number of cells added to each well. However, differences in the size and shape of 
the cells may impact on OD600 value, thus potentially affecting the dynamics of the 
adhesion assay by adding variable numbers of cells. 
 
Flow cytometry (FCM) was used to count the cells and therefore determine whether the 
OD600 value corresponds to an equivalent number of cells across the L. reuteri strains 
tested. Briefly, a selection of strains were diluted to an OD600 of 0.5 and the number of 
events (corresponding to cells) was counted for 1 min at a constant flow rate using an 
FC500 cytometer (Table 3.2). The FC500 cytometer aspirates the cell suspension and 
the fluidics system passes each cell in front of a laser, the detectors measure the light 
scattered and the number of “events” passing through the laser corresponds to the 
number of cells. 
 
Strain Count
* 
No. cells 
added to 
microtitre well 
x 10
6 
MM4-1a 282000 5.64 
CF4-6g 284000 5.68 
FJ1 283000 5.66 
LMS11-3 283000 5.66 
1063N 280000 5.6 
ATCC 55739 284000 5.68 
ATCC 53608 269000 5.38 
DSM 17509 274000 5.48 
DSM 20016 280000 5.6 
ML1 284000 5.68 
r13 277000 5.54 
MF2-3 255000 5.1 
sr11 275000 5.5 
R2LC 281000 5.62 
N2D 283000 5.66 
Table 3.2 Determination of the number of L. reuteri cells by FCM across selected strains. * In 
cell suspension measuring OD600 0.5. 
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The number of events counted was similar across the strains, with an average of 
278267 +/- 7796, corresponding to ~ 5.6 x 106 cells per well in the binding assay. 
 
To further optimise the adhesion assay, a range of bacterial cell concentrations was 
tested, the assay was performed with a 16 h culture of L. reuteri strain DSM 20016 at a 
range of OD600 values (Figure 3.5). Data are presented as percentage adhesion, 
comparing the fluorescent signal of bound bacteria to the fluorescent signal of the 
labelled bacterial aliquots originally added to the wells. The range of OD600 values 
chosen extends to above the theoretical maximum number of cells that can bind if 100 
% of cells adhered. The theoretical maximum number of cells that can bind is 377 x 
106, based on surface area of the well and size of cells, while an OD600 of 6.8 is 
equivalent to ~544 x 106 cells. 
 
 
Figure 3.5 Effect of cell numbers on adhesion of strain DSM 20016 to MCM-S (blue diamonds) 
and immobilised BSA as a control (green crosses). 
 
The measured maximum number of cells bound (11.2 % at OD600 6.8) corresponds to 
~61 x 106, indicating that the results are within the theoretical limits of the assay. A high 
percentage of adhesion of strain DSM 20016 to mucus was observed between OD600 
0.3 and 0.7 (Figure 3.5). Above an OD600 of 1, the adhesion stabilised at ~10 %, 
indicating that there is a proportional increase in the number of cells binding with the 
increase in cells added to the wells. A similar optimum adhesion range between OD600 
0.3 and 0.7 was observed for strain ATCC 53608 (data not shown), therefore an OD600 
of 0.5 was chosen from the middle of this range in the rest of the study. 
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Only bound cF labelled bacteria are detected under the conditions of the binding assay. 
If unlabelled cells (corresponding to either dead cells or cells with leaky membranes) 
are present in the bacterial mix, they may interfere with the assay by binding to the 
immobilised mucus and thus competing with the cF labelled cells, leading to potential 
inaccuracies in the calculated binding percentage. Selected L. reuteri strains, prepared 
as described in section 2.2.2 for the adhesion assay, were characterised by FCM to 
determine the percentage of cells which are cF labelled (Figure 3.6).  
 
 
Figure 3.6 Example of a FCM plot used to distinguish cF labelled population of L. reuteri cells 
from unlabelled population of cells. 
 
Cells are passed in single cell suspension through a laser and the fluorescent signal 
from the cells is detected. The SS signal gives information about the roughness and 
granularity of the cells, these two signals combined showed two distinct populations of 
cells, correspond to fluorescently labelled and unlabelled cells. 
 
Strain 
% cF 
labelled 
MM4-1a 99.7 
CF4-6g 99.8 
FJ1 99.7 
LMS11-3 99.7 
sr11 96.6 
1063N 99.8 
ATCC 55739 99.8 
ATCC 53608 99.8 
DSM 20016 99.6 
DSM 17509 99.5 
ML1 99.3 
r13 99.0 
MF2-3 99.2 
R2LC 98.3 
N2D 99.7 
Lr4020 99.3 
MM4KO 99.7 
Table 3.3 Percentage of cF-labelled bacteria, across L. reuteri strains as determined by FCM 
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For the majority of the strains tested, > 99 % of cells were cF-labelled (Table 3.3), 
indicating that any effect of unlabelled cells on the adhesion assay will be minimal. Two 
strains (sr11 and R2LC) showed higher numbers of unlabelled cells, sr11 (3.45% 
unlabelled) and R2LC (1.7% unlabelled), which may slightly affect the adhesion values 
of these two strains.  
 
In order to investigate the influence of growth phase on bacterial adhesion to mucus, 
the binding ability of strain ATCC 53608 was tested in both mid-exponential and early 
stationary phase, diluted to an OD600 0.5.  
 
 
Figure 3.7 Impact of growth phase on adhesion of strain ATCC 53608 binding to MCM-S (blue 
bars) and BSA (green bars). 
 
Significantly higher binding to mucus was observed when the cells were harvested in 
early stationary phase (16 h) compared to those in exponential phase (9.5 h) (Figure 
3.7), probably due to differential expression of cell surface proteins. Early stationary 
phase was chosen for the rest of the study. 
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3.3 Mucus adhesion ability of L. reuteri strains 
In order to investigate the mucus binding ability of L. reuteri, 26 strains (Table 3.4) were 
screened for adhesion ability to MCM-S, MSIM or PSIM (and BSA as non-specific 
binding control), using the microtitre plate binding assay. The identity of the L. reuteri 
strains in the collection was first confirmed by sequencing of a 194 bp fragment of 16S 
rRNA amplified by PCR from cells of the L. reuteri strains, showing 100 % identity with 
the sequence from type strain DSM 20016 (data not shown). The strains were originally 
isolated from five different vertebrate hosts, pig, human, chicken, mouse and rat (Table 
3.4). 
 
L. reuteri strain Vertebrate host origin 
ATCC 53608 Pig 
1063N Pig 
Lp167-67 Pig 
20-2 Pig 
3c6 Pig 
JW2015 Pig 
DSM 20016 Human 
MM4-1a Human 
MM4KO Human 
MF2-3 Human 
CF4-6g Human 
FJ1 Human 
MF14-C Human 
LMS11-3 Human 
sr11 Human 
LB54 Chicken 
#20 Mouse 
r13 Mouse 
Lr4020 Mouse 
ML1 Mouse 
CR Rat 
One-One Rat 
DSM 17509 Rat 
N2D Rat 
R2LC Rat 
ATCC 55739 Rat 
Table 3.4 Collection of L. reuteri strains used in this study 
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In order to compare adhesion between the strains, percentage adhesion was 
normalised to the mucus binding of ATCC 53608 which was set to a value of 100 %. 
 
 
Figure 3.8 Adhesion of L. reuteri strains to MCM-S (blue bars) with BSA as a control (green 
bars). * P <0.05. 
 
Adhesion to MCM-S was markedly varied for the different strains, with eight strains 
showing significantly higher binding to mucus compared to binding to BSA (Figure 3.8). 
Adhesion of L. reuteri strains to MCM-S was not correlated to the origin of the strain, 
i.e. there was no significant binding to mouse mucus by strains isolated from mice. Two 
strains (ATCC 53608 and ATCC 55739) showed significantly higher binding to mucus 
than to BSA but with a substantial binding to BSA. The six strains showing significant 
binding to mucus compared to BSA, but with very low levels of BSA binding (DSM 
20016, MM4-1a, MM4KO, CF4-6g, FJ1 and sr11) were all human origin. Strain LB54 
(chicken origin) showed significantly higher binding to BSA than to MCM-S.  
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In order to investigate whether mucus origin in the GI tract has an impact on L. reuteri 
ability to bind to mucus in vitro, the L. reuteri strains were tested against MSIM. 
 
 
Figure 3.9 Adhesion of L. reuteri strains to MSIM (blue bars) with BSA as a control (green bars) 
*P <0.05 
 
The eight strains showing significant binding to MCM-S all showed the same binding 
pattern to MSIM (Figure 3.9). Furthermore significant binding was observed for six 
other strains to MSIM, Lp167-67, MF2-3, MF14-C, CR, One-One and LB54, which 
indicates that the differences in mucus composition may affect the adhesion of specific 
strains and that adhesion is not specific to colonic mucus.  
 
The adhesion assay was also carried out against PSIM to assess whether the host 
origin of the mucus could have an impact on the adhesion of L. reuteri strains to mucus 
(Figure 3.10). 
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Figure 3.10 Adhesion of L. reuteri strains to PSIM (blue bars) with BSA as a negative control 
(green bars) *P <0.05 
 
Comparable to the binding to MCM-S and MSIM, strains ATCC 53608 and ATCC 
55739 showed very high binding to PSIM with high background binding to BSA, and 
human strains DSM 20016, MM4-1a, CF4-6g and FJ1 showed significant binding to 
PSIM. However, in contrast to the significant binding observed to MCM-S and MSIM, 
strains MM4KO and sr11 did not show any significant binding to PSIM. Strains Lp167-
67, MF14-C and One-One showed significant binding to PSIM, whilst there was no 
significant binding observed to MCM-S and MSIM. Strain MF2-3 showed significant 
binding to BSA. 
 
The specificity of the reported mucus binding ability can be inferred by comparing the 
binding to mucus to the binding to BSA. Binding ratios were calculated for each strain, 
where a higher ratio indicates a higher specificity for mucus (Table 3.5). Four strains 
(DSM 20016, MM4-1a, CF4-6g and FJ1) showed consistently high binding ratios along 
with significant binding to mucus. The ATCC 53608 and ATCC 55739 strains which 
displayed very high percentage binding to mucus, compared to the other L. reuteri 
strains tested in the present study, had a relatively low binding ratio (less than 2.5 for 
both strains), due to their high binding to BSA.  
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Strain Ratio 
  MCM-S MSIM PSIM 
ATCC 53608 2.42 1.63 1.59 
1063N 1.62 1.61 1.19 
Lp167-67 0.49 5.83 2.82 
20-2 0.25 3.91 0.83 
3c6 0.73 3.71 1.57 
JW2015 2.34 4.48 2.09 
DSM 20016 11.44 4.44 6.73 
MM4-1a 12.53 9.88 8.88 
MM4KO 2.11 9.69 1.23 
MF2-3 0.18 2.62 0.37 
CF4-6g 7.20 6.28 8.65 
FJ1 11.36 6.51 3.83 
MF14-C 0.45 7.95 2.10 
LMS11-3 20.14 4.19 3.46 
sr11 4.95 8.82 1.80 
LB54 0.23 6.72 1.65 
#20 1.12 1.43 1.04 
r13 0.67 1.02 1.05 
Lr4020 3.76 1.25 1.10 
ML1 0.71 1.23 1.03 
CR 1.31 2.01 1.70 
One-One 1.22 2.43 2.11 
DSM 17509 1.52 6.39 1.20 
N2D 0.79 1.15 1.04 
R2LC 1.21 1.17 1.25 
ATCC 55739 2.17 1.45 1.46 
Table 3.5 Binding ratios of L. reuteri strains (mucus: BSA). 
 
Strains DSM 20016, MM4-1a, CF4-6g and FJ1 all isolated from human sources 
consistently showed significant binding to mucus. Eleven strains exhibited no binding 
under these conditions, porcine isolates 1063N, 20-2, 3c6 and JW2015, murine 
isolates #20, r13, Lr4020, ML1 and rat isolates DSM 17509, N2D and R2LC. The 
human isolate LMS11-3 displayed a highly variable binding ability, with a trend for 
higher binding to mucus than to BSA, but this was not statistically significant. 
 
The pattern of mucus binding ability of L. reuteri strains remains similar across the 
mucus samples, with strains ATCC 53608 and ATCC 55739 consistently showing high 
binding to mucus.  
 
  
 73 
 
3.4 Role of autoaggregation in mucus binding 
Autoaggregation of L. reuteri has been reported [125], and this property may influence 
the mucus binding value reported in the above adhesion assay, since cell aggregates 
will release a higher fluorescent signal than individual cells.  
 
In order to assess the potential role of autoaggregation in L. reuteri adhesion to mucus, 
the autoaggregation phenotype of all 26 L. reuteri strains was assessed by 
spectrophotometric assay. Bacterial cells were grown in MRS to early stationary phase, 
washed and diluted to an OD600 of 0.5 in PBS. The OD600 value was measured every 
10 min for 5 h, at 37 °C closely mimicking the conditions of the binding assay. Strains 
which autoaggregate showed a rapid decrease in OD600 values due to the formation of 
aggregates settling out at the bottom of the cuvette, compared to non-autoaggregating 
strains.  
 
 
Figure 3.11.Measurement of OD600 over time of L. reuteri strains. The gradient of the line is a 
surrogate marker for autoaggregation ability. 
 
The OD600 values were plotted on a graph against time (Figure 3.11) and a line of best 
fit applied to the data points for each strain, the gradient of the line (m in equation y = 
mx+c), was used as a measure of the degree of autoaggregation ability. 
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Figure 3.12 Measurement of autoaggregation of L. reuteri cells by spectrophotometry. 
 
A clear autoaggregation phenotype was demonstrated for the majority of the rodent 
strains (#20, r13, Lr4020, ML1, CR, One-One, N2D, and R2LC) (Figure 3.12). Out of 
this group, only strains CR and One-One demonstrated mucus binding ability. Low 
levels of binding were exhibited by both strains, for CR 3.98 % to MSIM with a binding 
ratio of 2.01 while strain One-One showed binding to both MSIM and PSIM at 5.99 % 
and 2.33 %, with binding ratios of 2.43 and 2.11, respectively.   
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3.5 Genome sequencing of L. reuteri ATCC 53608 
Since L. reuteri ATCC 53608 showed the highest binding ability across the mucus 
samples tested, this strain was selected for genome sequencing in order to obtain 
insights on the molecular determinants mediating L. reuteri binding to mucus. 
 
Genomic DNA was extracted from early stationary phase culture of L. reuteri ATCC 
53608 following a modified protocol described in [101] for Gram-positive bacteria. The 
genome was sequenced by 454 sequencing platform, with both shotgun and 3-kbp 
paired-end libraries in collaboration with The Genome Analysis Centre (TGAC, Norwich 
Research Park). This approach generated in excess of 365 Mbp of sequence, which 
were further assembled into a draft genome of 99 large contigs. [259]. The draft 
genome of L. reuteri ATCC 53608 is 1,969,869 bp in length with an average G+C 
content of 38.4 % which is slightly lower when compared to the other L. reuteri strains 
with genome sequences available (Table 3.6). 
 
L. reuteri 
strain 
RefSeq 
Genome 
size (Mbp) 
G+C 
content 
(%) 
Genes Proteins 
ATCC 53608 CACS00000000.2 1.97 38.4 1910 1864 
JCM 1112 NC_010609.1 2.04 38.9 1901 1820 
DSM 20016 NC_009513.1 2.00 38.9 2027 1900 
100-23 NZ_AAPZ00000000.2 2.31 38.7 2269 2181 
ATCC 55730 
(SD2112) 
NC_015697.1 2.04 39.3 2370 2246 
CF48-3A NZ_ACHG00000000.1 2.03 38.7 2223 2164 
MM2-3 NZ_ACLB00000000.1 1.94 38.7 2105 2045 
MM4-1a NZ_ACGX00000000.2 2.07 38.7 2226 2095 
Table 3.6 Genomic characteristics of genome sequenced L. reuteri strains. 
 
Automatic annotation of the genome sequence of ATCC 53608 using Glimmer3 and 
GeneMark software revealed 2024 protein coding sequences [259], with 1864 
confirmed by RefSeq. Subsequently gaps in the genome were closed using PCR, 
automatic gene prediction was performed using Rapid Annotations using Subsystems 
Technology (RAST) [260] and prediction of secretion signals using SigP were 
performed in collaboration with Udo Wegman (IFR). Protein domain predictions were 
performed using the Interpro domain search tool from the European Bioinformatics 
Institute (EBI) website (www.ebi.ac.uk/interpro/).The characteristics of four large (> 750 
aa) cell surface proteins are described in Table 3.7 and their schematic representation 
is shown in Figure 3.13.  
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Protein (AA) 
Features 
(Interpro) 
Similar proteins 
(GenBank) 
Organisms 
(%identity/%coverage) 
Lb_C_0736 (1166) 
5 x MucBP 
LPxTG anchor 
YP_005854578.1 L. amylovorus (36/56) 
Lb_C_0892 (964) No hits 
ZP_03973805.1 
ZP_03073444.1 
YP_001270659.1 
L. reuteri CF48-3A (98/100) 
L. reuteri 100-23 (96/100) 
L. reuteri DSM 20016 (91/100) 
Lb_C_1034 (3269) 
14 x MucBP 
Gram-pos anchor 
YSIRK signal 
AAF25576.1 
ZP_09814175.1 
L. reuteri 1063 (100/100) 
L. mucosae LM1 (74/100) 
Lb_C_1846 (787) 
GH68 
Gram-pos anchor 
KxYKxGKxW 
signal 
ZP_03072364.1 L. reuteri 100-23 (66/100) 
Table 3.7 Large surface proteins (> 750 aa) predicted from genome of L. reuteri ATCC 53608. 
 
Two of the surface proteins are predicted to contain putative mucin-binding MucBP 
domains (Pfam PF06458), the largest of which is homologous to mucus binding protein 
MUB from strain 1063 (parent strain of L. reuteri ATCC 53608). Other large surface 
proteins included Lb_C_1846 with a glycoside hydrolase family 68 domain (Pfam 
PF02435) and Lb_C_0892 a protein of unknown function but with high similarity to 
proteins found in L. reuteri strains CF48-3A, 100-23 and DSM 20016. 
 
 
Figure 3.13 Large surface proteins (> 750 aa) predicted from genome sequence of L. reuteri 
ATCC 53608. 
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The genome sequence of ATCC 53608 along with those of strains MM4-1a, DSM 
20016, JCM 1112, and 100-23 were interrogated for all mucus binding proteins 
identified so far in lactobacilli (Table 3.8). MUB (Lb_C_1034) was found to be a 
distinguishing feature of ATCC 53608, while genes encoding MapA and the 
cytoplasmic proteins EF-Tu, GroEL and GAPDH were present in all strains (GAPDH 
appears to be missing from strain DSM 20016). The genes encoding putative pili 
proteins were absent from all strains. The gene encoding Lar_0958 was found in L. 
reuteri strain JCM 1112 and a homologue was found in strain MM4-1a. 
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Mucus Binding Protein Bacterial Strain 
TBLASTN 
against genome 
of ATCC 53608 
TBLASTN 
against genome 
of DSM 20016 
TBLASTN 
against genome 
of JCM1112 
TBLASTN 
against genome 
of MM4-1a 
TBLASTN 
against genome 
of 100-23 
Reference 
  
% 
Identity 
% 
Coverage 
% 
Identity 
% 
Coverage 
% 
Identity 
% 
Coverage 
% 
Identity 
% 
Coverage 
% 
Identity 
% 
Coverage 
 
MUB 
(GenBank AF120104) 
L. reuteri 1063 90 97 33 5 33 5 33 3 39 87 [124, 223] 
Map A 
(Previously MAPP) 
(GenBank AJ293860) 
L. reuteri 104R 
(previously 
named L. 
fermentum 104R) 
95 100 94 100 94 100 94 100 95 100 
[203, 222, 224-
227] 
EF-Tu 
(GenBank NP 964043) 
L. johnsonii La1 
NCC 533 
84 100 84 100 84 100 84 100 84 100 [228] 
GroEL 
(GenBank NP 964487) 
L. johnsonii La1 
NCC 533 
70 98 70 98 70 98 70 98 70 98 [229] 
GAPDH 
(GenBank AL935254) 
L. plantarum LA 
318 
72 100 X X 72 100 72 100 72 100 [230] 
Pilin subunit SpaC  
(GenBank YP003170190) 
L. rhamnosus GG X X X X X X X X 32 4 [173, 174] 
Pilin subunit SpaF  
(GenBank YP003172118) 
L. rhamnosus GG X X X X X X X X X X [173, 174] 
Pilin subunit SpaB  
(GenBank YP003170189) 
L. rhamnosus GG 31 20 31 20 31 20 31 20 47 32 [173, 174] 
Lar_0958 
(GenBank 
YP001841954.1)  
L. reuteri 
JCM1112 
31 31 60 4 97 100 96 100 59 66 
Personal 
Communication 
from Stefan 
Roos 
Table 3.8 Predicted mucus binding proteins in genome sequenced L. reuteri strains  
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3.6 Discussion 
In the lower GI tract the first point of contact between the bacteria and the host is the 
mucus covering the epithelial surfaces. Many studies have investigated direct 
interactions of the microbiota with epithelial cells and extracellular matrix (ECM) 
components of host [194]. These studies are more relevant for pathogens such as 
Entamoeba histolytica which can traverse the mucus layer and cause damage to the 
epithelium [261] or for bacterial-host interactions in the proximal regions of the GI tract 
where there is less mucus. Studies investigating adhesion interactions between gut 
microbes and mucus have focused on probiotic or pathogenic bacteria as mucus 
binding is generally thought to be a desirable trait for probiotic bacteria [188] and a 
virulence factor in pathogens [202], however the mechanisms underlying mucus 
binding is poorly understood for the resident microbiota. 
 
The Lactobacillus species reuteri was used in this study as a model gut symbiont since 
it is found to inhabit the GI tract of many vertebrate species including, humans, pigs, 
horses, rodents, birds, and fish. Our study showed that the ability of L. reuteri to bind to 
mucus is strain specific, confirming previous findings using other lactobacilli species, 
for example L. plantarum [199]. In the present work, 17 out of the 26 strains tested 
showed consistent mucus binding phenotypes irrespective of the mucus origin, 
indicating a general absence of host specificity, since only two of the six pig isolates 
showed significant binding ability to the pig mucus, and three of the ten rodent strains 
showed mucus binding ability to mouse mucus. Such an absence of host specificity 
was previously reported in several other lactic acid bacteria species by Rinkinen et al 
2003, including L. rhamnosus GG, L. johnsonii La1, and L. pentosus UK1A [193]. 
However, the human isolates in our study showed a trend for mucus binding ability, 
since eight out of the nine strains showed significant mucus binding ability to at least 
one type of mucus. This indicates that the mucus binding mechanism may be important 
in the colonisation of the particular niche specific to the human GI tract. Although L. 
reuteri is one of the most abundant species in GI tract of pigs rodents and chickens 
[113-116] and its prevalence is much lower in humans [110], lactobacilli are found in 
the human colon [71], where the mucosal associated microbial community is different 
to the lumen [262, 263] and microbial characteristics such as mucus binding are 
postulated to influence the colonisation of this microbial community [264]. This 
hypothesis is consistent with the genetic analysis of 126 L. reuteri strains showing host 
specific clades [101]. Following on from our work, the lack of mucus binding ability in 
mouse isolates may indicate that mucus binding is not a pre-requisite for L. reuteri 
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colonisation of this particular host environment. Instead the clear autoaggregating 
phenotype observed for the majority of rodent isolates indicates that this factor may be 
important for colonisation. Although inference of colonisation ability from in vitro mucus 
binding studies should be taken with caution, these data are in agreement with the 
colonisation of L. reuteri in rodents through biofilm-like association in the proximal 
regions (forestomach) [115, 265] of the GI tract where there is stratified squamous 
epithelium and reduced quantities of mucus compared to the colon. The idea that 
bacterial colonisation factors may vary depending on the target host is also indicated 
by the differential colonisation ability of L. reuteri strains Lr47 and Lr108. Lr47 was 
isolated from rat colon and found to have high colonisation ability in rats but not in 
humans while strain Lr108 which was isolated from human jejunum was found to have 
colonisation ability in humans, while no ability to colonise rats [266, 267]. 
 
The comparison of L. reuteri adhesion to mucus sourced from small or large intestine 
revealed that a small number of strains showed a specific preference (Lp167-67, 
MF14-C and One-One) for the small intestinal mucus. This observation of GI tract 
region specific preference is in line with the finding that a higher adhesion ability was 
exhibited by L. acidophilus I021 and L. fermentum I5007 to porcine ileal mucus 
compared to jejunal and duodenal mucus samples [111] and that mucosal conditions of 
the small intestine are different to those found in the colon in terms of amount of mucus 
[10], region-specific glycosylation of mucins [41], and surrounding pH [6]. This concept 
of region specific niches is also supported by the reported differences in the small 
intestinal microbiota compared to the colonic microbiota [71]. 
 
Mucus binding is regarded as a colonisation factor for many probiotics, for example the 
human probiotic Lactobacillus rhamnosus GG [268] has been shown to bind to mucus 
[269], and persists in human colonic mucosa more than a week after feeding [270]. 
However the term colonisation under these circumstances means persistence after 
consumption of the probiotic has ceased and is detected for a few days to weeks and it 
is unlikely that these probiotics would become permanent residents without continual 
input. Our study indicates that mucus binding may be a feature of autochthonous 
bacterial colonisation in the human GI tract for L. reuteri strains, however since 80 % of 
colonic mucosal associated bacteria remain uncultured [262] whether this is a general 
feature for all autochthonous bacteria remains to be determined. 
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Two very high mucus binders were highlighted by this study, strains ATCC 53608 (pig 
isolate) and ATCC 55739 (rat isolate), both of which also showed adhesion to BSA 
(Figure 3.8, Figure 3.9 and Figure 3.10). During the proteomic analysis of mouse 
colonic mucus, plasma proteins were identified including albumin [53], however it is not 
clear if this was due to a contamination during sample preparation or to plasma 
proteins secreted into the mucus, in which case albumin may be a potential adhesion 
target. The mucus binding and autoaggregation phenotype of strain ATCC 55739 was 
similar to the pig isolate ATCC 53608, which differs from the other rodent strains 
tested. Interestingly, the phylogenetic analysis performed by Oh et al showed that this 
strain clustered with the strains isolated from pigs (Figure 3.14) [101]. L. reuteri strains 
isolated from rodents generally show high colonisation ability in rodent models, such as 
strain 100-23 in a Lactobacillus free mouse model [102]. Additionally, rodent isolates 
R2LC and 6799jm-1 showed highest colonisation in a competition experiment with 
seven other L. reuteri strains from various origin performed in ex-germ-free mice [101]. 
In collaboration with Gerald Tannock, University of Otago, NZ, we tested the ability of 
strain ATCC 55739 to colonise a Lactobacillus free mouse model, unlike other rodent 
isolates, ATCC 55739 was unable to colonise, which taken together with previous 
results raises questions about the origin of this strain. 
 
 
Figure 3.14 Genealogy of L. reuteri strains inferred by ClonalFrame [101], showing single green 
line of ATCC 55739 in Cluster IV (Pig 1). 
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Sequencing the genome of L. reuteri ATCC 53608 enabled the search for the presence 
or absence of known mucus binding proteins and a comparison with other L. reuteri 
strains. Initial bioinformatics approaches revealed four very large (> 750 aa) cell 
surface proteins, two of which contain the putative mucus binding MucBP domains. 
The larger of the two proteins with 14 domains was revealed to be a MUB homologue 
which has been well characterised as a mucus binding protein [124]. MUB contains 14 
Mub repeats, each consisting of two domains (B1 and B2). The resolution of the crystal 
structure of one of the Mub repeats revealed that the B1 domain has structural 
homology to an immunoglobulin binding domain from Peptostreptococcus magnus and 
the B2 domain has structural homology to the MucBP domains [223]. The in silico 
search for Mub domains by Boekhorst et al 2006 [231], showed a wide distribution 
among the lactic acid bacteria and the recent in silico analysis of the exoproteomes of 
lactobacilli where a combination both MucBP domains and Mub domains to represent 
mucus binding proteins, a total of 47 were found in six Lactobacillus genomes and 
distributed over six separate Lactobacillales-specific clusters of orthologous protein-
coding genes [232]. However no functional characterisation of MucBP domains has 
been reported in gut commensals. 
 
Comparative genomics of the L. reuteri ATCC 53608 genome sequence with the other 
L. reuteri genomes available showed that MUB was specific to strain ATCC 53608, 
while Lar_0958 was specific to human isolates JCM 1112 and MM4-1a. The 
differences seen in mucus binding ability for these L. reuteri strains suggest that the 
specific expression of MUB and Lar_0958 may be important for mucus adhesion as the 
genes encoding these proteins are absent from the other L. reuteri genomes. 
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4 Role of MUB and Lar_0958 in L. reuteri adhesion to mucus 
The mub gene has been identified in L. reuteri strain ATCC 53608, encoding a large 
(385 kDa) multimodular mucus binding protein with 14 Mub repeats, comprising six 
type 1 and eight type 2 repeats (Figure 4.1) (See Introduction, section 1.4.3 for more 
details).  
 
 
Figure 4.1 Schematic representation of mucus binding protein MUB, with six type 1 Mub repeats 
(orange) and eight type 2 Mub repeats (white). Blue bracket indicates region targeted by 
primers. 
 
L. reuteri Lar_0958 is a smaller cell surface protein postulated to be involved in 
bacterial interaction with mucus and colonization of the digestive tract [271]. The 3690 
bp lar_0958 gene in L. reuteri JCM1112 encodes a protein of 1222 aa with a predicted 
molecular mass of 133 kDa. It is a modular protein containing six repeats domains, four 
of which are identical, the fifth has 99 % aa similarity and the sixth has only 46 % aa 
similarity (Figure 4.2).  
 
The N terminal domain of both proteins contains an YSIRK signal sequence, 
[YF]SIRKxxxGxxS[VIA], which is commonly found in Gram-positive bacteria. Both 
proteins have an LPXTG anchor present at the C-terminal end for attachment to the 
cell wall PG. 
 
 
Figure 4.2 Schematic representation of Lar_0958 from L. reuteri JCM 1112, showing six Lar 
repeat domains, repeats 1-4 are identical (blue), repeat 5 has 99% aa similarity (green) and 
repeat 6 has 46 % aa similarity (purple).  
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In this chapter, the occurrence of the genes for these proteins across the collection of 
L. reuteri strains was tested, followed by an investigation into the role of these proteins 
in adhesion to mucus for selected strains. 
 
4.1 Occurrence of mub genes and proteins in L. reuteri strains 
In order to investigate the occurrence of mub genes across L. reuteri strains, PCRs 
were performed on cells of 26 strains, using primers designed to amplify a 624 bp 
fragment corresponding to Mub repeat RVI (between aa 3050 and 3236, 
QEAQAIF………….DMTINITYK) (Figure 4.1). 
 
 
Figure 4.3 Agarose gel (1.5 %), used to separate mub PCR products amplified from L. reuteri 
strains. ATCC 53608 (lane1), MM4-1a (lane 2), MF2-3 (lane 3), CF4-6g (lane 4), FJ1 (lane 5), 
DSM 20016 (lane 6), MF14-C (lane 8), LMS11-3 (lane 9), sr11 (lane 10), 1063N (lane 11), 
JW2015 (lane 12), Lp167-67 (lane 13), 20-2 (lane 14), 3c6 (lane 15), CR (lane 16), One-One 
(lane 17), ATCC 55739 (lane 18), DSM 17509 (lane 19), N2D (lane 20), R2LC (lane 21), ML1 
(lane 23), #20 (lane 24), r13 (lane 25), Lr4020 (lane 26), LB54 (lane 27), with DNA ladder (lanes 
7 and 22) and negative control (lane 28). 
 
A PCR product of the expected size was generated from three of the 26 strains, ATCC 
53608, ATCC 55739 and 1063N (Figure 4.3). DNA sequencing of the PCR products 
confirmed 100 % identity to the predicted 624 bp fragment from mub.  
 
In order to confirm MUB expression at the protein level, strains ATCC 53608, ATCC 
55739, 1063N and mub negative DSM 20016 were grown overnight and the spent 
media (SM) extracts, soluble cytoplasmic extracts (SCE) and cell wall extracts (CWE) 
were analysed by electrophoresis. When required, proteins were transferred to PVDF 
membrane and probed with polyclonal anti-MUB antibody raised against the type 2 
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repeat MubR5 (anti-MubR5). For confirmation of their identity, protein samples were 
excised from SDS-PAGE and trypsinised before analysis by Matrix Assisted Laser 
Desorption Ionisation – Time of Flight (MALDI-ToF/ToF) mass spectrometry (MS) (in 
collaboration with Fran Mulholland at IFR). 
 
 
Figure 4.4 a) SDS-PAGE of cell wall extracts (CWE) and spent medium (SM) samples from L. 
reuteri strains. Lane 1, HiMark MW marker; lane 2, CWE from DSM 20016; lane 3, SM from 
DSM 20016; lane 4, CWE from 1063N; lane 5, SM from 1063N; lane 6, CWE from ATCC 
55739; lane 7, SM from ATCC 55739; lane 8, CWE from ATCC 53608; lane 9, SM from ATCC 
53608. MUBs are indicated by the arrowheads, the truncated MUB from 1063N by the open 
triangle and Lar_0958 from DSM20016 by the solid triangle. b) SDS-PAGE and anti-Mub 
Western blot of spent medium (SM) and soluble cytoplasmic extracts (SCE) from L. reuteri 
strains 1063N and ATCC 53608. Lane 1, HiMark MW marker; lanes 2 and 6 SM from 1063N; 
lanes 3 and 7 SCE from 1063N, lanes 4 and 8 SM from ATCC 53608, lanes 5 and 9 SCE from 
ATCC 53608. MUBs are indicated using the same symbols as in a). Taken from [271]. 
 
As indicated by SDS-PAGE and confirmed by MS, substantial amounts of MUB 
proteins were detected in the SM of strains ATCC 53608 and ATCC 55739 (Figure 
4.4a, lanes 9 and 7 respectively), with an apparent size of 500 kDa, in accordance with 
earlier observations that large amounts of MUB are secreted into the media compared 
to the CWE [124]. For strain DSM 20016, no MUB was detected, however the high MW 
protein observed in the SM, was identified by MS as a Lar_0958 homologue which was 
not predicted from analysis of the genome sequence. 
 
Strain 1063N produced a truncated MUB protein of approximately 200 kDa, substantial 
amounts of which were detected in the SM. Probing with anti-MubR5 confirmed the 
presence of the protein in both the SM and SCE (Figure 4.4b). MS data confirmed the 
identity of the protein and further analysis of 1063N DNA by PCR (in collaboration with 
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Donald MacKenzie from IFR) revealed the insertion of a duplicated 13 nt sequence in 
the mub gene causing a frameshift mutation leading to the secretion of a C-terminally 
truncated protein. The truncated MUB (MUBtrunc) has a predicted size of 1590 aa 
compared to full length MUB of 3269 aa, lacks the LPXTG cell wall anchor and consists 
of Mub repeats RI-RIV, R1 and the first part of Mub R2 (Figure 4.5) [271]. 
 
 
Figure 4.5 Schematic representation of the truncated mucus binding protein MUB
trunc
, with type 
1 Mub repeats (orange) and type 2 Mub repeats (white) from L. reuteri 1063N. 
 
Expression of MUB on the bacterial cell surface was further assessed by FCM. L. 
reuteri strains ATCC 53608, ATCC 55739, 1063N and mub negative DSM 20016, 
grown to early stationary phase, incubated with primary antibody anti-MubR5, followed 
by a fluorescein labelled anti-rabbit IgG secondary antibody.  
 
 
Figure 4.6 Quantification of cell surface MUB on L. reuteri strains detected by FCM. From 
MacKenzie et al 2010 [271]. 
 
MUB expression was confirmed for strains ATCC 53608 and ATCC 55739 with a 150-
200 fold difference in MUB expression between ATCC 53608 and 1063N (Figure 4.6). 
In order to further investigate the distribution of MUB at the cell surface of L. reuteri 
strains, we used immunogold labelling with polyclonal antibodies raised against the 
type 1 Mub repeat MubRI (anti-MubRI) and anti-MubR5, either separately or in 
combination. 
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Figure 4.7 Immunogold labelling of MUB with combined anti-MubRI and anti-MubR5 antibodies 
on the surface of L. reuteri strains A) ATCC 55739, B) ATCC 53608 C) DSM 20016 and D) 
1063N. Scale bar represents 100 nm. 
 
As expected from the FCM data, strains ATCC 55739 and ATCC 53608 labelled 
positively with both anti-MubR5 and anti-MubRI antibodies (Figure 4.7). Labelling 
appears to be distributed over the cell surface and not localised to specific areas. MUB 
negative strain DSM 20016 showed low levels of non-specific background staining. 
Strain 1063N showed higher labelling than expected from the FCM data, which may 
indicate a difference in sensitivity or specificity between the antibodies, as confirmed in 
Figure 4.8 below, where only background binding was observed with anti-MubR5, while 
a higher labelling was observed with anti-MubRI. 
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Figure 4.8 Immunogold labelling of MUB
trunc
 on surface of strain 1063N using A) anti-MubR5 
antibody, or B) anti-MubRI antibody. Scale bar represents 100 nm. 
 
The specificity of the two antibodies towards MUB was further assessed using 1063N 
and ATCC 53608 cell surface protein extracts, separated by electrophoresis, 
transferred to PVDF membrane and probed with anti-MubRI or anti-MubR5 (Figure 
4.9). 
 
 
Figure 4.9 Cell surface protein extracts from L. reuteri strains 1063N and ATCC 53608 
transferred to PVDF membrane after SDS-PAGE then A), probed with anti-MubRI (Lanes 1-3) 
or anti-MubR5 (Lanes 5-7) and B) followed by Gelcode blue stain of proteins. Lane 1 and 7, Hi 
MW markers; lane 2 and 5, extracts from ATCC 53608; lane 3 and 6, extracts from 1063N; lane 
4, prestained markers. 
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Both polyclonal antibodies recognised full length MUB and MUBtrunc indicating that the 
anti-MubR5 cross reacts with Mub repeats, other than MubR5, which is not present in 
the truncated protein. Furthermore the specificity of the antibodies to MUB was 
confirmed since there was no recognition of other cell surface proteins. The 
immunogold labelling of 1063N by anti-MubRI may be due to higher sensitivity of the 
antibody to MUBtrunc, perhaps due to the number and type of Mub repeats present in 
the truncated form.  
 
The autoaggregation phenotype of L. reuteri strain 1063, the parent strain of ATCC 
53608, is well documented [125], however ATCC 53608 did not show a high 
autoaggregation ability using the spectrophotometry assay in section 3.4. Here FCM 
was used to quantify the autoaggregation phenotype of MUB expressing strains ATCC 
53608 and ATCC 55739, MUBtrunc expressing strain 1063N and MUB negative strain 
DSM 20016. Briefly, bacterial cells were grown overnight, washed and diluted in PBS 
to an OD600 0.5. Cells were aspirated and using the fluidics system passed through a 
laser, the light scatter recorded in the FS and SS detectors was used to assess the 
autoaggregation. Bacteria exhibiting an autoaggregating phenotype displayed a “tail” 
on the scatter plots, whereas non autoaggregating strains showed an oval shaped 
population. For analysis, strains showing a value of less than 90 % of events as single 
cells were considered as autoaggregating (Figure 4.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Autoaggregation of L. reuteri cells determined by FCM, A) quantified by determining 
the percentage of events with high FS and SS. From MacKenzie et al 2010 [271]. B) FCM 
analysis showing percentage of events which are single cells.  
 
A 
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A clear autoaggregation phenotype was demonstrated for ATCC 53608 and ATCC 
55739 compared to strains DSM 20016 and 1063N. The discrepancy between the 
apparent non-autoaggregating phenotype of ATCC 53608 and ATCC 5573 as detected 
by spectrophotometry and the aggregating phenotype as measured by FCM may be 
due to the high sensitivity of the flow cytometric assay. Furthermore the conditions 
used in both assays are not directly comparable, since for the FCM analysis the 
bacterial cells were analysed at RT within a fluidics system, whereas in the 
spectrophotometry assay the cells were maintained statically at 37 °C. Taken together, 
the FCM data showed a correlation between the level of MUB at the cell surface and 
the ability of strains ATCC 53608 and ATCC 55739 to autoaggregate, indicating a 
novel role for MUB in autoaggregation. 
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4.2 Comparison of spontaneous mutant 1063N to wild type ATCC 53608  
In order to further characterise strain 1063N in comparison to ATCC 53608, Random 
Amplification of Polymorphic DNA (RAPD)-PCR analysis and cell surface proteomic 
surveys were conducted.  
 
RAPD-PCR can be used to accurately differentiate between bacterial species [246], 
and strains [112]. To this end, random short primers are used to generate a profile of 
PCR products specific to the bacterial strain which is then used for comparison. 
Primers used previously for RAPD analysis on lactobacilli were selected from the 
literature [246, 272] and first tested on the genomic DNA extracted from strain ATCC 
53608 (Figure 4.11). 
 
 
Figure 4.11 Agarose gel (1.5 %) was used to separate PCR products amplified from L. reuteri 
strain ATCC 53608, with primers M14 (lane 3), M13 (lane 4), XD8 (lane 6), XD9 (lane 7), OPL-
04 (lane 8), Coc (lane 9), 1254 (lane 10), 1247 (lane 11) and BF2 (lane 12), with DNA ladder 
(lane 1) and negative control (lanes 2 and 5). 
 
Four primers (M14, XD8, OPL-04 and Coc) produced a pattern of multiple PCR 
products and were subsequently used to obtain the RAPD profiles for strains 1063N 
and ATCC 53608. 
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Figure 4.12 Agarose gel (1.5 %) was used to separate PCR products amplified from L. reuteri 
strains. ATCC 53608 (lanes 3, 5, 8 and 11) and 1063N (lanes 4, 6, 9 and 12) with primers M14 
(lanes 3 and 4), XD8 (lanes 5 and 6), OPL-04 (lanes 8 and 9) and Coc lanes (11 and 12), with 
DNA ladder (lanes 1 and 7) and negative control (lanes 2 and 10). 
 
RAPD profiles of strains ATCC 53608 and 1063N showed no apparent differences 
(Figure 4.12), suggesting that MUB is the major difference between the two strains 
although the genome of 1063N would need to be sequenced to confirm these findings. 
 
In parallel, the two strains were compared in terms of their cell surface proteome 
(surfaceome). The extraction of the surfaceome using “shaving” methods has been 
successfully used to discover vaccine targets in pathogenic bacteria [273]. The use of 
proteases to digest the exposed peptides from the surface of intact bacterial cells can 
be problematic in terms of cytoplasmic protein contamination, which is why this 
technique is most suited to Gram-positive bacteria with their thick PG cell wall more 
resistant to spontaneous lysis. 
 
Briefly, the surfaceomes of strains ATCC 53608 and 1063N were shaved using trypsin, 
three biological replicates were performed. These extracts were then further digested 
with an in-solution digest using one of two treatments, trypsin or chymotrypsin, before 
separation of peptides by liquid chromatography followed by analysis using MS on the 
LTQ-Orbitrap. After treatment, cell integrity was confirmed by SEM ( 
Figure 4.13) and FCM (data not shown). 
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Figure 4.13 SEM images of intact L. reuteri ATCC 53608 bacterial cells. A) before trypsin 
shaving and B) after trypsin shaving. Scale bar represents 1 µm. 
 
MS data were analysed by Mascott to identify proteins from the peptide samples using 
an in-house protein database based on the annotated genome sequence of L. reuteri 
ATCC 53608 (courtesy of TGAC), and the surfaceome comparison was carried out in 
Scaffold. Identified proteins were tested for cell localisation using a combination of 
bioinformatics tools including SignalP for signal peptides, PSORTb for subcellular 
localisation, LipoP for lipoproteins, TMHMM for transmembrane helices and 
SecretomeP for non-classical protein secretion.  
 
 
Figure 4.14 Numbers of proteins identified in the surfaceomes of L. reuteri, strains 1063N and 
ATCC 53608. 
 
A total of 134 proteins were identified in the surfaceomes of ATCC 53608 and 1063N, 
127 shared by both strains (Figure 4.14), with 51 predicted to be surface located and 
83 cytoplasmic. The number of proteins predicted to be located in the cytoplasm should 
be taken with caution, as a number of them have been shown to have dual functions 
and localisation within cells, for example protein EF-Tu which is involved in protein 
synthesis via its guanosine nucleotide binding function when located in the cytoplasm 
and a role as a mucin binding protein when located on the cell surface of L. johnsonii 
NCC533 [228]. 
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MUB was identified from both strains and a quantification based on the intensity of the 
peaks obtained by MS, using software Progenesis LC-MS, showed a MUB expression 
ratio of 29 : 1, for ATCC 53608 : 1063N, which is perhaps a more accurate 
representation than the difference provided by the FCM data as MS does not rely on 
antibody recognition. Proteins AggH and APF, known to be involved in autoaggregation 
in Lactobacillus strains [125, 274], were identified in the surfaceomes of strains ATCC 
53608 and 1063N, with no differential expression found using Progenesis LC-MS. Of 
the strain specific proteins (1 for ATCC 53608 and 6 for 1063N), only NADH oxidase 
from 1063N was consistently found across the different biological and technical 
replicates. NADH oxidase is predicted to be a cytoplasmic protein produced during 
aerobic growth. This difference in expression by the two strains is perhaps due to a 
compensation for the loss of the autoaggregating phenotype for 1063N. During growth 
of ATCC 53608, the bacterial cells settle on the bottom of the culture flask where the 
oxygen concentration is at its lowest compared to the more dispersed growth of 1063N.  
 
The proteomics survey supported by data from the RAPD-PCR analysis, indicate no 
major difference in protein expression at the cell surface, apart from MUB, suggesting 
that the differences in phenotype observed between strains ATCC 53608 and 1063N, 
with regard to mucus binding and autoaggregation are due to the absence of MUB on 
the 1063N cell surface. 
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4.3 MUB contribution to bacterial cell adhesion to mucus 
As shown in section 3.3, the two strains expressing full length MUB on the surface of 
their cells (ATCC 53608 and ATCC 55739) showed highest mucus adhesion 
capacities, whereas MUB negative DSM 20016 showed lower percentage of adhesion 
to mucus and MUBtrunc strain 1063N showed no binding ability to MCM-S, MSIM, PSIM 
nor BSA. 
 
In order to test further the contribution of MUB to bacterial adhesion to mucus, cF-
labelled bacterial cells of strains ATCC 53608, ATCC 55739, DSM 20016 and 1063N 
were pre-incubated with anti-MubRI and anti-MubR5 antibodies, either individually 
(Figure 4.15) or in combination (Figure 4.16), or preimmume serum as a control, before 
adhesion to mucus was assessed.  
 
 
Figure 4.15 Effect of Anti-MubRI on L. reuteri ATCC 53608, ATCC 55739, DSM 20016 and 
1063N adhesion to mouse colonic mucus (Blue bars) and BSA (Green bars). Pre-immune 
serum (PIS) was used as a control. * = p <0.05. 
 
Incubation of L. reuteri ATCC 53608 and strain ATCC 55739 with anti-MubRI (Figure 
4.15) or anti-MubR5 (data not shown) significantly decreased the binding of the 
bacteria by ~2 fold and ~3 fold to MCM-S and BSA, respectively, providing indirect 
evidence of MUB involvement in bacterial adhesion. This difference was increased to 
~4 fold and ~8 fold when the antibodies were used in combination (Figure 4.16), 
indicating the involvement of both types of Mub repeats in mucus binding. The non-
binding phenotype of strain 1063N was unchanged by antibody incubation. 
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Figure 4.16 Effect of combined anti-MubR5 and anti-MubRI on L. reuteri ATCC 53608, ATCC 
55739, DSM 20016 and 1063N adhesion to mouse colonic mucus (Blue bars) and BSA (Green 
bars). Pre-immune serum (PIS) was used as a control. * = p <0.05 
 
L. reuteri DSM 20016, the MUB negative strain surprisingly showed a reduction in 
adhesion upon pre-incubation with anti-MubRI or anti-MubR5 (alone or in combination), 
or with the preimmune serum (Figure 4.15 and Figure 4.16), which indicates that L. 
reuteri strains may employ different molecular effectors for adhesion to mucus. 
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4.4 Adhesion of MUB protein to mucus 
In order to further assess the role of MUB in binding of ATCC 53608 to mucus, native 
MUB was purified from SM of ATCC 53608 cultures. Briefly, L. reuteri ATCC 53608 
cells were grown overnight in LDM II broth (Appendix 1) as used in [124]. Bacteria were 
centrifuged and the supernatant filtered through a 0.22 µm PVDF membrane to remove 
all bacterial cells. The vivaflow system was used on the filtered spent media to both 
remove low MW proteins (less than 50 kDa) and concentrate the extract. The extract 
was then dialysed extensively in PBS before further concentration using a 0.45 µm spin 
column.  
 
Figure 4.17 Elution profile (blue line) of MUB purification sample from FPLC with gel filtration 
column. (Fractions collected, indicated by red lines). 
 
The proteins were then fractionated by FPLC using a Superose 6 column (Figure 4.17), 
using absorbance at 280 nm to follow elution profile. Fractions were collected and 
analysed by SDS-PAGE (Figure 4.18) and the identity of MUB was confirmed by MS. 
Fractions C15 - E2 were pooled, corresponding to the first peak observed on the gel 
filtration elution profile, which separates MUB from the contaminating proteins of the 
second peak as shown by SDS-PAGE in lanes 6-10 (Figure 4.18).  
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Figure 4.18 SDS-PAGE of selected fractions from gel filtration of MUB purification. Lane 1, SM 
pre-gel filtration column; lane 2, MW markers; lane 3, fraction D6; lane 4, fraction D10; lane 5, 
fraction D14; lane 6, fraction E4; lane 7, fraction E7; lane 8, fraction E13; lane 9, fraction F12; 
lane 10, fraction G7. MUB indicated by arrow. 
 
The concentration of the purified MUB sample as measured by nanodrop (Abs280 1 = 
0.125 mg ml-1) was 0.08 mg ml-1. The MUB protein was used in mucus binding assays 
along with recombinant Mub repeat MubR5 and recombinant triple repeats MubRI-II-III 
(kindly provided by Donald MacKenzie and Sabrina Etzold, respectively).  
 
The purified proteins were tested for mucus binding ability to immobilised PSIM, MSIM 
and MCM-C. Adhesion of full length MUB and MubR5 was detected using primary 
antibody anti-MubR5 while the adhesion of triple domain MubRI-II-III was detected 
using primary antibody anti-MubRI. Binding was revealed following incubation with anti-
rabbit IgG-AP secondary antibody in combination with pNPP substrate. 
 
 
Figure 4.19 Full length MUB (purple bars) and recombinant MubR5 (purple and white bars) or 
PBS negative control (white bars) binding to mucus, PSIM, MSIM, and MCM-C. * = P>0.05. 
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The full length MUB was shown to bind to all three types of mucus tested (Figure 4.19), 
whereas the recombinant MubRI-II-III only showed significant binding to MCM-C 
(Figure 4.20), while the single repeat MubR5 did not show binding (Figure 4.19). These 
data indicate that the number and type of Mub repeats present in the protein may be 
significant for functional binding as well as for the specificity of the interaction. 
 
 
Figure 4.20 MubRI-II-III (purple and white bars) and PBS negative controls (white bars) binding 
to mucus, PSIM, MSIM, and MCM-C. * = P>0.05. 
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4.5 Occurrence of lar_0958 homologue genes and proteins in L. reuteri strains 
In order to assess the occurrence of lar_0958 homologues in L. reuteri, PCRs were 
performed on bacterial cells from 26 L. reuteri strains using primers designed to amplify 
Lar repeat 1 (corresponding to aa 577-671, KVTY…….NPLGI), which is 100 % 
identical to repeat regions 2, 3, and 4 (Figure 4.2). PCR products of the expected size 
were generated in six of the 26 strains, DSM 20016, MM4-1a, CF4-6g, FJ1, LMS11-3 
(Figure 4.21) and in strain MM4KO (data not shown).  
 
Strain MM4KO (full name MM4-1a Lar_0958 K/O) is a Lar_0958 homologue mutant, 
generated by Rob Britton and co-workers (Michigan State University, USA). A ctg stop 
codon inserted after bp 41; 
1 ATGCTATCAA  GAAAAAATTA  TAAGGAAACT  ATACGAAAAC  ActgACCTAC ….. 
resulted in a truncated translated product of 14 aa (MLSRKNYKETIRKH). 
 
DNA sequencing of the PCR products showed 100 % identity to the predicted 285 bp 
fragment from lar_0958 across the strains. Notably the six lar_0958 positive strains 
were all human isolates. 
 
 
Figure 4.21 Agarose gel (1.5 %) separating PCR products of lar_0958 amplified from L. reuteri 
strains. ATCC 53608 (lane 1), ATCC 55739 (lane 2), 1063N (lane 3), DSM 20016 (lane 4), 
MM4-1a (lane 5), MF2-3 (lane 6), CF4-6g (lane 8), FJ1 (lane 9), LMS11-3 (lane 10), sr11 (lane 
11), JW2015 (lane 12), Lp167-67 (lane 13), 20-2 (lane 14), 3c6 (lane 15), CR (lane 16), One-
One (lane 17), DSM 17509 (lane 18), N2D (lane 19), R2LC (lane 20), ML1 (lane 21), #20 (lane 
23), r13 (lane 24), Lr4020 (lane 25), LB54 (lane 26), with DNA ladder (lanes 7 and 22) and 
negative control (lane 27). Lane 28 is blank. 
 
 101 
 
Interestingly DSM 20016 gave a PCR product which was not predicted from the 
genome sequence. Strain JCM 1112 and DSM 20016 are both derived from the same 
human isolate (strain F275), however their genomes were sequenced in different 
laboratories and an alignment of the two sequences showed that strain JCM 1112 
contains two large unique regions which results in a 40 kb difference between the two 
strains [275]. One of the “unique” regions in JCM 1112 contains the sequence of 
lar_0958 which we have shown is present in DSM 20016. Originally the authors 
attributed the 40 kb difference between the two strains to the tendency of bacteria to 
undergo genomic changes during repeated laboratory culturing, however our work 
demonstrates the presence of at least part of one of the “unique” regions in the DSM 
20016 genome. 
 
Media extracts from overnight cultures were used to assess the expression of the 
Lar_0958 protein homologues by all PCR positive strains, DSM 20016, MM4-1a, 
MM4KO, CF4-6g, FJ1, LMS11-3 and negative control ATCC 53608. Protein extracts 
were analysed by electrophoresis followed by western blotting using the anti-Lar 
antibody directed against the 100 % identical repeat domain of Lar_0958. The blot was 
subsequently stained with gelcode blue for estimation of the apparent molecular mass 
by reference to the high MW marker. 
 
Figure 4.22 Western blot of Lar_0958 homologous proteins separated by electrophoresis from 
media extracts of L. reuteri strains, DSM 20016 (lane 2), MM4-1a (lane 3), CF4-6g (lane 4), FJ1 
(lane 5), LMS11-3 (lane 7), MM4KO (lane 8), ATCC 53608 (lane 9), and HiMark MW markers 
(lanes 1 and 6). A) Blot probed with anti-Lar antibody. B) Blot subsequently stained with gelcode 
blue. Lar_0958 homologues indicated with white star. MUB indicated with red star. 
 
Several protein bands of different molecular masses were recognised by the anti-Lar 
antibody in protein extracts from strains DSM 20016, MM4-1a, CF4-6g, FJ1 and 
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LMS11-3 (Figure 4.22). For each strain there was one strong band with a number of 
weaker bands evenly spaced at lower MW, this ladder effect may correspond to the 
degradation of the full length proteins or be a result of transcriptional processing due to 
the repeat nature of the DNA sequence. No Lar_0958 protein homologue was identified 
in protein extracts from strains MM4KO or ATCC 53608, as expected from the genome 
sequences. The apparent molecular mass of the Lar_0958 homologues was 
determined using TotalLab software showing that strains DSM 20016, MM4-1a, CF4-
6g, FJ1 and LMS11-3 expressed proteins of apparent MW ~182 kDa, ~174 kDa, ~176 
kDa, ~129 kDa and ~279 kDa, respectively. The difference in the size of Lar_0958 
homologues between the different L. reuteri strains may be due to the presence of a 
different number of repeat regions. 
 
FCM was used to determine whether the Lar_0958 homologues are expressed on the 
bacterial cell surface. Cells from overnight cultures of strains MM4-1a, MM4KO, DSM 
20016 and ATCC 53608 were incubated with primary anti-Lar antibody or PIS, followed 
by the secondary fluorescein labelled anti-rabbit IgG antibody before analysis by FCM 
(Figure 4.23). SS signals along with the fluorescent signals detected in the FL1 channel 
were used to measure the Lar_0958 expression at the cell surface. 
 
 
Figure 4.23 Quantification of Lar_0958 on cell surface of L. reuteri strains. Bacterial cells with 
high fluorescent signal were measured by FCM. 
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Lar_0958 homologues were clearly detected on the cell surface of strains MM4-1a and 
DSM 20016 (Figure 4.23), with a 22-33 fold higher expression of Lar_0958 compared 
to MM4KO and ATCC 53608 (Figure 4.24). 
 
 
Figure 4.24 FCM quantification of Lar_0958 homologue expression by selected L. reuteri 
strains, with anti-Lar_0958 antibody compared to preimmune serum (PIS). 
 
The localisation of Lar_0958 homologues on the cell surface of strains MM4-1a and 
DSM 20016 was further investigated by immunogold labelling using the anti-Lar 
antibody. Strain MM4KO was included as a negative control. 
 
Figure 4.25 Immunogold labelling of Lar_0958 homologues on the surface of L. reuteri strains 
with anti-Lar0958 antibody. A) MM4-1a, B) DSM 20016, C) MM4KO. Scale bar represents 100 
nm. 
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Lar_0958 homologues were detected on the cell surface of strains MM4-1a and DSM 
20016 and absent from the cell surface of MM4KO (Figure 4.25), confirming the FCM 
data, although a low level of labelling was observed indicating that this technique is 
less sensitive than FCM, and prohibiting an accurate assessment of the protein 
distribution on the cell surface. 
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4.6 Lar_0958 homologue contribution to bacterial cell adhesion to mucus 
The role of Lar_0958 homologues in the adhesion capacity of L. reuteri to mucus was 
investigated using two Lar_0958 expressing strains, MM4-1a and DSM 20016, and two 
non-expressing strains, MM4KO and ATCC 53608. A binding assay was performed 
where bacterial cells from overnight cultures were pre-incubated with either anti-Lar 
antibody, PIS, or left untreated, before testing their binding to MCM-S. 
 
 
Figure 4.26 Adhesion of L. reuteri strains to MCM-S with pre-incubated bacterial cells, with anti-
Lar_0958 antibody, PIS or left untreated. * P <0.05 
 
Adhesion of untreated bacterial cells to MCM-S confirmed the binding results in section 
3.3, with strain ATCC 53608 showing highest binding ability, MM4KO showing low 
levels of binding and strains MM4-1a and DSM20016 showing intermediate levels of 
binding. Pre-incubation of the bacterial cells with the anti-Lar antibody led to a 
significant decrease in the binding of strains MM4-1a and DSM 20016 to MCM-S, but 
had no effect on strains ATCC 53608 and MM4KO (Figure 4.26) which do not possess 
a Lar_0958 homologue. However the PIS also impacted significantly on the binding 
ability of Lar_0958 expressing strains MM4-1a and DSM 20016, and although the 
anti_Lar antibody has a more pronounced effect, this may indicate either an interaction 
of Lar_0958 with a component of the PIS or a non-specific interaction with other 
proteins. 
 
In order to test if the PIS recognises Lar_0958 homologues or other proteins, strains 
MM4-1a, MM4KO, DSM 20016 and ATCC 53608 were grown in LDM II, the proteins in 
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the spent media were separated by electrophoresis, transferred to PVDF membrane 
and probed with PIS. 
 
 
Figure 4.27 Western blot of SM proteins separated by electrophoresis from L. reuteri strains, 
ATCC 53608 (lane 1), DSM 20016 (lane 2), MM4KO (lane 3), MM4-1a (lane 4), with Broad 
range MW markers (lane 6), stained with ponceau red.  
 
Although proteins from the SM extracts were shown to have been efficiently transferred 
to the PVDF membrane by reversible ponceau red staining (Figure 4.27), no signal was 
observed when PIS was used to probe the blot (data not shown), indicating that the 
reduction in binding observed in the competition assay was not due to interactions of 
PIS with L. reuteri proteins. 
 
Since autoaggregation may also play a role in the ability of bacterial cells to bind to 
mucus, the autoaggregating phenotype of MM4-1a and MM4KO was investigated by 
FCM and compared to the non-aggregating DSM 20016 and the autoaggregating 
ATCC 53608 strains. FS and SS parameters were used to distinguish single cells from 
aggregates and the percentage of single cells was determined. Strains showing a 
single cell percentage value of less than 90 % were considered as autoaggregating 
(Figure 4.28). 
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Figure 4.28 Autoaggregation of L. reuteri cells determined by FCM, A) quantified by determining 
the percentage of events with high FS and SS. B) FCM analysis showing percentage of events 
which are single cells. 
 
The results indicate that strains MM4-1a, MM4KO and DSM 20016 are non-
aggregating, therefore the observed binding to mucus in these strains is not an effect of 
autoaggregation. 
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4.7 Adhesion of Lar_0958 to mucus 
In order to investigate the direct binding of Lar_0958 to mucus, a single Lar repeat, 
from aa 577 to 672 of DSM 20016 Lar_0958 homologue (Figure 4.29) was 
heterologously expressed in E. coli TUNER(DE3)pLacI cells using pETBlue-1 
AccepTor (Novagen) vector and purified by ion exchange chromatography (in 
collaboration with Donald MacKenzie).  
 
 
Figure 4.29 Schematic representation of Lar_0958 from L. reuteri JCM 1112, showing six Lar 
repeat domains, repeats 1-4 are identical (blue), repeat 5 has 99 % aa similarity (green) and 
repeat 6 is 46 % aa similarity (purple). Blue bracket indicating the region targeted for Lar repeat 
expression. 
 
The recombinant Lar repeat was incubated with immobilised PSIM, MSIM, MCM-S, or 
BSA, unbound protein was washed off and the bound Lar repeat was detected using 
the anti-Lar antibody followed by secondary antibody, anti-rabbit IgG-AP and pNPP 
substrate. The single Lar repeat did not bind significantly to any of the mucus 
preparations, when compared to BSA (data not shown). The high background noise 
meant that once subtraction had occurred the levels of binding detected were 
negligible. The low level of binding may due to the nature of the recombinant Lar_0958 
protein which contained only a single repeat.  
 
Therefore the purification of native Lar_0958 homologue from spent media of bacterial 
cultures was undertaken. L. reuteri strains MM4-1a and DSM 20016 were first tested 
for their ability to secrete a Lar_0958 homologue into different media (MRS or LDM II). 
Lar_0958 homologues were produced in all conditions. No differences were observed 
between DSM 20016 and MM4-1a strains (Figure 4.30). Strain MM4-1a grown in LDM 
II was chosen for the larger scale purification of Lar_0958 homologue.  
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Figure 4.30 Western blot of L. reuteri SM samples separated by electrophoresis. Extracted from 
different L. reuteri strains, DSM 20016 (lanes 1 and 3), and MM4-1a (lanes 2 and 4), with Broad 
range MW markers (lane 5), when cells were grown in different media, MRS (lanes 1 and 2), 
LDM II (lanes 3 and 4). A) Reversible staining with Ponceau Red B) Recognition of Lar_0958 
homologues with anti-Lar antibody.  
 
L. reuteri MM4-1a cells were grown overnight in LDM II broth, bacteria were centrifuged 
and the supernatant was filtered through 0.22 µm PVDF membrane to remove all 
bacterial cells and concentrated using the vivaflow system. The sample was then 
dialysed extensively in PBS before further concentration of proteins using a 0.45 µm 
spin column. The proteins were then fractionated on a Superose 6 column, where the 
elution profile showed one large peak (Figure 4.31). Fractions were collected and 
analysed by SDS-PAGE (Figure 4.32). 
 
 
Figure 4.31 Elution profile (blue line) of Lar_0958 homologue purification sample from FPLC 
with gel filtration column. (Fractions collected indicated by red lines). 
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Figure 4.32 SDS-PAGE of Lar_0958 homologue purification stages. A) Lane 1, Broad range 
MW markers; lane 2, SM after filtration, lane 3, SM after vivaflow; lane 4, SM pre-gel filtration 
column; lane 5, fraction A6; lane 6, fraction A7; lane 7, fraction A8; lane 8, fraction A9; lane 9, 
fraction A10; lane 10, fraction A11; lane 11, fraction A12; lane 12, fraction A13. B) Lane 1, 
Broad range MW markers; lane 2, fraction A14, lane 3, fraction A15; lane 4, fraction B1; lane 5, 
fraction B2; lane 6, fraction B3; lane 7, fraction B4; lane 8, fraction B5; lane 9, fraction B6; lane 
10, fraction B7; lane 11, fraction B8; lane 12, fraction B9. 
 
The transfer of proteins to PVDF membrane and probing with anti-Lar antibody (Figure 
4.33), in conjunction with excision from gel and MS analysis, confirmed the identity of 
the Lar_0958 homologue as a faint protein band at ~200 kDa, while the stronger 
protein band occurring at approximately 100 kDa did not react with the anti-Lar 
antibody (Figure 4.33), but was identified by MS to be an aldehyde-alcohol 
dehydrogenase with a MW of 97 kDa. The low recovery of Lar_0958 at this stage (10-
20 fold less than MUB), prevented further pursuit of native Lar_0958 purification. 
 
 
Figure 4.33 Western blot of SDS-PAGE of Lar_0958 homologue purification stages, probed with 
anti-Lar antibody (purple signal). A) Lane 1, Broad range MW markers; lane 2, SM after 
filtration, lane 3, SM after vivaflow; lane 4, SM pre-gel filtration column; lane 5, fraction A6; lane 
6, fraction A7; lane 7, fraction A8; lane 8, fraction A9; lane 9, fraction A10; lane 10, A11; lane 
11, fraction A12; lane 12, fraction A13. B) Lane 1, Broad range MW markers; lane 2, fraction 
A14, lane 3, fraction A15; lane 4, fraction B1; lane 5, fraction B2; lane 6, fraction B3; lane 7, 
fraction B4; lane 8, fraction B5; lane 9, fraction B6; lane 10, fraction B7; lane 11, fraction B8; 
lane 12, fraction B9.   
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4.8 Discussion 
Cell surface proteins are thought to play a major role in mediating bacterial adhesion to 
mucus, however very few of the bacteria-mucus binding studies investigate the 
molecular mechanisms of the interactions. Only a few proteins have been functionally 
shown to bind to mucus and MUB, which was originally identified in L. reuteri 1063 
(parent of ATCC 53608), was the first to have the crystal structure of one of the Mub 
repeats determined, providing structural insights into mucus binding proteins in Gram-
positive bacteria [223]. Our work showed that both MUB and Lar_0958 homologues are 
mediators of mucus adhesion of L. reuteri strains. MUB homologues are found in many 
lactic acid bacteria [231], and specifically in the exoproteomes of lactobacilli isolated 
from the GI tract [232]. Currently there are 949 homologous proteins identified across 
all bacterial phylotypes in the NCBI non-redundant protein sequences database. Our 
study showed that the full length MUB was expressed by L. reuteri ATCC 53608 and 
ATCC 55739, whereas, Lar_0958 homologues were expressed by a larger number of 
L. reuteri strains (human isolates DSM 20016, MM4-1a, CF4-6g, FJ1, and LMS11-3). 
Lar_0958 is a novel mucus binding protein and currently 306 homologous proteins 
have been identified across all bacterial phylotypes in the NCBI non-redundant protein 
sequences database. 
 
MUB and Lar_0958 share some structural and biochemical properties, they are both 
large, modular proteins with a cell surface anchor, they are much larger than the other 
functionally characterised mucus binding proteins in lactobacilli (Table 4.1) but share a 
similar acidic pI with the exceptions of MapA and SpaB. 
 
Mucus Binding Protein MW Predicted pI 
MUB 353 4.75 
Lar_0958 133 5.6 
Map A 26 9.7 
EF-Tu 43 4.9 
GroEL 57 4.7 
GAPDH 36 5.4 
Pili proteins SpaC 
SpaF 
SpaB 
91 
104 
21 
5 
5 
8 
Table 4.1 Mucus binding proteins in lactobacilli. 
 
Pili subunit SpaB is a small protein with a high pI (Table 4.1), interacts with mucus 
involving non-specific electrostatic interactions [174], due to the net difference in 
charge between mucus and SpaB. Although mucins remain net negatively charged at 
all values of pH, MUB and Lar_0958 with an acidic pI will have a net neutral to negative 
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charge in the GI tract, it is therefore likely that interactions between these mucus 
binding proteins and mucus involve specific interactions. The current hypothesis is that 
the target of mucus binding proteins are the O-glycan structures which decorate the 
mucin protein backbone, although this remains to be proved. Multivalency is the term 
used to describe the adhesion of multiple ligands with multiple receptors, a situation 
found in many biological interactions [276]. The repeat nature of both MUB and 
Lar_0958 homologues and the absence of mucus binding for single repeats may 
indicate the adaptation of these mucus binding proteins to the multivalent substrate. 
Due to the complexity of the mucin O-glycan structures, having an array of adhesive 
units with different sugar specificity would be an advantage for a mucus binding 
protein. It is also probable that the targets of adhesion involve the non-mucin mucus 
components as indicated by the binding of MubR5 to Igs [223] and the demonstrated 
role of MUB in autoaggregation.  
 
There was a clear autoaggregation phenotype for MUB expressing strains ATCC 
53608 and ATCC 55739. The difference in autoaggregation phenotype observed 
between ATCC 53608 and the non aggregating strain 1063N can be attributed to MUB. 
This dual role of adhesion and autoaggregation has also been shown for the 
extracellular protein, transaldolase in Bifidobacterium bifidum A8 [277]. Furthermore, 
aggregation factors glucosyltransferase and inulosucrase from L. reuteri TMW1.106 
were shown to have a dual role with biofilm formation leading to a reduction in 
colonisation ability in an ex-Lactobacillus-free mouse model [128]. In contrast, 
aggregation was not implicated in the specific mucus binding ability of Lar_0958 
expressing human isolates DSM 20016 and MM4-1a, suggesting that differences in the 
host environment require different mechanisms for host-bacterial interactions. 
 
We showed that MUB and Lar_0958 proteins are located on the bacterial cell surface 
and are also released into the growth media, as reported previously for MUB in strain 
1063 by Roos & Jonsson (2002) [124]. This feature is perhaps an indication of an 
alternative function for these adhesive molecules. The secretion of adhesins into the 
surrounding milieu is postulated to secure a competitive advantage, by acting to 
aggregate competing bacteria and facilitate clearance, as shown for example with 
GroEL from L. johnsonii La1 which mediates aggregation of H. pylori [229]. 
 
The competition assays showed that MUB and Lar_0958 homologues are not the sole 
mediators of mucus adhesion. There are a number of other possible effectors, 
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including non-proteinaceous cell surface structures such as EPS which has been 
implicated in the colonisation of L. reuteri strain 100-23 in a Lactobacillus free mouse 
model [278]. While proteins with assigned functions may have a dual role with a 
secondary function in mucus binding, as highlighted by the cytoplasmic proteins EF-Tu 
[228], GroEL [229] and GAPDH [230], the mechanisms of when and how they become 
associated with the cell surface remain unknown. This may be through an as yet 
unidentified secretion pathway or as cells lyse and release their contents the 
cytoplasmic proteins become associated with the surface of neighbouring cells. 
Another possible type of mediator may be other mucus binding proteins as yet 
unidentified. Recently there has been a growing interest in the surface exposed 
proteomes of bacteria, with advances in both proteomic [279, 280] and in silico [281, 
282] approaches. However the functions of up to 60 % of predicted extracellular 
proteins in lactobacilli are unknown [232], indicating a need for future functional 
studies. 
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5 Investigating novel L. reuteri mucus binding proteins 
As we showed in the previous chapters, L. reuteri adhesion to mucus is strain specific 
and involves large cell surface proteins, MUB for strains ATCC 53608 and ATCC 
55739 and Lar_0958 homologues for strains MM4-1a and DSM 20016, both proteins 
being constitutively expressed in vitro. These proteins are not the sole mediators of 
binding and the aim of the work reported in this chapter was to identify novel L. reuteri 
mucus binding protein candidates. A higher mucus binding phenotype can be induced 
in specific L. reuteri strains by the presence of mucin in the growth media, and using 
this characteristic in combination with a quantitative proteomics approach we 
investigated differentially expressed cell surface proteins when L. reuteri was grown in 
the presence and absence of mucin. 
 
5.1 Induction of bacterial binding to mucus 
L. reuteri strains DSM 20016, 100-23, ATCC 53608 and MM4-1a, for which the 
genome sequence is available, and related strains DSM 17509, 1063N, and MM4KO 
were tested for their mucus binding ability when grown in the presence of mucin, along 
with strains 11284 and DSM 17938 whose responses to mucin supplementation were 
reported earlier [191]. The factors responsible for this induction are unknown although 
changes in gene expression are likely to occur. 
 
Briefly, bacteria were grown overnight in MRS broth in the presence and absence of 
mucin supplementation and the adhesion of cells to immobilised PSIM was examined 
under an inverted microscope and quantified at 460 nm [191]. 
 
Strains 100-23, MM4KO and 11284 showed a significant increase in mucus binding 
when the bacteria were grown in medium supplemented with mucin (Figure 5.1). In 
contrast, strain DSM 17509 which is derived from the same parent strain as 100-23 
showed no difference in PSIM binding when cells were grown in the presence or 
absence of mucin. The difference in behaviour observed between strains DSM 17509 
and 100-23 may be due to the tendency of bacteria to undergo spontaneous changes 
during regular laboratory culturing. Strain ATCC 53608 showed a decrease in adhesion 
ability to PSIM when cultures were grown in the presence of mucin. In addition, the 
cells were observed by microscopy to form large aggregates which may affect binding 
to mucus. No increase in binding was observed with strains 1063N, MM4-1a, DSM 
20016 or DSM 17938. 
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Figure 5.1 Binding of L. reuteri strains grown in MRS (pale blue bars) or MRS supplemented 
with mucin (dark blue bars) to PSIM * = p <0.05. 
 
The binding of strain MM4KO to immobilised mucus, when cells were grown in the 
presence or absence of mucin, was further investigated with different mucus 
substrates, PSIM, MCM-C, and MSIM, with immobilised BSA as a control. 
 
 
Figure 5.2 Binding of L. reuteri strain MM4KO grown in MRS (pale blue bars) or MRS 
supplemented with mucin (dark blue bars) to mucus * = p <0.05. 
 
Induction of higher binding phenotype was observed for all mucus types tested, with 
binding to PSIM and MSIM showing a significant increase when cells were grown in the 
presence of mucin (Figure 5.2). The enhanced adhesion phenotype from non-induced 
to induced was most notable when cells were tested against PSIM with 1.8 fold 
change, compared to 1.3 fold change when binding was to MSIM. This may result from 
an adaption of the response to the porcine mucin used in the growth media.  
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In order to investigate the nature of the molecular mechanisms underlying the induction 
of a higher binding phenotype of strain MM4KO, the bacterial cells were pre-treated 
with trypsin before assessing binding to immobilised PSIM, non-induced cells were 
included as a control (Figure 5.3). 
 
 
Figure 5.3 Adhesion of L. reuteri strain MM4KO to immobilised PSIM. Cell were grown in MRS, 
A) supplemented with mucin, B) supplemented with mucin then treated with trypsin, C) cells 
grown in the absence of mucin, D) grown in the absence of mucin then treated with trypsin. 
Scale bar represents 20 µm. 
 
The protease treatment of the bacteria resulted in a reduction of mucus binding 
phenotype of strain MM4KO when grown in the presence of mucin (Figure 5.3 A and 
B), indicating the contribution of proteins expressed at the cell surface to the observed 
phenotype. No significant difference in adhesion was observed for cells grown in the 
absence of mucin followed by trypsin treatment (Figure 5.3 C and D), which may 
indicate that without induction, non-proteinaceous factors may contribute to the basal 
mucus binding level of strain MM4KO. 
 
Since MUB and Lar_0958 are not expressed by strain MM4KO, the present findings 
suggest that a novel cell surface protein involved in mucus binding may be expressed 
by strain MM4KO when the bacteria are grown in media supplemented with mucin.  
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5.2 Quantitative proteomic approach for differential expression of proteins. 
In order to quantitatively measure the differential expression of proteins when L. reuteri 
strain MM4KO is grown in the presence and absence of mucin, we used a proteomics 
approach called stable isotope labelling with amino acids in cell culture (SILAC). SILAC 
was originally developed within the context of human tissue culture however, the 
technique is perfectly suited for culturable bacteria due to their fast growth and 
relatively small genome sizes as shown by its successful use with Bifidobacterium 
longum [283], and E. coli [284].  
 
By growing bacterial cells in media containing “heavy” aa (with stable isotopes of 
carbon 13C and nitrogen 15N) the cells incorporate the labelled aa into all cellular 
proteins. The common usage of trypsin in MS to digest proteins to peptides specifically 
cleaving after arginine or lysine residues has prompted the use of heavy labelled 
arginine and lysine in many SILAC experiments. 
 
In a basic SILAC experiment, one cell population is labelled with heavy aa (population 
A), and the other one is labelled with light (unlabelled) aa (population B). The cells are 
mixed and their proteomes are extracted and measured by MS. MS spectra provide 
peptide mass and intensity information. Identification of peptides and therefore proteins 
is achieved through matching MS/MS spectra against a sequence database. In a 
SILAC experiment, peptide and protein ratios are obtained by direct comparison of the 
light and heavy isotopes as each peptide appears as a pair in the mass spectrometer, 
the peptide with the higher mass contains heavy aa and originates from population A, 
and the peptide with the lower mass contains the light aa and originates from 
population B. The difference in mass is dependent on the heavy aa used for example 
with heavy arginine (15N4
13C6-arginine) the difference would be 10 Da. If the SILAC 
peptide pair has a one-to-one, heavy to light (H/L) ratio then there is no difference in 
the abundance of this protein between the proteomes. 
 
The main advantage of SILAC over other quantitative techniques is the early pooling of 
samples which reduces variation due to sample processing [285, 286]. Another 
advantage is the sensitivity of SILAC compared to label free methods enabling the 
detection of smaller changes in protein expression [287].  
 
In order to label proteins efficiently with heavy aa, the growth medium must be defined 
and lack the corresponding light aa. For that reason SILAC experiments require the 
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use of a synthetic chemically defined media such as LDM [288], which does not contain 
the peptone and meat extract present in MRS. LDM III was specifically adapted for this 
purpose from LDM II to control the aa composition, by replacing the vitamin-free 
casamino acids with individual aa. “Light” cultures used LDM III with unlabelled aa, 
while “heavy” cultures replace arginine with arginine 13C6
15N4 and lysine with lysine 
13C6 
(Appendix 1). 
 
 
Figure 5.4 Growth curves of L. reuteri MM4KO in LDM III media A) in absence of mucin, B) in 
presence of mucin. 
 
There was no difference between the growth curves when L. reuteri MM4KO was 
grown in LDM III in the presence or absence of mucin (Figure 5.4).The bacteria 
reached an OD600 ~2 in LDM III whereas a higher stationary phase OD600 was achieved 
when cells were grown in MRS (OD600 6.3-6.8), reflecting the more stringent conditions 
of the synthetic medium. No growth was observed for L. reuteri MM4KO in mucin 
supplemented LDM III lacking both arginine and lysine (data not shown) indicating that 
MM4KO is auxotrophic for arginine and/or lysine. 
 
The binding of L. reuteri strain MM4KO to PSIM was performed using cells grown in 
LDM III, in the presence or absence of mucin, showing that the induction of higher 
binding phenotype is not dependent on the media used for growth (Figure 5.5) and that 
the conditions are suitable for identifying novel potential protein mediators of the 
binding to mucus. 
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Figure 5.5 Binding of strain MM4KO to PSIM, when grown in LDM III medium, A) in absence of 
mucin, or B) presence of mucin. Scale bar represents 20 µm. 
 
Since the ratio of heavy to light (H/L) labelled peptides is the measurement of change 
of protein expression under two experimental conditions (absence or presence of 
mucin), it was important to confirm that the heavy labelling of proteins attained a level > 
95 % to ensure accurate ratio calculation.  
 
We tested the incorporation of heavy arginine and heavy lysine into the proteins of L. 
reuteri strain MM4KO by growing cells in the presence of heavy aa, and performing a 
spent media protein extract before analysing the samples using LTQ-Orbitrap. 
Incomplete incorporation is indicated by identified peptides which exhibit a dual 
population of masses relating to both heavy and light labels.  
 
Using the most abundant proteins to assess the incorporation of heavy arginine and 
heavy lysine into the proteome of L. reuteri MM4KO, for example Elongation factor Tu 
(Figure 5.6 and Table 5.1), we found that heavy arginine was incorporated to > 99 %. 
However heavy lysine incorporation was much lower (~81 %) therefore only heavy 
arginine labelling was selected for our experimental setup. Addition of mucin to the 
media did not affect the incorporation of heavy arginine (data not shown),  
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Figure 5.6 Example MS plots, two of the peptides used to identify protein Elongation factor Tu, 
from L. reuteri MM4KO grown in LDM III with heavy aa, showing incorporation of A) heavy 
arginine and B) heavy lysine. 
 
Since bacterial conversion of arginine to proline, is a factor which may potentially affect 
the H/L ratios [289], we checked the proline containing peptides from the most 
abundant proteins of strain MM4KO for the occurrence of heavy proline. No evidence 
of arginine to proline conversion was found, indicating that the H/L ratios remained 
unaffected. 
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z Sequence Incl. L/H Std.Err. Intensity Modifications 
3 GISHDQIQR X 0.000924 2.1E-05 1.35E+07   
2 GISHDQIQR X 0.001594 0.00083 8.37E+06   
2 ALEGDPEQEK   0.1831 0.1101 2.91E+05   
3 STVTGLEMFHK   0.2304 0.01785 2.89E+07   
3 STVTGLEMFHK   0.2193 0.02741 2.32E+06 (8) Oxidation (M)  
2 STVTGLEMFHK   0.1924 0.01841 1.42E+06 (8) Oxidation (M)  
3 GQVLAEPGSIQTHK   0.2279 0.01932 3.56E+07   
2 GQVLAEPGSIQTHK   0.2204 0.01872 2.02E+07   
2 QVGVQYIVVFLNK   0.2397 0.00882 1.06E+07   
2 AEDYADIDAAPEEK   0.2081 0.02582 2.36E+06   
2 TLDLGEAGDNVGVLLR X 0.000952 8E-06 2.32E+07   
3 HYAHIDAPGHADYVK   0.1988 0.1608 1.19E+04   
4 HYAHIDAPGHADYVK   0.1711 0.0361 6.23E+04   
2 HYAHIDAPGHADYVK   0.1502 0.3469 1.91E+05   
3 GITINTAHVEYETEK   0.227 0.0307 2.51E+06   
2 GITINTAHVEYETEK   0.1943 0.04154 1.67E+06   
3 VGDEVEIVGLTEDVLK   0.2258 0.01237 7.34E+05   
2 VGDEVEIVGLTEDVLK   0.2434 0.00801 6.23E+06   
2 AEDYADIDAAPEEKER X 0.002834 0.00014 7.21E+05   
2 GITINTAHVEYETEKR X 0.00232 0.00016 3.47E+06   
4 GITINTAHVEYETEKR X 0.007291 9.8E-05 1.45E+07   
2 DLLSEYDFPGDDVPVVR X 0.000032 0 3.89E+06   
3 VILHLMDVIDDYIPTPK X 0.2362 0.01807 3.27E+06   
2 VILHLMDVIDDYIPTPK X 0.2075 0.01344 1.74E+06   
2 VILHLMDVIDDYIPTPK   0.1221 0.2767 3.31E+04 (6) Oxidation (M)  
3 VILHLMDVIDDYIPTPK X 0.2182 0.06384 1.16E+05 (6) Oxidation (M)  
3 TDLVDDDELVDLVEMEVR X 0.000028 0 1.84E+04   
2 TDLVDDDELVDLVEMEVR X 0.00003 0 6.20E+04   
2 TDLVDDDELVDLVEMEVR X 0.000035 0 5.32E+04 (15) Oxidation (M)  
4 RPTDKPFMMPVEDVFTITGR X 0.004892 8.8E-05 4.55E+06   
3 RPTDKPFMMPVEDVFTITGR X 0.000348 3.4E-05 7.07E+06   
3 RPTDKPFMMPVEDVFTITGR X 0.005092 0.00164 2.24E+05 (8) Oxidation (M)  
Table 5.1 Complete list of peptides used for identification of protein Elongation factor Tu. The 
two highlighted in yellow are shown in more detail in Figure 5.6. 
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5.3 SILAC experimental setup  
In order to identify differentially expressed proteins produced by strain MM4KO when 
grown in the presence or absence of mucin, we carried out a SILAC experiment using 
heavy arginine 13C6
15N4 (heavy vs. light arginine) with reciprocal labelling and three 
biological replicates. 
 
One culture of L. reuteri MM4KO was labelled with heavy arginine (population A), and 
grown in the presence of mucin, the other culture was labelled with light arginine 
(population B); this configuration was prepared in triplicate. The reciprocal arrangement 
was also prepared i.e. the mucin present in the media of population B. Since one of the 
cultures failed to grow at the same rate, it was excluded from the experiment resulting 
in two biological replicates for the reciprocal labelling and a total of five experimental 
samples (Figure 5.7). 
 
 
Figure 5.7 Growth conditions of L. reuteri MM4KO cultures for SILAC experiment 
 
In order to extract the secreted proteome (SP), the five SILAC samples were 
centrifuged and the supernatant collected and concentrated. The five SILAC cell pellets 
were “shaved” with trypsin in order to extract the cell surface proteome (CSP) as 
described previously in section 4.2. The cell wall proteome (CWP) was obtained after 
the five shaved SILAC cell pellets were lysed, any contaminating soluble cytoplasmic 
proteins were washed off and the cell wall proteins were extracted with lysozyme and 
mutanolysin. The proteins present in the SP and CWP samples were separated by 
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SDS-PAGE gel, and each lane was cut into five slices in order to reduce the complexity 
of the peptide mixture injected onto the MS (Figure 5.8). 
 
 
Figure 5.8 Cell wall protein extracts separated by electrophoresis, samples 1-5, were cut into 5 
slices A-E as shown by the red lines. 
 
The proteins in all samples were digested to peptides with trypsin; the SP and CWP 
extracts were processed with an in-gel digest protocol, while the CSP extracts were 
processed with an in-solution digest protocol. All samples were analysed by LTQ-
Orbitrap, with duplicate injections to ensure technical reproducibility (Figure 5.9). 
 
 
Figure 5.9 Sample processing pipeline for SILAC experiment 
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5.4 SILAC data processing and protein identification 
Data were analysed using the MaxQuant software suite containing the Andromeda 
search engine, which, along with the statistical programme Perseus, have been 
specifically designed to achieve the highest possible quantitative accuracy in 
conjunction with SILAC. For validation purposes the data were also analysed with 
Mascot Distiller combined with Scaffold for statistical analysis.  
 
MaxQuant uses a probabilistic approach for the identification of peptides that was 
originally pioneered by Mascot, i.e. calculating the probability that the observed number 
of matches between the calculated and measured fragment masses could have 
occurred by chance. As a commercial program, the exact algorithms used by Mascot 
Distiller are unknown. MaxQuant employs algorithms that determine the mass precision 
and accuracy of peptides individually combined with a “second peptide identification” 
algorithm used to resolve the frequent occurrence in complex mixtures of two peptides 
co-fragmenting. The first stage of the data analysis uses MS/MS spectra to give 
information on peptide sequences, to compare to known protein sequences in the L. 
reuteri database. 
 
Using MaxQuant linked to search engine Andromeda, a total of 690, 1046 and 532 
proteins were identified in CWP, SP and CSP respectively with high confidence across 
the biological and technical replicates (Appendix 2). Protein identifications were only 
accepted if the following quality parameters were met; a false discovery rate (FDR) of < 
0.1 %, a minimum number of 2 unique peptides and a posterior error probability of < 
0.05. 
 
Using Mascot Distiller, a total of 429, 642 and 298 proteins were identified in CWP, 
SP and CSP respectively. The quality parameters used for acceptable protein 
identification were; a FDR of < 0.1 %, a minimum number of 2 unique peptides and a 
protein identification probability > 95 %. Considerably fewer identifications were made 
using the Mascot search engine compared to Andromeda. The sensitivity and 
specificity of both search engines was previously compared and found to be equivalent 
[249]. The differences can occur during the process of peak picking, the highest 
scoring peptide for each MS/MS spectrum is taken, which is not necessarily the same 
for Mascot and Andromeda scoring. 
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Among the potential mucus binding proteins previously identified in Lactobacillus 
species (Table 1.5), no peptides corresponding to MUB or pili (SpaC, SpaF, SpaB) 
were identified as expected from the genome sequence of parent strain MM4-1a. 
Lar_0958 was also absent as expected from the mutant strain. EF-Tu, GroEL, and 
GAPDH were identified in all three proteome extracts in agreement with their reported 
cell surface expression. However the lack of MapA identification was somewhat 
surprising since the gene encoding the protein is present in parent strain L. reuteri 
MM4-1a, and MapA is implicated in the adhesion of L. reuteri 104R to mucus [224] and 
L. reuteri DSM 20016 to Caco2 cells [225], consistent with a cell surface localisation. 
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5.5 SILAC ratio calculation and statistical analysis 
During the second stage of the analysis, the H/L ratios determined for the identified 
proteins in each of the five SILAC samples were normalised across all data sets, since 
for the majority of proteins, no change in protein expression was expected under the 
two different experimental conditions. Not all identified proteins will possess a H/L ratio, 
only peptides containing arginine can be used for quantitation. In order to be 
considered in the statistical analysis a minimum of 3 H/L ratios must be present for 
each protein. Theoretically there may be proteins expressed only in one experimental 
condition, which would result in a H/L ratio of infinity. By searching the data for signal 
intensity values it is possible to identify proteins with a light only or heavy only label 
signal, it was confirmed that none of the proteins identified in these samples were 
expressed only in one experimental condition. 
 
Data were exported from Mascot Distiller to Scaffold, where Log2 fold change of 2 was 
used to indicate differential expression. The data exported from MaxQuant to Perseus, 
was tested for significant changes using the Significance B test with Benjamini 
Hochberg FDR threshold of 0.05. Differentially expressed proteins were then subjected 
to bioinformatics analysis for cell localisation using SigP, SecretomeP, LipoP, TMHMM 
and PSORTB. 
 
SP CSP CWP 
↓ Zinc/iron ABC super family 
ATP binding cassette 
transporter (MP) 
↑ Cystathionine gamma-
lyase (MP) 
↑ mannosyl-glycoprotein 
endo-β-N-
acetylglucosamidase  
(MP & MS) 
↑ Phage replication protein 
(MP) 
↓ SSU ribosomal protein 
S14P (MP) 
↓ ATPase AAA 2 domain 
protein (MS) 
↑ SSU ribosomal protein 
S3P (MP) 
↑ Translation initiation factor 
IF-2 (MS) 
 
↑ 50S ribosomal protein L19 
(MS) 
↑ 1,3 propanediol 
dehydrogenase (MS) 
 
↑ 30S ribosomal protein S12 
(MS) 
↑ FAD dependent pyridine 
nucleotide disulphide 
oxidoreductase (MS) 
 
↓ Peptidyl-tRNA hydrolase 
(MS) 
↑ Cold shock DNA binding 
protein (MS) 
 
 
↑ UDP-N-acetyl 
enolpyruvoylglucosamine 
reductase (MS) 
 
 
↑ Putative cold shock 
protein (MS) 
 
Table 5.2 Proteins differentially expressed in the different proteome extracts from L. reuteri 
MM4KO grown in the presence of mucin. Arrows indicate up-or down expression. Data analysis 
performed in MaxQuant and Perseus (MP) or Mascot Distiller and Scaffold (MS). 
 
 127 
 
In total 16 proteins were found to be differentially expressed across the different 
proteome extracts (Table 5.2). Identified in all samples, mannosyl-glycoprotein endo-β-
N-acetylglucosamidase was found to be differentially expressed in the CWP samples 
and was the sole protein identified by both computational analysis approaches. 
Mannosyl-glycoprotein endo-β-N-acetylglucosamidase was also the only differentially 
expressed protein predicted by SigP, SecretomeP, LipoP, TMHMM and PSORTB to be 
cell surface located. All other proteins identified as differentially expressed were 
predicted to be cytoplasmic, indicating that their involvement in cell surface adhesion 
mechanisms is unlikely, although these predictions should be taken with caution as 
several proteins, predicted to be cytoplasmic have been shown to be present on the 
cell surface and involved in mucus adhesion [228-230]. Mucus binding proteins EF-Tu, 
GroEL, and GAPDH were not found to be differentially expressed in any of the 
proteome extracts indicating that they are not playing a role in induced mucus binding 
for L. reuteri MM4KO grown in presence of mucin. The protease treatment of cells 
indicated non-proteinaceous mechanisms for the basal level of mucus binding, 
indicating that these proteins are not playing any role in mucus binding for strain 
MM4KO. 
 
The overall expression of mannosyl-glycoprotein endo-β-N-acetylglucosamidase 
showed two-fold Log2 change when L. reuteri MM4KO cells were grown in LDM III in 
the presence of mucin. In addition, an increased expression was consistently detected 
across the different biological and technical replicates (Figure 5.10).  
 
 
Figure 5.10 H/L ratios of mannosyl-glycoprotein endo-β-N-acetylglucosamidase peptides in 
Scaffold, identified in CWP samples from bacterial cells grown in LDM III (blue bars) or LDM III 
supplemented with mucin (pink bars). Samples on x axis refer to the biological and technical 
replicates. 
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The peptides detected from MM4KO gave a 37 % coverage (209/568 aa) of mannosyl 
endo-β-N-acetylglucosamidase (ABQ84091) from L. reuteri DSM 20016. The protein 
was predicted to be 56 kDa in size with a pI between 9.3-9.7. The deduced aa 
sequence of mannosyl endo-β-N-acetylglucosamidase contains three types of domain, 
KxYKxGKxW, FlgJ and LysM (Figure 5.11) 
(www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). The KxYKxGKxW domain is an N-
terminal signal peptide to target the protein to the cell surface in Gram-positive 
bacteria. 
 
 
Figure 5.11 Domain structural homology of mannosyl endo-β-N-acetylglucosamidase 
 
The FlgJ domain refers to the muramidase catalytic domain of the FlgJ protein, one of 
approximately ten proteins required to construct the basal rod portion of flagella and 
originally described in Salmonella typhimurium SJW1437. [290-293]. The muramidase 
domain belongs to the CAZy glycoside hydrolase (GH) family 73 (www.cazy.org), 
which contains enzymes which cleave the β-1,4-glycosidic linkage between N-
acetylglucosaminyl (GlcNAc) and N-acetylmuramyl (MurNAc) moieties in the 
carbohydrate backbone of bacterial PGs. Enzymes from the GH73 family are mostly 
cell surface located and as for L. reuteri MM4KO mannosyl endo-β-N-
acetylglucosamidase, exhibit repeat sequences involved in bacterial cell wall binding, in 
the form of LysM domains. 
 
Four LysM domains were identified at the C-terminal end of L. reuteri mannosyl endo-
β-N-acetylglucosamidase. LysMs are small (44-65 aa) globular domains, commonly 
found to non-covalently attach proteins to bacterial PG layer and also found to be 
involved in chitin binding in eukaryotes [294, 295]. The binding of LysM domains to PG 
is mediated through GlcNac, but whether this is the sole moiety recognised is yet to be 
determined [294]. The combination of a muramidase catalytic domain with multiple 
LysM domains is typical for cell wall hydrolases for example AcmA from Lactococcus 
lactis [296]. Cell wall hydrolases enzymatically degrade the PG layer of bacteria and 
are cell surface or secreted proteins, often classified into five groups in terms of their 
specificity, N-acetylmuramidases (lysozymes), N-acetylglucosaminidases, N-
acetylmuramyl-L-alanine amidases, endopeptidases and transglycosylases [296]. 
Functions of cell wall hydrolases include cell separation, autolysis, cell wall turnover, 
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cell division, cell competence for DNA transformation, sporulation, bacterial motility, 
signalling and adhesion to surfaces. 
 
No change in growth was observed when L. reuteri MM4KO was grown in the presence 
of mucin (Figure 5.4) and no evidence of autolysis was detected after 80 h growth, 
indicating that a role of mannosyl endo-β-N-acetylglucosamidase in mucin degradation/ 
utilisation or autolysis is unlikely in L. reuteri MM4KO. Hence the differential expression 
of mannosyl endo-β-N-acetylglucosamidase when L. reuteri MM4KO was grown in the 
presence of mucin, may indicate a role of this enzyme in mucus binding (possibly via 
LysM domains) as supported by the increased mucus binding phenotype of this strain 
reported under the same conditions. 
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5.6 Discussion 
In this chapter we showed that the binding to mucus of L. reuteri strains can be induced 
by differential expression of proteins in response to mucin. 
 
5.6.1 Stimulation of mucus binding 
The environment in the GI tract influences the colonisation ability of the microbiota, in 
the same way, the outcome of in vitro adhesion assays can be influenced by the 
environment in which bacteria are grown, for example bile salts stimulate E. coli 
binding to HeLa cells [297], glucose stimulates Staphylococcus epidermidis binding to 
polymer surfaces [298], anaerobic growth induces mucus binding in Salmonella 
typhimurium [299] and mucin stimulates L. reuteri (strains T1, 11284, SD2112 and #71) 
adhesion to mucus [191]. In this study we showed that L. reuteri MM4KO and 100-23 
can be induced to a higher mucus binding phenotype by the supplementation of the 
growth medium with mucin. The induced phenotype was observed across all mucus 
samples and was abolished when cells were treated with trypsin, suggesting that the 
nature of the factor responsible for the increased mucus binding was proteinaceous.  
 
5.6.2 Methodology for quantitatively measuring cell surface proteins 
In Gram-positive bacteria proteins can be sorted into four different destinations, the 
cytoplasm, the cytoplasmic membrane, the peptidoglycan cell wall and the extracellular 
environment [300]. It is the extracellular proteins and those protruding from the cell wall 
and cytoplasmic membrane which form the cell surface proteome, interacting with the 
host and other bacteria. Cell surface proteomes have been studied in both pathogenic 
bacteria for example Streptococcus in an attempt to identify targets for vaccines [273] 
and probiotic bacteria such as Bifidobacteria to explore mechanisms of bacterial-host 
interactions [283]. When extracting cell surface proteomes there is a well-documented 
risk of cytoplasmic protein contamination through cell lysis [301]. Through method 
development we limited the risk of cytoplasmic contamination. It should be noted that 
cytoplasmic proteins are commonly found in bacterial cell surface extracts, however 
their localisation on the cell surface should be confirmed by techniques such as 
immunogold labelling or FCM analysis [228, 301, 302].  
 
Here SILAC was chosen as a sensitive quantitative proteomic approach. SILAC has 
been successfully applied to monitoring the changes in proteomes of bacteria in 
different conditions such as, i) stationary phase adaptation of Bacillus subtilis [303], ii) 
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response to nutritional challenges in B. subtilis [304], iii) comparison between 
pathogenic and non-pathogenic E. coli [284], and iv) the response to bile salts [283], 
and mucus [305] of Bifidobacterium longum. To date there has been no SILAC studies 
on L. reuteri. Here we used this method to both map the secreted, cell surface and cell 
wall proteomes, and also to determine the influence of mucin on protein expression 
level in these proteomes.  
 
A requirement of SILAC is the complete labelling of proteins with the heavy aa in order 
to achieve accurate quantitation. Many bacteria possess metabolic pathways for aa 
synthesis and degradation, which may interfere with the heavy labelling of peptides 
[304]. L. reuteri strain JCM 1112 was extensively studied for metabolic pathways, 
lysine is non-essential for growth as JCM 1112 has a full complement of biosynthetic 
pathways, whereas arginine is an essential aa [306]. Our work indicated that strain 
MM4KO was similarly auxotrophic for arginine allowing > 99 % labelling with heavy 
arginine. The biological and technical replicates along with the reciprocal labelling led 
to a robust experimental design, however it was shown here and documented in 
previous SILAC experiments that some of the differentially expressed surface proteins 
were not found in all samples (proteomes and replicates) [284], indicating the 
importance of biological and technical replicates to decrease the number of false 
positives. The full list of proteins identified in the different proteomes can be found in 
Appendix 2. 
 
5.6.3 Mannosyl glycoprotein endo-β-N-acetylglucosamidase is a candidate mucus 
binding protein 
This study showed that expression of mannosyl glycoprotein endo-β-N-
acetylglucosamidase was upregulated when L. reuteri strain MM4KO was grown in 
presence of mucin, which may contribute to the induction of higher mucus binding 
phenotype of this strain. N-acetylglucosamidases are cell wall hydrolases which may 
have multiple functions, for example AcmA from Lactococcus lactis ssp. cremoris 
MG1363 is involved in autolysis and cell separation [296, 307] and EndoD from 
Streptococcus pneumoniae has both hydrolase and transglycosylation activity [308]. 
Additionally the N-acetylglucosamidase from B. longum NCIMB8809 hydrolyses the 
glycans of host glycoproteins, thereby liberating nutrients to support growth [305]. 
Since data from the growth curves showed no evidence of autolysis or increased cell 
numbers in L. reuteri MM4KO when grown in the presence of mucin, this suggests that 
mannosyl endo-β-N-acetylglucosamidase does not play a role in autolysis and mucin 
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degradation/utilisation in vitro. Instead, this may indicate a role of the enzyme in mucus 
binding. 
 
The LysM domains of muramidases are often found in multiple copies, the number of 
which is crucial to the function of the enzyme. For example, in AcmA from L. lactis, 
three LysMs are required for optimum enzyme activity and the removal or addition of 
LysM domains led to a reduction of autolysis and cell separation [309]. The enzyme 
activity of N-acetylglucosaminidase AltA from Enterococcus faecalis was found to be 
dependent on the presence of six LysM domains with a 580-fold decrease in activity 
when the domains were removed [310]. The mechanism by which LysM domains affect 
enzyme activity has not been elucidated but it may be due to proper positioning of the 
catalytic domain towards the substrate or to promote the correct folding of the catalytic 
domain itself. LysM domains have been implicated in directing the subcellular 
localisation of their proteins, as demonstrated for the cell wall hydrolases Sle1 and 
LytN from S. aureus Newman [311].  
 
LysM containing proteins are also implicated in host-microbial interactions for example 
autolysin Aaa from S. aureus 4074 was shown to have fibrinogen and fibronectin 
binding activity [312] and the in silico analysis of 126 L. reuteri ATCC 55730 
extracellular proteins found seven proteins with LysM domains, including four with 
putative hydrolase functions and three of unknown function, but conserved across 
bacteria and similar to each other [185]. Mutation of LysM containing protein Lr_70152 
in L. reuteri 100-23 was shown to drastically decrease the colonisation of the mutant 
strain to the forestomach of germ free mice compared to the wild type strain, indicating 
that LysM domains may play an important role in bacteria-host interactions (Personal 
communication, Steve Frese and Jens Walter), although the direct involvement of 
LysM in mucus adhesion remains to be demonstrated. Taken together, these studies 
suggest that the increased binding phenotype of L. reuteri MM4KO when grown in the 
presence of mucin may be due to the induction of mannosyl glycoprotein endo-β-N-
acetylglucosamidase mediated mucus binding via LysM domains. 
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6 Conclusions and Future Work 
One of the main findings of this work is that the mucus binding ability and the 
autoaggregation phenotype of L. reuteri is strain-specific, highlighting a potential 
adaptation of the strains to specific hosts or regions of the GI tract via different 
mechanisms. Indeed the rodent strains displayed a strong autoaggregation phenotype 
but low mucus binding ability, whereas the human isolates showed consistent mucus 
binding but no autoaggregation ability. The adaptation potential of L. reuteri strains was 
demonstrated by comparative genomic analysis of 126 different L. reuteri strains 
suggesting fundamentally different trends of genome evolution in rodent and human 
isolates, with the former possessing a large and adaptable pan-genome while the latter 
being subjected to a process of reductive evolution [101].  
 
In order to gain further insights into the mechanisms of adhesion of the pig isolate L. 
reuteri ATCC 53608, the genome was sequenced, assembled and automatically 
annotated. Genome analysis highlighted the presence of a number of genes encoding 
cell surface proteins which have been implicated in mucus binding, in particular MUB 
and MucBPs. A comprehensive genome exploitation for strain ATCC 53608 will take 
place once full manual annotation has been achieved. This will include a comparative 
genomic analysis with other pig isolates, pg_3b, Lp167-67, 20-2 and 3c6 (currently 
being sequenced at TGAC), in order to evaluate the number and types of mucus 
binding proteins in the pig pangenome. 
 
Here we functionally characterised strain specific mediators of mucus binding i.e. the 
MUB protein from pig isolate ATCC 53608 and the Lar_0958 homologue found in 
human isolates MM4-1a, DSM 20016, CF4-6g, LMS11-3 and FJ1. We showed that 
their contribution to bacterial adhesion involved specific interactions with mucus 
components although these are not the sole mediators of the interaction. MUB and 
Lar_0958 are constitutively expressed in vitro and attached to the bacterial cell surface 
in accordance with their function. The MUB and Lar_0958 non-expressing strains 
(1063N and MM4KO respectively) showed a dramatic decrease in binding to mucus, 
although a basal level of binding was observed for MM4KO to MCM-S and MSIM. We 
also showed that MUB contributed to the autoaggregation phenotype of L. reuteri 
ATCC 53608. The interactions between MUB and mucus may be direct recognition of 
mucus components or an indirect mechanism by promoting autoaggregation of the 
bacterial cells and perhaps inducing biofilm formation. A dual role for mucus binding 
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and autoaggregation has been reported earlier for transaldolase from B. bifidum [277]. 
This dual functionality could act as an important colonisation factor favouring bacteria 
establishment in the gut. These cell surface proteins may thus represent a molecular 
target for rational selection of probiotic L. reuteri strains in the future. 
 
Our SILAC experiment identified a novel L. reuteri potential mucus binding protein 
candidate, mannosyl-glycoprotein endo-β-N-acetylglucosamidase. Expression of this 
protein was upregulated when strain MM4KO was grown in the presence of mucin, 
thus closer to the conditions of the gut environment. Future mutagenesis studies will be 
required to abolish the expression of the enzyme in bacteria and assess binding activity 
of the L. reuteri K/O strains to mucus. Furthermore, heterologous expression of 
individual LysM and catalytic domains will enable discrimination of which of the 
domains are responsible for binding to mucus and help confirm the role of mannosyl 
glycoprotein endo-β-N-acetylglucosamidase in L. reuteri adhesion to mucus.  
 
MUB and Lar_0958 are modular proteins, characterised by a variable number of 
repeats. The crystal structure of MubR5 revealed two domains, B1 with structural 
homology to an immunoglobulin binding protein and B2 with structural homology to 
MucBP domain [223]. Mucus adhesins with their modular nature may have adapted to 
recognise multiple ligands within mucus. The exact nature of the receptors is still a 
matter of debate. Potentially hundreds of heterogeneous glycans structures attached to 
mucins are present but it is difficult to identify the biologically accessible epitopes and 
focusing on individual oligosaccharide components does not reflect the native 
environment of the mucin glycans in mucus. Future work will exploit the recent 
construction of mucin glycan arrays which display mucins from GI tracts of different 
vertebrates [313, 314]. These will be used to reveal the molecular targets recognised 
by the different mucus binding proteins and protein modules we identified and 
characterised in this study and to further assess their host and tissue specificity to GI 
mucins. 
 
The contribution of specific interactions and non-specific interactions of MUB and 
Lar_0958 to mucus adhesion needs further investigation. Methodologies such as AFM, 
FCM and SPR have been successfully used with whole bacteria to measure kinetic 
association constants and to obtain information on the differential contributions of non-
specific and specific forces [196, 207, 315]. Taking advantage of the L. reuteri mutant 
strains 1063N and MM4KO and their corresponding adhesins MUB and Lar_0958 
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respectively, these techniques could be used in competition experiments to decipher 
the specific contribution of these cell surface proteins in the mucus and mucin binding 
ability of bacteria and to determine whether the adhesion is mediated by lectin-
carbohydrate type interactions. 
 
Despite a few functionally characterised mucus binding proteins, mainly in 
Lactobacillus species, there is a paucity of information regarding the nature and 
structure of the bacterial adhesins mediating binding to mucus and mucins in 
commensal bacteria. This is despite the critical role played by the mucus layer in the 
maintenance of a homeostatic relationship with the microbiota. Lactobacilli are 
dominant gut microbes in many domesticated animals species important in our food 
chain such as pigs, although they only contribute 0.01 % to the bacterial count in 
human faecal samples [110]. Work on these lactobacilli strains isolated from humans is 
therefore more relevant for the selection of probiotics with increased persistence in the 
gut. More functional and structural work is needed in order to exploit the data coming 
from the large genome and metagenome sequencing projects. Combining these 
approaches will help us to understand how to keep the beneficial relationship with our 
gut bacteria, which may lead to novel strategies to readjust microbial communities or 
prevent dysbiosis. 
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Appendix 1  
Composition of LDM II and LDM III 
 
LDM II broth: 
Ingredient Amount per L 
K2HPO4 (anhydrous) 1.5 g 
KH2PO4 (anhydrous) 1.5 g 
Vitamin-free casamino acids 10 g 
Sodium acetate 15 g 
Sodium citrate 0.22 g 
Tryptophan 50 mg 
Asparagine 0.2 g 
Cysteine-HCl 0.2 g 
Thiamine-HCl 0.2 mg 
para-Aminobenzoic acid 0.04 mg 
Calcium pantothenic acid 0.4 mg 
Niacin 1.0 mg 
Pyridoxine-HCl 0.5 mg 
Biotin 0.05 mg 
Folic acid 0.1 mg 
Riboflavin 0.4 mg 
Adenine sulphate 10 mg 
Uracil 20 mg 
Guanine-HCl 10 mg 
Cytidine (acid) 50 mg 
Thymidine 1.6 µg 
Tween-80 1.0 ml 
MgSO4.7H2O 0.163 g 
MnSO4.H2O 23.4 mg 
FeSO4.7H2O 13 mg 
Sucrose 20 g 
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LDM III broth: 
Ingredient Amount per L 
K2HPO4 (anhydrous) 1.5 g 
KH2PO4 (anhydrous) 1.5 g 
Sodium acetate 15 g 
Sodium citrate 0.22 g 
Tryptophan 50 mg 
Asparagine 50 mg 
Cysteine 50 mg 
Glycine 50 mg 
Serine 50 mg 
Alanine 50 mg 
Phenylalanine 50 mg 
Histidine 50 mg 
Isoleucine 50 mg 
Methionine 50 mg 
Proline 50 mg 
Threonine 50 mg 
Valine 50 mg 
Tyrosine 50 mg 
Leucine 50 mg 
Glutamine 50 mg 
Aspartic acid 50 mg 
Glutamic acid 50 mg 
Thiamine-HCl 0.2 mg 
para-Aminobenzoic acid 0.04 mg 
Calcium pantothenic acid 0.4 mg 
Niacin 1.0 mg 
Pyridoxine-HCl 0.5 mg 
Biotin 0.05 mg 
Folic acid 0.1 mg 
Riboflavin 0.4 mg 
Adenine sulphate 10 mg 
Uracil 20 mg 
Guanine-HCl 10 mg 
Cytidine (acid) 50 mg 
Thymidine 1.6 µg 
Tween-80 1.0 ml 
MgSO4.7H2O 0.163 g 
MnSO4.H2O 23.4 mg 
FeSO4.7H2O 13 mg 
Sucrose 20 g 
Optional amino acids (arginine and lysine) 50 mg (each) 
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Appendix 2 
Secreted proteome of L. reuteri MM4KO 
Appendix 2 - SP Proteins Identified Peptides 
Peptides 
Sample 1 
Peptides 
Sample 2 
Peptides 
Sample 3 
Peptides 
Sample 4 
Peptides 
Sample 5 
Sequence 
Coverage 
[%] 
Mol. 
Weight 
[kDa] 
Sequence 
Length 
>gi|148531499|gb|ABQ83498.1| bacterial translation initiation factor 3 (bIF-3) [Lactobacillus 
reuteri DSM 20016] 6 4 5 3 5 4 40 19.487 170 
>gi|148531703|gb|ABQ83702.1| LSU ribosomal protein L17P [Lactobacillus reuteri DSM 20016] 12 10 11 7 11 9 68.5 14.201 127 
>gi|133930435|gb|ABO43789.1| DNA-binding protein [Lactobacillus reuteri];> 14 13 13 11 14 13 85.7 9.5238 91 
>gi|183226688|dbj|BAG27204.1| pyruvate kinase [Lactobacillus fermentum IFO 3956]; 15 10 11 12 9 12 29.4 51.641 473 
>gi|337728600|emb|CCC03706.1| putative muramidase [Lactobacillus reuteri ATCC 53608] 15 13 10 11 14 11 39.1 60.348 565 
>gi|194453977|gb|EDX42874.1| ribosomal protein L5 [Lactobacillus reuteri 100-23] 16 16 15 14 14 14 69.4 20.172 180 
>gi|148531718|gb|ABQ83717.1| LSU ribosomal protein L5P [Lactobacillus reuteri DSM 20016] 16 16 16 15 15 15 69.4 20.171 180 
>gi|148531711|gb|ABQ83710.1| LSU ribosomal protein L15P [Lactobacillus reuteri DSM 20016] 17 15 16 12 14 13 75.7 15.447 144 
>gi|148532099|gb|ABQ84098.1| Alcohol dehydrogenase GroES domain protein [Lactobacillus 
reuteri DSM 20016] 18 13 16 15 17 14 68.5 35.918 336 
>gi|183225377|dbj|BAG25894.1| 50S ribosomal protein L18 [Lactobacillus reuteri JCM 1112]  18 17 17 13 16 18 77.7 13.342 121 
>gi|148530829|gb|ABQ82828.1| acetate kinase [Lactobacillus reuteri DSM 20016]ref 19 11 14 10 15 11 57.5 43.595 398 
>gi|148532080|gb|ABQ84079.1| glycerol 2-dehydrogenase (NAD+) [Lactobacillus reuteri DSM 
20016] 19 11 14 18 16 15 57.6 40.698 373 
>gi|148531716|gb|ABQ83715.1| SSU ribosomal protein S8P [Lactobacillus reuteri DSM 20016] 19 18 17 13 18 18 87.9 14.536 132 
>gi|148530404|gb|ABQ82403.1| Formate-tetrahydrofolate ligase [Lactobacillus reuteri DSM 
20016] 20 14 15 17 18 12 42.3 60.251 553 
>gi|148530792|gb|ABQ82791.1| RecA protein [Lactobacillus reuteri DSM 20016] 20 15 12 11 17 17 57.5 39.063 362 
>gi|183226438|dbj|BAG26954.1| elongation factor Tu [Lactobacillus fermentum IFO 3956] 20 16 17 17 17 15 57.8 43.474 396 
>gi|183224383|dbj|BAG24900.1| enolase [Lactobacillus reuteri JCM 1112] 20 18 19 19 20 18 57.1 49.951 457 
>gi|148532119|gb|ABQ84118.1| Bleomycin hydrolase [Lactobacillus reuteri DSM 20016] 21 12 14 17 10 12 51.4 50.851 440 
>gi|148531290|gb|ABQ83289.1| LPXTG-motif cell wall anchor domain [Lactobacillus reuteri DSM 
20016] 21 13 17 18 17 16 33.1 80.889 752 
>gi|148530989|gb|ABQ82988.1| aspartyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 21 15 16 17 14 12 38.5 68.43 600 
>gi|148531743|gb|ABQ83742.1| Alcohol dehydrogenase GroES domain protein [Lactobacillus 
reuteri DSM 20016] 22 19 19 18 19 18 59.6 36.124 342 
>gi|227186481|gb|EEI66552.1| D-alanine--D-alanine ligase [Lactobacillus reuteri CF48-3A] 23 18 19 18 17 16 68.8 42.569 378 
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>gi|183224464|dbj|BAG24981.1| D-alanine--D-alanine ligase [Lactobacillus reuteri JCM 1112] 23 18 20 18 18 17 69.9 43.001 382 
>gi|337727906|emb|CCC02995.1| L-lactate dehydrogenase [Lactobacillus reuteri ATCC 53608] 23 21 16 17 19 19 50.8 34.069 319 
>gi|148531688|gb|ABQ83687.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit A 
[Lactobacillus reuteri DSM 20016] 23 21 17 14 18 14 59.4 53.009 490 
>gi|148532092|gb|ABQ84091.1| Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 
[Lactobacillus reuteri DSM 20016 24 21 20 21 23 23 52.6 60.446 568 
>gi|227070122|gb|EEI08498.1| malate dehydrogenase (NAD) [Lactobacillus reuteri MM2-3] 24 22 17 18 20 20 50.3 34.901 326 
>gi|148530447|gb|ABQ82446.1| pyridine nucleotide-disulfide oxidoreductase dimerization region 
[Lactobacillus reuteri DSM 20016] 28 23 25 23 24 22 63.9 49.944 451 
>gi|227071557|gb|EEI09855.1| glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) 
[Lactobacillus reuteri MM2-3 28 24 24 22 23 22 72.5 37.062 345 
>gi|112943172|gb|ABI26299.1| glutamine synthetase [Lactobacillus reuteri 28 24 26 24 24 21 65.3 50.777 447 
>gi|148531006|gb|ABQ83005.1| glycyl-tRNA synthetase beta chain [Lactobacillus reuteri DSM 
20016] 28 25 24 23 23 22 44.6 78.536 691 
>gi|148531459|gb|ABQ83458.1| glutamyl-tRNA synthetase [Lactobacillus reuteri DSM 20016]; 29 23 25 23 24 24 47.9 58.349 501 
>gi|148530917|gb|ABQ82916.1| translation elongation factor 1A (EF-1A/EF-Tu) [Lactobacillus 
reuteri DSM 20016] 29 26 27 26 27 25 77.8 43.432 396 
>gi|143798699|gb|ABF06644.2| sucrose phosphorylase [Lactobacillus reuteri] 30 26 21 26 23 26 49.5 55.969 485 
>gi|148530345|gb|ABQ82344.1| Adenylosuccinate synthetase [Lactobacillus reuteri DSM 20016] 31 25 25 28 26 22 69.7 47.725 432 
>gi|227186263|gb|EEI66334.1| maltose phosphorylase [Lactobacillus reuteri CF48-3A] 32 25 22 26 28 26 34.9 87.449 757 
>gi|148531528|gb|ABQ83527.1| arginyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 32 27 28 27 26 26 53.9 63.878 562 
>gi|148530903|gb|ABQ82902.1| GTP-binding protein TypA [Lactobacillus reuteri DSM 20016] 32 29 26 26 28 25 52.3 68.827 614 
>gi|183225744|dbj|BAG26261.1| threonyl-tRNA synthase [Lactobacillus reuteri JCM 1112] 33 25 23 24 26 23 47.8 71.776 627 
>gi|194454660|gb|EDX43557.1| methionyl-tRNA synthetase [Lactobacillus reuteri 100-23] 33 29 23 22 29 21 53.6 76.583 675 
>gi|337729319|emb|CCC04448.1| ribonucleoside-diphosphate reductase alpha subunit 
[Lactobacillus reuteri ATCC 53608] 34 23 22 21 27 20 56.8 82.667 723 
>gi|148532121|gb|ABQ84120.1| lysyl aminopeptidase, Metallo peptidase, MEROPS family M01 
[Lactobacillus reuteri DSM 20016 34 27 28 27 31 27 42.3 95.323 843 
>gi|227071019|gb|EEI09341.1| bifunctional GMP synthase/glutamine amidotransferase protein 
[Lactobacillus reuteri MM2-3 34 29 24 27 23 25 56.1 59.912 538 
>gi|337729108|emb|CCC04231.1| alanyl-tRNA synthase [Lactobacillus reuteri ATCC 53608] 35 27 30 30 28 26 44.8 98.679 884 
>gi|337728287|emb|CCC03382.1| translation elongation factor G [Lactobacillus reuteri ATCC 
53608] 35 29 28 25 28 21 57.4 76.758 695 
>gi|148530972|gb|ABQ82971.1| chaperone protein DnaK [Lactobacillus reuteri DSM 20016] 37 19 11 19 22 16 60.4 67.211 621 
>gi|148530481|gb|ABQ82480.1| methionyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 37 31 28 26 33 24 60.7 76.638 675 
>gi|148530594|gb|ABQ82593.1| ribonucleoside-diphosphate reductase class Ib alpha subunit 38 26 29 26 33 26 59.2 82.738 723 
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[Lactobacillus reuteri DSM 20016] 
>gi|227184598|gb|EEI64669.1| phosphoketolase [Lactobacillus reuteri CF48-3A] 38 33 29 31 37 32 43.2 91.435 803 
>gi|148530417|gb|ABQ82416.1| IMP cyclohydrolase [Lactobacillus reuteri DSM 20016] 39 26 28 26 32 20 70.5 57.032 512 
>gi|148530592|gb|ABQ82591.1| alcohol dehydrogenase AdhE / acetaldehyde dehydrogenase 
[Lactobacillus reuteri DSM 20016] 39 33 30 34 35 32 43.8 97.187 878 
>gi|337729321|emb|CCC04450.1| aldehyde-alcohol dehydrogenase [Lactobacillus reuteri ATCC 
53608] 39 34 25 29 32 28 42 97.181 878 
>gi|183224518|dbj|BAG25035.1| alanyl-tRNA synthase [Lactobacillus reuteri JCM 1112] 40 30 35 34 31 30 49.4 98.648 885 
>gi|145202295|gb|ABF06651.2| pyruvate kinase [Lactobacillus reuteri] 40 32 34 33 33 27 76.7 51.853 473 
>gi|337728521|emb|CCC03625.1| glucose-6-phosphate 1-dehydrogenase [Lactobacillus reuteri 
ATCC 53608] 41 36 36 32 37 30 75.5 56.355 493 
>gi|194452990|gb|EDX41888.1| chaperonin GroEL [Lactobacillus reuteri 100-23] 43 32 25 33 38 29 79 57.092 542 
>gi|337728005|emb|CCC03094.1| isoleucyl-tRNA synthase [Lactobacillus reuteri ATCC 53608] 43 33 28 35 37 27 36.8 106.67 931 
>gi|183224381|dbj|BAG24898.1| phosphoglycerate kinase [Lactobacillus reuteri JCM 1112] 43 34 33 36 36 32 85 42.96 401 
>gi|337727862|emb|CCC02950.1| 30S ribosomal protein S1 [Lactobacillus reuteri ATCC 53608] 43 36 32 33 36 33 76.4 45.982 416 
>gi|148531028|gb|ABQ83027.1| SSU ribosomal protein S1P [Lactobacillus reuteri DSM 20016] 43 36 34 35 36 34 76.4 45.995 416 
>gi|148531733|gb|ABQ83732.1| translation elongation factor 2 (EF-2/EF-G) [Lactobacillus reuteri 
DSM 20016]  43 36 36 34 37 29 67.9 76.77 695 
>gi|227070837|gb|EEI09162.1| glucose-6-phosphate 1-dehydrogenase [Lactobacillus reuteri 
MM2-3] 43 38 39 35 40 33 78.8 56.713 496 
>gi|148530624|gb|ABQ82623.1| chaperonin GroEL [Lactobacillus reuteri DSM 20016] 44 33 26 34 39 30 78.2 57.123 542 
>gi|148531571|gb|ABQ83570.1| hypothetical protein Lreu_1313 [Lactobacillus reuteri DSM 
20016] 46 30 31 30 33 30 71.7 64.749 566 
>gi|148530866|gb|ABQ82865.1| Isoleucyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 47 36 32 39 41 31 39.2 109.95 960 
>gi|148530773|gb|ABQ82772.1| valyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 47 40 41 38 43 38 50.3 102.29 884 
>gi|337728522|emb|CCC03626.1| 6-phosphogluconate dehydrogenase [Lactobacillus reuteri ATCC 
53608] 50 43 37 37 44 37 92.7 53.444 478 
>gi|183225653|dbj|BAG26170.1| 6-phosphogluconate dehydrogenase [Lactobacillus reuteri JCM 
1112] 51 44 39 38 45 38 92.7 53.417 478 
>gi|337728440|emb|CCC03541.1| xylulose 5-phosphate phosphoketolase [Lactobacillus reuteri 
ATCC 53608] 54 48 43 42 52 43 62.1 91.372 803 
>gi|194454221|gb|EDX43118.1| Phosphoketolase [Lactobacillus reuteri 100-23] 54 48 44 44 52 45 60.1 91.374 803 
>gi|148531926|gb|ABQ83925.1| Phosphoketolase [Lactobacillus reuteri DSM 20016] 54 49 45 44 52 44 62.1 91.403 803 
>gi|183225401|dbj|BAG25918.1| DNA-directed RNA polymerase beta subunit [Lactobacillus 
reuteri JCM 1112] 55 46 43 43 49 41 48.5 135.36 1205 
>gi|227185605|gb|EEI65676.1| DNA-directed RNA polymerase [Lactobacillus reuteri CF48-3A]; 65 45 46 45 54 50 46.1 135.39 1211 
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>gi|148531738|gb|ABQ83737.1| DNA-directed RNA polymerase subunit beta [Lactobacillus reuteri 
DSM 20016] 66 45 48 47 55 51 46.7 135.42 1211 
>gi|148530322|gb|ABQ82321.1| ATPase AAA-2 domain protein [Lactobacillus reuteri DSM 20016] 71 61 56 58 68 56 79.2 82.305 745 
>gi|337728095|emb|CCC03185.1| methionyl-tRNA synthase [Lactobacillus reuteri ATCC 53608] 32 28 22 21 28 19 55 76.572 675 
>gi|148530410|gb|ABQ82409.1| phosphoribosylaminoimidazole-succinocarboxamide synthase 
[Lactobacillus reuteri DSM 20016] 23 17 21 15 16 6 73.6 27.308 239 
>gi|148530492|gb|ABQ82491.1| ribose-phosphate pyrophosphokinase [Lactobacillus reuteri DSM 
20016] 15 10 12 13 12 12 40.7 36.16 329 
>gi|148531725|gb|ABQ83724.1| LSU ribosomal protein L22P [Lactobacillus reuteri DSM 20016] 9 9 9 6 9 9 61.7 12.394 115 
>gi|148530650|gb|ABQ82649.1| alpha-phosphoglucomutase [Lactobacillus reuteri DSM 20016] 26 20 23 20 23 18 47 63.706 574 
>gi|194453644|gb|EDX42541.1| glutamine synthetase, type I [Lactobacillus reuteri 100-23] 25 21 22 20 21 19 57.5 50.84 447 
>gi|148531706|gb|ABQ83705.1| SSU ribosomal protein S13P [Lactobacillus reuteri DSM 20016] 16 14 15 13 14 15 60.3 13.687 121 
>gi|148531009|gb|ABQ83008.1| aminotransferase [Lactobacillus reuteri DSM 20016] 20 13 16 16 17 17 49 43.107 394 
>gi|148531526|gb|ABQ83525.1| protein of unknown function DUF964 [Lactobacillus reuteri DSM 
20016] 15 12 14 10 14 12 91.9 14.096 123 
>gi|148530555|gb|ABQ82554.1| putative nicotinate phosphoribosyltransferase [Lactobacillus 
reuteri DSM 20016] 21 17 15 14 15 17 47.3 55.609 488 
>gi|148530580|gb|ABQ82579.1| LSU ribosomal protein L1P [Lactobacillus reuteri DSM 20016] 17 12 10 8 12 13 45.8 27.362 253 
>gi|227070018|gb|EEI08398.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3] 12 10 11 9 10 11 70.9 15.313 134 
>gi|133930433|gb|ABO43788.1| ribosomal protein L15 [Lactobacillus reuteri] 14 12 13 9 12 10 69.4 15.516 144 
>gi|227186353|gb|EEI66424.1| membrane alanyl aminopeptidase [Lactobacillus reuteri CF48-3A] 26 21 21 21 22 22 31.6 95.388 843 
>gi|148530679|gb|ABQ82678.1| phosphoglucosamine mutase [Lactobacillus reuteri DSM 20016] 18 14 11 12 11 9 47.2 48.902 451 
>gi|148531932|gb|ABQ83931.1| (R)-2-hydroxyisocaproate dehydrogenase [Lactobacillus reuteri 
DSM 20016] 22 15 17 17 16 15 69.8 37.358 334 
>gi|269930518|gb|ACZ53529.1| phosphoketolase [Lactobacillus reuteri] 15 13 12 11 15 11 87.3 21.654 189 
>gi|269930626|gb|ACZ53583.1| phosphoketolase [Lactobacillus reuteri] 15 13 12 10 15 10 92.1 21.656 189 
>gi|183225128|dbj|BAG25645.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112] 17 12 12 13 13 14 49.2 35.441 297 
>gi|148531898|gb|ABQ83897.1| Inosine/uridine-preferring nucleoside hydrolase [Lactobacillus 
reuteri DSM 20016] 8 6 7 7 6 7 30.6 34.905 320 
>gi|148530950|gb|ABQ82949.1| SSU ribosomal protein S2P [Lactobacillus reuteri DSM 20016] 20 17 15 15 14 16 78.2 29.657 262 
>gi|148531171|gb|ABQ83170.1| L-lactate dehydrogenase [Lactobacillus reuteri DSM 20016] 19 15 14 15 14 13 45.7 35.005 324 
>gi|337727880|emb|CCC02968.1| amino acid aminotransferase [Lactobacillus reuteri ATCC 
53608] 18 11 12 13 14 14 47 43.078 394 
>gi|148531464|gb|ABQ83463.1| glucokinase [Lactobacillus reuteri DSM 20016] 13 9 10 12 11 9 34.4 34.42 323 
>gi|148530610|gb|ABQ82609.1| UDP-galactose 4-epimerase [Lactobacillus reuteri DSM 20016] 16 11 8 7 13 9 54.4 36.598 331 
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>gi|148531776|gb|ABQ83775.1| flavocytochrome c [Lactobacillus reuteri DSM 20016] 21 14 15 15 19 17 50 50.13 464 
>gi|227186110|gb|EEI66181.1| protein of hypothetical function DUF964 [Lactobacillus reuteri 
CF48-3A] 12 12 11 9 12 10 91.9 14.126 123 
>gi|148531709|gb|ABQ83708.1| Adenylate kinase [Lactobacillus reuteri DSM 20016] 16 12 12 12 10 10 73.5 24.609 219 
>gi|148530419|gb|ABQ82418.1| phosphoglycerate mutase [Lactobacillus reuteri DSM 20016] 14 12 14 13 12 13 45.6 26.121 228 
>gi|337728628|emb|CCC03738.1| aminopeptidase N [Lactobacillus reuteri ATCC 53608] 26 21 20 19 22 20 31.6 95.484 843 
>gi|148530736|gb|ABQ82735.1| ATP synthase F1 subcomplex beta subunit [Lactobacillus reuteri 
DSM 20016] 21 17 14 13 17 15 58.5 51.631 475 
>gi|148530959|gb|ABQ82958.1| prolyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 29 22 18 21 21 17 53.6 64.256 577 
>gi|148530771|gb|ABQ82770.1| aminotransferase, class V [Lactobacillus reuteri DSM 20016]  22 13 17 16 13 16 49.5 42.097 382 
>gi|148530951|gb|ABQ82950.1| translation elongation factor Ts (EF-Ts) [Lactobacillus reuteri DSM 
20016] 23 14 14 15 16 19 57.7 31.962 291 
>gi|148531543|gb|ABQ83542.1| ribokinase [Lactobacillus reuteri DSM 20016] 15 13 11 11 13 10 54.7 32.041 307 
>gi|148531713|gb|ABQ83712.1| SSU ribosomal protein S5P [Lactobacillus reuteri DSM 20016] 18 16 17 17 17 17 82.2 17.646 169 
>gi|148530918|gb|ABQ82917.1| trigger factor [Lactobacillus reuteri DSM 20016] 30 26 20 21 23 20 59.9 48.747 436 
>gi|148531777|gb|ABQ83776.1| fumarate lyase [Lactobacillus reuteri DSM 20016] 23 17 17 14 16 18 61 50.312 462 
>gi|148530389|gb|ABQ82388.1| inosine-5-monophosphate dehydrogenase [Lactobacillus reuteri 
DSM 20016] 16 14 12 11 14 12 56.1 39.373 380 
>gi|148531734|gb|ABQ83733.1| SSU ribosomal protein S7P [Lactobacillus reuteri DSM 20016] 15 14 14 11 14 12 63.5 17.985 156 
>gi|148531715|gb|ABQ83714.1| LSU ribosomal protein L6P [Lactobacillus reuteri DSM 20016] 16 14 15 14 13 12 58.4 19.635 178 
>gi|148531102|gb|ABQ83101.1| hypothetical protein Lreu_0838 [Lactobacillus reuteri DSM 
20016] 22 15 15 17 19 18 48.3 39.346 358 
>gi|227070899|gb|EEI09222.1| D-lactate dehydrogenase [Lactobacillus reuteri MM2-3] 12 4 7 10 7 9 46.3 37.311 337 
>gi|148532070|gb|ABQ84069.1| histidyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 21 17 15 15 18 17 41.6 49.318 433 
>gi|148531517|gb|ABQ83516.1| YSIRK Gram-positive signal peptide [Lactobacillus reuteri DSM 
20016] 10 8 9 9 9 9 33.8 35.991 328 
>gi|148531730|gb|ABQ83729.1| LSU ribosomal protein L3P [Lactobacillus reuteri DSM 20016] 16 13 16 11 12 13 74 23.757 219 
>gi|148530755|gb|ABQ82754.1| UspA domain protein [Lactobacillus reuteri DSM 20016] 17 11 16 12 11 11 87 18.017 162 
>gi|148530642|gb|ABQ82641.1| UDP-glucose pyrophosphorylase [Lactobacillus reuteri DSM 
20016] 12 10 9 10 10 11 44.1 34.101 304 
>gi|148532032|gb|ABQ84031.1| cysteine synthase [Lactobacillus reuteri DSM 20016] 17 12 11 13 8 13 62.2 32.241 307 
>gi|148530861|gb|ABQ82860.1| cell division protein FtsZ [Lactobacillus reuteri DSM 20016] 19 15 12 13 12 14 48.4 44.45 415 
>gi|148530501|gb|ABQ82500.1| CTP synthase [Lactobacillus reuteri DSM 20016] 24 15 16 19 17 16 44.6 59.6 534 
>gi|148531108|gb|ABQ83107.1| hypothetical protein Lreu_0844 [Lactobacillus reuteri DSM 
20016] 10 6 9 8 9 10 71.3 20.426 181 
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>gi|337727883|emb|CCC02971.1| glycyl-tRNA synthase beta subunit [Lactobacillus reuteri ATCC 
53608] 28 25 21 20 23 19 44 78.605 691 
>gi|148531554|gb|ABQ83553.1| methionine adenosyltransferase [Lactobacillus reuteri DSM 
20016] 16 8 10 11 8 11 39.7 43.195 395 
>gi|183227647|dbj|BAG28163.1| dehydrogenase [Lactobacillus fermentum IFO 3956] 6 4 5 6 5 5 25.9 35.835 336 
>gi|148530919|gb|ABQ82918.1| ATP-dependent Clp protease ATP-binding subunit ClpX 
[Lactobacillus reuteri DSM 20016] 24 14 13 14 15 18 58.4 45.969 416 
>gi|148530340|gb|ABQ82339.1| 2,5-didehydrogluconate reductase [Lactobacillus reuteri DSM 
20016] 15 11 10 13 10 13 49.7 32.62 288 
>gi|227186142|gb|EEI66213.1| S-adenosylmethionine synthetase [Lactobacillus reuteri CF48-3A] 15 9 9 10 8 10 38 43.222 395 
>gi|148530778|gb|ABQ82777.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016] 17 13 8 12 14 11 41.6 44.031 404 
>gi|148530584|gb|ABQ82583.1| LSU ribosomal protein L10P [Lactobacillus reuteri DSM 20016] 11 10 11 11 11 10 68.7 18.139 166 
>gi|148531929|gb|ABQ83928.1| dipeptidase A, Cysteine peptidase, MEROPS family C69 
[Lactobacillus reuteri DSM 20016] 25 21 16 15 14 17 60.3 54.294 478 
>gi|337729082|emb|CCC04205.1| acetate kinase [Lactobacillus reuteri ATCC 53608] 12 7 8 5 9 5 41.2 43.41 398 
>gi|148530734|gb|ABQ82733.1| ATP synthase F1 subcomplex alpha subunit [Lactobacillus reuteri 
DSM 20016] 24 19 16 16 21 19 40.7 55.226 509 
>gi|148530593|gb|ABQ82592.1| ribonucleoside-diphosphate reductase class Ib beta subunit 
[Lactobacillus reuteri DSM 20016] 15 12 11 11 11 13 44.5 39.248 339 
>gi|227070649|gb|EEI08979.1| 1,3-propanediol dehydrogenase [Lactobacillus reuteri MM2-3] 19 14 15 11 17 14 57.8 44.01 405 
>gi|148530684|gb|ABQ82683.1| Cof-like hydrolase [Lactobacillus reuteri DSM 20016] 10 8 7 5 8 7 44.8 30.206 268 
>gi|148530579|gb|ABQ82578.1| LSU ribosomal protein L11P [Lactobacillus reuteri DSM 20016] 14 12 12 10 12 10 61.7 14.869 141 
>gi|148530680|gb|ABQ82679.1| glutamine--fructose-6-phosphate transaminase [Lactobacillus 
reuteri DSM 20016] 24 18 17 20 18 14 46.9 66.611 606 
>gi|148530542|gb|ABQ82541.1| lysyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 31 25 20 19 26 21 46.9 58.296 508 
>gi|148531729|gb|ABQ83728.1| LSU ribosomal protein L4P [Lactobacillus reuteri DSM 20016] 9 7 8 6 5 6 53.6 22.29 207 
>gi|148530491|gb|ABQ82490.1| UDP-N-acetylglucosamine pyrophosphorylase [Lactobacillus 
reuteri DSM 20016] 18 11 13 9 10 6 48.6 50.01 455 
>gi|183225183|dbj|BAG25700.1| ligase [Lactobacillus reuteri JCM 1112] 17 13 13 13 12 11 48.1 49.294 441 
>gi|227186160|gb|EEI66231.1| possible peptidoglycan-binding protein [Lactobacillus reuteri CF48-
3A] 7 3 5 6 4 4 33.1 27.744 266 
>gi|148530567|gb|ABQ82566.1| amino acid ABC transporter substrate-binding protein, PAAT 
family [Lactobacillus reuteri DSM 20016] 24 19 13 15 20 16 59.7 28.516 263 
>gi|148530455|gb|ABQ82454.1| Substrate-binding region of ABC-type glycine betaine transport 
system [Lactobacillus reuteri DSM 20016] 20 13 10 10 12 12 61.2 32.953 299 
>gi|148530288|gb|ABQ82287.1| LSU ribosomal protein L9P [Lactobacillus reuteri DSM 20016] 15 11 12 12 11 10 65.3 16.692 150 
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>gi|183226571|dbj|BAG27087.1| heat shock protein DnaK [Lactobacillus fermentum IFO 3956] 21 9 6 9 12 9 29 67.123 618 
>gi|183226183|dbj|BAG26699.1| glyceraldehyde 3-phosphate dehydrogenase [Lactobacillus 
fermentum IFO 3956] 10 8 8 9 8 7 25.5 36.208 337 
>gi|148531037|gb|ABQ83036.1| degV family protein [Lactobacillus reuteri DSM 20016] 16 11 14 12 11 13 60 30.742 280 
>gi|148531050|gb|ABQ83049.1| Inorganic diphosphatase [Lactobacillus reuteri DSM 20016] 12 8 11 9 9 8 37 34.194 311 
>gi|148531450|gb|ABQ83449.1| LSU ribosomal protein L21P [Lactobacillus reuteri DSM 20016] 10 8 6 5 8 9 73.5 11.256 102 
>gi|148531692|gb|ABQ83691.1| ATP-dependent DNA helicase PcrA [Lactobacillus reuteri DSM 
20016] 21 15 13 14 16 15 35.7 86.29 757 
>gi|183225283|dbj|BAG25800.1| putative autolysin [Lactobacillus reuteri JCM 1112] 12 7 5 5 7 8 33.1 60.393 532 
>gi|148530740|gb|ABQ82739.1| cell shape determining protein, MreB/Mrl family [Lactobacillus 
reuteri DSM 20016] 15 11 8 11 10 13 44.2 35.48 330 
>gi|148531505|gb|ABQ83504.1| DNA polymerase I [Lactobacillus reuteri DSM 20016] 28 21 19 14 24 17 32.2 100.78 888 
>gi|148531486|gb|ABQ83485.1| two component transcriptional regulator, winged helix family 
[Lactobacillus reuteri DSM 20016] 18 13 15 12 15 12 56.1 26.33 228 
>gi|148530409|gb|ABQ82408.1| Adenylosuccinate lyase [Lactobacillus reuteri DSM 20016] 22 15 17 19 16 13 52.9 49.454 431 
>gi|148531824|gb|ABQ83823.1| translation elongation factor P (EF-P) [Lactobacillus reuteri DSM 
20016] 13 13 11 11 11 11 60 20.518 185 
>gi|148531585|gb|ABQ83584.1| ATPase AAA-2 domain protein [Lactobacillus reuteri DSM 20016] 27 17 17 21 20 16 42.4 81.867 734 
>gi|148530811|gb|ABQ82810.1| non-canonical purine NTP pyrophosphatase, rdgB/HAM1 family 
[Lactobacillus reuteri DSM 20016] 13 12 12 10 9 7 80.5 21.286 195 
>gi|194454505|gb|EDX43402.1| 2,5-didehydrogluconate reductase [Lactobacillus reuteri 100-23] 14 10 9 12 9 12 43.8 32.469 288 
>gi|183225729|dbj|BAG26246.1| hypothetical protein [Lactobacillus reuteri JCM 1112]  11 7 11 8 9 8 69.2 19.891 169 
>gi|148530835|gb|ABQ82834.1| hypothetical protein Lreu_0566 [Lactobacillus reuteri DSM 
20016] 11 9 9 8 8 8 52.1 18.628 163 
>gi|148530865|gb|ABQ82864.1| DivIVA family protein [Lactobacillus reuteri DSM 20016] 17 10 9 8 9 11 47.2 27.591 246 
>gi|148530646|gb|ABQ82645.1| thioredoxin reductase [Lactobacillus reuteri DSM 20016] 11 7 7 10 8 9 41.6 33.305 310 
>gi|148530962|gb|ABQ82961.1| NusA antitermination factor [Lactobacillus reuteri DSM 20016] 11 9 8 9 9 8 31.4 44.525 395 
>gi|148531641|gb|ABQ83640.1| oxidoreductase domain protein [Lactobacillus reuteri DSM 
20016]  9 8 8 9 9 8 28.3 38.272 339 
>gi|183226006|dbj|BAG26522.1| methionyl-tRNA synthase [Lactobacillus fermentum IFO 3956] 9 5 6 4 5 6 13.8 74.982 666 
>gi|148530953|gb|ABQ82952.1| ribosome recycling factor [Lactobacillus reuteri DSM 20016] 12 8 10 9 11 6 67.4 20.783 187 
>gi|227071142|gb|EEI09458.1| acetoin dehydrogenase [Lactobacillus reuteri MM2-3] 10 8 9 7 7 5 55.8 28.157 267 
>gi|148530952|gb|ABQ82951.1| uridylate kinase [Lactobacillus reuteri DSM 20016] 12 10 10 10 8 8 43.8 25.876 240 
>gi|148531003|gb|ABQ83002.1| GTP-binding protein Era [Lactobacillus reuteri DSM 20016]  10 9 8 7 7 8 36.2 33.79 301 
>gi|148530283|gb|ABQ82282.1| DNA gyrase subunit A [Lactobacillus reuteri DSM 20016] 31 24 19 21 26 25 39.8 92.891 834 
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>gi|148531724|gb|ABQ83723.1| SSU ribosomal protein S3P [Lactobacillus reuteri DSM 20016] 17 16 13 13 14 13 58.4 24.696 221 
>gi|148530413|gb|ABQ82412.1| phosphoribosylformylglycinamidine synthase subunit II 
[Lactobacillus reuteri DSM 20016] 17 10 9 10 13 4 30.9 80.944 742 
>gi|148531658|gb|ABQ83657.1| nitroreductase [Lactobacillus reuteri DSM 20016] 9 5 6 6 8 6 49.3 24.752 217 
>gi|183225222|dbj|BAG25739.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112] 11 9 11 10 8 9 67.6 18.557 170 
>gi|148531704|gb|ABQ83703.1| DNA-directed RNA polymerase subunit alpha [Lactobacillus 
reuteri DSM 20016] 18 14 11 10 13 14 42 34.901 314 
>gi|148530846|gb|ABQ82845.1| 6-phosphogluconolactonase [Lactobacillus reuteri DSM 20016] 15 9 10 12 14 12 52 37.901 342 
>gi|183225901|dbj|BAG26417.1| inosine-5-monophosphate dehydrogenase [Lactobacillus 
fermentum IFO 3956] 7 6 7 5 6 4 22.4 39.708 380 
>gi|227071794|gb|EEI10083.1| glycerone kinase [Lactobacillus reuteri MM2-3] 15 8 6 7 8 10 28.7 62.132 575 
>gi|148531728|gb|ABQ83727.1| LSU ribosomal protein L23P [Lactobacillus reuteri DSM 20016] 11 8 11 9 10 9 79.6 11.25 98 
>gi|183224807|dbj|BAG25324.1| hypothetical protein [Lactobacillus reuteri JCM 1112] 12 4 3 9 8 9 35.6 43.954 413 
>gi|148530695|gb|ABQ82694.1| ornithine carbamoyltransferase [Lactobacillus reuteri DSM 
20016] 17 12 11 11 12 12 43 37.559 335 
>gi|183226422|dbj|BAG26938.1| GTP-binding protein [Lactobacillus fermentum IFO 3956] 15 12 11 12 15 13 22.4 68.695 615 
>gi|194454225|gb|EDX43122.1| peptidase U34 dipeptidase [Lactobacillus reuteri 100-23] 22 18 14 12 13 15 49.6 54.429 478 
>gi|148531722|gb|ABQ83721.1| LSU ribosomal protein L29P [Lactobacillus reuteri DSM 20016] 5 5 4 2 4 4 58.8 8.0041 68 
>gi|183226702|dbj|BAG27218.1| DNA-binding protein [Lactobacillus fermentum IFO 3956] 6 6 5 4 6 5 63.7 9.5519 91 
>gi|148531027|gb|ABQ83026.1| cytidylate kinase [Lactobacillus reuteri DSM 20016] 15 10 12 11 11 11 69.7 25.015 228 
>gi|148530344|gb|ABQ82343.1| guanosine monophosphate reductase [Lactobacillus reuteri DSM 
20016] 12 8 7 7 7 9 33.3 35.96 324 
>gi|148530769|gb|ABQ82768.1| SSU ribosomal protein S4P [Lactobacillus reuteri DSM 20016] 20 17 16 15 17 18 66.7 22.943 201 
>gi|227070613|gb|EEI08943.1| possible asparagine synthase (glutamine-hydrolyzing) 
[Lactobacillus reuteri MM2-3] 28 21 21 20 24 20 37.3 76.34 652 
>gi|183225853|dbj|BAG26369.1| ATP-dependent Clp protease ATP-binding subunit [Lactobacillus 
fermentum IFO 3956] 9 8 6 5 9 6 11.8 76.678 697 
>gi|148530284|gb|ABQ82283.1| SSU ribosomal protein S6P [Lactobacillus reuteri DSM 20016] 10 9 9 8 10 8 92.9 11.378 98 
>gi|148531553|gb|ABQ83552.1| leucyl-tRNA synthetase [Lactobacillus reuteri DSM 20016] 23 17 16 18 21 16 28.8 92.918 806 
>gi|183226626|dbj|BAG27142.1| L-lactate dehydrogenase [Lactobacillus fermentum IFO 3956] 6 6 5 5 5 5 18.3 33.736 317 
>gi|148532158|gb|ABQ84157.1| hypoxanthine phosphoribosyltransferase [Lactobacillus reuteri 
DSM 20016] 9 7 9 8 6 5 47.2 20.407 178 
>gi|148530724|gb|ABQ82723.1| serine hydroxymethyltransferase [Lactobacillus reuteri DSM 
20016] 15 14 12 10 14 11 34.3 44.95 411 
>gi|148531687|gb|ABQ83686.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B 
[Lactobacillus reuteri DSM 20016] 22 14 13 13 14 13 48.3 53.424 474 
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>gi|148531720|gb|ABQ83719.1| LSU ribosomal protein L14P [Lactobacillus reuteri DSM 20016] 10 9 10 8 8 8 66.4 13.144 122 
>gi|227071143|gb|EEI09459.1| ribosomal protein S9 [Lactobacillus reuteri MM2-3] 10 10 8 7 10 9 66.9 14.494 133 
>gi|148530367|gb|ABQ82366.1| NADPH-dependent FMN reductase [Lactobacillus reuteri DSM 
20016] 12 10 12 10 11 8 36.8 45.674 416 
>gi|148531899|gb|ABQ83898.1| short-chain dehydrogenase/reductase SDR [Lactobacillus reuteri 
DSM 20016] 16 10 11 7 8 9 68.1 26.924 251 
>gi|148530597|gb|ABQ82596.1| DNA polymerase III, subunits gamma and tau [Lactobacillus 
reuteri DSM 20016] 9 4 5 5 8 3 17.2 68.85 611 
>gi|148531323|gb|ABQ83322.1| glycerol kinase [Lactobacillus reuteri DSM 20016] 9 6 6 5 5 7 19.2 55.388 500 
>gi|148530634|gb|ABQ82633.1| SSU ribosomal protein S30P [Lactobacillus reuteri DSM 20016] 6 6 6 5 6 4 37.4 21.144 182 
>gi|148530387|gb|ABQ82386.1| purine nucleoside phosphorylase [Lactobacillus reuteri DSM 
20016]  8 8 6 7 5 7 41.1 25.751 236 
>gi|227070055|gb|EEI08433.1| GTP-binding protein EngA [Lactobacillus reuteri MM2-3] 13 9 9 10 11 10 30.5 49.465 440 
>gi|337728993|emb|CCC04113.1| hypoxanthine-guanine phosphoribosyltransferase [Lactobacillus 
reuteri ATCC 53608] 9 6 9 8 6 4 47.2 20.349 178 
>gi|148530685|gb|ABQ82684.1| Peptidoglycan-binding LysM [Lactobacillus reuteri DSM 20016] 9 7 8 8 7 7 36.9 21.661 203 
>gi|183224273|dbj|BAG24790.1| transcription accessory protein [Lactobacillus reuteri JCM 1112]; 19 14 15 11 15 14 31.2 82.072 727 
>gi|148531705|gb|ABQ83704.1| SSU ribosomal protein S11P [Lactobacillus reuteri DSM 20016]; 5 5 5 5 4 5 32.6 13.759 129 
>gi|148531448|gb|ABQ83447.1| LSU ribosomal protein L27P [Lactobacillus reuteri DSM 20016]; 8 5 8 6 7 6 60.2 9.9211 93 
>gi|148531114|gb|ABQ83113.1| hypothetical protein Lreu_0850 [Lactobacillus reuteri DSM 
20016]; 7 6 6 4 7 6 75.6 10.169 90 
>gi|148530453|gb|ABQ82452.1| 3-beta hydroxysteroid dehydrogenase/isomerase [Lactobacillus 
reuteri DSM 20016]; 9 8 9 7 8 8 40.1 31.632 284 
>gi|148531583|gb|ABQ83582.1| Phosphotransferase system, phosphocarrier protein HPr 
[Lactobacillus reuteri DSM 20016]; 7 6 7 4 6 4 56.8 9.4076 88 
>gi|148531727|gb|ABQ83726.1| LSU ribosomal protein L2P [Lactobacillus reuteri DSM 20016]; 21 17 18 16 17 19 69.8 30.47 281 
>gi|148531731|gb|ABQ83730.1| SSU ribosomal protein S10P [Lactobacillus reuteri DSM 
20016];>gi|148544697|ref|YP_001272067.1| 30S ribosomal protein S10 [Lactobacillus reuteri DSM 
20016];>gi|166991569|sp|A5VLK6.1|RS10_LACRD RecName: Full=30S ribosomal protein 12 12 9 7 10 10 67.6 11.777 102 
>gi|148530343|gb|ABQ82342.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016] 10 9 9 9 9 8 24.5 49.604 449 
>gi|148530566|gb|ABQ82565.1| amino acid ABC transporter ATP-binding protein, PAAT family 
[Lactobacillus reuteri DSM 20016]; 11 7 8 4 7 8 52.6 27.538 249 
>gi|148531225|gb|ABQ83224.1| hypothetical protein Lreu_0962 [Lactobacillus reuteri DSM 
20016] 16 9 10 9 12 7 23.8 88.735 774 
>gi|227071698|gb|EEI09989.1| phosphoesterase [Lactobacillus reuteri MM2-3] 7 6 6 6 7 7 37.5 19.857 176 
>gi|148530877|gb|ABQ82876.1| ribose-phosphate pyrophosphokinase [Lactobacillus reuteri DSM 13 10 10 12 12 10 38 36.06 324 
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20016] 
>gi|148530924|gb|ABQ82923.1| GTP-binding protein Obg/CgtA [Lactobacillus reuteri DSM 20016]; 22 16 11 12 16 15 56.6 47.975 438 
>gi|148532124|gb|ABQ84123.1| asparaginyl-tRNA synthetase [Lactobacillus reuteri DSM 20016]; 21 16 18 17 16 19 47 50.092 432 
>gi|148531475|gb|ABQ83474.1| phenylalanyl-tRNA synthetase beta subunit [Lactobacillus reuteri 
DSM 20016]; 14 10 9 13 12 9 19.4 89.003 805 
>gi|227071324|gb|EEI09633.1| heat shock protein Hsp33 [Lactobacillus reuteri MM2-3]; 14 10 9 9 9 12 53.9 35.232 323 
>gi|148531494|gb|ABQ83493.1| protein of unknown function UPF0044 [Lactobacillus reuteri DSM 
20016]; 5 5 4 3 5 5 62.1 11.655 103 
>gi|227071790|gb|EEI10079.1| ribulose-5-phosphate 3-epimerase [Lactobacillus reuteri MM2-3]; 8 4 6 4 4 6 23.4 25.102 231 
>gi|337729037|emb|CCC04160.1| aminotransferase [Lactobacillus reuteri ATCC 53608]; 16 11 11 9 11 11 43.6 43.766 397 
>gi|148530370|gb|ABQ82369.1| seryl-tRNA synthetase [Lactobacillus reuteri DSM 20016]; 14 12 10 11 10 11 32.6 49.29 435 
>gi|227070129|gb|EEI08505.1| D-tyrosyl-tRNA(Tyr) deacylase [Lactobacillus reuteri MM2-3];  7 7 7 3 5 3 57.9 17.733 159 
>gi|148530819|gb|ABQ82818.1| transcriptional regulator, LacI family [Lactobacillus reuteri DSM 
20016]; 13 12 8 8 10 10 44.6 36.722 336 
>gi|148531721|gb|ABQ83720.1| SSU ribosomal protein S17P [Lactobacillus reuteri DSM 20016]; 8 7 7 6 7 6 67 10.168 88 
>gi|148530382|gb|ABQ82381.1| GTP-binding protein YchF [Lactobacillus reuteri DSM 20016]; 14 8 7 8 6 9 38.6 39.844 365 
>gi|148530808|gb|ABQ82807.1| thioredoxin [Lactobacillus reuteri DSM 20016]; 7 7 6 6 7 7 62.5 11.889 104 
>gi|183224298|dbj|BAG24815.1| aminotransferase [Lactobacillus reuteri JCM 1112];  16 11 11 9 10 11 42 44.088 400 
>gi|148530585|gb|ABQ82584.1| LSU ribosomal protein L12P [Lactobacillus reuteri DSM 20016]; 18 13 16 8 14 13 95 12.356 121 
>gi|148530810|gb|ABQ82809.1| glutamate racemase [Lactobacillus reuteri DSM 20016]; 11 7 10 8 7 5 51.7 28.92 267 
>gi|324978533|gb|EGC15482.1| cysteine--tRNA ligase [Lactobacillus reuteri MM4-1A]; 16 8 13 10 8 9 37.2 54.852 478 
>gi|148530870|gb|ABQ82869.1| methylthioadenosine nucleosidase [Lactobacillus reuteri DSM 
20016]; 8 3 7 4 3 4 39.4 24.687 231 
>gi|183225282|dbj|BAG25799.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112]; 11 7 7 8 7 10 24.9 49.015 438 
>gi|148531735|gb|ABQ83734.1| SSU ribosomal protein S12P [Lactobacillus reuteri DSM 20016]; 9 9 6 6 8 8 38.8 15.503 139 
>gi|148531549|gb|ABQ83548.1| peptidase V, Metallo peptidase, MEROPS family M20A 
[Lactobacillus reuteri DSM 20016];  20 14 15 16 15 10 53.3 51.22 467 
>gi|183227319|dbj|BAG27835.1| 50S ribosomal protein L18 [Lactobacillus fermentum IFO 3956]; 7 7 6 6 7 7 45.5 13.301 121 
>gi|227185831|gb|EEI65902.1| nucleoside-triphosphatase [Lactobacillus reuteri CF48-3A] 9 8 7 8 5 4 60.5 21.213 195 
>gi|148531869|gb|ABQ83868.1| GTP-binding protein, HSR1-related [Lactobacillus reuteri DSM 
20016];  11 8 10 10 10 8 31.1 47.758 425 
>gi|148532009|gb|ABQ84008.1| UspA domain protein [Lactobacillus reuteri DSM 20016]; 12 9 12 9 9 8 74.7 17.199 154 
>gi|194453762|gb|EDX42659.1| Peptidoglycan-binding LysM [Lactobacillus reuteri 100-23]; 6 3 4 5 3 3 25.7 27.902 269 
>gi|148532168|gb|ABQ84167.1| signal peptidase I [Lactobacillus reuteri DSM 20016]; 9 7 7 6 7 5 41.3 22.703 201 
>gi|148531417|gb|ABQ83416.1| RNAse III [Lactobacillus reuteri DSM 20016]; 11 10 10 7 10 9 44.2 26.606 233 
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>gi|148530347|gb|ABQ82346.1| Uracil phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016]; 10 9 8 8 8 8 69.3 20.252 179 
>gi|148531497|gb|ABQ83496.1| LSU ribosomal protein L20P [Lactobacillus reuteri DSM 20016]; 9 8 9 5 9 7 46.2 13.515 117 
>gi|148531439|gb|ABQ83438.1| farnesyl-diphosphate synthase [Lactobacillus reuteri DSM 
20016]; 4 2 3 1 2 2 16.9 31.64 290 
>gi|148530402|gb|ABQ82401.1| cyclopropane-fatty-acyl-phospholipid synthase [Lactobacillus 
reuteri DSM 20016] 14 10 11 7 9 10 33.3 46.488 403 
>gi|337728387|emb|CCC03488.1| GTPases [Lactobacillus reuteri ATCC 53608] 10 7 8 8 9 7 28.7 47.753 425 
>gi|194453681|gb|EDX42578.1| ribosomal protein L20 [Lactobacillus reuteri 100-23]; 9 8 8 5 8 7 46.2 13.545 117 
>gi|227186201|gb|EEI66272.1| response regulator [Lactobacillus reuteri CF48-3A]; 9 7 7 5 7 7 43 26.602 237 
>gi|148531061|gb|ABQ83060.1| hypothetical protein Lreu_0797 [Lactobacillus reuteri DSM 
20016]; 4 4 2 2 4 3 20.4 31.07 285 
>gi|148532037|gb|ABQ84036.1| Endothelin-converting protein 1 [Lactobacillus reuteri DSM 
20016];  22 10 10 13 11 14 30.4 72.39 634 
>gi|148531183|gb|ABQ83182.1| penicillin-binding protein, 1A family [Lactobacillus reuteri DSM 
20016]; 10 9 7 6 9 10 14.1 82.075 754 
>gi|148530721|gb|ABQ82720.1| bacterial peptide chain release factor 1 (bRF-1) [Lactobacillus 
reuteri DSM 20016]; 18 11 13 15 12 14 47.5 41.287 362 
>gi|148530772|gb|ABQ82771.1| thiamine biosynthesis/tRNA modification protein ThiI 
[Lactobacillus reuteri DSM 20016]; 20 14 9 10 17 12 39.4 45.726 406 
>gi|148531412|gb|ABQ83411.1| SSU ribosomal protein S16P [Lactobacillus reuteri DSM 20016]; 7 7 7 5 7 6 62.6 10.449 91 
>gi|148531107|gb|ABQ83106.1| hypothetical protein Lreu_0843 [Lactobacillus reuteri DSM 
20016] 6 4 6 3 4 4 30.2 23.788 215 
>gi|148530883|gb|ABQ82882.1| dihydrodipicolinate synthase [Lactobacillus reuteri DSM 20016] 6 5 5 5 5 4 20.5 33.823 307 
>gi|183224279|dbj|BAG24796.1| putative lipase/esterase [Lactobacillus reuteri JCM 1112] 9 6 6 5 6 7 37.7 33.174 292 
>gi|148530326|gb|ABQ82325.1| DNA helicase/exodeoxyribonuclease V, subunit B [Lactobacillus 
reuteri DSM 20016] 25 17 17 16 19 16 19.9 143.74 1260 
>gi|183224869|dbj|BAG25386.1| cell division protein [Lactobacillus reuteri JCM 1112] 8 8 8 7 8 7 56.9 14.251 123 
>gi|148531415|gb|ABQ83414.1| signal recognition particle-docking protein FtsY [Lactobacillus 
reuteri DSM 20016] 18 13 14 9 14 11 37 55.604 508 
>gi|112943316|gb|ABI26304.1| predicted flavoprotein [Lactobacillus reuteri]; 10 10 10 9 9 9 47.4 21.504 190 
>gi|194452797|gb|EDX41695.1| Inorganic diphosphatase [Lactobacillus reuteri 100-
23];>gi|194467944|ref|ZP_03073930.1| Inorganic diphosphatase [Lactobacillus reuteri 100-
23];>gi|337727840|emb|CCC02928.1| inorganic pyrophosphatase [Lactobacillus reuteri ATCC  12 8 10 8 9 7 37 34.18 311 
>gi|148530279|gb|ABQ82278.1| DNA polymerase III, beta subunit [Lactobacillus reuteri DSM 
20016]; 10 8 7 9 9 7 30.8 41.831 380 
>gi|337728969|emb|CCC04089.1| two-component response regulator [Lactobacillus reuteri ATCC 9 7 6 4 7 6 44.5 25.811 229 
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53608] 
>gi|148530514|gb|ABQ82513.1| UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase 
[Lactobacillus reuteri DSM 20016]; 10 5 7 5 6 7 28.5 50.527 459 
>gi|183226118|dbj|BAG26634.1| ornithine carbamoyltransferase [Lactobacillus fermentum IFO 
3956]; 7 6 5 6 7 4 18.9 37.095 333 
>gi|148531756|gb|ABQ83755.1| UspA domain protein [Lactobacillus reuteri DSM 20016]; 9 7 8 6 7 6 55.1 17.57 158 
>gi|148531407|gb|ABQ83406.1| LSU ribosomal protein L19P [Lactobacillus reuteri DSM 20016]; 15 13 13 14 14 14 56.2 14.824 128 
>gi|148530556|gb|ABQ82555.1| NH(3)-dependent NAD(+) synthetase [Lactobacillus reuteri DSM 
20016]; 10 6 7 6 6 6 47.3 30.54 275 
>gi|148530564|gb|ABQ82563.1| cystathionine gamma-lyase [Lactobacillus reuteri DSM 20016]; 11 5 5 5 7 5 31.8 41.498 380 
>gi|148530664|gb|ABQ82663.1| RNAse R [Lactobacillus reuteri DSM 20016]; 21 14 14 13 20 14 26.1 91.867 801 
>gi|183224806|dbj|BAG25323.1| hypothetical protein [Lactobacillus reuteri JCM 1112]; 8 3 6 3 8 8 49.7 21.08 183 
>gi|148531690|gb|ABQ83689.1| CamS sex pheromone cAM373 family protein [Lactobacillus 
reuteri DSM 20016]; 11 3 7 4 6 8 36.1 40.775 371 
>gi|112943099|gb|ABI26296.1| single-stranded DNA-binding protein [Lactobacillus reuteri] 8 7 8 5 5 8 38.5 20.605 187 
>gi|148530282|gb|ABQ82281.1| DNA gyrase subunit B [Lactobacillus reuteri DSM 20016]; 18 13 10 13 13 12 29 72.528 649 
>gi|148531419|gb|ABQ83418.1| phosphate:acyl-[acyl carrier protein] acyltransferase 
[Lactobacillus reuteri DSM 20016]; 6 3 1 3 1 3 22.2 36.975 343 
>gi|148530523|gb|ABQ82522.1| D-alanine-activating enzyme [Lactobacillus reuteri DSM 20016]; 12 7 6 10 11 6 24.4 55.989 508 
>gi|148531918|gb|ABQ83917.1| UspA domain protein [Lactobacillus reuteri DSM 20016]; 7 4 6 4 5 5 55.5 17.168 155 
>gi|148531570|gb|ABQ83569.1| Peptidoglycan-binding LysM [Lactobacillus reuteri DSM 20016]; 6 3 4 4 4 5 34 24.901 235 
>gi|227071637|gb|EEI09931.1| uracil phosphoribosyltransferase [Lactobacillus reuteri MM2-3]; 11 9 10 9 9 8 48.9 24.512 221 
>gi|148531434|gb|ABQ83433.1| guanylate kinase [Lactobacillus reuteri DSM 20016]; 7 5 5 4 6 4 33.5 23.546 206 
>gi|227071240|gb|EEI09554.1| possible glutathione-disulfide reductase [Lactobacillus reuteri 
MM2-3]; 7 5 3 6 5 5 18.1 48.997 443 
>gi|148530857|gb|ABQ82856.1| UDP-N-acetylmuramoylalanine--D-glutamate ligase [Lactobacillus 
reuteri DSM 20016]; 10 5 6 4 5 3 34.9 50.332 456 
>gi|148531033|gb|ABQ83032.1| ABC transporter related [Lactobacillus reuteri DSM 20016]; 14 9 4 9 8 8 26.1 72.792 636 
>gi|227071437|gb|EEI09740.1| transcriptional antiterminator NusG [Lactobacillus reuteri MM2-3];  9 6 9 4 5 6 59.1 20.875 186 
>gi|148530327|gb|ABQ82326.1| Recombination helicase AddA [Lactobacillus reuteri DSM 20016]; 32 22 26 25 25 21 23.9 159.71 1392 
>gi|194453194|gb|EDX42092.1| glutamate racemase [Lactobacillus reuteri 100-23]; 9 7 8 6 5 4 33 29 267 
>gi|183224141|dbj|BAG24658.1| tyrosyl-tRNA synthase [Lactobacillus reuteri JCM 1112]; 14 10 9 6 10 12 35 47.69 420 
>gi|148530732|gb|ABQ82731.1| ATP synthase F0 subcomplex B subunit [Lactobacillus reuteri 
DSM 20016]; 6 3 5 2 3 3 34.9 19.254 172 
>gi|148530418|gb|ABQ82417.1| phosphoribosylamine--glycine ligase [Lactobacillus reuteri DSM 
20016]; 15 6 10 11 9 6 36.8 45.76 419 
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>gi|148530821|gb|ABQ82820.1| protein of unknown function DUF28 [Lactobacillus reuteri DSM 
20016] 7 4 6 5 5 5 28.6 27.161 248 
>gi|148530781|gb|ABQ82780.1| cell shape determining protein, MreB/Mrl family [Lactobacillus 
reuteri DSM 20016]; 12 7 8 8 11 10 35.4 34.966 333 
>gi|148531188|gb|ABQ83187.1| putative RNA methylase [Lactobacillus reuteri DSM 20016];  12 7 9 7 7 8 29.6 44.845 398 
>gi|148530874|gb|ABQ82873.1| Phosphoglycerate mutase [Lactobacillus reuteri DSM 20016];  10 8 7 4 5 8 45 24.793 218 
>gi|194454328|gb|EDX43225.1| histidyl-tRNA synthetase [Lactobacillus reuteri 100-23] 16 11 12 13 12 12 40.9 48.223 425 
>gi|148530899|gb|ABQ82898.1| Dihydrolipoyllysine-residue succinyltransferase [Lactobacillus 
reuteri DSM 20016]; 8 5 4 4 6 6 26.8 48.372 444 
>gi|148530995|gb|ABQ82994.1| Choloylglycine hydrolase [Lactobacillus reuteri DSM 20016]; 11 10 7 8 6 7 50.2 36.104 325 
>gi|148531491|gb|ABQ83490.1| iojap-like protein [Lactobacillus reuteri DSM 20016]; 5 3 4 1 3 4 30.5 13.309 118 
>gi|148532087|gb|ABQ84086.1| histidyl-tRNA synthetase [Lactobacillus reuteri DSM 20016]; 16 12 13 14 11 12 40.9 48.236 425 
>gi|1667472|gb|AAB53259.1| chloramphenicol acetyltransferase-TC [Lactobacillus reuteri] 5 5 4 4 4 4 22.7 27.351 238 
>gi|148530526|gb|ABQ82525.1| alanine racemase [Lactobacillus reuteri DSM 20016]; 4 3 3 3 3 4 13.3 41.162 375 
>gi|148530412|gb|ABQ82411.1| phosphoribosylformylglycinamidine synthase subunit I 
[Lactobacillus reuteri DSM 20016]; 7 5 6 5 5 2 42.5 24.732 226 
>gi|148531495|gb|ABQ83494.1| Nitric-oxide synthase [Lactobacillus reuteri DSM 20016] 10 7 6 7 8 8 28.8 42.288 375 
>gi|194453001|gb|EDX41899.1| sigma 54 modulation protein/ribosomal protein S30EA 
[Lactobacillus reuteri 100-23] 5 4 4 3 5 3 35.7 21.176 182 
>gi|183224883|dbj|BAG25400.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112] 8 5 8 4 4 3 60.2 20.834 181 
>gi|148531698|gb|ABQ83697.1| LSU ribosomal protein L13P [Lactobacillus reuteri DSM 20016]; 14 11 12 10 13 12 65.3 16.304 147 
>gi|148530415|gb|ABQ82414.1| phosphoribosylformylglycinamidine cyclo-ligase [Lactobacillus 
reuteri DSM 20016]; 11 6 9 5 8 2 40.6 36.975 345 
>gi|148530504|gb|ABQ82503.1| LSU ribosomal protein L31P [Lactobacillus reuteri DSM 20016]; 9 7 8 5 8 7 95.1 9.123 81 
>gi|148531691|gb|ABQ83690.1| DNA ligase, NAD-dependent [Lactobacillus reuteri DSM 20016] 20 13 11 13 14 18 35.9 76.002 680 
>gi|227186428|gb|EEI66499.1| mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 
[Lactobacillus reuteri CF48-3A]; 8 5 5 5 6 4 37.4 25.86 222 
>gi|337728946|emb|CCC04066.1| phosphoribosylformylglycinamidine synthase I [Lactobacillus 
reuteri ATCC 53608]; 7 5 5 4 4 2 42.5 24.714 226 
>gi|148531057|gb|ABQ83056.1| gluconate kinase, FGGY family [Lactobacillus reuteri DSM 20016]  13 10 9 11 11 9 31.2 55.417 509 
>gi|148530885|gb|ABQ82884.1| aminotransferase [Lactobacillus reuteri DSM 20016]; 11 8 5 6 8 7 36.3 42.991 394 
>gi|148530622|gb|ABQ82621.1| CoA-binding domain protein [Lactobacillus reuteri DSM 20016]; 14 10 12 8 8 9 57 23.939 214 
>gi|183227331|dbj|BAG27847.1| 30S ribosomal protein S19 [Lactobacillus fermentum IFO 3956]; 9 8 9 5 8 9 57 10.489 93 
>gi|148530569|gb|ABQ82568.1| ribose-5-phosphate isomerase [Lactobacillus reuteri DSM 20016]; 13 12 12 7 10 10 52 25.036 227 
>gi|148530641|gb|ABQ82640.1| glycerol 3-phosphate dehydrogenase (NAD(P)+) [Lactobacillus 
reuteri DSM 20016]; 17 16 11 11 12 13 46.7 36.905 338 
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>gi|148531075|gb|ABQ83074.1| RecT protein [Lactobacillus reuteri DSM 20016]; 13 5 5 6 8 13 41.7 34.762 309 
>gi|148530913|gb|ABQ82912.1| SSU ribosomal protein S20P [Lactobacillus reuteri DSM 20016]; 4 2 3 2 4 2 36.9 9.2436 84 
>gi|183225285|dbj|BAG25802.1| muramidase [Lactobacillus reuteri JCM 1112]; 6 4 3 4 5 5 14.2 55.89 492 
>gi|337727893|emb|CCC02982.1| conjugated bile salt hydrolase [Lactobacillus reuteri ATCC 
53608] 9 8 4 6 5 4 36.9 36.06 325 
>gi|148530832|gb|ABQ82831.1| HAD-superfamily subfamily IIA hydrolase like protein 
[Lactobacillus reuteri DSM 20016]; 7 4 4 5 4 5 25.8 28.505 256 
>gi|148530611|gb|ABQ82610.1| peptidase M22, glycoprotease [Lactobacillus reuteri DSM 20016]; 5 4 4 2 3 3 28.2 26.806 241 
>gi|148530799|gb|ABQ82798.1| protein translocase subunit yajC [Lactobacillus reuteri DSM 
20016]; 5 5 5 5 5 5 28.6 16.384 154 
>gi|148530760|gb|ABQ82759.1| Glyoxalase/bleomycin resistance protein/dioxygenase 
[Lactobacillus reuteri DSM 20016]; 5 5 5 4 4 5 45.2 15.166 135 
>gi|148531622|gb|ABQ83621.1| lipopolysaccharide biosynthesis protein [Lactobacillus reuteri 
DSM 20016]; 4 2 3 1 4 2 23.4 22.766 209 
>gi|183224808|dbj|BAG25325.1| pantothenate metabolism flavoprotein [Lactobacillus reuteri 
JCM 1112]; 5 2 1 2 3 4 17 44.905 401 
>gi|148531723|gb|ABQ83722.1| LSU ribosomal protein L16P [Lactobacillus reuteri DSM 20016]; 7 6 6 5 6 6 42.4 16.006 144 
>gi|183225457|dbj|BAG25974.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112]; 5 5 4 4 5 4 26.8 20.101 179 
>gi|148531131|gb|ABQ83130.1| hypothetical protein Lreu_0867 [Lactobacillus reuteri DSM 
20016]; 11 9 10 6 8 9 60.4 10.576 91 
>gi|148531141|gb|ABQ83140.1| Purine nucleosidase [Lactobacillus reuteri DSM 20016]; 5 3 4 3 4 4 23.9 34.734 314 
>gi|148532166|gb|ABQ84165.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016]; 11 5 5 8 7 7 34.1 32.371 287 
>gi|148530735|gb|ABQ82734.1| ATP synthase F1 subcomplex gamma subunit [Lactobacillus 
reuteri DSM 20016]; 9 6 2 7 4 6 36 34.796 314 
>gi|133930513|gb|ABO43828.1| triosephosphate isomerase [Lactobacillus reuteri]; 7 6 4 4 4 4 31.1 29.214 264 
>gi|148532120|gb|ABQ84119.1| NAD-dependent epimerase/dehydratase [Lactobacillus reuteri 
DSM 20016];  9 6 8 5 6 7 59.2 23.187 213 
>gi|148530457|gb|ABQ82456.1| ABC transporter related [Lactobacillus reuteri DSM 20016]; 11 7 8 6 6 8 49.6 29.359 256 
>gi|148531523|gb|ABQ83522.1| PpiC-type peptidyl-prolyl cis-trans isomerase [Lactobacillus 
reuteri DSM 20016]; 10 3 5 3 6 6 38.8 34.663 312 
>gi|148530974|gb|ABQ82973.1| GTP-binding protein LepA [Lactobacillus reuteri DSM 20016]; 12 6 8 7 8 8 25.5 68.063 611 
>gi|148531054|gb|ABQ83053.1| protein of unknown function DUF322 [Lactobacillus reuteri DSM 
20016] 10 9 9 4 7 7 81.9 13.85 127 
>gi|148531034|gb|ABQ83033.1| thymidylate synthase [Lactobacillus reuteri DSM 20016];  9 5 7 4 7 7 30.6 36.982 320 
>gi|148531575|gb|ABQ83574.1| ribonucleoside-triphosphate reductase class III catalytic subunit / 
ribonucleoside-triphosphate reductase [Lactobacillus reuteri DSM 20016] 24 10 14 6 18 17 32.3 85.159 744 
>gi|148531479|gb|ABQ83478.1| tRNA/rRNA methyltransferase (SpoU) [Lactobacillus reuteri DSM 6 3 6 3 4 3 30.6 28.31 258 
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20016]; 
>gi|227071710|gb|EEI10001.1| phosphoesterase [Lactobacillus reuteri MM2-3]; 10 6 3 2 7 7 27.2 37.97 342 
>gi|148532170|gb|ABQ84169.1| UDP-N-acetylmuramyl-tripeptide synthetase [Lactobacillus 
reuteri DSM 20016]; 13 7 7 7 10 9 30.6 57.457 516 
>gi|148531941|gb|ABQ83940.1| porphobilinogen synthase [Lactobacillus reuteri DSM 20016]; 13 9 7 7 9 11 41.2 35.84 323 
>gi|148531221|gb|ABQ83220.1| 1-deoxy-D-xylulose-5-phosphate synthase [Lactobacillus reuteri 
DSM 20016]; 13 6 4 6 6 7 26.6 65.608 591 
>gi|148532085|gb|ABQ84084.1| carbohydrate kinase, YjeF related protein [Lactobacillus reuteri 
DSM 20016]; 6 4 6 2 4 3 34 22.43 212 
>gi|148530512|gb|ABQ82511.1| LemA family protein [Lactobacillus reuteri DSM 20016]; 9 9 8 5 7 6 50.3 21.33 189 
>gi|148530623|gb|ABQ82622.1| chaperonin Cpn10 [Lactobacillus reuteri DSM 20016] 9 6 8 2 7 6 67 10.149 94 
>gi|112943728|gb|ABI26320.1| fructose-2,6-bisphosphatase [Lactobacillus reuteri]; 8 7 7 5 6 5 48.8 24.287 217 
>gi|227070968|gb|EEI09291.1| glutamate-1-semialdehyde 2,1-aminomutase [Lactobacillus reuteri 
MM2-3] 6 4 4 3 5 6 19.2 48.026 443 
>gi|148530654|gb|ABQ82653.1| Excinuclease ABC subunit A [Lactobacillus reuteri DSM 20016] 19 10 10 10 14 16 20.4 105.77 954 
>gi|148530696|gb|ABQ82695.1| carbamate kinase [Lactobacillus reuteri DSM 20016]; 12 6 7 6 6 8 41.6 33.008 310 
>gi|183227302|dbj|BAG27818.1| 30S ribosomal protein S9 [Lactobacillus fermentum IFO 3956] 5 4 4 3 5 4 31.3 14.285 131 
>gi|148531005|gb|ABQ83004.1| glycyl-tRNA synthetase alpha chain [Lactobacillus reuteri DSM 
20016] 10 6 7 8 7 6 25.6 37.843 328 
>gi|148532002|gb|ABQ84001.1| NrdI family protein [Lactobacillus reuteri DSM 20016] 6 4 5 4 5 3 41.9 17.501 155 
>gi|227069775|gb|EEI08201.1| GDSL family lipase [Lactobacillus reuteri MM2-3]; 7 4 5 5 5 6 24 42.852 384 
>gi|148530668|gb|ABQ82667.1| phosphotransacetylase [Lactobacillus reuteri DSM 20016];  13 7 9 8 12 7 45.7 34.699 324 
>gi|148530868|gb|ABQ82867.1| NUDIX hydrolase [Lactobacillus reuteri DSM 20016]; 9 7 8 6 7 5 55.2 20.827 183 
>gi|130893190|gb|ABO32597.1| ATP-dependent Clp protease ATP-binding subunit ClpC 
[Lactobacillus reuteri]; 20 10 6 5 12 18 27.5 92.89 830 
>gi|227184502|gb|EEI64573.1| phosphoribosylformylglycinamidine cyclo-ligase [Lactobacillus 
reuteri CF48-3A]; 10 5 7 3 7 1 34.5 37.031 345 
>gi|148530788|gb|ABQ82787.1| peptidase M16 domain protein [Lactobacillus reuteri DSM 
20016];  8 4 6 4 6 6 24.5 49.689 432 
>gi|194453205|gb|EDX42103.1| protein of unknown function DUF28 [Lactobacillus reuteri 100-
23]; 7 4 6 4 5 4 28.6 27.188 248 
>gi|148530714|gb|ABQ82713.1| arginine deiminase [Lactobacillus reuteri DSM 20016]; 1 15 10 11 12 12 10 34.4 46.242 410 
>gi|148530503|gb|ABQ82502.1| UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
[Lactobacillus reuteri DSM 20016]; 15 6 7 5 10 10 46.8 45.676 425 
>gi|194454673|gb|EDX43570.1| conserved hypothetical protein [Lactobacillus reuteri 100-23]; 5 3 3 4 3 3 26.8 25.988 246 
>gi|183225058|dbj|BAG25575.1| phage major head protein [Lactobacillus reuteri JCM 1112]; 7 4 3 4 3 5 19.3 43.887 394 
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>gi|148530963|gb|ABQ82962.1| protein of unknown function DUF448 [Lactobacillus reuteri DSM 
20016]; 7 5 5 4 5 4 46 11.662 100 
>gi|183224780|dbj|BAG25297.1| hypothetical protein [Lactobacillus reuteri JCM 1112]; 4 3 1 0 2 1 49.1 12.105 106 
>gi|148531719|gb|ABQ83718.1| LSU ribosomal protein L24P [Lactobacillus reuteri DSM 20016]; 4 4 4 2 4 4 47.1 10.975 102 
>gi|148531712|gb|ABQ83711.1| LSU ribosomal protein L30P [Lactobacillus reuteri DSM 20016]; 5 4 5 3 4 4 76.7 6.5566 60 
>gi|227070988|gb|EEI09311.1| precorrin-8X methylmutase [Lactobacillus reuteri MM2-3]; 6 2 6 1 1 1 34.3 25.708 230 
>gi|194453265|gb|EDX42163.1| NLP/P60 protein [Lactobacillus reuteri 100-23]; 4 3 3 3 4 3 7.8 48.822 477 
>gi|148530538|gb|ABQ82537.1| hypoxanthine phosphoribosyltransferase [Lactobacillus reuteri 
DSM 20016]; 10 5 8 7 6 6 53.3 20.464 180 
>gi|227071376|gb|EEI09682.1| malate dehydrogenase (NAD) [Lactobacillus reuteri MM2-3]; 10 5 4 5 4 8 28 35.211 321 
>gi|148531436|gb|ABQ83435.1| DNA replication and repair protein RecN [Lactobacillus reuteri 
DSM 20016]; 6 5 2 5 3 3 12.3 62.895 559 
>gi|133930481|gb|ABO43812.1| RuvA [Lactobacillus reuteri]; 3 0 2 0 2 2 16.6 22.369 199 
>gi|148530310|gb|ABQ82309.1| pyrroline-5-carboxylate reductase [Lactobacillus reuteri DSM 
20016]; 5 1 5 1 3 2 24.1 29.38 270 
>gi|148531444|gb|ABQ83443.1| protein of unknown function DUF322 [Lactobacillus reuteri DSM 
20016] 10 7 7 2 6 5 73.8 15.835 145 
>gi|296313256|gb|ACZ97544.2| D-alanine-D-alanine ligase [Lactobacillus reuteri] 4 3 3 3 3 3 16.6 33.684 301 
>gi|183226359|dbj|BAG26875.1| catabolite control protein [Lactobacillus fermentum IFO 3956] 5 4 3 4 3 5 14.1 37.084 340 
>gi|227071420|gb|EEI09725.1| FMN reductase [Lactobacillus reuteri MM2-3]; 7 7 6 4 7 7 31.9 26.152 238 
>gi|148531276|gb|ABQ83275.1| thiamine-phosphate diphosphorylase [Lactobacillus reuteri DSM 
20016] 10 6 9 4 5 5 40.5 23.849 215 
>gi|148531008|gb|ABQ83007.1| RNA polymerase, sigma 70 subunit, RpoD [Lactobacillus reuteri 
DSM 20016] 15 10 8 9 8 12 38.9 43.385 380 
>gi|148530920|gb|ABQ82919.1| small GTP-binding protein [Lactobacillus reuteri DSM 20016] 7 6 6 5 5 6 38.3 22.641 196 
>gi|148530377|gb|ABQ82376.1| 16S rRNA m(7)G-527 methyltransferase [Lactobacillus reuteri 
DSM 20016]; 9 6 7 4 7 6 41.1 26.539 241 
>gi|148531801|gb|ABQ83800.1| TrkA-N domain protein [Lactobacillus reuteri DSM 20016]; 5 4 5 4 2 3 27.9 24.531 222 
>gi|183225758|dbj|BAG26275.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112]; 7 6 6 4 6 7 32.5 22.577 203 
>gi|148531442|gb|ABQ83441.1| methenyltetrahydrofolate cyclohydrolase / 5,10-
methylenetetrahydrofolate dehydrogenase (NADP+) [Lactobacillus reuteri DSM 20016]; 4 3 4 3 3 3 16.8 30.424 286 
>gi|148532172|gb|ABQ84171.1| glucose inhibited division protein A [Lactobacillus reuteri DSM 
20016]; 8 5 5 5 5 7 15.9 71.918 647 
>gi|183227567|dbj|BAG28083.1| phosphoketolase [Lactobacillus fermentum IFO 3956];] 7 4 5 4 6 5 8.1 90.724 799 
>gi|148530828|gb|ABQ82827.1| Adenine-specific DNA methylase-like protein [Lactobacillus 
reuteri DSM 20016]; 5 3 4 4 4 3 18.8 31.155 277 
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>gi|148530723|gb|ABQ82722.1| translation factor SUA5 [Lactobacillus reuteri DSM 20016]; 11 6 4 5 6 6 39.2 37.261 342 
>gi|148530659|gb|ABQ82658.1| ATP-dependent Clp protease proteolytic subunit ClpP 
[Lactobacillus reuteri DSM 20016]; 6 5 5 5 5 4 26.9 21.433 197 
>gi|148531956|gb|ABQ83955.1| precorrin-4 C11-methyltransferase [Lactobacillus reuteri DSM 
20016]; 8 4 4 2 3 2 33.2 27.872 253 
>gi|148530886|gb|ABQ82885.1| aspartate semialdehyde dehydrogenase [Lactobacillus reuteri 
DSM 20016]; 7 4 2 3 3 5 29.5 38.274 352 
>gi|194454462|gb|EDX43359.1| peptidase S1 and S6 chymotrypsin/Hap [Lactobacillus reuteri 100-
23]; 6 1 2 3 2 5 20.2 43.882 425 
>gi|148531416|gb|ABQ83415.1| condensin subunit Smc [Lactobacillus reuteri DSM 20016]; 18 13 13 13 12 12 16.4 135.2 1187 
>gi|183227323|dbj|BAG27839.1| 50S ribosomal protein L5 [Lactobacillus fermentum IFO 3956];  5 5 4 4 5 5 27.8 20.091 180 
>gi|148531330|gb|ABQ83329.1| Peroxiredoxin [Lactobacillus reuteri DSM 20016]; 6 5 5 3 4 5 38.5 21.041 187 
>gi|227184503|gb|EEI64574.1| amidophosphoribosyltransferase [Lactobacillus reuteri CF48-3A]; 12 5 9 9 8 4 26.9 53.593 490 
>gi|227071347|gb|EEI09654.1| DNA-directed RNA polymerase delta subunit [Lactobacillus reuteri 
MM2-3]; 4 2 4 1 1 1 36.5 21.639 189 
>gi|148530787|gb|ABQ82786.1| peptidase M16 domain protein [Lactobacillus reuteri DSM 
20016]; 10 8 6 5 5 8 24.3 47.131 415 
>gi|148530614|gb|ABQ82613.1| pyrroline-5-carboxylate reductase [Lactobacillus reuteri DSM 
20016] 7 3 5 3 2 3 37 26.78 257 
>gi|148530971|gb|ABQ82970.1| GrpE protein [Lactobacillus reuteri DSM 20016]; 9 5 7 5 5 4 44.7 21.43 190 
>gi|148530601|gb|ABQ82600.1| thymidylate kinase [Lactobacillus reuteri DSM 20016]; 9 6 8 3 5 6 46.5 24.198 213 
>gi|148531757|gb|ABQ83756.1| amino acid ABC transporter ATP-binding protein, PAAT family 
[Lactobacillus reuteri DSM 20016]; 10 6 8 3 5 5 37.8 27.486 246 
>gi|148530925|gb|ABQ82924.1| RNAse Z [Lactobacillus reuteri DSM 20016];  5 1 3 3 4 4 22.7 34.498 309 
>gi|148530374|gb|ABQ82373.1| Na+ dependent nucleoside transporter domain protein 
[Lactobacillus reuteri DSM 20016]; 7 6 6 6 7 6 16.6 44.04 403 
>gi|148531352|gb|ABQ83351.1| N-acetylmuramoyl-L-alanine amidase, family 2 [Lactobacillus 
reuteri DSM 20016]; 3 2 1 1 3 2 10.8 44.687 399 
>gi|148530635|gb|ABQ82634.1| protein translocase subunit secA [Lactobacillus reuteri DSM 
20016];  15 7 9 6 8 12 20.8 90.351 787 
>gi|148530576|gb|ABQ82575.1| RNA methyltransferase, TrmH family, group 3 [Lactobacillus 
reuteri DSM 20016]; 8 7 6 4 3 5 33.7 27.28 249 
>gi|183227087|dbj|BAG27603.1| 50S ribosomal protein L27 [Lactobacillus fermentum IFO 
3956];>gi|184155743|ref|YP_001844083.1| 50S ribosomal protein L27 [Lactobacillus fermentum 
IFO 3956];>gi|226737943|sp|B2GD71.1|RL27_LACF3 RecName: Full=50S ribosomal prote 5 2 4 3 3 3 40.9 9.9871 93 
>gi|148532139|gb|ABQ84138.1| protein of unknown function DUF1002 [Lactobacillus reuteri DSM 
20016]; 10 2 4 5 4 8 35.1 35.908 333 
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>gi|148530405|gb|ABQ82404.1| acetolactate synthase, catabolic [Lactobacillus reuteri DSM 
20016] 8 6 3 5 6 3 16.3 60.994 559 
>gi|183225693|dbj|BAG26210.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112]; 7 3 5 2 3 3 22.3 41.737 364 
>gi|148531530|gb|ABQ83529.1| malate dehydrogenase (NAD) [Lactobacillus reuteri DSM 20016] 6 3 3 3 3 5 26.3 33.353 312 
>gi|148531170|gb|ABQ83169.1| LrgB family protein [Lactobacillus reuteri DSM 20016]; 4 4 3 2 4 3 22.8 26.306 246 
>gi|183226402|dbj|BAG26918.1| isoleucyl-tRNA synthase [Lactobacillus fermentum IFO 3956]; 7 6 4 5 6 4 6.5 105.63 930 
>gi|148531897|gb|ABQ83896.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016] 5 4 2 4 2 3 22 35.791 332 
>gi|148531115|gb|ABQ83114.1| hypothetical protein Lreu_0851 [Lactobacillus reuteri DSM 
20016] 7 4 3 0 5 4 61.1 10.116 90 
>gi|148531196|gb|ABQ83195.1| degV family protein [Lactobacillus reuteri DSM 20016] J 4 1 4 2 1 3 17.5 32.228 292 
>gi|148531360|gb|ABQ83359.1| hypothetical protein Lreu_1102 [Lactobacillus reuteri DSM 
20016] 6 3 4 0 3 2 61.8 10.015 89 
>gi|148531143|gb|ABQ83142.1| riboflavin synthase, alpha subunit [Lactobacillus reuteri DSM 
20016]  6 4 4 4 4 4 37 21.593 200 
>gi|183225127|dbj|BAG25644.1| hypothetical protein [Lactobacillus reuteri JCM 1112];> 7 5 4 5 6 6 21.6 40.161 352 
>gi|148531613|gb|ABQ83612.1| hypothetical protein Lreu_1363 [Lactobacillus reuteri DSM 
20016]; 3 3 1 3 3 3 15.9 19.693 189 
>gi|227070209|gb|EEI08583.1| diaminopimelate decarboxylase [Lactobacillus reuteri MM2-3];  5 4 3 2 4 2 15.2 48.355 441 
>gi|194453840|gb|EDX42737.1| conserved hypothetical protein [Lactobacillus reuteri 100-23] 5 5 4 3 4 4 24.1 28.451 245 
>gi|148531348|gb|ABQ83347.1| exodeoxyribonuclease III Xth [Lactobacillus reuteri DSM 20016 7 3 5 5 7 5 28.7 31.516 275 
>gi|148531041|gb|ABQ83040.1| Ras superfamily GTP-binding protein YlqF [Lactobacillus reuteri 
DSM 20016] 5 2 2 2 1 2 23.8 32.562 290 
>gi|148531780|gb|ABQ83779.1| Peptidylprolyl isomerase [Lactobacillus reuteri DSM 20016]; 5 4 5 3 3 3 32 22.199 197 
>gi|183227321|dbj|BAG27837.1| 30S ribosomal protein S8 [Lactobacillus fermentum IFO 3956];  6 6 5 4 5 6 35.6 14.515 132 
>gi|183225444|dbj|BAG25961.1| hypothetical protein [Lactobacillus reuteri JCM 1112  8 5 5 6 5 4 18.1 62.062 536 
>gi|148530896|gb|ABQ82895.1| peptide deformylase [Lactobacillus reuteri DSM 20016 9 8 7 8 8 9 48.4 20.898 186 
>gi|148530878|gb|ABQ82877.1| diaminopimelate epimerase [Lactobacillus reuteri DSM 20016 4 3 3 4 2 3 16.5 36.381 333 
>gi|227071504|gb|EEI09804.1| glutamate-5-semialdehyde dehydrogenase [Lactobacillus reuteri 
MM2-3]; 7 2 4 4 4 6 16.3 45.499 416 
>gi|148530690|gb|ABQ82689.1| glucose-6-phosphate isomerase [Lactobacillus reuteri DSM 20016 11 5 6 5 11 6 29.9 50.35 452 
>gi|183224052|dbj|BAG24569.1| beta-phosphoglucomutase [Lactobacillus reuteri JCM 1112 11 7 8 6 3 6 52.4 24.587 225 
>gi|148530375|gb|ABQ82374.1| Inosine/uridine-preferring nucleoside hydrolase [Lactobacillus 
reuteri DSM 20016] 5 4 3 5 4 4 21.5 32.573 302 
>gi|148530984|gb|ABQ82983.1| protein of unknown function DUF558 [Lactobacillus reuteri DSM 
20016]; 5 3 3 3 5 3 20.7 26.768 246 
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>gi|148530483|gb|ABQ82482.1| RNAse M5 [Lactobacillus reuteri DSM 20016]; 4 1 4 0 2 0 28.7 21.042 188 
>gi|148530478|gb|ABQ82477.1| hypothetical protein Lreu_0207 [Lactobacillus reuteri DSM 
20016]; 6 5 2 1 5 3 25.1 36.908 319 
>gi|227070615|gb|EEI08945.1| tRNA modification GTPase TrmE [Lactobacillus reuteri MM2-3];>  7 4 4 4 5 4 17.2 52.527 477 
>gi|148530926|gb|ABQ82925.1| short-chain dehydrogenase/reductase SDR [Lactobacillus reuteri 
DSM 20016] 7 6 4 3 5 5 26.4 31.787 284 
>gi|148530761|gb|ABQ82760.1| hypothetical protein Lreu_0492 [Lactobacillus reuteri DSM 
20016]; 5 3 4 2 3 3 16.6 27.759 247 
>gi|148531462|gb|ABQ83461.1| hypothetical protein Lreu_1204 [Lactobacillus reuteri DSM 
20016] 4 2 4 2 3 2 69 6.3153 58 
>gi|148530860|gb|ABQ82859.1| cell division protein FtsA [Lactobacillus reuteri DSM 20016]; 11 5 3 5 10 6 25.2 50.485 457 
>gi|227071203|gb|EEI09517.1| UDP-galactopyranose mutase [Lactobacillus reuteri MM2-3 9 5 5 3 4 6 21.1 44.975 384 
>gi|183224788|dbj|BAG25305.1| hypothetical phage protein [Lactobacillus reuteri JCM 1112] 12 8 9 9 10 9 58.9 25.075 219 
>gi|183226202|dbj|BAG26718.1| glutamine-fructose-6-phosphate transaminase [Lactobacillus 
fermentum IFO 3956]; 5 4 2 4 4 5 7.8 66.739 606 
>gi|227070517|gb|EEI08850.1| deoxyribose-phosphate aldolase [Lactobacillus reuteri MM2-3];> 6 5 4 3 3 3 23.2 25.76 237 
>gi|148531361|gb|ABQ83360.1| hypothetical protein Lreu_1103 [Lactobacillus reuteri DSM 20016 5 5 5 2 4 3 60 9.0878 80 
>gi|148530541|gb|ABQ82540.1| tRNA-U20-dihydrouridine synthase [Lactobacillus reuteri DSM 
20016] 8 5 7 3 4 7 29.7 37.061 333 
>gi|227070638|gb|EEI08968.1| DNA-binding response regulator [Lactobacillus reuteri MM2-3] 7 4 5 3 4 4 32.4 27.524 241 
>gi|183225783|dbj|BAG26300.1| putative aminotransferase [Lactobacillus reuteri JCM 1112]; 10 6 7 3 4 7 33 44.073 400 
>gi|183224121|dbj|BAG24638.1| hypothetical protein [Lactobacillus reuteri JCM 1112];  4 1 4 3 3 2 21.5 24.277 219 
>gi|227070121|gb|EEI08497.1| possible malate dehydrogenase [Lactobacillus reuteri MM2-3];> 6 2 2 2 2 2 24.2 39.19 360 
>gi|337729312|emb|CCC04441.1| thymidylate kinase [Lactobacillus reuteri ATCC 53608];> 8 7 6 3 5 5 36.6 24.299 213 
>gi|148530673|gb|ABQ82672.1| UDP-N-acetylmuramate dehydrogenase [Lactobacillus reuteri 
DSM 20016] 9 4 3 3 6 6 38.6 32.389 298 
>gi|148530879|gb|ABQ82878.1| aspartate kinase [Lactobacillus reuteri DSM 20016 6 2 3 3 3 4 13.3 50.12 452 
>gi|148531987|gb|ABQ83986.1| Glycerol dehydratase [Lactobacillus reuteri DSM 20016] 10 2 3 5 10 4 22.4 62.092 558 
>gi|148530435|gb|ABQ82434.1| short-chain dehydrogenase/reductase SDR [Lactobacillus reuteri 
DSM 20016] 6 5 4 3 3 4 32.5 26.39 246 
>gi|146749585|gb|ABQ44378.1| deoxynucleoside kinase [Lactobacillus reuteri]; 5 3 4 3 3 4 31 24.773 210 
>gi|148530473|gb|ABQ82472.1| nucleoside diphosphate kinase [Lactobacillus reuteri DSM 
20016]; 5 5 4 3 5 4 38.1 16.772 147 
>gi|148530817|gb|ABQ82816.1| hypothetical protein Lreu_0548 [Lactobacillus reuteri DSM 
20016]; 5 2 4 2 2 2 52 16.479 152 
>gi|133930437|gb|ABO43790.1| cytosine deaminase [Lactobacillus reuteri]; 5 4 4 5 4 4 17.7 46.441 412 
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>gi|148531474|gb|ABQ83473.1| NLP/P60 protein [Lactobacillus reuteri DSM 20016]; 4 3 2 2 3 3 22.6 22.822 212 
>gi|227070071|gb|EEI08449.1| aldose 1-epimerase [Lactobacillus reuteri MM2-3] 3 2 3 3 3 2 15.5 34.581 304 
>gi|148530286|gb|ABQ82285.1| SSU ribosomal protein S18P [Lactobacillus reuteri DSM 20016] 11 8 9 5 8 8 70.5 9.1536 78 
>gi|148530311|gb|ABQ82310.1| aldehyde dehydrogenase [Lactobacillus reuteri DSM 20016]; 6 1 5 2 3 5 18.4 50.505 457 
>gi|148531138|gb|ABQ83137.1| type I site-specific deoxyribonuclease, HsdR family [Lactobacillus 
reuteri DSM 20016]; 17 11 9 9 12 5 17.2 118.77 1041 
>gi|148530873|gb|ABQ82872.1| tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase 
[Lactobacillus reuteri DSM 20016]; 10 7 6 5 6 6 28.4 42.769 377 
>gi|183224607|dbj|BAG25124.1| pyruvate dehydrogenase complex E1 component alpha subunit 
[Lactobacillus reuteri JCM 1112 8 7 4 6 5 5 21.3 41.361 371 
>gi|133930439|gb|ABO43791.1| 2-keto-4-pentenoate hydratase [Lactobacillus reuteri]; 5 4 2 3 2 4 17.5 29.068 263 
>gi|148532084|gb|ABQ84083.1| ErfK/YbiS/YcfS/YnhG family protein [Lactobacillus reuteri DSM 
20016 5 4 3 3 3 3 24.8 24.726 218 
>gi|148530720|gb|ABQ82719.1| thymidine kinase [Lactobacillus reuteri DSM 20016]; 12 9 11 8 7 7 58.6 22.171 191 
>gi|148531875|gb|ABQ83874.1| phage shock protein C, PspC [Lactobacillus reuteri DSM 20016]; 2 2 2 2 2 2 18.1 9.3228 83 
>gi|148531473|gb|ABQ83472.1| uridine kinase [Lactobacillus reuteri DSM 20016 6 5 6 3 5 4 33.9 25.134 218 
>gi|148531098|gb|ABQ83097.1| phage portal protein, SPP1 family [Lactobacillus reuteri DSM 
20016]; 14 4 3 5 9 12 27.3 63.32 553 
>gi|227070201|gb|EEI08575.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3 7 4 6 3 3 4 60.7 13.567 117 
>gi|148531447|gb|ABQ83446.1| alanine racemase domain protein [Lactobacillus reuteri DSM 
20016];> 6 4 5 3 4 3 32.8 26.995 235 
>gi|148532169|gb|ABQ84168.1| ATP-grasp protein-like protein [Lactobacillus reuteri DSM 20016 9 7 4 7 6 7 19.6 48.604 414 
>gi|183227039|dbj|BAG27555.1| 50S Ribosomal protein L19 [Lactobacillus fermentum IFO 3956]; 5 4 4 3 4 4 25.2 13.668 119 
>gi|148530494|gb|ABQ82493.1| Cof-like hydrolase [Lactobacillus reuteri DSM 20016 7 2 6 4 3 5 28.2 30.465 273 
>gi|148530507|gb|ABQ82506.1| sortase family protein [Lactobacillus reuteri DSM 20016];> 5 5 3 2 2 2 26.5 26.348 234 
>gi|337727992|emb|CCC03081.1| diaminopimelate epimerase [Lactobacillus reuteri ATCC 53608] 2 1 1 1 1 1 9.5 35.836 328 
>gi|148530602|gb|ABQ82601.1| protein of unknown function DUF970 [Lactobacillus reuteri DSM 
20016];> 5 5 5 2 4 4 69.2 11.874 107 
>gi|183224278|dbj|BAG24795.1| phosphoglycerate mutase [Lactobacillus reuteri JCM 1112];> 7 5 5 4 5 3 30.6 29.591 255 
>gi|148530464|gb|ABQ82463.1| NLPA lipoprotein [Lactobacillus reuteri DSM 20016 8 5 4 5 4 7 31.4 31.931 283 
>gi|148530378|gb|ABQ82377.1| Effector of nucleoid occlusion Noc [Lactobacillus reuteri DSM 
20016];> 9 6 4 2 5 6 28.3 36.94 322 
>gi|148531122|gb|ABQ83121.1| holin, Cph1 family [Lactobacillus reuteri DSM 20016];> 2 2 2 0 2 2 10.1 17.139 149 
>gi|148530319|gb|ABQ82318.1| OsmC family protein [Lactobacillus reuteri DSM 20016];> 5 4 5 4 3 5 29.6 15.724 142 
>gi|148530539|gb|ABQ82538.1| membrane protease FtsH catalytic subunit [Lactobacillus reuteri 
DSM 20016 14 5 5 6 8 10 24.8 77.238 702 
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>gi|148531693|gb|ABQ83692.1| 5-(carboxyamino)imidazole ribonucleotide synthase 
[Lactobacillus reuteri DSM 20016 7 6 6 3 7 4 21.5 42.001 377 
>gi|183225042|dbj|BAG25559.1| hypothetical phage protein [Lactobacillus reuteri JCM 
1112];>gi|184153698|ref|YP_001842039.1| hypothetical protein LAR_1043 [Lactobacillus reuteri 
JCM 1112];>gi|227069922|gb|EEI08309.1| conserved hypothetical protein [Lactobac 6 2 2 5 4 4 15.8 41.121 386 
>gi|148531022|gb|ABQ83021.1| ribosomal large subunit pseudouridine synthase B [Lactobacillus 
reuteri DSM 20016];> 6 3 6 3 4 3 29.8 26.693 238 
>gi|148531286|gb|ABQ83285.1| Phosphoglycerate mutase [Lactobacillus reuteri DSM 20016 7 3 4 5 4 5 31.3 30.347 278 
>gi|227070559|gb|EEI08890.1| possible gamma-glutamyl-gamma-aminobutyrate hydrolase 
[Lactobacillus reuteri MM2-3]; 4 3 4 3 4 3 23.9 27.281 247 
>gi|148531976|gb|ABQ83975.1| ATP:cob(I)alamin adenosyltransferase [Lactobacillus reuteri DSM 
20016];> 4 3 3 2 2 2 28 16.903 157 
>gi|148530321|gb|ABQ82320.1| aromatic amino acid aminotransferase apoenzyme [Lactobacillus 
reuteri DSM 20016];> 8 5 4 5 5 6 25.6 42.52 395 
>gi|183224315|dbj|BAG24832.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 4 4 3 0 2 2 55.7 11.883 106 
>gi|183226271|dbj|BAG26787.1| D-alanine-D-alanine ligase [Lactobacillus fermentum IFO 3956];> 2 2 2 2 2 2 7.2 42.344 377 
>gi|148530914|gb|ABQ82913.1| SSU ribosomal protein S15P [Lactobacillus reuteri DSM 20016 7 7 7 5 6 6 64 10.416 89 
>gi|148531241|gb|ABQ83240.1| DSBA oxidoreductase [Lactobacillus reuteri DSM 20016]; 5 3 3 1 2 1 27.4 24.566 215 
>gi|227071111|gb|EEI09429.1| Dyp family peroxidase family protein [Lactobacillus reuteri MM2-
3];>  8 6 5 7 6 5 24 36.463 317 
>gi|148531694|gb|ABQ83693.1| xanthine phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016] 5 4 3 1 3 2 24.6 21.113 191 
>gi|112943339|gb|ABI26305.1| sphingosine kinase [Lactobacillus reuteri];> 8 4 2 4 4 3 26.1 37.14 337 
>gi|148530942|gb|ABQ82941.1| hydroxymethylglutaryl-CoA synthase [Lactobacillus reuteri DSM 
20016];> 4 3 3 3 3 4 10.4 42.757 385 
>gi|227070978|gb|EEI09301.1| cobalt-precorrin-2 C(20)-methyltransferase [Lactobacillus reuteri 
MM2-3 5 3 4 1 2 3 26.7 26.806 240 
>gi|148531000|gb|ABQ82999.1| PhoH family protein [Lactobacillus reuteri DSM 20016]; 7 3 3 5 3 7 19.7 37.467 335 
>gi|148531487|gb|ABQ83486.1| LSU ribosomal protein L32P [Lactobacillus reuteri DSM 20016 5 4 4 2 4 4 64.4 6.5727 59 
>gi|148530956|gb|ABQ82955.1| Undecaprenyl pyrophosphate synthetase [Lactobacillus reuteri 
DSM 20016] 7 5 6 5 4 2 28.1 30.635 270 
>gi|148530459|gb|ABQ82458.1| methionine-R-sulfoxide reductase [Lactobacillus reuteri DSM 
20016];  6 4 4 2 3 6 40.1 16.101 142 
>gi|148531657|gb|ABQ83656.1| methylated-DNA--protein-cysteine methyltransferase 
[Lactobacillus reuteri DSM 20016]; 2 1 2 0 1 0 13.8 17.204 152 
>gi|227185629|gb|EEI65700.1| SMC structural maintenance of chromosomes partitioning protein 
[Lactobacillus reuteri CF48-3A] 13 10 8 9 7 8 12 135.26 1187 
 159 
 
>gi|148531334|gb|ABQ83333.1| hypothetical protein Lreu_1076 [Lactobacillus reuteri DSM 20016 3 2 3 1 2 2 21.4 17.798 154 
>gi|183225185|dbj|BAG25702.1| thioredoxin [Lactobacillus reuteri JCM 1112 4 3 2 2 3 2 27.5 12.828 109 
>gi|194453683|gb|EDX42580.1| translation initiation factor IF-3 [Lactobacillus reuteri 100-23 6 3 5 3 4 4 40 19.488 170 
>gi|183227137|dbj|BAG27653.1| DNA-directed DNA polymerase I [Lactobacillus fermentum IFO 
3956 6 4 5 3 6 3 7.2 99.23 886 
>gi|148530407|gb|ABQ82406.1| 5-(carboxyamino)imidazole ribonucleotide mutase [Lactobacillus 
reuteri DSM 20016];> 6 3 6 2 4 2 59 16.958 161 
>gi|148530785|gb|ABQ82784.1| amino acid ABC transporter ATP-binding protein, PAAT family 
[Lactobacillus reuteri DSM 20016]; 6 6 5 4 5 5 29.2 23.926 216 
>gi|148531433|gb|ABQ83432.1| DNA-directed RNA polymerase subunit omega [Lactobacillus 
reuteri DSM 20016]; 6 4 4 0 6 2 87.5 7.9219 72 
>gi|227070037|gb|EEI08415.1| S-adenosyl-L-methionine-dependent methyltransferase 
[Lactobacillus reuteri MM2-3]; 6 6 6 4 5 3 33.2 26.69 238 
>gi|112943293|gb|ABI26303.1| pyruvate/2-oxoglutarate dehydrogenase complex 
dihydrolipoamide dehydrogenase (E3) component [Lactobacillus reuteri];> 8 7 6 6 7 7 21.3 50.725 475 
>gi|148530921|gb|ABQ82920.1| MazG nucleotide pyrophosphohydrolase [Lactobacillus reuteri 
DSM 20016];> 2 1 2 0 1 1 20.2 11.475 99 
>gi|148530490|gb|ABQ82489.1| purine operon repressor, PurR [Lactobacillus reuteri DSM 20016 5 5 2 3 5 5 22.4 30.926 281 
>gi|130893136|gb|ABO32595.1| D-lactate dehydrogenase [Lactobacillus reuteri];> 6 2 2 5 1 5 23.3 36.867 330 
>gi|148530385|gb|ABQ82384.1| phosphopentomutase [Lactobacillus reuteri DSM 20016];> 7 3 3 2 7 5 25.2 44.002 397 
>gi|148531430|gb|ABQ83429.1| methionyl-tRNA formyltransferase [Lactobacillus reuteri DSM 
20016];> 9 4 4 6 3 7 27.4 34.729 317 
>gi|148530733|gb|ABQ82732.1| ATP synthase F1 subcomplex delta subunit [Lactobacillus reuteri 
DSM 20016];> 2 2 1 1 1 2 10.6 20.468 180 
>gi|148531544|gb|ABQ83543.1| transcriptional regulator, LacI family [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 5 37.693 338 
>gi|148531488|gb|ABQ83487.1| protein of unknown function DUF177 [Lactobacillus reuteri DSM 
20016];> 3 0 2 1 2 2 19.5 20.961 185 
>gi|227070644|gb|EEI08974.1| phosphatidylglycerophosphatase [Lactobacillus reuteri MM2-3];> 7 5 7 4 5 5 36.7 18.978 169 
>gi|148531067|gb|ABQ83066.1| prophage antirepressor [Lactobacillus reuteri DSM 20016]; 10 2 2 3 3 9 37 28.734 257 
>gi|183224776|dbj|BAG25293.1| phage replication protein [Lactobacillus reuteri JCM 1112 7 2 3 2 3 4 23.5 34.382 294 
>gi|183224461|dbj|BAG24978.1| cell division membrane protein [Lactobacillus reuteri JCM 
1112];> 1 1 0 1 0 1 4 44.8 399 
>gi|183225137|dbj|BAG25654.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 2 2 2 2 2 2 13.7 16.242 139 
>gi|148531954|gb|ABQ83953.1| precorrin-3 methyltransferase [Lactobacillus reuteri DSM 
20016];>  10 7 8 5 7 6 32.4 26.233 241 
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>gi|148531795|gb|ABQ83794.1| Esterase/lipase-like protein [Lactobacillus reuteri DSM 20016];> 5 0 4 1 4 0 32.8 26.628 238 
>gi|148531986|gb|ABQ83985.1| dehydratase, medium subunit [Lactobacillus reuteri DSM 20016]; 5 2 3 1 2 5 24.2 25.808 236 
>gi|148532132|gb|ABQ84131.1| hypothetical protein Lreu_1894 [Lactobacillus reuteri DSM 20016 4 3 3 1 2 2 45.8 13.741 120 
>gi|133930453|gb|ABO43798.1| DnaB [Lactobacillus reuteri];> 2 1 1 1 1 2 5.2 51.331 463 
>gi|183225054|dbj|BAG25571.1| hypothetical phage protein [Lactobacillus reuteri JCM 1112];> 5 4 1 0 3 4 38.6 14.835 132 
>gi|148531744|gb|ABQ83743.1| Deoxyadenosine kinase [Lactobacillus reuteri DSM 20016 8 4 6 0 3 1 53.1 24.647 213 
>gi|227184813|gb|EEI64884.1| aspartate racemase [Lactobacillus reuteri CF48-3A];> 5 4 4 4 4 5 17.2 27.131 239 
>gi|148530653|gb|ABQ82652.1| Excinuclease ABC subunit B [Lactobacillus reuteri DSM 20016];> 11 5 2 6 4 5 17.1 79.421 690 
>gi|227070656|gb|EEI08986.1| ABC superfamily ATP binding cassette transporter, ABC protein 
[Lactobacillus reuteri MM2-3];>g 2 1 2 0 1 1 12.2 26.94 238 
>gi|148531689|gb|ABQ83688.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C 
[Lactobacillus reuteri DSM 20016]; 3 3 3 1 3 3 43.8 11.572 105 
>gi|183225864|dbj|BAG26380.1| adenylosuccinate synthase [Lactobacillus fermentum IFO 
3956];>  2 1 2 1 1 1 5.6 47.282 429 
>gi|227185635|gb|EEI65706.1| protein of hypothetical function DUF322 [Lactobacillus reuteri 
CF48-3A];>  4 3 4 3 3 3 36.1 13.014 122 
>gi|336449796|gb|AEI58411.1| HD domain protein [Lactobacillus reuteri SD2112];> 1 1 1 1 1 1 3.5 29.851 257 
>gi|148530379|gb|ABQ82378.1| chromosome segregation ATPase [Lactobacillus reuteri DSM 
20016];> 4 1 2 1 0 0 21.1 28.007 256 
>gi|227070139|gb|EEI08514.1| MazG nucleotide pyrophosphohydrolase [Lactobacillus reuteri 
MM2-3];> 2 1 1 1 1 1 13.3 13.023 113 
>gi|227070646|gb|EEI08976.1| SPOUT methyltransferase superfamily protein [Lactobacillus 
reuteri MM2-3 6 2 3 3 3 3 35.3 19.733 173 
>gi|148530662|gb|ABQ82661.1| preprotein translocase, SecG subunit [Lactobacillus reuteri DSM 
20016];> 1 1 1 0 1 0 24.1 8.5972 79 
>gi|183227656|dbj|BAG28172.1| asparagine synthase [Lactobacillus fermentum IFO 3956];> 7 5 6 6 6 6 8.8 73.993 636 
>gi|148531843|gb|ABQ83842.1| Peptidoglycan-binding LysM [Lactobacillus reuteri DSM 20016];> 3 1 2 3 2 2 17.5 37.509 355 
>gi|148530941|gb|ABQ82940.1| RNase HI [Lactobacillus reuteri DSM 20016];> 7 2 5 2 4 2 39.6 24.902 222 
>gi|148531708|gb|ABQ83707.1| bacterial translation initiation factor 1 (bIF-1) [Lactobacillus 
reuteri DSM 20016]; 5 3 4 4 3 3 66.7 8.1615 72 
>gi|148530520|gb|ABQ82519.1| DltD, C-terminal domain protein [Lactobacillus reuteri DSM 
20016];> 5 4 3 4 5 5 15.2 49.455 429 
>gi|183225184|dbj|BAG25701.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 5 3 3 0 2 2 33.8 23.595 216 
>gi|227070541|gb|EEI08874.1| phosphoribosylaminoimidazole carboxylase [Lactobacillus reuteri 
MM2-3]; 4 1 4 2 2 2 10.4 42.428 384 
>gi|148530742|gb|ABQ82741.1| hypothetical protein Lreu_0473 [Lactobacillus reuteri DSM 3 2 3 2 2 2 50 8.7648 74 
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20016]; 
>gi|148530901|gb|ABQ82900.1| protein of unknown function UPF0223 [Lactobacillus reuteri DSM 
20016]; 5 4 5 1 5 3 37.3 11.867 102 
>gi|148531400|gb|ABQ83399.1| phage antirepressor protein [Lactobacillus reuteri DSM 20016];> 10 3 2 2 4 10 36.7 30.203 267 
>gi|227186252|gb|EEI66323.1| possible aspartate transaminase [Lactobacillus reuteri CF48-3A  7 5 3 4 4 4 23 42.745 395 
>gi|148531531|gb|ABQ83530.1| hypothetical protein Lreu_1273 [Lactobacillus reuteri DSM 
20016];> 4 3 4 3 3 2 48.9 10.018 90 
>gi|227070870|gb|EEI09194.1| iron-containing alcohol dehydrogenase [Lactobacillus reuteri 
MM2-3 3 2 3 0 2 3 11.9 40.929 379 
>gi|148530842|gb|ABQ82841.1| NAD(+) kinase [Lactobacillus reuteri DSM 20016];> 7 4 6 4 5 4 29.3 30.666 270 
>gi|183225766|dbj|BAG26283.1| aspartate-ammonia ligase [Lactobacillus reuteri JCM 1112]; 13 7 6 5 7 8 42.8 39.72 339 
>gi|148530479|gb|ABQ82478.1| Silent information regulator protein Sir2 [Lactobacillus reuteri 
DSM 20016];> 5 2 4 1 1 1 23.7 26.454 232 
>gi|148530853|gb|ABQ82852.1| S-adenosyl-methyltransferase MraW [Lactobacillus reuteri DSM 
20016];> 3 3 3 3 3 3 11.6 35.666 318 
>gi|337728180|emb|CCC03271.1| Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase 
[Lactobacillus reuteri ATCC 53608] 3 2 2 1 3 2 8.8 55.966 499 
>gi|183225556|dbj|BAG26073.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 4 3 3 2 1 1 16.1 33.021 286 
>gi|148530571|gb|ABQ82570.1| deoxyuridine 5-triphosphate nucleotidohydrolase [Lactobacillus 
reuteri DSM 20016]; 5 4 4 1 3 3 29.2 20.3 178 
>gi|148531772|gb|ABQ83771.1| Uracil-DNA glycosylase superfamily [Lactobacillus reuteri DSM 
20016];> 2 1 2 1 1 1 12 24.505 217 
>gi|148531752|gb|ABQ83751.1| iron dependent repressor [Lactobacillus reuteri DSM 20016] 7 6 5 5 5 4 31.7 25.242 224 
>gi|148530329|gb|ABQ82328.1| acetyl-CoA acetyltransferase [Lactobacillus reuteri DSM 20016];> 6 4 2 4 2 5 17.9 41.055 392 
>gi|183226447|dbj|BAG26963.1| metal-dependent hydrolase of the beta-lactamase superfamily 
III [Lactobacillus fermentum IFO 3956 2 1 1 1 1 1 6.8 34.44 310 
>gi|183225182|dbj|BAG25699.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112  1 1 1 1 1 1 5.9 25.715 238 
>gi|148530346|gb|ABQ82345.1| hypothetical protein Lreu_0070 [Lactobacillus reuteri DSM 20016 3 2 2 2 2 2 13.4 29.491 261 
>gi|133930447|gb|ABO43795.1| E1 component beta subunit [Lactobacillus reuteri];> 5 2 1 2 3 3 18.5 35.243 325 
>gi|148531423|gb|ABQ83422.1| LSU ribosomal protein L28P [Lactobacillus reuteri DSM 20016 5 3 5 3 4 4 45.9 6.9271 61 
>gi|148530383|gb|ABQ82382.1| membrane protein of unknown function UCP033111 
[Lactobacillus reuteri DSM 20016];> 5 4 4 2 2 4 24.6 28.788 256 
>gi|148531981|gb|ABQ83980.1| microcompartments protein [Lactobacillus reuteri DSM 20016];> 5 1 3 2 3 3 81.2 9.7479 96 
>gi|148530744|gb|ABQ82743.1| glycine cleavage H-protein [Lactobacillus reuteri DSM 20016];> 6 4 3 0 4 2 83.5 10.641 97 
>gi|148531828|gb|ABQ83827.1| quorum-sensing autoinducer 2 (AI-2), LuxS [Lactobacillus reuteri 
DSM 20016];> 7 6 6 4 4 3 41.8 17.695 158 
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>gi|148531111|gb|ABQ83110.1| protein of unknown function DUF1306 [Lactobacillus reuteri DSM 
20016];> 6 3 3 3 4 6 22 33.264 295 
>gi|148531643|gb|ABQ83642.1| conserved hypothetical protein 730 [Lactobacillus reuteri DSM 
20016];> 3 3 3 2 3 3 14.9 21.895 195 
>gi|227070830|gb|EEI09155.1| BS_ykrK family protein [Lactobacillus reuteri MM2-3];> 5 4 4 1 3 4 23.3 21.839 193 
>gi|148531602|gb|ABQ83601.1| bacterial peptide chain release factor 3 (bRF-3) [Lactobacillus 
reuteri DSM 20016];>  9 6 5 6 6 5 19.6 59.477 525 
>gi|148531012|gb|ABQ83011.1| protein of unknown function DUF34 [Lactobacillus reuteri DSM 
20016];> 5 4 4 2 3 3 20.4 30.534 274 
>gi|148532059|gb|ABQ84058.1| ABC transporter related [Lactobacillus reuteri DSM 20016];> 6 2 5 0 2 1 33.9 28.077 254 
>gi|148531953|gb|ABQ83952.1| precorrin-6A reductase [Lactobacillus reuteri DSM 20016 6 5 4 4 4 4 29 28.054 252 
>gi|148530871|gb|ABQ82870.1| aminotransferase, class V [Lactobacillus reuteri DSM 20016];>  4 3 3 4 3 4 11.2 42.481 384 
>gi|183227153|dbj|BAG27669.1| arginyl-tRNA synthase [Lactobacillus fermentum IFO 3956]; 2 2 1 1 1 1 4.6 63.149 562 
>gi|183224876|dbj|BAG25393.1| carbamoyl-phosphate synthase large subunit [Lactobacillus 
reuteri JCM 1112 12 4 7 5 8 4 16.7 92.789 825 
>gi|148532146|gb|ABQ84145.1| hypothetical protein Lreu_1908 [Lactobacillus reuteri DSM 
20016];> 2 1 2 1 1 1 13 18.28 161 
>gi|154705574|gb|ABS84213.1| AsnC-type transcription regulator [Lactobacillus reuteri];> 6 5 4 3 3 3 40.4 17.782 156 
>gi|148531797|gb|ABQ83796.1| cystathionine beta-synthase (acetylserine-dependent) 
[Lactobacillus reuteri DSM 20016] 8 5 3 3 4 6 28.6 32.602 304 
>gi|183224612|dbj|BAG25129.1| myo-inositol-1(or 4)-monophosphatase [Lactobacillus reuteri 
JCM 1112];> 8 5 7 6 4 4 26.1 28.91 261 
>gi|148530548|gb|ABQ82547.1| amino acid/peptide transporter [Lactobacillus reuteri DSM 
20016];>  2 1 1 2 1 1 4.4 54.667 499 
>gi|148531329|gb|ABQ83328.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016]; 4 3 2 1 2 2 10.8 60.056 555 
>gi|183225947|dbj|BAG26463.1| phosphoribosylformylglycinamidine synthase II [Lactobacillus 
fermentum IFO 3956];> 3 2 2 3 2 1 4.7 79.944 741 
>gi|148530906|gb|ABQ82905.1| putative methyltransferase [Lactobacillus reuteri DSM 20016];> 7 5 5 4 4 4 33.7 20.85 187 
>gi|148530816|gb|ABQ82815.1| protein of unknown function DUF948 [Lactobacillus reuteri DSM 
20016]; 2 2 2 2 2 2 11 16.569 146 
>gi|227071772|gb|EEI10061.1| transcription antitermination protein NusB [Lactobacillus reuteri 
MM2-3];> 7 5 6 1 4 4 41.1 16.148 141 
>gi|148531472|gb|ABQ83471.1| transcription elongation factor GreA [Lactobacillus reuteri DSM 
20016];> 7 3 6 4 5 2 47.5 18.019 158 
>gi|148530351|gb|ABQ82350.1| peptidase C26 [Lactobacillus reuteri DSM 20016];> 5 3 3 3 4 4 20.1 26.977 244 
>gi|148531326|gb|ABQ83325.1| dipeptidase A, Cysteine peptidase, MEROPS family C69 
[Lactobacillus reuteri DSM 20016] 8 5 6 4 5 4 17.8 52.667 467 
 163 
 
>gi|183226119|dbj|BAG26635.1| carbamate kinase [Lactobacillus fermentum IFO 3956];> 4 3 1 1 2 2 12.3 32.714 309 
>gi|148531458|gb|ABQ83457.1| aminotransferase [Lactobacillus reuteri DSM 20016];> 9 4 5 5 3 7 23.9 43.367 393 
>gi|148531418|gb|ABQ83417.1| acyl carrier protein [Lactobacillus reuteri DSM 20016]; 4 4 2 1 3 2 52.4 9.4942 84 
>gi|194454108|gb|EDX43005.1| conserved hypothetical protein [Lactobacillus reuteri 100-23];> 3 2 0 1 3 2 11.7 38.01 350 
>gi|148531410|gb|ABQ83409.1| 16S rRNA processing protein RimM [Lactobacillus reuteri DSM 
20016];> 4 4 2 1 2 1 23.2 19.219 168 
>gi|183224799|dbj|BAG25316.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  11 2 5 4 9 8 9.5 132.13 1198 
>gi|227070039|gb|EEI08417.1| peptidase T [Lactobacillus reuteri MM2-3];> 5 3 1 3 2 3 16.2 46.484 419 
>gi|227071446|gb|EEI09749.1| possible acetyltransferase [Lactobacillus reuteri MM2-3 7 5 6 2 5 4 79.8 12.089 104 
>gi|148530794|gb|ABQ82793.1| DNA mismatch repair protein MutS [Lactobacillus reuteri DSM 
20016 8 5 3 1 7 6 8.5 99.674 881 
>gi|148531477|gb|ABQ83476.1| transcriptional regulator, HxlR family [Lactobacillus reuteri DSM 
20016 5 3 4 2 3 3 33 13.039 112 
>gi|148531144|gb|ABQ83143.1| GTP cyclohydrolase II [Lactobacillus reuteri DSM 20016];> 7 2 3 2 5 3 25.7 43.927 393 
>gi|194454301|gb|EDX43198.1| protein of unknown function DUF534 [Lactobacillus reuteri 100-
23];> 2 0 1 0 0 1 7.5 37.857 345 
>gi|148531619|gb|ABQ83618.1| hypothetical protein Lreu_1369 [Lactobacillus reuteri DSM 20016 5 5 3 3 3 2 11.2 38.188 338 
>gi|148531536|gb|ABQ83535.1| GTP cyclohydrolase I [Lactobacillus reuteri DSM 20016 3 1 2 1 2 2 16.7 22.03 192 
>gi|146345339|gb|ABQ23681.1| Zn-dependent alcohol dehydrogenase [Lactobacillus reuteri 5 4 4 5 4 4 14.7 37.938 348 
>gi|148530718|gb|ABQ82717.1| CobB/CobQ domain protein glutamine amidotransferase 
[Lactobacillus reuteri DSM 20016];> 6 5 4 2 2 4 30.6 26.134 235 
>gi|183227318|dbj|BAG27834.1| 30S ribosomal protein S5 [Lactobacillus fermentum IFO 3956 5 5 4 3 4 5 18.9 17.581 169 
>gi|148531533|gb|ABQ83532.1| Dihydropteroate synthase [Lactobacillus reuteri DSM 20016 6 2 5 3 4 2 18.3 43.584 387 
>gi|148531039|gb|ABQ83038.1| Uncharacterized protein [Lactobacillus reuteri DSM 20016 5 4 2 3 3 3 20.5 22.591 200 
>gi|148531975|gb|ABQ83974.1| LSU ribosomal protein L29P [Lactobacillus reuteri DSM 20016 6 3 2 3 3 4 15.7 51.127 477 
>gi|148530997|gb|ABQ82996.1| argininosuccinate lyase [Lactobacillus reuteri DSM 20016 3 0 2 1 2 1 5 51.92 461 
>gi|148530789|gb|ABQ82788.1| Uncharacterized protein [Lactobacillus reuteri DSM 20016 4 3 3 1 3 3 14.5 38.296 345 
>gi|148531438|gb|ABQ83437.1| hemolysin A [Lactobacillus reuteri DSM 20016 5 4 3 5 3 3 20.5 30.273 273 
>gi|227069946|gb|EEI08331.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3 5 3 1 0 4 0 33.1 19.78 175 
>gi|148530657|gb|ABQ82656.1| protein of unknown function UPF0052 and CofD [Lactobacillus 
reuteri DSM 20016];> 1 1 1 1 1 1 4.6 36.198 328 
>gi|183225679|dbj|BAG26196.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 4 2 3 1 2 3 24.7 18.055 170 
>gi|183224651|dbj|BAG25168.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112  4 4 4 4 4 4 42.7 8.6646 75 
>gi|148532042|gb|ABQ84041.1| protein of unknown function DUF488 [Lactobacillus reuteri DSM 
20016 3 2 3 1 2 2 33.1 14.61 124 
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>gi|148531026|gb|ABQ83025.1| hypothetical protein Lreu_0761 [Lactobacillus reuteri DSM 
20016];> 3 2 3 3 2 3 17.9 21.977 190 
>gi|148530739|gb|ABQ82738.1| UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
[Lactobacillus reuteri DSM 20016 5 1 2 2 4 2 16.4 47.242 438 
>gi|148531404|gb|ABQ83403.1| protein of unknown function DUF1535 [Lactobacillus reuteri DSM 
20016];> 3 2 1 2 1 2 23.7 18.631 169 
>gi|148530475|gb|ABQ82474.1| tryptophanyl-tRNA synthetase [Lactobacillus reuteri DSM 
20016];> 6 4 3 1 3 4 18.8 38.062 340 
>gi|227070750|gb|EEI09077.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3];> 10 7 8 5 6 5 37.1 25.173 221 
>gi|183224190|dbj|BAG24707.1| DNA helicase [Lactobacillus reuteri JCM 1112];>  8 1 4 2 5 7 12.2 88.988 773 
>gi|227070893|gb|EEI09216.1| DNA helicase [Lactobacillus reuteri MM2-3 11 7 6 6 7 8 14.7 90.014 775 
>gi|227071654|gb|EEI09947.1| oxalyl-CoA decarboxylase [Lactobacillus reuteri MM2-3 6 3 3 6 5 4 12.3 63.052 583 
>gi|148531126|gb|ABQ83125.1| GCN5-related N-acetyltransferase [Lactobacillus reuteri DSM 
20016 3 2 1 1 2 2 22.6 20.109 177 
>gi|148530420|gb|ABQ82419.1| hypothetical protein Lreu_0147 [Lactobacillus reuteri DSM 20016 7 4 5 3 3 3 15.8 40.003 349 
>gi|148532108|gb|ABQ84107.1| Methionine synthase, vitamin-B12 independent [Lactobacillus 
reuteri DSM 20016 6 4 2 5 5 4 21.7 42.352 378 
>gi|183226173|dbj|BAG26689.1| excinuclease ABC subunit B [Lactobacillus fermentum IFO 3956 5 3 2 3 2 3 7.2 76.358 671 
>gi|148531106|gb|ABQ83105.1| hypothetical protein Lreu_0842 [Lactobacillus reuteri DSM 20016 5 3 5 3 3 4 43.4 15.738 136 
>gi|183224586|dbj|BAG25103.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 3 2 2 1 3 1 13 26.479 230 
>gi|148532020|gb|ABQ84019.1| PEBP family protein [Lactobacillus reuteri DSM 20016 5 4 4 3 4 3 29.8 18.294 168 
>gi|148531367|gb|ABQ83366.1| phage major tail protein [Lactobacillus reuteri DSM 20016 2 1 2 1 1 1 14.8 25.3 236 
>gi|148531440|gb|ABQ83439.1| Exodeoxyribonuclease VII small subunit [Lactobacillus reuteri 
DSM 20016 1 1 1 0 1 1 18.3 10.268 93 
>gi|148532023|gb|ABQ84022.1| hypothetical protein Lreu_1783 [Lactobacillus reuteri DSM 20016 5 1 1 1 2 4 14.7 43.26 373 
>gi|148531467|gb|ABQ83466.1| 5-formyltetrahydrofolate cyclo-ligase [Lactobacillus reuteri DSM 
20016 3 2 3 2 2 2 18.5 21.115 184 
>gi|148532091|gb|ABQ84090.1| transcriptional regulator, LacI family [Lactobacillus reuteri DSM 
20016 7 6 5 3 6 3 20.7 35.062 314 
>gi|148531468|gb|ABQ83467.1| LSU ribosomal protein L33P [Lactobacillus reuteri DSM 20016 2 2 2 2 2 2 46.9 5.9998 49 
>gi|148530805|gb|ABQ82804.1| protein of unknown function DUF1292 [Lactobacillus reuteri DSM 
20016 2 2 1 0 2 2 35.7 11.401 98 
>gi|227070920|gb|EEI09243.1| possible phosphatase [Lactobacillus reuteri MM2-3 7 4 3 3 4 2 28.9 24.08 218 
>gi|148531215|gb|ABQ83214.1| Glyoxalase/bleomycin resistance protein/dioxygenase 
[Lactobacillus reuteri DSM 20016 5 5 5 1 4 4 36.9 14.777 130 
>gi|148530484|gb|ABQ82483.1| dimethyladenosine transferase [Lactobacillus reuteri DSM 20016  8 5 6 3 6 5 31.6 33.039 297 
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>gi|148530964|gb|ABQ82963.1| LSU ribosomal protein L7AE [Lactobacillus reuteri DSM 20016 
DSM 20016];> 3 3 3 3 2 3 33 11.651 103 
>gi|183224803|dbj|BAG25320.1| hypothetical protein [Lactobacillus reuteri JCM 1112 4 1 1 3 3 4 12.1 40.672 371 
>gi|148530978|gb|ABQ82977.1| hypothetical protein Lreu_0712 [Lactobacillus reuteri DSM 20016 3 3 2 3 3 3 19.7 17.36 152 
>gi|148531985|gb|ABQ83984.1| dehydratase, small subunit [Lactobacillus reuteri DSM 20016 4 2 4 2 2 1 27.9 19.319 172 
>gi|148531413|gb|ABQ83412.1| signal recognition particle subunit FFH/SRP54 (srp54) 
[Lactobacillus reuteri DSM 20016];> 6 2 4 1 2 4 14.1 54.114 481 
>gi|148531627|gb|ABQ83626.1| hypothetical protein Lreu_1377 [Lactobacillus reuteri DSM 20016 4 3 3 1 1 2 20.4 30.386 255 
>gi|227070716|gb|EEI09044.1| NAD-dependent epimerase/dehydratase [Lactobacillus reuteri 
MM2-3 6 5 3 4 4 4 22.7 27.234 242 
>gi|148531500|gb|ABQ83499.1| replicative DNA helicase loader DnaI [Lactobacillus reuteri DSM 
20016 2 1 2 1 0 1 8.6 35.847 313 
>gi|227070756|gb|EEI09083.1| ABC superfamily ATP binding cassette transporter, ABC/membrane 
protein [Lactobacillus reuteri MM2-3 5 2 1 1 2 4 7.4 72.445 666 
>gi|148531133|gb|ABQ83132.1| N-6 DNA methylase [Lactobacillus reuteri DSM 20016 5 2 3 4 3 2 10 58.018 510 
>gi|148531233|gb|ABQ83232.1| nucleotide deoxyribosyltransferase [Lactobacillus reuteri DSM 
20016];> 5 3 5 3 4 2 33.8 18.201 160 
>gi|148530565|gb|ABQ82564.1| amino acid ABC transporter membrane protein, PAAT family 
[Lactobacillus reuteri DSM 20016];> 5 5 5 4 4 4 21 26.062 233 
>gi|148530719|gb|ABQ82718.1| domain of unknown function DUF1727 [Lactobacillus reuteri 
DSM 20016];> 6 4 4 2 2 4 14.4 50.191 445 
>gi|148531973|gb|ABQ83972.1| acetate kinase [Lactobacillus reuteri DSM 20016 6 5 4 4 5 6 18.5 43.802 394 
>gi|112943862|gb|ABI26325.1| tetrahydrodipicolinate N-succinyltransferase [Lactobacillus reuteri 4 1 3 2 2 2 18.6 24.845 236 
>gi|148530534|gb|ABQ82533.1| RNA-binding S4 domain protein [Lactobacillus reuteri DSM 
20016];> 3 3 3 1 3 2 31.1 10.249 90 
>gi|183224722|dbj|BAG25239.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 4 2 2 3 3 4 16.6 33.759 296 
>gi|148530568|gb|ABQ82567.1| aminopeptidase C, Cysteine peptidase, MEROPS family C01B 
[Lactobacillus reuteri DSM 20016];> 5 4 2 4 1 5 13.2 51.985 446 
>gi|148531846|gb|ABQ83845.1| tRNA/rRNA methyltransferase (SpoU) [Lactobacillus reuteri DSM 
20016 4 1 3 2 3 1 16.6 31.804 290 
>gi|148531889|gb|ABQ83888.1| prolinase, Serine peptidase, MEROPS family S33 [Lactobacillus 
reuteri DSM 20016];> 2 1 1 2 1 1 8.6 34.841 303 
>gi|148531496|gb|ABQ83495.1| HAD superfamily (subfamily IIIA) phosphatase, TIGR01668 
[Lactobacillus reuteri DSM 20016 2 2 2 1 2 2 13.1 20.274 176 
>gi|148531368|gb|ABQ83367.1| protein of unknown function DUF806 [Lactobacillus reuteri DSM 
20016 4 3 2 1 3 4 26.8 14.543 127 
>gi|148531335|gb|ABQ83334.1| SSU ribosomal protein S14P [Lactobacillus reuteri DSM 20016 5 5 2 1 2 3 30.3 10.399 89 
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>gi|227071316|gb|EEI09625.1| peptidyl-tRNA hydrolase [Lactobacillus reuteri MM2-3];> 5 3 4 2 1 3 32.7 22.79 205 
>gi|148530966|gb|ABQ82965.1| ribosome-binding factor A [Lactobacillus reuteri DSM 20016 6 5 3 2 5 3 32.8 13.412 119 
>gi|227071224|gb|EEI09538.1| glutamate-cysteine ligase [Lactobacillus reuteri MM2-3 6 5 4 3 4 4 12 60.334 517 
>gi|148531529|gb|ABQ83528.1| phosphomethylpyrimidine kinase [Lactobacillus reuteri DSM 
20016 3 2 2 1 2 3 14.8 29.317 271 
>gi|148532138|gb|ABQ84137.1| asparaginase [Lactobacillus reuteri DSM 20016 3 2 2 2 1 3 10 35.705 329 
>gi|183224804|dbj|BAG25321.1| hypothetical protein [Lactobacillus reuteri JCM 1112 2 1 2 1 2 2 21.2 15.336 137 
>gi|148530837|gb|ABQ82836.1| Negative regulator of genetic competence [Lactobacillus reuteri 
DSM 20016 3 2 3 1 2 1 19.7 25.701 223 
>gi|148530994|gb|ABQ82993.1| GatB/Yqey domain protein [Lactobacillus reuteri DSM 20016 6 5 4 1 4 1 47.3 16.725 148 
>gi|148530371|gb|ABQ82370.1| amino acid ABC transporter membrane protein, PAAT family / 
amino acid ABC transporter substrate-binding protein, PAAT family [Lactobacillus reuteri DSM 
20016];> 3 0 0 0 1 2 8.6 53.65 487 
>gi|148532131|gb|ABQ84130.1| glutamine amidotransferase class-I [Lactobacillus reuteri DSM 
20016];> 5 3 2 2 2 1 25.1 25.353 223 
>gi|148531683|gb|ABQ83682.1| N-6 DNA methylase [Lactobacillus reuteri DSM 20016 6 3 3 3 3 2 13.9 59.038 517 
>gi|148530993|gb|ABQ82992.1| SSU ribosomal protein S21P [Lactobacillus reuteri DSM 20016];> 4 3 4 2 4 3 44.4 7.7178 63 
>gi|227184649|gb|EEI64720.1| alcohol dehydrogenase class IV [Lactobacillus reuteri CF48-3A];> 3 3 2 0 2 3 11.3 40.915 379 
>gi|133930561|gb|ABO43851.1| TetW [Lactobacillus reuteri];> 2 1 1 0 0 0 2.2 71.362 639 
>gi|194453331|gb|EDX42228.1| cell envelope-related transcriptional attenuator [Lactobacillus 
reuteri 100-23];>  5 4 2 4 4 4 20.1 38.126 334 
>gi|148530463|gb|ABQ82462.1| ABC transporter related [Lactobacillus reuteri DSM 20016 5 3 2 0 4 1 10.5 39.639 354 
>gi|227070164|gb|EEI08539.1| protein of hypothetical function DUF896 [Lactobacillus reuteri 
MM2-3];> 2 2 2 1 2 2 25.6 10.422 86 
>gi|148531087|gb|ABQ83086.1| hypothetical protein Lreu_0823 [Lactobacillus reuteri DSM 20016 2 1 2 1 1 2 24.4 10.395 86 
>gi|148531103|gb|ABQ83102.1| hypothetical protein Lreu_0839 [Lactobacillus reuteri DSM 20016 2 1 1 0 1 1 16.5 13.733 121 
>gi|227184567|gb|EEI64638.1| possible calcium-transporting ATPase [Lactobacillus reuteri CF48-
3A  6 3 4 3 4 2 7.6 100.19 911 
>gi|183226408|dbj|BAG26924.1| tRNA (5-methylaminomethyl-2-thiouridylate)- methyltransferase 
[Lactobacillus fermentum IFO 3956 2 1 1 2 1 0 5 42.445 377 
>gi|6707064|gb|AAF25576.1|AF120104_1 mucus binding protein precursor [Lactobacillus reuteri 
ATCC 53608];> 5 3 0 0 3 0 9.9 357.95 3269 
>gi|148530803|gb|ABQ82802.1| protein of unknown function DUF965 [Lactobacillus reuteri DSM 
20016];> 3 3 3 1 3 2 37.5 10.353 88 
>gi|148531074|gb|ABQ83073.1| putative transcriptional regulator, XRE family [Lactobacillus 
reuteri DSM 20016 3 1 2 1 1 1 36.7 10.465 90 
>gi|148531375|gb|ABQ83374.1| phage Terminase [Lactobacillus reuteri DSM 20016 5 2 0 0 1 5 8.7 72.459 629 
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>gi|183227399|dbj|BAG27915.1| alcohol dehydrogenase [Lactobacillus fermentum IFO 3956 3 1 2 2 1 2 8.6 37.11 347 
>gi|148531370|gb|ABQ83369.1| phage head-tail adaptor, putative [Lactobacillus reuteri DSM 
20016];> 5 3 3 3 4 3 48.3 13.324 116 
>gi|148531476|gb|ABQ83475.1| phenylalanyl-tRNA synthetase, alpha subunit [Lactobacillus 
reuteri DSM 20016 5 1 1 3 1 1 16.4 39.026 348 
>gi|148531362|gb|ABQ83361.1| Chromosome segregation ATPase-like protein [Lactobacillus 
reuteri DSM 20016 5 1 4 2 4 4 4.5 149.31 1359 
>gi|148530554|gb|ABQ82553.1| transcriptional regulator, GntR family [Lactobacillus reuteri DSM 
20016 7 3 7 2 3 3 35.2 26.59 233 
>gi|148530960|gb|ABQ82959.1| DNA polymerase III catalytic subunit, PolC type [Lactobacillus 
reuteri DSM 20016 5 1 1 0 4 4 3.9 163.27 1443 
>gi|148531168|gb|ABQ83167.1| two component transcriptional regulator, LytTR family 
[Lactobacillus reuteri DSM 20016 5 3 4 4 2 2 21.4 27.714 243 
>gi|148531521|gb|ABQ83520.1| histidine triad (HIT) protein [Lactobacillus reuteri DSM 20016 6 3 3 0 2 0 43.8 16.333 144 
>gi|227070057|gb|EEI08435.1| tetratricopeptide repeat family protein [Lactobacillus reuteri 
MM2-3];>  3 2 1 2 1 2 10.8 50.211 434 
>gi|148531165|gb|ABQ83164.1| Fmu (Sun) domain protein [Lactobacillus reuteri DSM 20016];> 2 0 1 2 0 0 6.4 51.193 455 
>gi|227071872|gb|EEI10159.1| DNA-3-methyladenine glycosylase I [Lactobacillus reuteri MM2-
3];> 3 1 2 2 2 2 14.8 23.171 196 
>gi|227070793|gb|EEI09119.1| NADPH dehydrogenase [Lactobacillus reuteri MM2-3];> 2 1 2 1 1 1 10.9 26.711 230 
>gi|148531635|gb|ABQ83634.1| methionine aminopeptidase, type I [Lactobacillus reuteri DSM 
20016 6 3 3 3 4 4 16.1 31.665 285 
>gi|183225571|dbj|BAG26088.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 4 3 3 2 2 1 18.1 27.624 249 
>gi|148530588|gb|ABQ82587.1| large conductance mechanosensitive channel protein 
[Lactobacillus reuteri DSM 20016];> 4 1 3 1 1 1 40.7 13.773 123 
>gi|148530784|gb|ABQ82783.1| amino acid ABC transporter membrane protein, PAAT family 
[Lactobacillus reuteri DSM 20016 3 2 1 0 1 0 17.7 24.169 215 
>gi|227184608|gb|EEI64679.1| ribonucleotide reductase, alpha subunit [Lactobacillus reuteri 
CF48-3A 4 3 1 1 0 1 6.1 82.149 734 
>gi|148530458|gb|ABQ82457.1| binding-protein-dependent transport systems inner membrane 
component [Lactobacillus reuteri DSM 20016 1 1 1 0 1 1 8.5 23.399 212 
>gi|183224626|dbj|BAG25143.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 3 1 1 1 1 3 10.5 35.43 304 
>gi|148532063|gb|ABQ84062.1| thioredoxin [Lactobacillus reuteri DSM 20016];> 5 2 3 1 3 1 42.9 12.064 105 
>gi|148531426|gb|ABQ83425.1| ribosome small subunit-dependent GTPase A [Lactobacillus 
reuteri DSM 20016 3 2 1 2 2 3 12.5 33.257 296 
>gi|183226120|dbj|BAG26636.1| arginine deiminase [Lactobacillus fermentum IFO 3956];> 3 2 3 2 3 2 8.4 45.948 407 
>gi|148530884|gb|ABQ82883.1| dihydrodipicolinate reductase [Lactobacillus reuteri DSM 20016 3 1 0 2 1 2 18.5 27.932 259 
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>gi|227071059|gb|EEI09378.1| phosphate regulatory protein [Lactobacillus reuteri MM2-3 3 2 1 1 1 1 13.2 27.712 243 
>gi|148530686|gb|ABQ82685.1| two component transcriptional regulator, winged helix family 
[Lactobacillus reuteri DSM 20016];> 3 1 3 2 2 2 16.7 27.76 239 
>gi|148531492|gb|ABQ83491.1| metal dependent phosphohydrolase [Lactobacillus reuteri DSM 
20016];> 2 2 1 1 0 1 9.8 23.131 204 
>gi|148531710|gb|ABQ83709.1| protein translocase subunit secY/sec61 alpha [Lactobacillus 
reuteri DSM 20016 5 1 1 2 3 4 12.6 47.772 438 
>gi|148530858|gb|ABQ82857.1| UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-acetylglucosamine transferase [Lactobacillus reuteri DSM 
20016];>  5 1 2 1 4 2 18.6 40.606 370 
>gi|148531274|gb|ABQ83273.1| Hydroxyethylthiazole kinase [Lactobacillus reuteri DSM 20016];> 2 0 1 1 1 0 11.2 29.028 269 
>gi|148531574|gb|ABQ83573.1| ribonucleoside-triphosphate reductase class III activase subunit 
[Lactobacillus reuteri DSM 20016];> 3 2 2 2 3 3 15.1 22.234 192 
>gi|183224837|dbj|BAG25354.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 6 3 3 3 3 3 17 48.212 430 
>gi|148531338|gb|ABQ83337.1| demethylmenaquinone methyltransferase [Lactobacillus reuteri 
DSM 20016];> 3 0 3 0 0 0 14.2 26.083 233 
>gi|148531151|gb|ABQ83150.1| 1,4-Dihydroxy-2-naphthoate synthase [Lactobacillus reuteri DSM 
20016 4 3 2 3 3 2 17.9 30.019 273 
>gi|227186158|gb|EEI66229.1| ribonucleoside-triphosphate reductase class III activase subunit 
[Lactobacillus reuteri CF48-3A 3 2 2 3 2 2 15.6 22.224 192 
>gi|227070128|gb|EEI08504.1| GTP diphosphokinase [Lactobacillus reuteri MM2-3 4 1 0 2 3 2 5.3 85.34 751 
>gi|148531503|gb|ABQ83502.1| dephospho-CoA kinase [Lactobacillus reuteri DSM 20016] 4 2 3 1 2 3 24.1 21.94 199 
>gi|148531891|gb|ABQ83890.1| Ferritin, Dps family protein [Lactobacillus reuteri DSM 20016 4 4 2 2 3 4 31 18.223 155 
>gi|148530416|gb|ABQ82415.1| formyltetrahydrofolate-dependent phosphoribosylglycinamide 
formyltransferase [Lactobacillus reuteri DSM 20016 4 2 3 0 2 0 27.9 21.163 190 
>gi|148530943|gb|ABQ82942.1| SOS-response transcriptional repressor, LexA [Lactobacillus 
reuteri DSM 20016 3 3 2 1 2 2 18.3 23.184 208 
>gi|148531520|gb|ABQ83519.1| ABC transporter related [Lactobacillus reuteri DSM 20016];> 5 2 4 3 2 3 26.5 27.345 245 
>gi|148531166|gb|ABQ83165.1| band 7 protein [Lactobacillus reuteri DSM 20016 5 3 3 3 2 4 17.7 31.856 288 
>gi|148532015|gb|ABQ84014.1| transcriptional regulator, LacI family [Lactobacillus reuteri DSM 
20016 3 2 0 3 3 3 9.1 36.929 330 
>gi|148531145|gb|ABQ83144.1| 6,7-dimethyl-8-ribityllumazine synthase [Lactobacillus reuteri 
DSM 20016 2 1 1 1 1 2 22.4 16.637 152 
>gi|148531193|gb|ABQ83192.1| carbamoyl-phosphate synthase small subunit [Lactobacillus 
reuteri DSM 20016];> 3 2 3 3 3 3 11.6 39.871 361 
>gi|148530977|gb|ABQ82976.1| hypothetical protein Lreu_0711 [Lactobacillus reuteri DSM 
20016];> 1 1 1 0 1 1 8.7 16.649 149 
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>gi|148531429|gb|ABQ83428.1| sun protein [Lactobacillus reuteri DSM 20016 4 2 3 2 2 2 11.6 50.377 449 
>gi|148531957|gb|ABQ83956.1| precorrin-6Y C5,15-methyltransferase (decarboxylating), CbiT 
subunit [Lactobacillus reuteri DSM 20016];> 4 3 3 1 3 3 20.7 20.387 184 
>gi|183225646|dbj|BAG26163.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  4 2 3 2 2 1 18.5 19.84 178 
>gi|148530983|gb|ABQ82982.1| [LSU ribosomal protein L11P]-lysine N-methyltransferase 
[Lactobacillus reuteri DSM 20016 5 3 3 3 2 2 17.6 34.966 319 
>gi|148531099|gb|ABQ83098.1| phage putative head morphogenesis protein, SPP1 gp7 family 
[Lactobacillus reuteri DSM 20016];> 2 1 2 1 1 2 7.6 35.825 316 
>gi|227071855|gb|EEI10143.1| penicillin-binding protein [Lactobacillus reuteri MM2-3];> 3 1 2 2 2 2 5.3 76.108 699 
>gi|183224027|dbj|BAG24544.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 6 4 1 1 4 3 29.4 20.228 180 
>gi|227071501|gb|EEI09801.1| LL-diaminopimelate aminotransferase [Lactobacillus reuteri MM2-
3 4 2 1 2 2 4 10.6 43.448 395 
>gi|336448856|gb|AEI57471.1| sensor histidine kinase [Lactobacillus reuteri SD2112 5 2 0 1 0 2 17.9 44.299 390 
>gi|227071080|gb|EEI09398.1| metallo-beta-lactamase [Lactobacillus reuteri MM2-3];> 4 2 2 1 1 2 7.3 70.828 628 
>gi|148531079|gb|ABQ83078.1| hypothetical protein Lreu_0815 [Lactobacillus reuteri DSM 20016 4 3 3 2 3 4 24.4 14.305 123 
>gi|336448233|gb|AEI56848.1| ribosomal large subunit pseudouridine synthase D [Lactobacillus 
reuteri SD2112 3 0 3 1 0 0 11.1 37.027 325 
>gi|148531769|gb|ABQ83768.1| DJ-1 family protein [Lactobacillus reuteri DSM 20016 2 1 2 0 1 1 17.9 20.995 190 
>gi|148531874|gb|ABQ83873.1| transcriptional regulator, TetR family [Lactobacillus reuteri DSM 
20016];> 2 2 1 1 1 1 15.2 20.576 178 
>gi|183224587|dbj|BAG25104.1| exodeoxyribonuclease V alpha subunit [Lactobacillus reuteri JCM 
1112 6 3 2 0 5 2 7.6 91.732 828 
>gi|148531084|gb|ABQ83083.1| hypothetical protein Lreu_0820 [Lactobacillus reuteri DSM 
20016];> 2 0 2 0 1 2 27.9 9.6179 86 
>gi|148531409|gb|ABQ83408.1| tRNA (Guanine37-N(1)-) methyltransferase [Lactobacillus reuteri 
DSM 20016];> 2 2 1 1 1 1 6.7 28.476 252 
>gi|227070907|gb|EEI09230.1| possible Bis(5-nucleosyl)-tetraphosphatase (asymmetrical) 
[Lactobacillus reuteri MM2-3];> 3 0 3 1 2 1 24.4 19.718 168 
>gi|148530818|gb|ABQ82817.1| Xaa-Pro aminopeptidase, Metallo peptidase, MEROPS family 
M24B [Lactobacillus reuteri DSM 20016];>  6 1 4 2 2 0 24.9 40.615 369 
>gi|148530572|gb|ABQ82571.1| DNA replication and repair protein RadA [Lactobacillus reuteri 
DSM 20016 3 2 1 1 2 2 9.4 49.96 457 
>gi|227071188|gb|EEI09504.1| transcriptional regulator CtsR [Lactobacillus reuteri MM2-3];> 3 3 1 1 1 1 17.4 19.037 167 
>gi|148530278|gb|ABQ82277.1| chromosomal replication initiator protein DnaA [Lactobacillus 
reuteri DSM 20016 3 1 1 1 1 3 8.4 49.942 440 
>gi|148530753|gb|ABQ82752.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016];> 4 0 0 0 2 3 18.2 32.082 280 
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>gi|148531032|gb|ABQ83031.1| Polynucleotide adenylyltransferase region [Lactobacillus reuteri 
DSM 20016 2 2 1 2 1 2 6.7 45.099 403 
>gi|227185796|gb|EEI65867.1| rod shape-determining protein MreC [Lactobacillus reuteri CF48-
3A];> 4 2 0 2 1 3 15.5 31.961 291 
>gi|148531235|gb|ABQ83234.1| hypothetical protein Lreu_0972 [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 10 13.528 120 
>gi|148531292|gb|ABQ83291.1| SMC domain protein [Lactobacillus reuteri DSM 20016 3 2 1 1 1 1 3.3 118.56 1033 
>gi|148531095|gb|ABQ83094.1| ParB domain protein nuclease [Lactobacillus reuteri DSM 
20016];> 4 1 2 1 2 3 13.9 29.81 259 
>gi|148531518|gb|ABQ83517.1| tRNA (guanine-N(7)-)-methyltransferase [Lactobacillus reuteri 
DSM 20016];> 2 1 0 1 2 2 8.5 24.675 213 
>gi|148531324|gb|ABQ83323.1| 4-oxalocrotonate tautomerase [Lactobacillus reuteri DSM 20016 1 1 1 1 1 1 18 6.8159 61 
>gi|148531516|gb|ABQ83515.1| LPXTG-motif cell wall anchor domain [Lactobacillus reuteri DSM 
20016 2 0 1 2 0 2 18.5 81.784 745 
>gi|148530737|gb|ABQ82736.1| ATP synthase F1 subcomplex epsilon subunit [Lactobacillus 
reuteri DSM 20016 2 1 1 0 1 1 17.5 15.452 143 
>gi|148531100|gb|ABQ83099.1| hypothetical protein Lreu_0836 [Lactobacillus reuteri DSM 20016  3 2 2 0 3 3 42 9.5449 81 
>gi|148530907|gb|ABQ82906.1| Phosphopantetheine adenylyltransferase [Lactobacillus reuteri 
DSM 20016 3 3 2 2 2 3 15 19.361 173 
>gi|148531640|gb|ABQ83639.1| DEAD/DEAH box helicase domain protein [Lactobacillus reuteri 
DSM 20016 3 3 1 0 2 1 8.1 48.772 433 
>gi|148530656|gb|ABQ82655.1| uncharacterized P-loop ATPase protein UPF0042 [Lactobacillus 
reuteri DSM 20016 3 1 2 0 2 1 12.1 33.671 297 
>gi|148531339|gb|ABQ83338.1| Methionine synthase, vitamin-B12 independent [Lactobacillus 
reuteri DSM 20016 4 1 2 2 1 3 11.6 42.705 379 
>gi|148532077|gb|ABQ84076.1| Phosphoglycerate mutase [Lactobacillus reuteri DSM 20016  2 2 0 0 1 1 10.6 24.661 217 
>gi|227185170|gb|EEI65241.1| amidohydrolase [Lactobacillus reuteri CF48-3A 2 1 1 1 1 0 5.7 42.662 383 
>gi|148531787|gb|ABQ83786.1| penicillin-binding protein, transpeptidase [Lactobacillus reuteri 
DSM 20016 2 1 2 2 0 1 6.8 29.751 265 
>gi|148530613|gb|ABQ82612.1| O-sialoglycoprotein endopeptidase [Lactobacillus reuteri DSM 
20016 3 3 2 1 2 3 11.1 37.453 343 
>gi|148530631|gb|ABQ82630.1| protein of unknown function UPF0029 [Lactobacillus reuteri DSM 
20016 3 2 1 0 2 2 19.5 23.548 210 
>gi|148530910|gb|ABQ82909.1| ComE operon protein 2 [Lactobacillus reuteri DSM 20016];> 3 2 2 1 3 1 18 18.085 161 
>gi|183224312|dbj|BAG24829.1| putative glutaredoxin [Lactobacillus reuteri JCM 1112 2 1 1 0 1 2 40 8.662 75 
>gi|148530511|gb|ABQ82510.1| protein tyrosine phosphatase [Lactobacillus reuteri DSM 20016[ 3 3 1 1 0 1 33.1 17.398 154 
>gi|148532003|gb|ABQ84002.1| 3-demethylubiquinone-9 3-methyltransferase [Lactobacillus 
reuteri DSM 20016];> 2 1 2 1 1 1 15.6 15.941 141 
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>gi|148531566|gb|ABQ83565.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016 2 1 1 2 1 1 7.1 30.851 282 
>gi|148531980|gb|ABQ83979.1| Propanediol utilization protein [Lactobacillus reuteri DSM 20016 5 2 3 2 5 3 25.2 23.962 214 
>gi|148531174|gb|ABQ83173.1| protein of unknown function DUF1440 [Lactobacillus reuteri DSM 
20016  3 3 3 2 3 3 20.5 18.375 166 
>gi|183226397|dbj|BAG26913.1| cell division protein FtsZ [Lactobacillus fermentum IFO 3956 3 2 1 3 0 1 6.1 45.111 429 
>gi|336448991|gb|AEI57606.1| zinc/iron ABC superfamily ATP binding cassette transporter, ABC 
protein [Lactobacillus reuteri SD2112 3 3 2 1 2 2 13.2 27.995 250 
>gi|183226087|dbj|BAG26603.1| transcription antitermination protein [Lactobacillus fermentum 
IFO 3956 2 1 2 1 2 1 21 20.377 181 
>gi|183224767|dbj|BAG25284.1| hypothetical protein [Lactobacillus reuteri JCM 1112  1 0 0 1 1 1 13.7 20.916 190 
>gi|148530495|gb|ABQ82494.1| metal dependent phosphohydrolase [Lactobacillus reuteri DSM 
20016];> 4 1 3 2 2 0 9.7 53.542 455 
>gi|148530334|gb|ABQ82333.1| two component transcriptional regulator, winged helix family 
[Lactobacillus reuteri DSM 20016];> 2 1 1 1 1 1 11.3 24.908 221 
>gi|148531751|gb|ABQ83750.1| cold-shock DNA-binding protein family [Lactobacillus reuteri DSM 
20016];>  2 2 1 1 1 1 34.8 7.3269 66 
>gi|148530599|gb|ABQ82598.1| DNA replication and repair protein RecR [Lactobacillus reuteri 
DSM 20016 4 1 3 1 1 1 15.5 22.089 200 
>gi|148530841|gb|ABQ82840.1| RelA/SpoT domain protein [Lactobacillus reuteri DSM 20016];> 4 3 2 1 1 2 17.5 25.826 217 
>gi|227070166|gb|EEI08541.1| 1-acyl-sn-glycerol-3-phosphate acyltransferase [Lactobacillus 
reuteri MM2-3 2 1 2 1 1 1 9.5 28.013 243 
>gi|148531758|gb|ABQ83757.1| amino acid ABC transporter substrate-binding protein, PAAT 
family [Lactobacillus reuteri DSM 20016];> 3 2 2 3 2 2 12.3 30.556 276 
>gi|183224605|dbj|BAG25122.1| hypothetical protein [Lactobacillus reuteri JCM 1112];> 1 1 0 0 1 1 9.3 18.717 161 
>gi|227071315|gb|EEI09624.1| cystathionine beta-synthase (CBS) domain protein [Lactobacillus 
reuteri MM2-3];> 3 3 1 1 2 1 15.8 24.393 215 
>gi|148530804|gb|ABQ82803.1| Holliday junction resolvase YqgF [Lactobacillus reuteri DSM 
20016];> 3 2 2 1 2 0 23.1 16.525 147 
>gi|148530575|gb|ABQ82574.1| ribonuclease III [Lactobacillus reuteri DSM 20016 2 1 1 1 2 1 16.8 15.515 137 
>gi|183224778|dbj|BAG25295.1| hypothetical protein [Lactobacillus reuteri JCM 1112];> 6 0 3 0 1 4 44.5 15.26 128 
>gi|148531760|gb|ABQ83759.1| amino acid ABC transporter membrane protein 2, PAAT family 
[Lactobacillus reuteri DSM 20016];> 2 1 1 1 1 2 13.8 24.332 217 
>gi|148531927|gb|ABQ83926.1| transcriptional regulator, GntR family [Lactobacillus reuteri DSM 
20016 2 2 1 1 2 2 9.5 27.747 243 
>gi|148530515|gb|ABQ82514.1| DEAD/DEAH box helicase domain protein [Lactobacillus reuteri 
DSM 20016];> 4 3 1 0 1 3 8.4 56.522 498 
>gi|148530636|gb|ABQ82635.1| bacterial peptide chain release factor 2 (bRF-2) [Lactobacillus 
reuteri DSM 20016];> 2 2 1 2 0 1 8.4 37.463 332 
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>gi|227185380|gb|EEI65451.1| site-specific DNA-methyltransferase (adenine-specific) 
[Lactobacillus reuteri CF48-3A];> 2 1 1 1 2 1 3.3 57.986 512 
>gi|148530461|gb|ABQ82460.1| acetylornithine deacetylase [Lactobacillus reuteri DSM 20016];> 2 1 1 0 0 0 6 41.681 381 
>gi|148531774|gb|ABQ83773.1| transcriptional regulator, LysR family [Lactobacillus reuteri DSM 
20016];> 4 1 3 1 2 0 11.9 33.598 295 
>gi|148531428|gb|ABQ83427.1| Protein phosphatase 2C-like protein [Lactobacillus reuteri DSM 
20016];> 3 2 3 1 2 2 12.2 26.923 246 
>gi|183224761|dbj|BAG25278.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  2 2 1 1 1 2 10.9 21.003 184 
>gi|148530813|gb|ABQ82812.1| CBS domain containing protein [Lactobacillus reuteri DSM 
20016];> 3 3 2 1 2 2 17 16.967 147 
>gi|227070532|gb|EEI08865.1| orotidine-5-phosphate decarboxylase [Lactobacillus reuteri MM2-
3];> 2 1 2 1 1 1 8.5 26.968 248 
>gi|148530848|gb|ABQ82847.1| RNA methyltransferase, TrmH family, group 2 [Lactobacillus 
reuteri DSM 20016];> 3 1 3 0 1 1 20.7 19.557 169 
>gi|194453849|gb|EDX42746.1| cell envelope-related transcriptional attenuator [Lactobacillus 
reuteri 100-23 2 1 1 1 1 1 5.3 55.148 489 
>gi|119390607|pdb|2NT8|A Chain A, Atp Bound At The Active Site Of A Pduo Type Atp:co(I) 
Rrinoid Adenosyltransferase From Lactobacillus Reuteri;> 2 1 1 0 1 2 9.9 25.598 223 
>gi|148531071|gb|ABQ83070.1| transcriptional regulator, XRE family [Lactobacillus reuteri DSM 
20016];> 3 1 1 0 3 3 37.8 9.7862 82 
>gi|148530790|gb|ABQ82789.1| CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase [Lactobacillus reuteri DSM 20016];> 2 1 1 0 1 0 11.8 21.79 195 
>gi|227070045|gb|EEI08423.1| possible reductase [Lactobacillus reuteri MM2-3 2 1 1 1 1 2 20.8 14.924 125 
>gi|148531512|gb|ABQ83511.1| L-glutaminase [Lactobacillus reuteri DSM 20016];> 2 1 1 2 1 1 6.9 33.392 306 
>gi|148532176|gb|ABQ84175.1| ribonuclease P protein component [Lactobacillus reuteri DSM 
20016 2 2 2 0 2 1 18.8 13.651 117 
>gi|148531992|gb|ABQ83991.1| major intrinsic protein [Lactobacillus reuteri DSM 20016 1 1 1 1 1 1 4.7 25.304 235 
>gi|183225835|dbj|BAG26351.1| two-component response regulator [Lactobacillus fermentum 
IFO 3956 3 1 1 2 1 3 9.8 26.747 235 
>gi|148530393|gb|ABQ82392.1| branched-chain amino acid transport [Lactobacillus reuteri DSM 
20016];>  1 1 1 1 1 1 8.8 12.954 114 
>gi|300379508|gb|ADK08386.1| alkyl hydroperoxide reductase F subunit [Lactobacillus reuteri] 2 1 1 0 1 0 4.9 55.347 512 
>gi|148531175|gb|ABQ83174.1| isopentenyl-diphosphate delta-isomerase, type 2 [Lactobacillus 
reuteri DSM 20016];> 3 2 1 2 3 2 10.3 38.769 348 
>gi|148531449|gb|ABQ83448.1| protein of unknown function DUF464 [Lactobacillus reuteri DSM 
20016];> 2 1 2 0 1 1 32.7 11.705 107 
>gi|227070762|gb|EEI09089.1| NRAMP family manganese (Mn2+) transporter [Lactobacillus 
reuteri MM2-3 3 1 1 1 3 2 6.4 59.447 546 
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>gi|148530836|gb|ABQ82835.1| arsenate reductase-like protein [Lactobacillus reuteri DSM 20016 4 2 3 0 3 3 34.6 15.539 133 
>gi|183224289|dbj|BAG24806.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 2 1 1 1 2 2 6.5 43.741 383 
>gi|148530487|gb|ABQ82486.1| periplasmic solute binding protein [Lactobacillus reuteri DSM 
20016];> 2 1 2 1 0 0 7.3 34.078 303 
>gi|148530499|gb|ABQ82498.1| Domain of unknown function DUF1934 [Lactobacillus reuteri 
DSM 20016];> 3 1 1 1 2 0 22.7 15.33 132 
>gi|227070084|gb|EEI08461.1| metal-dependent hydrolase [Lactobacillus reuteri MM2-3 2 1 1 1 1 2 11.2 18.134 160 
>gi|337729366|emb|CCC04496.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608] 2 2 0 0 0 0 4.7 44.72 402 
>gi|227071130|gb|EEI09446.1| TrmA family tRNA (uracil-5-)-methyltransferase [Lactobacillus 
reuteri MM2-3 3 1 2 0 1 1 7.9 53.815 480 
>gi|148530400|gb|ABQ82399.1| orotate phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016];> 2 2 1 0 1 1 8 23.434 213 
>gi|227184596|gb|EEI64667.1| transcriptional regulator [Lactobacillus reuteri CF48-3A  2 1 1 1 2 1 9.1 27.898 243 
>gi|148531537|gb|ABQ83536.1| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
pyrophosphokinase [Lactobacillus reuteri DSM 20016  3 1 2 2 1 1 14.1 19.815 170 
>gi|183225948|dbj|BAG26464.1| amidophosphoribosyltransferase [Lactobacillus fermentum IFO 
3956 3 1 2 1 1 1 6.2 53.518 487 
>gi|148530649|gb|ABQ82648.1| thioesterase superfamily protein [Lactobacillus reuteri DSM 
20016 2 2 2 2 1 1 13.7 19.242 168 
>gi|148531190|gb|ABQ83189.1| hypothetical protein Lreu_0927 [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 8.1 15.956 135 
>gi|148531700|gb|ABQ83699.1| cobalt transport protein [Lactobacillus reuteri DSM 20016 3 1 2 0 1 1 12.4 30.347 267 
>gi|183226825|dbj|BAG27341.1| 1-deoxy-D-xylulose-5-phosphate synthase [Lactobacillus 
fermentum IFO 3956 2 2 0 1 0 1 5.4 65.874 592 
>gi|183225944|dbj|BAG26460.1| phosphoribosylaminoimidazole-succinocarboxamide synthase 
[Lactobacillus fermentum IFO 3956 1 1 1 1 1 0 5.4 27.483 240 
>gi|148532142|gb|ABQ84141.1| Hydratase/decarboxylase [Lactobacillus reuteri DSM 20016 2 2 2 2 2 2 6.3 29.863 270 
>gi|148530456|gb|ABQ82455.1| binding-protein-dependent transport systems inner membrane 
component [Lactobacillus reuteri DSM 20016 1 1 1 0 1 1 5 24.06 221 
>gi|148530651|gb|ABQ82650.1| hydrolase of HD superfamily-like protein [Lactobacillus reuteri 
DSM 20016];>gi|148543617|ref|YP_001270987.1| HD superfamily hydrolase-like protein 
[Lactobacillus reuteri DSM 20016];> 4 0 2 1 2 0 18.9 24.304 212 
>gi|148532000|gb|ABQ83999.1| ABC-type multidrug transport system ATPase component-like 
protein [Lactobacillus reuteri DSM 20016];> 1 1 1 1 1 1 3.5 31.737 287 
>gi|148531803|gb|ABQ83802.1| 67 kDa myosin-cross-reactive antigen family protein 
[Lactobacillus reuteri DSM 20016];> 4 2 3 1 3 3 8.1 67.715 590 
>gi|227184772|gb|EEI64843.1| protein-tyrosine-phosphatase [Lactobacillus reuteri CF48-3A];> 2 1 1 0 1 2 9.8 30.178 265 
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>gi|148531939|gb|ABQ83938.1| adenosylcobinamide kinase [Lactobacillus reuteri DSM 20016];> 2 2 0 0 0 1 12.2 22.192 196 
>gi|148530976|gb|ABQ82975.1| hypothetical protein Lreu_0710 [Lactobacillus reuteri DSM 
20016];> 2 0 1 1 0 1 8.2 28.409 244 
>gi|194453872|gb|EDX42769.1| hypothetical protein Lreu23DRAFT_4288 [Lactobacillus reuteri 
100-23 1 1 0 1 1 1 1.6 69.515 629 
>gi|148531699|gb|ABQ83698.1| tRNA pseudouridine synthase A [Lactobacillus reuteri DSM 
20016];> 4 1 2 0 1 1 15.2 29.138 256 
>gi|148531457|gb|ABQ83456.1| NLPA lipoprotein [Lactobacillus reuteri DSM 20016];> 1 1 0 0 0 1 4.2 31.575 283 
>gi|148531446|gb|ABQ83445.1| peptidase M24 [Lactobacillus reuteri DSM 20016 2 1 1 1 2 1 6.1 39.767 358 
>gi|148531411|gb|ABQ83410.1| hypothetical protein Lreu_1153 [Lactobacillus reuteri DSM 
20016];> 3 1 2 2 2 2 34.9 9.7331 86 
>gi|148531080|gb|ABQ83079.1| hypothetical protein Lreu_0816 [Lactobacillus reuteri DSM 20016 1 1 1 0 0 0 16.3 10.515 92 
>gi|148530356|gb|ABQ82355.1| Protein of unknown function DUF1975 [Lactobacillus reuteri DSM 
20016];> 2 1 0 1 0 1 4.5 59.726 513 
>gi|148531785|gb|ABQ83784.1| hypothetical protein Lreu_1539 [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 1 1 15.1 16.827 146 
>gi|148530965|gb|ABQ82964.1| bacterial translation initiation factor 2 (bIF-2) [Lactobacillus 
reuteri DSM 20016];> 2 1 0 0 1 2 3.1 83.537 752 
>gi|148531636|gb|ABQ83635.1| flavodoxin [Lactobacillus reuteri DSM 20016];> 2 2 2 1 1 2 12.5 16.373 152 
>gi|148531996|gb|ABQ83995.1| B3/4 domain protein [Lactobacillus reuteri DSM 20016 3 1 2 1 2 2 12.4 27.29 241 
>gi|148532096|gb|ABQ84095.1| ABC transporter related [Lactobacillus reuteri DSM 20016 2 1 2 0 0 0 11.4 25.064 229 
>gi|148530932|gb|ABQ82931.1| phage head-tail adaptor, putative [Lactobacillus reuteri DSM 
20016  1 1 1 1 1 1 10.1 13.175 119 
>gi|148531401|gb|ABQ83400.1| transcriptional regulator, XRE family [Lactobacillus reuteri DSM 
20016 1 1 1 1 1 1 14.9 7.715 67 
>gi|148531835|gb|ABQ83834.1| cytochrome b5 [Lactobacillus reuteri DSM 20016 1 1 0 0 1 0 21.2 8.6688 80 
>gi|148531212|gb|ABQ83211.1| protein of unknown function DUF21 [Lactobacillus reuteri DSM 
20016 1 1 1 1 1 1 2.4 52.119 453 
>gi|148531490|gb|ABQ83489.1| Methyltransferase type 12 [Lactobacillus reuteri DSM 20016];> 2 2 1 2 1 1 7.7 28.291 246 
>gi|183225246|dbj|BAG25763.1| hypothetical protein [Lactobacillus reuteri JCM 1112  2 1 1 1 2 1 6.4 33.488 297 
>gi|148531620|gb|ABQ83619.1| glycosyl transferase, group 1 [Lactobacillus reuteri DSM 20016 2 1 1 1 0 0 7.4 40.131 349 
>gi|148531272|gb|ABQ83271.1| hypothetical protein Lreu_1011 [Lactobacillus reuteri DSM 20016 3 1 0 0 1 1 5.2 72.576 629 
>gi|227070859|gb|EEI09184.1| nicotinamide mononucleotide transporter [Lactobacillus reuteri 
MM2-3];> 2 2 1 2 2 2 6.2 30.903 276 
>gi|148530683|gb|ABQ82682.1| transcriptional regulator, MarR family [Lactobacillus reuteri DSM 
20016];> 2 2 1 0 0 0 12.6 17.828 151 
>gi|194453686|gb|EDX42583.1| ATP-cone domain protein [Lactobacillus reuteri 100-23];> 2 1 2 1 1 2 15.5 18.122 155 
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>gi|183227385|dbj|BAG27901.1| malolactic regulator [Lactobacillus fermentum IFO 3956 2 2 1 0 1 0 8.4 33.124 297 
>gi|148531137|gb|ABQ83136.1| restriction modification system DNA specificity domain 
[Lactobacillus reuteri DSM 20016];> 2 0 0 1 1 1 4.8 42.885 375 
>gi|337729524|emb|CCC04655.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608] 3 2 0 0 0 1 3.8 94.907 821 
>gi|148531374|gb|ABQ83373.1| phage portal protein, HK97 family [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 2 1 6.8 43.309 396 
>gi|148531707|gb|ABQ83706.1| LSU ribosomal protein L36P [Lactobacillus reuteri DSM 20016];> 1 0 0 1 0 1 25.6 4.5345 39 
>gi|227185263|gb|EEI65334.1| aldo/keto reductase [Lactobacillus reuteri CF48-3A 2 1 2 0 2 0 6.4 35.985 326 
>gi|194454517|gb|EDX43414.1| Protein of unknown function DUF1975 [Lactobacillus reuteri 100-
23];> 2 0 0 1 0 2 6.2 59.739 513 
>gi|148530372|gb|ABQ82371.1| amino acid ABC transporter ATP-binding protein, PAAT family 
[Lactobacillus reuteri DSM 20016 3 3 2 1 2 1 15 27.521 247 
>gi|227071659|gb|EEI09952.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3 2 1 1 0 0 2 11 19.844 173 
>gi|337727943|emb|CCC03032.1| adenine phosphoribosyltransferase [Lactobacillus reuteri ATCC 
53608];> 3 3 0 0 0 0 19.2 18.664 172 
>gi|148531452|gb|ABQ83451.1| hypothetical protein Lreu_1194 [Lactobacillus reuteri DSM 
20016];> 2 0 1 0 2 0 8.3 19.53 168 
>gi|148531179|gb|ABQ83178.1| DnaQ family exonuclease/DinG family helicase, putative 
[Lactobacillus reuteri DSM 20016];> 3 0 0 0 3 0 4 108.2 954 
>gi|227070539|gb|EEI08872.1| acetolactate decarboxylase [Lactobacillus reuteri MM2-3];> 3 1 1 2 2 2 9.3 27.238 246 
>gi|148531565|gb|ABQ83564.1| heat shock protein Hsp20 [Lactobacillus reuteri DSM 20016];> 2 0 2 0 2 0 16.1 16.747 143 
>gi|148531789|gb|ABQ83788.1| major facilitator superfamily MFS_1 [Lactobacillus reuteri DSM 
20016 1 1 1 1 1 1 2.2 43.836 405 
>gi|183227479|dbj|BAG27995.1| transposase [Lactobacillus fermentum IFO 3956];>] 2 1 0 0 1 0 5.9 29.427 256 
>gi|148531804|gb|ABQ83803.1| nitroreductase [Lactobacillus reuteri DSM 20016 2 1 1 0 0 2 8.7 28.863 253 
>gi|183224791|dbj|BAG25308.1| hypothetical phage protein [Lactobacillus reuteri JCM 1112];> 1 1 1 0 1 1 15.9 12.096 107 
>gi|148531759|gb|ABQ83758.1| amino acid ABC transporter membrane protein 1, PAAT family 
[Lactobacillus reuteri DSM 20016];> 2 2 2 1 1 2 11.3 23.543 212 
>gi|148531353|gb|ABQ83352.1| hypothetical protein Lreu_1095 [Lactobacillus reuteri DSM 
20016];> 1 1 0 0 1 1 13 13.383 123 
>gi|227071585|gb|EEI09882.1| uracil-DNA glycosylase [Lactobacillus reuteri MM2-3 1 1 1 1 1 1 6.9 27.942 245 
>gi|148530839|gb|ABQ82838.1| dipeptidase A, Cysteine peptidase, MEROPS family C69 
[Lactobacillus reuteri DSM 20016];> 2 2 1 2 2 2 4.6 51.591 458 
>gi|148531952|gb|ABQ83951.1| uroporphyrinogen-III C-methyltransferase [Lactobacillus reuteri 
DSM 20016];> 2 0 0 1 1 0 6 51.349 464 
>gi|148530411|gb|ABQ82410.1| phosphoribosylformylglycinamidine synthase, purS [Lactobacillus 2 0 1 0 1 0 22 9.3323 82 
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reuteri DSM 20016 
>gi|148530320|gb|ABQ82319.1| D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding 
protein [Lactobacillus reuteri DSM 20016 1 1 1 0 0 1 4.2 36.471 331 
>gi|183225293|dbj|BAG25810.1| galactosyltransferase [Lactobacillus reuteri JCM 1112 [ 4 2 1 3 2 2 16.1 25.338 218 
>gi|148531784|gb|ABQ83783.1| aldose 1-epimerase [Lactobacillus reuteri DSM 20016 1 1 0 1 0 1 2.9 37.927 345 
>gi|148530754|gb|ABQ82753.1| transcriptional regulator, GntR family [Lactobacillus reuteri DSM 
20016 2 1 1 0 1 2 4.9 41.571 365 
>gi|148532052|gb|ABQ84051.1| Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 
[Lactobacillus reuteri DSM 20016 2 1 1 1 2 1 14.7 22.38 197 
>gi|148530678|gb|ABQ82677.1| YbbR family protein [Lactobacillus reuteri DSM 20016 J 3 0 0 2 1 0 13.4 32.748 299 
>gi|337728183|emb|CCC03274.1| hypothetical protein LRATCC53608_0523 [Lactobacillus reuteri 
ATCC 53608] 3 2 1 0 2 1 13.4 22.62 209 
>gi|227185256|gb|EEI65327.1| peptidase M10A and M12B, matrixin and adamalysin 
[Lactobacillus reuteri CF48-3A];> 2 1 2 1 2 1 7.8 26.997 244 
>gi|148530694|gb|ABQ82693.1| response regulator receiver protein [Lactobacillus reuteri DSM 
20016];>  1 1 1 0 0 0 5.4 31.663 279 
>gi|148531048|gb|ABQ83047.1| DNA topoisomerase IV subunit A [Lactobacillus reuteri DSM 
20016];> 4 1 1 2 4 1 6.1 92.718 821 
>gi|49242758|emb|CAG41483.1| transport system membrane protein [Staphylococcus aureus 
subsp. aureus MRSA252];> 2 1 1 2 1 1 9.2 26.496 239 
>gi|183224486|dbj|BAG25003.1| cell division regulatory protein [Lactobacillus reuteri JCM 
1112];> 3 1 0 2 0 1 6.3 66.585 570 
>gi|148532145|gb|ABQ84144.1| transcriptional regulator [Lactobacillus reuteri DSM 20016];> 2 2 0 1 1 0 6.9 32.842 289 
>gi|148531083|gb|ABQ83082.1| hypothetical protein Lreu_0819 [Lactobacillus reuteri DSM 20016 1 1 0 0 1 1 17.2 7.5354 64 
>gi|148531988|gb|ABQ83987.1| microcompartments protein [Lactobacillus reuteri DSM 20016 3 1 0 0 0 2 18.5 24.945 238 
>gi|112944062|gb|ABI26332.1| phosphoglycerate mutase [Lactobacillus reuteri 2 0 1 1 1 1 7.8 24.692 218 
>gi|194454116|gb|EDX43013.1| hypothetical protein Lreu23DRAFT_4532 [Lactobacillus reuteri 
100-23 1 0 0 1 1 0 19.5 4.7396 41 
>gi|227070651|gb|EEI08981.1| rhodanese domain protein [Lactobacillus reuteri MM2-3];> 2 1 2 1 2 1 8.8 29.725 261 
>gi|148531180|gb|ABQ83179.1| Uncharacterized protein [Lactobacillus reuteri DSM 20016];> 2 1 0 0 1 2 12.2 19.912 172 
>gi|227070790|gb|EEI09116.1| possible DNA-3-methyladenine glycosylase II [Lactobacillus reuteri 
MM2-3];> 2 1 1 0 1 1 9 24.938 222 
>gi|337728658|emb|CCC03769.1| putative lipoprotein [Lactobacillus reuteri ATCC 53608 2 2 0 0 0 0 10.2 24.095 216 
>gi|148530603|gb|ABQ82602.1| DNA polymerase III, delta prime subunit [Lactobacillus reuteri 
DSM 20016 1 1 1 0 1 0 4.5 37.892 337 
>gi|148530535|gb|ABQ82534.1| Septum formation initiator [Lactobacillus reuteri DSM 20016];>  1 0 1 1 0 1 8.5 14.01 118 
>gi|148530915|gb|ABQ82914.1| beta-lactamase domain protein [Lactobacillus reuteri DSM 2 1 1 1 1 2 3.5 66.72 593 
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20016];> 
>gi|148532105|gb|ABQ84104.1| ketopantoate reductase [Lactobacillus reuteri DSM 20016];> 2 1 0 0 1 2 5.3 36.285 318 
>gi|227184639|gb|EEI64710.1| propanediol dehydratase, large subunit [Lactobacillus reuteri 
CF48-3A];> 2 1 2 1 1 2 2.3 65.4 615 
>gi|148531951|gb|ABQ83950.1| anaerobic cobaltochelatase [Lactobacillus reuteri DSM 20016];> 3 1 0 1 1 2 16.6 29.176 259 
>gi|194454644|gb|EDX43541.1| hypothetical protein Lreu23DRAFT_5063 [Lactobacillus reuteri 
100-23 1 1 1 1 1 0 5.9 19.747 169 
>gi|148532114|gb|ABQ84113.1| transcriptional regulator, HxlR family [Lactobacillus reuteri DSM 
20016];> 2 0 2 0 1 0 11.5 14.22 122 
>gi|148530779|gb|ABQ82778.1| FolC bifunctional protein [Lactobacillus reuteri DSM 20016];>  1 1 1 0 1 0 3.2 47.999 437 
>gi|227071709|gb|EEI10000.1| ATP-dependent RNA helicase [Lactobacillus reuteri MM2-3 2 0 1 1 0 2 4.7 53.802 467 
>gi|148531437|gb|ABQ83436.1| transcriptional regulator, ArgR family [Lactobacillus reuteri DSM 
20016 1 1 1 1 1 0 8.7 16.881 150 
>gi|148530337|gb|ABQ82336.1| glutamate-cysteine ligase [Lactobacillus reuteri DSM 20016 2 0 1 0 1 0 5.8 51.01 446 
>gi|337728749|emb|CCC03868.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608 3 0 1 1 1 1 13.7 33.684 292 
>gi|148532016|gb|ABQ84015.1| UTP-hexose-1-phosphate uridylyltransferase [Lactobacillus 
reuteri DSM 20016 1 1 1 1 1 1 2.3 54.926 483 
>gi|148531876|gb|ABQ83875.1| hypothetical protein Lreu_1635 [Lactobacillus reuteri DSM 
20016];> 2 2 2 2 2 2 5.4 31.711 279 
>gi|148531224|gb|ABQ83223.1| DNA/RNA non-specific endonuclease [Lactobacillus reuteri DSM 
20016 2 0 2 1 1 1 8.8 31.236 284 
>gi|228752976|gb|EEM02516.1| Transposase IS116/IS110/IS902 [Bacillus mycoides Rock1-4];> 2 1 2 1 2 0 5.7 47.304 403 
>gi|148531644|gb|ABQ83643.1| malate dehydrogenase (NAD) [Lactobacillus reuteri DSM 20016 3 1 1 0 2 1 10.7 33.353 307 
>gi|227070914|gb|EEI09237.1| ABC superfamily ATP binding cassette transporter, ABC protein 
[Lactobacillus reuteri MM2-3];> 2 1 0 1 2 1 6.8 41.798 370 
>gi|148531298|gb|ABQ83297.1| hypothetical protein Lreu_1037 [Lactobacillus reuteri DSM 
20016];> 1 1 0 0 1 0 2.1 69.932 630 
>gi|148530908|gb|ABQ82907.1| secreted protein containing a PDZ domain-like protein 
[Lactobacillus reuteri DSM 20016 1 1 1 0 1 0 4.3 38.633 350 
>gi|183224812|dbj|BAG25329.1| putative amidase [Lactobacillus reuteri JCM 1112];> 2 1 1 2 1 1 2.6 70.612 645 
>gi|148531534|gb|ABQ83533.1| Ham1 family protein [Lactobacillus reuteri DSM 20016];>  1 1 1 1 0 1 6.2 21.804 195 
>gi|183227658|dbj|BAG28174.1| glucose inhibited division protein [Lactobacillus fermentum IFO 
3956];> 2 1 2 1 1 1 3.2 70.176 634 
>gi|148531919|gb|ABQ83918.1| translation elongation factor 2 (EF-2/EF-G) [Lactobacillus reuteri 
DSM 20016];> 2 2 1 2 1 1 2.6 71.217 642 
>gi|194453810|gb|EDX42707.1| VRR-NUC domain protein [Lactobacillus reuteri 100-23];> 1 1 1 1 1 1 7.1 12.669 112 
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>gi|148530713|gb|ABQ82712.1| beta-lactamase [Lactobacillus reuteri DSM 20016 2 0 0 0 2 0 6.5 38.305 339 
>gi|133930445|gb|ABO43794.1| AraA [Lactobacillus reuteri];>gi|148530751|gb|ABQ82750.1| L-
arabinose isomerase [Lactobacillus reuteri DSM 20016];> 2 1 0 1 0 0 4 53.759 473 
>gi|337728903|emb|CCC04023.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608];> 2 1 0 2 1 2 5.6 30.777 286 
>gi|183225651|dbj|BAG26168.1| putative transport protein [Lactobacillus reuteri JCM 1112 2 1 1 0 0 0 4.3 42.512 392 
>gi|183224728|dbj|BAG25245.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 1 1 1 1 1 1 2.6 40.889 344 
>gi|227186022|gb|EEI66093.1| recombination regulator RecX [Lactobacillus reuteri CF48-3A];> 2 0 1 0 1 1 8.5 31.88 271 
>gi|148530715|gb|ABQ82714.1| transcriptional regulator, ArgR family [Lactobacillus reuteri DSM 
20016];>  2 1 2 0 2 0 14.4 17.482 153 
>gi|148532081|gb|ABQ84080.1| protein of unknown function DUF915, hydrolase family protein 
[Lactobacillus reuteri DSM 20016];> 1 1 1 0 1 0 3.2 31.277 284 
>gi|148531717|gb|ABQ83716.1| SSU ribosomal protein S14P [Lactobacillus reuteri DSM 20016 3 2 3 1 3 1 27.9 7.1065 61 
>gi|324978619|gb|EGC15568.1| APC family amino acid transporter [Lactobacillus reuteri MM4-
1A];> [ 4 2 0 1 2 1 7.2 49.893 460 
>gi|148530702|gb|ABQ82701.1| hypothetical protein Lreu_0432 [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 7 18.525 158 
>gi|148531105|gb|ABQ83104.1| hypothetical protein Lreu_0841 [Lactobacillus reuteri DSM 
20016];> 2 0 0 0 0 2 9.7 20.695 186 
>gi|183226724|dbj|BAG27240.1| topoisomerase IV subunit A [Lactobacillus fermentum IFO 3956] 3 2 2 1 2 1 3.4 92.09 825 
>gi|148531178|gb|ABQ83177.1| mevalonate kinase [Lactobacillus reuteri DSM 20016 3 2 0 0 1 1 13.3 34.209 316 
>gi|227185375|gb|EEI65446.1| type I site-specific deoxyribonuclease [Lactobacillus reuteri CF48-
3A];> 2 1 1 2 2 1 1.5 118.02 1038 
>gi|183224941|dbj|BAG25458.1| molybdopterin biosynthesis protein MoeA [Lactobacillus reuteri 
JCM 1112];> 1 1 0 1 1 1 3.2 44.877 405 
>gi|148530373|gb|ABQ82372.1| amino acid/polyamine/organocation transporter, APC 
superfamily [Lactobacillus reuteri DSM 20016 1 1 1 0 1 1 2.7 49.337 449 
>gi|148531063|gb|ABQ83062.1| hypothetical protein Lreu_0799 [Lactobacillus reuteri DSM 
20016];> 2 0 0 0 1 1 20.9 14.8 134 
>gi|148530513|gb|ABQ82512.1| Heat shock protein, Metallo peptidase, MEROPS family M48B 
[Lactobacillus reuteri DSM 20016];>gi| 1 1 1 0 0 0 3.7 32.779 298 
>gi|183224263|dbj|BAG24780.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  2 0 1 1 2 1 11 25.982 237 
>gi|148532141|gb|ABQ84140.1| malate dehydrogenase (NAD) [Lactobacillus reuteri DSM 
20016];> 3 0 0 0 1 2 9.5 34.793 316 
>gi|148530922|gb|ABQ82921.1| hypothetical protein Lreu_0656 [Lactobacillus reuteri DSM 
20016];> 1 1 1 0 0 0 22.2 5.307 45 
>gi|148530863|gb|ABQ82862.1| protein of unknown function YGGT [Lactobacillus reuteri DSM 1 1 1 1 1 1 8.1 9.7797 86 
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20016];> 
>gi|148531540|gb|ABQ83539.1| hypothetical protein Lreu_1282 [Lactobacillus reuteri DSM 
20016];> 1 1 0 0 1 0 14.1 10.138 92 
>gi|227185036|gb|EEI65107.1| DNA primase [Lactobacillus reuteri CF48-3A];>  1 1 1 1 1 1 2.1 59.979 522 
>gi|148531397|gb|ABQ83396.1| RecT protein [Lactobacillus reuteri DSM 20016];> 1 1 0 0 0 1 4.3 36.317 329 
>gi|227071516|gb|EEI09815.1| APC family amino acid-polyamine-organocation transporter 
[Lactobacillus reuteri MM2-3];> 4 1 0 1 3 1 7.6 48.252 445 
>gi|133930409|gb|ABO43776.1| triosephosphate isomerase [Lactobacillus reuteri  1 1 1 1 0 0 4.4 27.379 249 
>gi|148530376|gb|ABQ82375.1| 3-hydroxyacyl-CoA dehydrogenase [Lactobacillus reuteri DSM 
20016 1 0 1 0 0 1 3.7 32.931 294 
>gi|183224401|dbj|BAG24918.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 1 1 1 1 0 1 4.9 32.584 287 
>gi|148532054|gb|ABQ84053.1| ABC transporter related [Lactobacillus reuteri DSM 20016 2 0 0 1 1 1 3.3 58.081 513 
>gi|227071701|gb|EEI09992.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3];> 1 0 1 0 1 0 5.2 22.201 193 
>gi|112943598|gb|ABI26315.1| modification methylase HemK [Lactobacillus reuteri 1 1 1 0 0 0 3.1 32.592 288 
>gi|227069913|gb|EEI08301.1| P27 family phage terminase small subunit [Lactobacillus reuteri 
MM2-3 1 1 0 0 1 0 6.3 18.213 158 
>gi|148531525|gb|ABQ83524.1| metallophosphoesterase [Lactobacillus reuteri DSM 20016];> 1 0 0 1 0 1 2 45.056 394 
>gi|183225267|dbj|BAG25784.1| dextransucrase [Lactobacillus reuteri JCM 1112 3 3 2 1 1 3 2.1 167.91 1488 
>gi|148530536|gb|ABQ82535.1| RNA binding S1 domain protein [Lactobacillus reuteri DSM 
20016];> p 2 0 2 1 1 0 11 18.376 164 
>gi|183224509|dbj|BAG25026.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 1 1 0 1 0 0 1.7 57.982 517 
>gi|183225365|dbj|BAG25882.1| cobalt ABC transporter ATP-binding component [Lactobacillus 
reuteri JCM 1112];> 2 0 2 1 1 1 7.5 31.093 281 
>gi|148530666|gb|ABQ82665.1| hypothetical protein Lreu_0396 [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 0 1 5.2 22.065 194 
>gi|148531021|gb|ABQ83020.1| condensin subunit ScpB [Lactobacillus reuteri DSM 20016];> 2 1 2 1 1 0 8.5 22.54 201 
>gi|148531177|gb|ABQ83176.1| diphosphomevalonate decarboxylase [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 2 2 7.4 35.168 323 
>gi|183225010|dbj|BAG25527.1| hypothetical protein [Lactobacillus reuteri JCM 1112  2 1 1 0 1 0 13.5 20.282 170 
>gi|148531200|gb|ABQ83199.1| protein of unknown function DUF915, hydrolase family protein 
[Lactobacillus reuteri DSM 20016];>  2 1 1 0 0 0 7.5 31.402 281 
>gi|148531569|gb|ABQ83568.1| exodeoxyribonuclease III Xth [Lactobacillus reuteri DSM 20016];> 2 1 0 2 0 0 8.3 29.639 253 
>gi|183226310|dbj|BAG26826.1| thiamine biosynthesis protein ThiI [Lactobacillus fermentum IFO 
3956];> 2 1 0 0 1 0 4.2 45.199 406 
>gi|183225665|dbj|BAG26182.1| hypothetical protein [Lactobacillus reuteri JCM 1112  2 0 2 0 0 0 25.6 10.074 86 
>gi|148530665|gb|ABQ82664.1| SsrA-binding protein [Lactobacillus reuteri DSM 20016];>] 2 1 1 0 1 2 9.6 18.262 157 
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>gi|148530982|gb|ABQ82981.1| hypothetical protein Lreu_0717 [Lactobacillus reuteri DSM 
20016];> 2 0 2 1 0 1 17.9 13.889 112 
>gi|337729355|emb|CCC04485.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608] 2 1 0 1 1 0 6.4 58.193 517 
>gi|148530791|gb|ABQ82790.1| competence/damage-inducible protein cinA [Lactobacillus 
reuteri DSM 20016];> 2 1 0 1 1 1 5.8 45.373 415 
>gi|183226723|dbj|BAG27239.1| topoisomerase IV subunit B [Lactobacillus fermentum IFO 
3956];> 2 1 0 2 2 2 2.4 73.864 665 
>gi|337729337|emb|CCC04466.1| putative phage minor tail protein [Lactobacillus reuteri ATCC 
53608] 2 1 1 1 2 1 0.8 335.06 3023 
>gi|148530533|gb|ABQ82532.1| transcription-repair coupling factor [Lactobacillus reuteri DSM 
20016];> 2 1 2 0 1 1 1.6 133.43 1179 
>gi|133930577|gb|ABO43859.1| putative replication protein [Lactobacillus reuteri];> 2 1 1 2 1 1 2.1 80.698 705 
>gi|183226575|dbj|BAG27091.1| histidyl-tRNA synthase [Lactobacillus fermentum IFO 3956];> 2 0 1 0 0 1 5.2 43.193 386 
>gi|183227095|dbj|BAG27611.1| glutamine synthase [Lactobacillus fermentum IFO 3956 2 1 0 0 0 1 4 50.271 450 
>gi|194453843|gb|EDX42740.1| ABC transporter related [Lactobacillus reuteri 100-23];> 1 0 0 1 1 0 3.5 32.935 288 
>gi|134081895|emb|CAK42150.1| unnamed protein product [Aspergillus niger] 2 0 1 1 0 0 2.8 60.461 541 
>gi|148532031|gb|ABQ84030.1| Homoserine O-succinyltransferase [Lactobacillus reuteri DSM 
20016 2 1 1 2 1 1 5.8 32.139 275 
>gi|227185207|gb|EEI65278.1| ATPase family protein [Lactobacillus reuteri CF48-3A];> 2 0 1 0 1 0 1.4 139.08 1221 
>gi|194454127|gb|EDX43024.1| GCN5-related N-acetyltransferase [Lactobacillus reuteri 100-23 2 1 0 0 0 1 10.4 20.084 173 
>gi|183224053|dbj|BAG24570.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 2 1 2 1 1 1 8.7 24.002 206 
>gi|183225802|dbj|BAG26319.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 2 1 1 0 0 0 7.1 24.47 225 
>gi|194454399|gb|EDX43296.1| aminotransferase class I and II [Lactobacillus reuteri 100-23];> 2 0 1 1 2 1 3.6 43.686 386 
>gi|148531015|gb|ABQ83014.1| DNA polymerase III catalytic subunit, DnaE type [Lactobacillus 
reuteri DSM 20016];> 3 0 1 0 2 1 2.5 126.23 1115 
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Peptides 
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Peptides 
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Sequence 
Coverage 
[%] 
Mol. 
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[kDa] 
Sequence 
Length 
>gi|148531475|gb|ABQ83474.1| phenylalanyl-tRNA synthetase beta subunit [Lactobacillus reuteri 
DSM 20016 6 4 3 3 1 5 11.7 89.003 805 
>gi|183226183|dbj|BAG26699.1| glyceraldehyde 3-phosphate dehydrogenase [Lactobacillus 
fermentum IFO 3956 7 4 4 4 3 5 28.8 36.208 337 
>gi|227186429|gb|EEI66500.1| acetoin dehydrogenase [Lactobacillus reuteri CF48-3A];> 7 6 5 4 4 5 42.7 28.27 267 
>gi|227071142|gb|EEI09458.1| acetoin dehydrogenase [Lactobacillus reuteri MM2-3 8 6 6 6 6 7 65.5 28.157 267 
>gi|133930435|gb|ABO43789.1| DNA-binding protein [Lactobacillus reuteri];> 8 8 6 6 7 6 72.5 9.5238 91 
>gi|148531729|gb|ABQ83728.1| LSU ribosomal protein L4P [Lactobacillus reuteri DSM 20016 8 8 7 7 7 7 49.8 22.29 207 
>gi|183224383|dbj|BAG24900.1| enolase [Lactobacillus reuteri JCM 1112 15 9 11 14 15 12 47.3 49.951 457 
>gi|148530951|gb|ABQ82950.1| translation elongation factor Ts (EF-Ts) [Lactobacillus reuteri DSM 
20016 15 12 12 11 11 13 66 31.962 291 
>gi|148531718|gb|ABQ83717.1| LSU ribosomal protein L5P [Lactobacillus reuteri DSM 20016];> 17 12 14 13 11 13 87.8 20.171 180 
>gi|148532099|gb|ABQ84098.1| Alcohol dehydrogenase GroES domain protein [Lactobacillus 
reuteri DSM 20016 17 14 14 12 14 13 74.4 35.918 336 
>gi|148530650|gb|ABQ82649.1| alpha-phosphoglucomutase [Lactobacillus reuteri DSM 20016 19 15 15 13 11 13 40.8 63.706 574 
>gi|227070122|gb|EEI08498.1| malate dehydrogenase (NAD) [Lactobacillus reuteri MM2-
3];>gi|227185101|gb|EEI65172.1| L-lactate dehydrogenase [Lactobacillus reuteri CF48-
3A];>gi|227364859|ref|ZP_03848906.1| malate dehydrogenase (NAD) [Lactobacillus reuteri MM 20 16 16 15 16 16 74.2 34.901 326 
>gi|148531743|gb|ABQ83742.1| Alcohol dehydrogenase GroES domain protein [Lactobacillus 
reuteri DSM 20016];>gi|148544709|ref|YP_001272079.1| alcohol dehydrogenase [Lactobacillus 
reuteri DSM 20016];>gi|183225405|dbj|BAG25922.1| alcohol dehydrogenase [Lactoba 22 17 18 18 20 17 87.4 36.124 342 
>gi|148531460|gb|ABQ83459.1| L-glutamine synthetase [Lactobacillus reuteri DSM 20016 23 14 18 15 18 18 66.2 50.835 447 
>gi|148530455|gb|ABQ82454.1| Substrate-binding region of ABC-type glycine betaine transport 
system [Lactobacillus reuteri DSM 20016];> 24 17 20 20 13 15 59.9 32.953 299 
>gi|148530917|gb|ABQ82916.1| translation elongation factor 1A (EF-1A/EF-Tu) [Lactobacillus 
reuteri DSM 20016];>gi|148543883|ref|YP_001271253.1| elongation factor Tu [Lactobacillus 
reuteri DSM 20016];>gi|183224627|dbj|BAG25144.1| elongation factor Tu [Lacto 24 22 22 23 22 22 75.8 43.432 396 
>gi|227186481|gb|EEI66552.1| D-alanine--D-alanine ligase [Lactobacillus reuteri CF48-3A];> 25 24 18 19 16 13 70.9 42.569 378 
>gi|183224464|dbj|BAG24981.1| D-alanine--D-alanine ligase [Lactobacillus reuteri JCM 1112 25 24 19 20 17 14 72 43.001 382 
>gi|227071557|gb|EEI09855.1| glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) 
[Lactobacillus reuteri MM2-3 26 23 23 22 21 22 77.7 37.062 345 
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>gi|148530918|gb|ABQ82917.1| trigger factor [Lactobacillus reuteri DSM 20016 27 18 18 15 19 18 64.4 48.747 436 
>gi|143798699|gb|ABF06644.2| sucrose phosphorylase [Lactobacillus reuteri 27 21 18 21 20 20 66.8 55.969 485 
>gi|183224381|dbj|BAG24898.1| phosphoglycerate kinase [Lactobacillus reuteri JCM 1112];> 27 25 23 19 14 12 82.3 42.96 401 
>gi|148530972|gb|ABQ82971.1| chaperone protein DnaK [Lactobacillus reuteri DSM 20016 29 14 18 18 21 20 65.9 67.211 621 
>gi|148530417|gb|ABQ82416.1| IMP cyclohydrolase [Lactobacillus reuteri DSM 20016 30 22 25 23 21 10 65.2 57.032 512 
>gi|148530345|gb|ABQ82344.1| Adenylosuccinate synthetase [Lactobacillus reuteri DSM 20016 30 23 20 22 21 22 75.5 47.725 432 
>gi|145202295|gb|ABF06651.2| pyruvate kinase [Lactobacillus reuteri 31 23 28 26 24 22 73.6 51.853 473 
>gi|227184598|gb|EEI64669.1| phosphoketolase [Lactobacillus reuteri CF48-3A];> 32 31 26 27 29 25 41.2 91.435 803 
>gi|337728287|emb|CCC03382.1| translation elongation factor G [Lactobacillus reuteri ATCC 
53608] 33 26 28 26 25 27 67.2 76.758 695 
>gi|148531028|gb|ABQ83027.1| SSU ribosomal protein S1P [Lactobacillus reuteri DSM 20016 33 27 27 28 24 27 85.6 45.995 416 
>gi|148531528|gb|ABQ83527.1| arginyl-tRNA synthetase [Lactobacillus reuteri DSM 20016 34 26 25 28 23 22 67.4 63.878 562 
>gi|337727862|emb|CCC02950.1| 30S ribosomal protein S1 [Lactobacillus reuteri ATCC 53608] 34 28 26 27 24 26 88.9 45.982 416 
>gi|337728521|emb|CCC03625.1| glucose-6-phosphate 1-dehydrogenase [Lactobacillus reuteri 
ATCC 53608] 36 28 29 31 28 27 73.8 56.355 493 
>gi|148530624|gb|ABQ82623.1| chaperonin GroEL [Lactobacillus reuteri DSM 20016];> 36 28 30 29 30 26 75.5 57.123 542 
>gi|148531733|gb|ABQ83732.1| translation elongation factor 2 (EF-2/EF-G) [Lactobacillus reuteri 
DSM 20016  37 27 35 33 31 33 74.2 76.77 695 
>gi|227070837|gb|EEI09162.1| glucose-6-phosphate 1-dehydrogenase [Lactobacillus reuteri 
MM2-3 38 30 32 34 30 29 77.2 56.713 496 
>gi|148531571|gb|ABQ83570.1| hypothetical protein Lreu_1313 [Lactobacillus reuteri DSM 20016 39 26 31 32 29 25 79.5 64.749 566 
>gi|183225653|dbj|BAG26170.1| 6-phosphogluconate dehydrogenase [Lactobacillus reuteri JCM 
1112 41 38 37 38 36 34 87.9 53.417 478 
>gi|337729321|emb|CCC04450.1| aldehyde-alcohol dehydrogenase [Lactobacillus reuteri ATCC 
53608];> 43 37 36 34 27 34 61.5 97.181 878 
>gi|148530322|gb|ABQ82321.1| ATPase AAA-2 domain protein [Lactobacillus reuteri DSM 
20016];> 50 44 37 32 44 38 71.4 82.305 745 
>gi|337728440|emb|CCC03541.1| xylulose 5-phosphate phosphoketolase [Lactobacillus reuteri 
ATCC 53608] 51 49 42 43 45 41 70.2 91.372 803 
>gi|194454221|gb|EDX43118.1| Phosphoketolase [Lactobacillus reuteri 100-23];> 52 50 43 45 46 42 70.2 91.374 803 
>gi|148531926|gb|ABQ83925.1| Phosphoketolase [Lactobacillus reuteri DSM 20016 52 50 44 45 46 44 71.2 91.403 803 
>gi|148530592|gb|ABQ82591.1| alcohol dehydrogenase AdhE / acetaldehyde dehydrogenase 
[Lactobacillus reuteri DSM 20016];>gi|148543558|ref|YP_001270928.1| bifunctional 
acetaldehyde-CoA/alcohol dehydrogenase [Lactobacillus reuteri DSM 20016];>gi|183224309|dbj 55 46 50 46 39 47 74.8 97.187 878 
>gi|337727906|emb|CCC02995.1| L-lactate dehydrogenase [Lactobacillus reuteri ATCC 53608] 19 15 15 14 15 15 75.2 34.069 319 
>gi|269930626|gb|ACZ53583.1| phosphoketolase [Lactobacillus reuteri] 14 14 11 12 13 12 89.9 21.656 189 
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>gi|183227647|dbj|BAG28163.1| dehydrogenase [Lactobacillus fermentum IFO 3956];>] 7 5 5 4 4 5 25.9 35.835 336 
>gi|183224518|dbj|BAG25035.1| alanyl-tRNA synthase [Lactobacillus reuteri JCM 1112 22 20 16 15 15 14 36.3 98.648 885 
>gi|148530453|gb|ABQ82452.1| 3-beta hydroxysteroid dehydrogenase/isomerase [Lactobacillus 
reuteri DSM 20016];> 11 7 8 10 8 7 51.8 31.632 284 
>gi|148532121|gb|ABQ84120.1| lysyl aminopeptidase, Metallo peptidase, MEROPS family M01 
[Lactobacillus reuteri DSM 20016];> 23 13 14 15 11 8 37.1 95.323 843 
>gi|148531698|gb|ABQ83697.1| LSU ribosomal protein L13P [Lactobacillus reuteri DSM 20016];> 13 13 12 10 9 8 80.3 16.304 147 
>gi|148532092|gb|ABQ84091.1| Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 
[Lactobacillus reuteri DSM 20016];> 21 17 14 16 15 16 51.8 60.446 568 
>gi|148531290|gb|ABQ83289.1| LPXTG-motif cell wall anchor domain [Lactobacillus reuteri DSM 
20016];> 22 12 19 15 15 13 45.7 80.889 752 
>gi|148530866|gb|ABQ82865.1| Isoleucyl-tRNA synthetase [Lactobacillus reuteri DSM 
20016];>gi|148543832|ref|YP_001271202.1| isoleucyl-tRNA synthetase [Lactobacillus reuteri DSM 
20016];> 33 22 16 21 15 17 48.3 109.95 960 
>gi|148530340|gb|ABQ82339.1| 2,5-didehydrogluconate reductase [Lactobacillus reuteri DSM 
20016];> 15 10 11 9 7 7 72.6 32.62 288 
>gi|148530567|gb|ABQ82566.1| amino acid ABC transporter substrate-binding protein, PAAT 
family [Lactobacillus reuteri DSM 20016];> 19 14 18 15 11 15 57.8 28.516 263 
>gi|337729108|emb|CCC04231.1| alanyl-tRNA synthase [Lactobacillus reuteri ATCC 53608] 21 19 13 15 14 12 35.5 98.679 884 
>gi|183225729|dbj|BAG26246.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  10 8 4 3 9 7 68 19.891 169 
>gi|148531932|gb|ABQ83931.1| (R)-2-hydroxyisocaproate dehydrogenase [Lactobacillus reuteri 
DSM 20016];> 21 14 16 13 14 12 80.5 37.358 334 
>gi|148530447|gb|ABQ82446.1| pyridine nucleotide-disulfide oxidoreductase dimerization region 
[Lactobacillus reuteri DSM 20016];> 16 16 13 13 11 14 50.3 49.944 451 
>gi|148531711|gb|ABQ83710.1| LSU ribosomal protein L15P [Lactobacillus reuteri DSM 20016];> 14 12 12 12 10 11 72.9 15.447 144 
>gi|227186263|gb|EEI66334.1| maltose phosphorylase [Lactobacillus reuteri CF48-3A];> 24 15 19 15 14 10 40 87.449 757 
>gi|148531526|gb|ABQ83525.1| protein of unknown function DUF964 [Lactobacillus reuteri DSM 
20016];> 12 9 8 10 8 8 88.6 14.096 123 
>gi|148530584|gb|ABQ82583.1| LSU ribosomal protein L10P [Lactobacillus reuteri DSM 20016];> 11 8 9 10 8 9 66.3 18.139 166 
>gi|337728005|emb|CCC03094.1| isoleucyl-tRNA synthase [Lactobacillus reuteri ATCC 53608] 29 20 14 18 13 14 43 106.67 931 
>gi|148531713|gb|ABQ83712.1| SSU ribosomal protein S5P [Lactobacillus reuteri DSM 20016];> 16 14 15 14 14 13 81.1 17.646 169 
>gi|148530953|gb|ABQ82952.1| ribosome recycling factor [Lactobacillus reuteri DSM 20016];> 9 9 7 8 7 7 57.8 20.783 187 
>gi|148531724|gb|ABQ83723.1| SSU ribosomal protein S3P [Lactobacillus reuteri DSM 20016];> 10 9 9 7 9 9 58.8 24.696 221 
>gi|148531543|gb|ABQ83542.1| ribokinase [Lactobacillus reuteri DSM 20016];> 14 11 11 12 9 11 66.8 32.041 307 
>gi|133930433|gb|ABO43788.1| ribosomal protein L15 [Lactobacillus reuteri 12 10 9 9 8 8 66.7 15.516 144 
>gi|148531716|gb|ABQ83715.1| SSU ribosomal protein S8P [Lactobacillus reuteri DSM 20016];> 11 8 9 8 8 9 75.8 14.536 132 
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>gi|148530580|gb|ABQ82579.1| LSU ribosomal protein L1P [Lactobacillus reuteri DSM 20016];> 11 9 7 6 7 8 47.4 27.362 253 
>gi|183225401|dbj|BAG25918.1| DNA-directed RNA polymerase beta subunit [Lactobacillus 
reuteri JCM 1112];> 28 22 18 20 19 22 33.3 135.36 1205 
>gi|148530865|gb|ABQ82864.1| DivIVA family protein [Lactobacillus reuteri DSM 20016];> 12 9 11 10 11 11 44.3 27.591 246 
>gi|148530679|gb|ABQ82678.1| phosphoglucosamine mutase [Lactobacillus reuteri DSM 
20016];> 13 12 11 9 9 9 37.9 48.902 451 
>gi|148530736|gb|ABQ82735.1| ATP synthase F1 subcomplex beta subunit [Lactobacillus reuteri 
DSM 20016];> 14 9 9 10 7 4 48.4 51.631 475 
>gi|148530962|gb|ABQ82961.1| NusA antitermination factor [Lactobacillus reuteri DSM 20016];> 11 7 9 8 10 9 45.3 44.525 395 
>gi|148530642|gb|ABQ82641.1| UDP-glucose pyrophosphorylase [Lactobacillus reuteri DSM 
20016];> 14 10 8 10 11 8 65.5 34.101 304 
>gi|148531722|gb|ABQ83721.1| LSU ribosomal protein L29P [Lactobacillus reuteri DSM 20016];> 5 4 2 4 3 3 58.8 8.0041 68 
>gi|337728880|emb|CCC04000.1| hypothetical protein LRATCC53608_1247 [Lactobacillus reuteri 
ATCC 53608] 10 7 6 9 8 7 79.7 14.126 123 
>gi|148531553|gb|ABQ83552.1| leucyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 17 9 10 12 11 7 37.6 92.918 806 
>gi|148530989|gb|ABQ82988.1| aspartyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];>; 13 9 6 7 6 5 27.5 68.43 600 
>gi|148530903|gb|ABQ82902.1| GTP-binding protein TypA [Lactobacillus reuteri DSM 20016];> 25 22 21 21 21 19 48 68.827 614 
>gi|148531725|gb|ABQ83724.1| LSU ribosomal protein L22P [Lactobacillus reuteri DSM 20016];> 6 6 6 6 6 6 52.2 12.394 115 
>gi|148531009|gb|ABQ83008.1| aminotransferase [Lactobacillus reuteri DSM 20016];> 17 14 11 14 11 12 52.3 43.107 394 
>gi|148530950|gb|ABQ82949.1| SSU ribosomal protein S2P [Lactobacillus reuteri DSM 20016];> 18 15 13 15 13 15 80.2 29.657 262 
>gi|148530959|gb|ABQ82958.1| prolyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 20 17 15 16 15 14 52.3 64.256 577 
>gi|148531738|gb|ABQ83737.1| DNA-directed RNA polymerase subunit beta [Lactobacillus reuteri 
DSM 20016 29 19 18 19 17 20 32.7 135.42 1211 
>gi|183225377|dbj|BAG25894.1| 50S ribosomal protein L18 [Lactobacillus reuteri JCM 1112];>  9 9 7 7 8 8 69.4 13.342 121 
>gi|148531730|gb|ABQ83729.1| LSU ribosomal protein L3P [Lactobacillus reuteri DSM 20016];> 11 9 8 7 7 7 57.5 23.757 219 
>gi|227186160|gb|EEI66231.1| possible peptidoglycan-binding protein [Lactobacillus reuteri CF48-
3A];> 5 3 3 2 5 5 23.3 27.744 266 
>gi|183225744|dbj|BAG26261.1| threonyl-tRNA synthase [Lactobacillus reuteri JCM 1112];> 18 11 10 13 10 11 33.5 71.776 627 
>gi|148530419|gb|ABQ82418.1| phosphoglycerate mutase [Lactobacillus reuteri DSM 20016];> 13 10 11 9 10 11 53.5 26.121 228 
>gi|227071019|gb|EEI09341.1| bifunctional GMP synthase/glutamine amidotransferase protein 
[Lactobacillus reuteri MM2-3];> 26 18 20 18 20 15 61.3 59.912 538 
>gi|130893166|gb|ABO32596.1| ATP-dependent Clp protease ATP-binding subunit ClpX 
[Lactobacillus reuteri];>  15 11 4 6 5 8 52.6 45.969 416 
>gi|337727880|emb|CCC02968.1| amino acid aminotransferase [Lactobacillus reuteri ATCC 
53608] 14 12 10 14 11 10 41.4 43.078 394 
>gi|148530413|gb|ABQ82412.1| phosphoribosylformylglycinamidine synthase subunit II 17 7 14 14 12 6 40 80.944 742 
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[Lactobacillus reuteri DSM 20016 
>gi|148530404|gb|ABQ82403.1| Formate-tetrahydrofolate ligase [Lactobacillus reuteri DSM 
20016 19 7 16 15 16 10 41.4 60.251 553 
>gi|148531727|gb|ABQ83726.1| LSU ribosomal protein L2P [Lactobacillus reuteri DSM 20016];> 18 17 17 13 13 13 65.1 30.47 281 
>gi|148532119|gb|ABQ84118.1| Bleomycin hydrolase [Lactobacillus reuteri DSM 20016];> 14 12 9 8 5 4 38.2 50.851 440 
>gi|148530623|gb|ABQ82622.1| chaperonin Cpn10 [Lactobacillus reuteri DSM 20016];> 8 7 8 7 5 5 61.7 10.149 94 
>gi|194454505|gb|EDX43402.1| 2,5-didehydrogluconate reductase [Lactobacillus reuteri 100-
23];> 11 9 8 6 6 4 46.2 32.469 288 
>gi|148532124|gb|ABQ84123.1| asparaginyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 18 14 12 11 9 11 60.2 50.092 432 
>gi|148531709|gb|ABQ83708.1| Adenylate kinase [Lactobacillus reuteri DSM 20016];> 12 9 9 9 11 9 68.5 24.609 219 
>gi|183225183|dbj|BAG25700.1| ligase [Lactobacillus reuteri JCM 1112];> 18 11 10 12 11 13 59.2 49.294 441 
>gi|183225853|dbj|BAG26369.1| ATP-dependent Clp protease ATP-binding subunit [Lactobacillus 
fermentum IFO 3956];> 7 6 4 4 6 6 10.8 76.678 697 
>gi|148531554|gb|ABQ83553.1| methionine adenosyltransferase [Lactobacillus reuteri DSM 
20016];> 12 7 8 8 7 6 40.8 43.195 395 
>gi|227071143|gb|EEI09459.1| ribosomal protein S9 [Lactobacillus reuteri MM2-3];> 6 5 6 6 6 6 55.6 14.494 133 
>gi|148530769|gb|ABQ82768.1| SSU ribosomal protein S4P [Lactobacillus reuteri DSM 20016 18 16 13 14 12 14 83.6 22.943 201 
>gi|227071324|gb|EEI09633.1| heat shock protein Hsp33 [Lactobacillus reuteri MM2-3];> 11 8 9 7 5 5 48.3 35.232 323 
>gi|148531687|gb|ABQ83686.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B 
[Lactobacillus reuteri DSM 20016];> 15 11 7 8 5 8 44.7 53.424 474 
>gi|194453944|gb|EDX42841.1| glutamyl-tRNA(Gln) amidotransferase, B subunit [Lactobacillus 
reuteri 100-23];>/ 15 11 6 8 5 8 44.7 53.408 474 
>gi|148531171|gb|ABQ83170.1| L-lactate dehydrogenase [Lactobacillus reuteri DSM 20016];> 14 10 13 11 11 11 55.9 35.005 324 
>gi|148531688|gb|ABQ83687.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit A 
[Lactobacillus reuteri DSM 20016];> 13 10 9 8 8 9 45.1 53.009 490 
>gi|148532166|gb|ABQ84165.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016];> 11 10 7 5 5 2 47.7 32.371 287 
>gi|183224883|dbj|BAG25400.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 6 5 5 4 5 4 50.3 20.834 181 
>gi|148531824|gb|ABQ83823.1| translation elongation factor P (EF-P) [Lactobacillus reuteri DSM 
20016];> 12 9 9 9 7 7 72.4 20.518 185 
>gi|148531706|gb|ABQ83705.1| SSU ribosomal protein S13P [Lactobacillus reuteri DSM 20016];> 11 11 9 9 9 10 70.2 13.687 121 
>gi|148530668|gb|ABQ82667.1| phosphotransacetylase [Lactobacillus reuteri DSM 20016];>  13 7 8 7 8 3 61.7 34.699 324 
>gi|194453968|gb|EDX42865.1| Adenylate kinase [Lactobacillus reuteri 100-23];> 12 9 8 8 10 8 68.5 24.61 219 
>gi|148530585|gb|ABQ82584.1| LSU ribosomal protein L12P [Lactobacillus reuteri DSM 20016 11 8 8 7 9 8 90.1 12.356 121 
>gi|337727893|emb|CCC02982.1| conjugated bile salt hydrolase [Lactobacillus reuteri ATCC 
53608 9 7 0 4 2 0 48.3 36.06 325 
>gi|148530857|gb|ABQ82856.1| UDP-N-acetylmuramoylalanine--D-glutamate ligase [Lactobacillus 4 2 3 4 3 3 17.8 50.332 456 
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reuteri DSM 20016];> 
>gi|148531728|gb|ABQ83727.1| LSU ribosomal protein L23P [Lactobacillus reuteri DSM 20016];> 7 6 4 7 5 4 60.2 11.25 98 
>gi|148531734|gb|ABQ83733.1| SSU ribosomal protein S7P [Lactobacillus reuteri DSM 20016];> 13 12 10 11 6 7 74.4 17.985 156 
>gi|148532158|gb|ABQ84157.1| hypoxanthine phosphoribosyltransferase [Lactobacillus reuteri 
DSM 20016];> 4 2 3 4 3 3 27 20.407 178 
>gi|148530771|gb|ABQ82770.1| aminotransferase, class V [Lactobacillus reuteri DSM 20016];>  11 7 8 7 6 8 43.2 42.097 382 
>gi|148530744|gb|ABQ82743.1| glycine cleavage H-protein [Lactobacillus reuteri DSM 20016];> 5 3 4 2 3 4 79.4 10.641 97 
>gi|183224141|dbj|BAG24658.1| tyrosyl-tRNA synthase [Lactobacillus reuteri JCM 1112];> 13 7 9 9 10 9 35.7 47.69 420 
>gi|148530610|gb|ABQ82609.1| UDP-galactose 4-epimerase [Lactobacillus reuteri DSM 20016];> 12 8 6 9 8 7 62.5 36.598 331 
>gi|148531721|gb|ABQ83720.1| SSU ribosomal protein S17P [Lactobacillus reuteri DSM 20016];> r 7 6 5 4 3 4 65.9 10.168 88 
>gi|227070899|gb|EEI09222.1| D-lactate dehydrogenase [Lactobacillus reuteri MM2-3];> g 11 9 11 8 8 7 53.1 37.311 337 
>gi|148530564|gb|ABQ82563.1| cystathionine gamma-lyase [Lactobacillus reuteri DSM 20016 10 6 6 5 5 5 47.4 41.498 380 
>gi|148531054|gb|ABQ83053.1| protein of unknown function DUF322 [Lactobacillus reuteri DSM 
20016];> 7 6 4 5 5 6 59.8 13.85 127 
>gi|148530646|gb|ABQ82645.1| thioredoxin reductase [Lactobacillus reuteri DSM 20016];> 7 6 4 4 4 3 33.2 33.305 310 
>gi|148530685|gb|ABQ82684.1| Peptidoglycan-binding LysM [Lactobacillus reuteri DSM 20016];> 7 4 1 5 4 6 40.9 21.661 203 
>gi|183227337|dbj|BAG27853.1| elongation factor G [Lactobacillus fermentum IFO 3956];> 11 6 10 9 9 9 29.1 76.351 694 
>gi|148530861|gb|ABQ82860.1| cell division protein FtsZ [Lactobacillus reuteri DSM 20016 14 7 10 9 5 9 51.8 44.45 415 
>gi|148530828|gb|ABQ82827.1| Adenine-specific DNA methylase-like protein [Lactobacillus 
reuteri DSM 20016];> 4 2 3 3 3 3 22.4 31.155 277 
>gi|148530755|gb|ABQ82754.1| UspA domain protein [Lactobacillus reuteri DSM 20016];> 11 9 7 10 8 8 74.7 18.017 162 
>gi|148530284|gb|ABQ82283.1| SSU ribosomal protein S6P [Lactobacillus reuteri DSM 20016];> 7 6 5 7 5 6 84.7 11.378 98 
>gi|148530503|gb|ABQ82502.1| UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
[Lactobacillus reuteri DSM 20016 10 5 5 7 6 5 34.1 45.676 425 
>gi|141553038|gb|ABD13939.2| ornithine carbamoyltransferase [Lactobacillus reuteri];> 13 9 4 8 8 5 50.1 37.56 335 
>gi|148531703|gb|ABQ83702.1| LSU ribosomal protein L17P [Lactobacillus reuteri DSM 20016];> 6 5 5 6 5 4 52 14.201 127 
>gi|148530504|gb|ABQ82503.1| LSU ribosomal protein L31P [Lactobacillus reuteri DSM 20016];> 9 7 6 8 7 7 95.1 9.123 81 
>gi|148531412|gb|ABQ83411.1| SSU ribosomal protein S16P [Lactobacillus reuteri DSM 20016];> 7 5 6 6 4 4 68.1 10.449 91 
>gi|148531704|gb|ABQ83703.1| DNA-directed RNA polymerase subunit alpha [Lactobacillus 
reuteri DSM 20016];> 16 8 12 10 8 12 71 34.901 314 
>gi|148531459|gb|ABQ83458.1| glutamyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];>; 12 5 5 7 6 5 32.7 58.349 501 
>gi|148530870|gb|ABQ82869.1| methylthioadenosine nucleosidase [Lactobacillus reuteri DSM 
20016];> 7 3 5 6 4 4 51.1 24.687 231 
>gi|148531720|gb|ABQ83719.1| LSU ribosomal protein L14P [Lactobacillus reuteri DSM 20016];> 6 6 6 6 6 6 43.4 13.144 122 
>gi|148530773|gb|ABQ82772.1| valyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 23 16 13 16 15 10 31.7 102.29 884 
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>gi|227070649|gb|EEI08979.1| 1,3-propanediol dehydrogenase [Lactobacillus reuteri MM2-3];> 15 11 12 11 10 7 55.8 44.01 405 
>gi|227184503|gb|EEI64574.1| amidophosphoribosyltransferase [Lactobacillus reuteri CF48-3A];> 6 5 5 5 5 1 20 53.593 490 
>gi|148531751|gb|ABQ83750.1| cold-shock DNA-binding protein family [Lactobacillus reuteri DSM 
20016];>  4 4 3 4 4 4 74.2 7.3269 66 
>gi|194452927|gb|EDX41825.1| Cystathionine gamma-synthase [Lactobacillus reuteri 100-23];> 9 5 4 5 5 4 41.8 41.471 380 
>gi|337729137|emb|CCC04260.1| valyl-tRNA synthase [Lactobacillus reuteri ATCC 53608];> 22 16 11 15 14 8 30.4 102.21 884 
>gi|337729037|emb|CCC04160.1| aminotransferase [Lactobacillus reuteri ATCC 53608];> 16 14 9 10 8 5 55.7 43.766 397 
>gi|148530808|gb|ABQ82807.1| thioredoxin [Lactobacillus reuteri DSM 20016];> 4 4 3 4 3 3 42.3 11.889 104 
>gi|148532037|gb|ABQ84036.1| Endothelin-converting protein 1 [Lactobacillus reuteri DSM 
20016];>  12 6 5 6 2 4 25.2 72.39 634 
>gi|227071240|gb|EEI09554.1| possible glutathione-disulfide reductase [Lactobacillus reuteri 
MM2-3];> 6 2 3 3 4 2 19.9 48.997 443 
>gi|148531145|gb|ABQ83144.1| 6,7-dimethyl-8-ribityllumazine synthase [Lactobacillus reuteri 
DSM 20016];> 6 3 4 6 3 5 78.3 16.637 152 
>gi|148530382|gb|ABQ82381.1| GTP-binding protein YchF [Lactobacillus reuteri DSM 20016];> L 8 5 4 2 2 3 38.4 39.844 365 
>gi|148530410|gb|ABQ82409.1| phosphoribosylaminoimidazole-succinocarboxamide synthase 
[Lactobacillus reuteri DSM 20016];> 11 5 9 3 7 5 47.3 27.308 239 
>gi|148531006|gb|ABQ83005.1| glycyl-tRNA synthetase beta chain [Lactobacillus reuteri DSM 
20016];> 17 12 11 13 13 9 34.4 78.536 691 
>gi|148532032|gb|ABQ84031.1| cysteine synthase [Lactobacillus reuteri DSM 20016];> 7 7 3 0 0 0 34.9 32.241 307 
>gi|148531464|gb|ABQ83463.1| glucokinase [Lactobacillus reuteri DSM 20016];> 8 7 6 5 4 6 34.1 34.42 323 
>gi|148530343|gb|ABQ82342.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016];> 8 7 6 6 6 6 30.1 49.604 449 
>gi|148532080|gb|ABQ84079.1| glycerol 2-dehydrogenase (NAD+) [Lactobacillus reuteri DSM 
20016];> 8 6 7 5 6 6 39.1 40.698 373 
>gi|148531715|gb|ABQ83714.1| LSU ribosomal protein L6P [Lactobacillus reuteri DSM 
20016];>gi|148544681|ref|YP_001272051.1| 50S ribosomal protein L6 [Lactobacillus reuteri DSM 
20016];>gi|166990974|sp|A5VLJ0.1|RL6_LACRD RecName: Full=50S ribosomal protein L6 9 8 7 8 7 8 44.4 19.635 178 
>gi|148532070|gb|ABQ84069.1| histidyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 12 8 8 8 7 7 33.7 49.318 433 
>gi|148531549|gb|ABQ83548.1| peptidase V, Metallo peptidase, MEROPS family M20A 
[Lactobacillus reuteri DSM 20016  9 9 2 5 3 2 25.7 51.22 467 
>gi|148532120|gb|ABQ84119.1| NAD-dependent epimerase/dehydratase [Lactobacillus reuteri 
DSM 20016];>  10 7 6 4 4 5 61.5 23.187 213 
>gi|183225184|dbj|BAG25701.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 8 4 5 4 6 5 62 23.595 216 
>gi|148531583|gb|ABQ83582.1| Phosphotransferase system, phosphocarrier protein HPr 
[Lactobacillus reuteri DSM 20016];> 3 2 2 2 1 2 55.7 9.4076 88 
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>gi|148530367|gb|ABQ82366.1| NADPH-dependent FMN reductase [Lactobacillus reuteri DSM 
20016];> 12 6 9 9 4 8 47.6 45.674 416 
>gi|148530579|gb|ABQ82578.1| LSU ribosomal protein L11P [Lactobacillus reuteri DSM 20016];> 6 5 6 6 4 4 40.4 14.869 141 
>gi|148530781|gb|ABQ82780.1| cell shape determining protein, MreB/Mrl family [Lactobacillus 
reuteri DSM 20016];> 10 7 6 7 4 5 46.2 34.966 333 
>gi|148530402|gb|ABQ82401.1| cyclopropane-fatty-acyl-phospholipid synthase [Lactobacillus 
reuteri DSM 20016];> 4 2 3 4 3 2 14.1 46.488 403 
>gi|148530721|gb|ABQ82720.1| bacterial peptide chain release factor 1 (bRF-1) [Lactobacillus 
reuteri DSM 20016];> 6 4 4 3 4 4 26.5 41.287 362 
>gi|148531108|gb|ABQ83107.1| hypothetical protein Lreu_0844 [Lactobacillus reuteri DSM 
20016];> 5 2 1 2 0 5 41.4 20.426 181 
>gi|148530491|gb|ABQ82490.1| UDP-N-acetylglucosamine pyrophosphorylase [Lactobacillus 
reuteri DSM 20016];> 15 11 12 7 5 4 42.4 50.01 455 
>gi|148530418|gb|ABQ82417.1| phosphoribosylamine--glycine ligase [Lactobacillus reuteri DSM 
20016 11 5 6 7 5 2 37.5 45.76 419 
>gi|148531723|gb|ABQ83722.1| LSU ribosomal protein L16P [Lactobacillus reuteri DSM 20016];> 7 6 6 6 6 5 54.9 16.006 144 
>gi|148530555|gb|ABQ82554.1| putative nicotinate phosphoribosyltransferase [Lactobacillus 
reuteri DSM 20016];> 9 6 4 3 3 4 25.8 55.609 488 
>gi|148530811|gb|ABQ82810.1| non-canonical purine NTP pyrophosphatase, rdgB/HAM1 family 
[Lactobacillus reuteri DSM 20016 8 5 4 7 4 5 67.2 21.286 195 
>gi|148531499|gb|ABQ83498.1| bacterial translation initiation factor 3 (bIF-3) [Lactobacillus 
reuteri DSM 20016];> 6 3 3 3 3 4 46.5 19.487 170 
>gi|146142505|gb|ABQ01722.1| fumarase [Lactobacillus reuteri];> 15 7 11 8 11 8 42 50.302 462 
>gi|148531491|gb|ABQ83490.1| iojap-like protein [Lactobacillus reuteri DSM 20016 4 3 4 4 3 3 47.5 13.309 118 
>gi|227071376|gb|EEI09682.1| malate dehydrogenase (NAD) [Lactobacillus reuteri MM2-3];> 5 3 3 3 3 3 27.4 35.211 321 
>gi|148531450|gb|ABQ83449.1| LSU ribosomal protein L21P [Lactobacillus reuteri DSM 20016];> 5 5 3 2 3 3 54.9 11.256 102 
>gi|148531929|gb|ABQ83928.1| dipeptidase A, Cysteine peptidase, MEROPS family C69 
[Lactobacillus reuteri DSM 20016];> 10 9 7 6 6 6 29.5 54.294 478 
>gi|148530366|gb|ABQ82365.1| NADPH-dependent FMN reductase [Lactobacillus reuteri DSM 
20016];> 7 5 6 7 7 6 56.2 23.02 203 
>gi|148530739|gb|ABQ82738.1| UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
[Lactobacillus reuteri DSM 20016 4 4 2 3 1 1 15.8 47.242 438 
>gi|148530965|gb|ABQ82964.1| bacterial translation initiation factor 2 (bIF-2) [Lactobacillus 
reuteri DSM 20016];> 8 3 5 5 4 8 17.2 83.537 752 
>gi|227071794|gb|EEI10083.1| glycerone kinase [Lactobacillus reuteri MM2-3];> 9 1 5 4 3 6 25.2 62.132 575 
>gi|148530288|gb|ABQ82287.1| LSU ribosomal protein L9P [Lactobacillus reuteri DSM 20016];> 11 8 9 7 8 7 61.3 16.692 150 
>gi|148530542|gb|ABQ82541.1| lysyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 15 11 11 10 9 4 33.7 58.296 508 
 189 
 
>gi|148532090|gb|ABQ84089.1| hypothetical protein Lreu_1851 [Lactobacillus reuteri DSM 
20016];> L 2 1 2 2 2 1 52.5 7.0627 61 
>gi|148531050|gb|ABQ83049.1| Inorganic diphosphatase [Lactobacillus reuteri DSM 20016];> 9 4 4 7 6 7 36.3 34.194 311 
>gi|148531705|gb|ABQ83704.1| SSU ribosomal protein S11P [Lactobacillus reuteri DSM 20016];> 5 3 5 4 5 3 58.1 13.759 129 
>gi|183225766|dbj|BAG26283.1| aspartate-ammonia ligase [Lactobacillus reuteri JCM 1112];> 7 6 2 5 3 4 25.4 39.72 339 
>gi|183224315|dbj|BAG24832.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 3 2 2 2 2 2 55.7 11.883 106 
>gi|148530407|gb|ABQ82406.1| 5-(carboxyamino)imidazole ribonucleotide mutase [Lactobacillus 
reuteri DSM 20016];> 6 3 4 5 4 1 62.1 16.958 161 
>gi|148531889|gb|ABQ83888.1| prolinase, Serine peptidase, MEROPS family S33 [Lactobacillus 
reuteri DSM 20016];> 4 2 3 3 2 2 19.1 34.841 303 
>gi|148531413|gb|ABQ83412.1| signal recognition particle subunit FFH/SRP54 (srp54) 
[Lactobacillus reuteri DSM 20016 7 4 4 3 3 2 16.6 54.114 481 
>gi|227071709|gb|EEI10000.1| ATP-dependent RNA helicase [Lactobacillus reuteri MM2-3];> 6 5 1 0 0 1 17.8 53.802 467 
>gi|148530526|gb|ABQ82525.1| alanine racemase [Lactobacillus reuteri DSM 20016 4 2 3 2 3 1 14.7 41.162 375 
>gi|148530594|gb|ABQ82593.1| ribonucleoside-diphosphate reductase class Ib alpha subunit 
[Lactobacillus reuteri DSM 20016| 17 15 12 10 9 10 34.7 82.738 723 
>gi|148530370|gb|ABQ82369.1| seryl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 9 6 7 5 8 7 32 49.29 435 
>gi|148531225|gb|ABQ83224.1| hypothetical protein Lreu_0962 [Lactobacillus reuteri DSM 
20016];> 4 1 1 1 4 2 14.1 88.735 774 
>gi|148531486|gb|ABQ83485.1| two component transcriptional regulator, winged helix family 
[Lactobacillus reuteri DSM 20016];> 3 2 1 2 2 2 20.6 26.33 228 
>gi|183224607|dbj|BAG25124.1| pyruvate dehydrogenase complex E1 component alpha subunit 
[Lactobacillus reuteri JCM 1112 7 5 4 5 3 5 28.6 41.361 371 
>gi|148530556|gb|ABQ82555.1| NH(3)-dependent NAD(+) synthetase [Lactobacillus reuteri DSM 
20016];> 7 6 2 4 2 2 42.9 30.54 275 
>gi|227070039|gb|EEI08417.1| peptidase T [Lactobacillus reuteri MM2-3];> 6 4 3 3 5 2 24.1 46.484 419 
>gi|148530942|gb|ABQ82941.1| hydroxymethylglutaryl-CoA synthase [Lactobacillus reuteri DSM 
20016];> 4 4 3 3 3 1 16.4 42.757 385 
>gi|148531575|gb|ABQ83574.1| ribonucleoside-triphosphate reductase class III catalytic subunit / 
ribonucleoside-triphosphate reductase [Lactobacillus reuteri DSM 20016];> 4 1 2 1 2 1 5 85.159 744 
>gi|296313256|gb|ACZ97544.2| D-alanine-D-alanine ligase [Lactobacillus reuteri] 3 3 2 2 2 2 17.9 33.684 301 
>gi|183227099|dbj|BAG27615.1| glucose kinase [Lactobacillus fermentum IFO 3956];> 4 4 4 2 1 2 17.2 33.926 320 
>gi|148530994|gb|ABQ82993.1| GatB/Yqey domain protein [Lactobacillus reuteri DSM 20016];> 3 2 2 2 3 1 25.7 16.725 148 
>gi|148531735|gb|ABQ83734.1| SSU ribosomal protein S12P [Lactobacillus reuteri DSM 20016];> 8 6 5 5 5 4 56.8 15.503 139 
>gi|148531417|gb|ABQ83416.1| RNAse III [Lactobacillus reuteri DSM 20016];> 5 2 3 4 3 3 39.9 26.606 233 
>gi|148531286|gb|ABQ83285.1| Phosphoglycerate mutase [Lactobacillus reuteri DSM 20016];> 10 9 6 7 7 4 38.1 30.347 278 
 190 
 
>gi|133930489|gb|ABO43816.1| conserved hypothetical protein [Lactobacillus reuteri];> 3 1 2 2 2 3 54.8 8.2855 73 
>gi|148530501|gb|ABQ82500.1| CTP synthase [Lactobacillus reuteri DSM 20016];> 11 6 9 6 6 3 30.7 59.6 534 
>gi|148531497|gb|ABQ83496.1| LSU ribosomal protein L20P [Lactobacillus reuteri DSM 20016];> 8 8 7 6 5 5 46.2 13.515 117 
>gi|148530553|gb|ABQ82552.1| aspartate racemase [Lactobacillus reuteri DSM 20016];> 1112];> 7 6 4 5 4 4 39 26.763 236 
>gi|194453683|gb|EDX42580.1| translation initiation factor IF-3 [Lactobacillus reuteri 100-23];> 6 3 4 4 2 3 46.5 19.488 170 
>gi|183225693|dbj|BAG26210.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 4 3 2 2 3 2 16.2 41.737 364 
>gi|148530484|gb|ABQ82483.1| dimethyladenosine transferase [Lactobacillus reuteri DSM 
20016];>  7 4 2 2 2 4 26.9 33.039 297 
>gi|148530409|gb|ABQ82408.1| Adenylosuccinate lyase [Lactobacillus reuteri DSM 20016];> 7 0 5 5 4 3 23.2 49.454 431 
>gi|227186201|gb|EEI66272.1| response regulator [Lactobacillus reuteri CF48-3A];> 6 4 4 4 5 4 41.4 26.602 237 
>gi|148530993|gb|ABQ82992.1| SSU ribosomal protein S21P [Lactobacillus reuteri DSM 20016];> 5 3 4 4 4 3 44.4 7.7178 63 
>gi|148531037|gb|ABQ83036.1| degV family protein [Lactobacillus reuteri DSM 20016];> 8 7 4 5 5 4 35.4 30.742 280 
>gi|183225222|dbj|BAG25739.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 5 1 3 3 3 1 46.5 18.557 170 
>gi|148531899|gb|ABQ83898.1| short-chain dehydrogenase/reductase SDR [Lactobacillus reuteri 
DSM 20016 6 4 2 1 2 2 37.5 26.924 251 
>gi|148530952|gb|ABQ82951.1| uridylate kinase [Lactobacillus reuteri DSM 20016];> 9 7 6 5 5 4 42.5 25.876 240 
>gi|148531003|gb|ABQ83002.1| GTP-binding protein Era [Lactobacillus reuteri DSM 20016];>  3 2 2 3 1 1 13.6 33.79 301 
>gi|148530492|gb|ABQ82491.1| ribose-phosphate pyrophosphokinase [Lactobacillus reuteri DSM 
20016 7 6 4 3 3 1 24.9 36.16 329 
>gi|148531468|gb|ABQ83467.1| LSU ribosomal protein L33P [Lactobacillus reuteri DSM 20016];> 3 3 3 3 3 3 49 5.9998 49 
>gi|148530899|gb|ABQ82898.1| Dihydrolipoyllysine-residue succinyltransferase [Lactobacillus 
reuteri DSM 20016];> 3 1 1 1 1 2 10.4 48.372 444 
>gi|148530412|gb|ABQ82411.1| phosphoribosylformylglycinamidine synthase subunit I 
[Lactobacillus reuteri DSM 20016];> 5 2 5 3 3 2 33.6 24.732 226 
>gi|183227331|dbj|BAG27847.1| 30S ribosomal protein S19 [Lactobacillus fermentum IFO 3956];> 7 5 6 4 4 6 37.6 10.489 93 
>gi|148531529|gb|ABQ83528.1| phosphomethylpyrimidine kinase [Lactobacillus reuteri DSM 
20016L 3 1 1 1 0 1 22.9 29.317 271 
>gi|148530995|gb|ABQ82994.1| Choloylglycine hydrolase [Lactobacillus reuteri DSM 20016];> 8 6 0 3 1 0 42.2 36.104 325 
>gi|148531731|gb|ABQ83730.1| SSU ribosomal protein S10P [Lactobacillus reuteri DSM 20016];> 10 8 8 8 9 7 73.5 11.777 102 
>gi|148532002|gb|ABQ84001.1| NrdI family protein [Lactobacillus reuteri DSM 20016];> 4 4 3 3 3 3 27.1 17.501 155 
>gi|112943421|gb|ABI26308.1| carbamate kinase [Lactobacillus reuteri];> 7 2 2 1 4 2 35.8 33.007 310 
>gi|133930543|gb|ABO43842.1| tryptophanyl-tRNA synthetase [Lactobacillus reuteri];> 5 4 3 3 4 3 22.4 38.079 340 
>gi|148530877|gb|ABQ82876.1| ribose-phosphate pyrophosphokinase [Lactobacillus reuteri DSM 
20016];> 9 7 5 5 0 3 33.3 36.06 324 
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>gi|148530673|gb|ABQ82672.1| UDP-N-acetylmuramate dehydrogenase [Lactobacillus reuteri 
DSM 20016 4 4 3 2 2 2 19.1 32.389 298 
>gi|227071578|gb|EEI09875.1| ribokinase [Lactobacillus reuteri MM2-3];> 3 3 2 2 2 3 11.7 34.703 326 
>gi|227184829|gb|EEI64900.1| cysteinyl-tRNA synthetase [Lactobacillus reuteri CF48-3A];> 4 1 2 1 2 1 10.3 54.866 478 
>gi|148530914|gb|ABQ82913.1| SSU ribosomal protein S15P [Lactobacillus reuteri DSM 20016 5 4 3 3 3 3 52.8 10.416 89 
>gi|148531141|gb|ABQ83140.1| Purine nucleosidase [Lactobacillus reuteri DSM 20016 4 1 2 2 0 0 24.8 34.734 314 
>gi|148530515|gb|ABQ82514.1| DEAD/DEAH box helicase domain protein [Lactobacillus reuteri 
DSM 20016];> 8 7 2 1 1 1 22.5 56.522 498 
>gi|337728387|emb|CCC03488.1| GTPases [Lactobacillus reuteri ATCC 53608] 6 3 2 3 1 4 16.9 47.753 425 
>gi|183225282|dbj|BAG25799.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 3 1 1 1 1 1 12.6 49.015 438 
>gi|148530772|gb|ABQ82771.1| thiamine biosynthesis/tRNA modification protein ThiI 
[Lactobacillus reuteri DSM 20016];> 8 7 0 2 1 1 30.5 45.726 406 
>gi|112943728|gb|ABI26320.1| fructose-2,6-bisphosphatase [Lactobacillus reuteri];> 5 4 4 3 2 2 33.2 24.287 217 
>gi|148531523|gb|ABQ83522.1| PpiC-type peptidyl-prolyl cis-trans isomerase [Lactobacillus 
reuteri DSM 20016];> 3 3 1 0 3 2 11.2 34.663 312 
>gi|148530411|gb|ABQ82410.1| phosphoribosylformylglycinamidine synthase, purS [Lactobacillus 
reuteri DSM 20016];> 3 0 2 2 3 1 54.9 9.3323 82 
>gi|148531415|gb|ABQ83414.1| signal recognition particle-docking protein FtsY [Lactobacillus 
reuteri DSM 20016];> 4 4 4 4 4 4 11.2 55.604 508 
>gi|183227650|dbj|BAG28166.1| threonyl-tRNA synthase [Lactobacillus fermentum IFO 3956 5 4 2 3 2 3 8 72.259 634 
>gi|148530821|gb|ABQ82820.1| protein of unknown function DUF28 [Lactobacillus reuteri DSM 
20016];> p 5 3 3 3 5 3 32.3 27.161 248 
>gi|148531458|gb|ABQ83457.1| aminotransferase [Lactobacillus reuteri DSM 20016 2 1 1 2 2 1 7.1 43.367 393 
>gi|183224869|dbj|BAG25386.1| cell division protein [Lactobacillus reuteri JCM 1112];> 4 2 1 2 4 2 43.1 14.251 123 
>gi|148531448|gb|ABQ83447.1| LSU ribosomal protein L27P [Lactobacillus reuteri DSM 20016];> 4 4 3 3 3 4 48.4 9.9211 93 
>gi|148531400|gb|ABQ83399.1| phage antirepressor protein [Lactobacillus reuteri DSM 20016];> 2 1 0 0 1 2 12.7 30.203 267 
>gi|227071437|gb|EEI09740.1| transcriptional antiterminator NusG [Lactobacillus reuteri MM2-
3];>  3 3 3 3 2 1 28.5 20.875 186 
>gi|148531005|gb|ABQ83004.1| glycyl-tRNA synthetase alpha chain [Lactobacillus reuteri DSM 
20016];> 5 5 4 4 4 3 19.2 37.843 328 
>gi|148530913|gb|ABQ82912.1| SSU ribosomal protein S20P [Lactobacillus reuteri DSM 20016];> 3 2 3 3 3 2 34.5 9.2436 84 
>gi|148530415|gb|ABQ82414.1| phosphoribosylformylglycinamidine cyclo-ligase [Lactobacillus 
reuteri DSM 20016];> 10 8 6 7 6 3 49 36.975 345 
>gi|148531712|gb|ABQ83711.1| LSU ribosomal protein L30P [Lactobacillus reuteri DSM 20016];> 3 3 3 3 3 2 58.3 6.5566 60 
>gi|148531102|gb|ABQ83101.1| hypothetical protein Lreu_0838 [Lactobacillus reuteri DSM 
20016];> 12 11 6 8 5 8 37.4 39.346 358 
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>gi|148530311|gb|ABQ82310.1| aldehyde dehydrogenase [Lactobacillus reuteri DSM 20016];> 3 2 1 0 1 1 9.6 50.505 457 
>gi|148531407|gb|ABQ83406.1| LSU ribosomal protein L19P [Lactobacillus reuteri DSM 20016 10 10 9 8 8 8 49.2 14.824 128 
>gi|183224788|dbj|BAG25305.1| hypothetical phage protein [Lactobacillus reuteri JCM 1112 5 2 3 3 2 3 28.8 25.075 219 
>gi|183225283|dbj|BAG25800.1| putative autolysin [Lactobacillus reuteri JCM 1112];> 2 0 1 1 2 1 7.9 60.393 532 
>gi|148530734|gb|ABQ82733.1| ATP synthase F1 subcomplex alpha subunit [Lactobacillus reuteri 
DSM 20016 12 8 5 9 6 3 25.7 55.226 509 
>gi|148530873|gb|ABQ82872.1| tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase 
[Lactobacillus reuteri DSM 20016 5 3 2 1 1 4 21 42.769 377 
>gi|148531869|gb|ABQ83868.1| GTP-binding protein, HSR1-related [Lactobacillus reuteri DSM 
20016];>  7 4 3 4 2 5 19.3 47.758 425 
>gi|227071698|gb|EEI09989.1| phosphoesterase [Lactobacillus reuteri MM2-3];> 1 1 1 0 0 0 8.5 19.857 176 
>gi|148531433|gb|ABQ83432.1| DNA-directed RNA polymerase subunit omega [Lactobacillus 
reuteri DSM 20016];> 4 3 3 2 3 3 75 7.9219 72 
>gi|148531769|gb|ABQ83768.1| DJ-1 family protein [Lactobacillus reuteri DSM 20016];> 4 1 3 4 1 1 31.1 20.995 190 
>gi|148531430|gb|ABQ83429.1| methionyl-tRNA formyltransferase [Lactobacillus reuteri DSM 
20016];> 3 2 1 1 1 1 15.5 34.729 317 
>gi|148530792|gb|ABQ82791.1| RecA protein [Lactobacillus reuteri DSM 20016];> 5 2 1 2 1 4 19.1 39.063 362 
>gi|148531196|gb|ABQ83195.1| degV family protein [Lactobacillus reuteri DSM 20016];> 4 0 2 3 1 2 27.4 32.228 292 
>gi|148530459|gb|ABQ82458.1| methionine-R-sulfoxide reductase [Lactobacillus reuteri DSM 
20016  4 3 1 2 2 1 36.6 16.101 142 
>gi|148531776|gb|ABQ83775.1| flavocytochrome c [Lactobacillus reuteri DSM 20016];> 9 7 7 7 6 6 27.8 50.13 464 
>gi|112943339|gb|ABI26305.1| sphingosine kinase [Lactobacillus reuteri];> 2 2 0 0 1 0 8.9 37.14 337 
>gi|227071203|gb|EEI09517.1| UDP-galactopyranose mutase [Lactobacillus reuteri MM2-3];> 6 4 5 5 5 2 21.1 44.975 384 
>gi|227185166|gb|EEI65237.1| aspartate semialdehyde dehydrogenase [Lactobacillus reuteri 
CF48-3A];> 6 2 3 4 5 3 29.3 38.935 358 
>gi|148531329|gb|ABQ83328.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016];> 4 2 1 2 2 2 7.6 60.056 555 
>gi|148530569|gb|ABQ82568.1| ribose-5-phosphate isomerase [Lactobacillus reuteri DSM 
20016];> 5 5 4 4 4 3 26 25.036 227 
>gi|133930447|gb|ABO43795.1| E1 component beta subunit [Lactobacillus reuteri];> 3 1 2 2 1 2 18.8 35.243 325 
>gi|148530634|gb|ABQ82633.1| SSU ribosomal protein S30P [Lactobacillus reuteri DSM 20016];> 5 3 3 1 3 3 46.2 21.144 182 
>gi|227070968|gb|EEI09291.1| glutamate-1-semialdehyde 2,1-aminomutase [Lactobacillus reuteri 
MM2-3 5 3 3 4 4 2 18.1 48.026 443 
>gi|148531476|gb|ABQ83475.1| phenylalanyl-tRNA synthetase, alpha subunit [Lactobacillus 
reuteri DSM 20016];> 3 1 1 0 2 1 11.5 39.026 348 
>gi|148531008|gb|ABQ83007.1| RNA polymerase, sigma 70 subunit, RpoD [Lactobacillus reuteri 
DSM 20016];> 5 4 2 4 2 2 17.6 43.385 380 
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>gi|148531221|gb|ABQ83220.1| 1-deoxy-D-xylulose-5-phosphate synthase [Lactobacillus reuteri 
DSM 20016];> 6 3 2 4 4 3 18.3 65.608 591 
>gi|148530819|gb|ABQ82818.1| transcriptional regulator, LacI family [Lactobacillus reuteri DSM 
20016];> 7 5 5 4 4 3 27.4 36.722 336 
>gi|148530319|gb|ABQ82318.1| OsmC family protein [Lactobacillus reuteri DSM 20016];> 3 3 2 2 2 1 22.5 15.724 142 
>gi|337729366|emb|CCC04496.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608] 3 3 0 0 0 0 8.2 44.72 402 
>gi|227070870|gb|EEI09194.1| iron-containing alcohol dehydrogenase [Lactobacillus reuteri 
MM2-3];> 3 0 2 1 2 1 12.9 40.929 379 
>gi|148531487|gb|ABQ83486.1| LSU ribosomal protein L32P [Lactobacillus reuteri DSM 20016];> 2 2 2 2 2 1 25.4 6.5727 59 
>gi|148530523|gb|ABQ82522.1| D-alanine-activating enzyme [Lactobacillus reuteri DSM 20016];> 9 4 5 8 3 1 28.3 55.989 508 
>gi|148530389|gb|ABQ82388.1| inosine-5-monophosphate dehydrogenase [Lactobacillus reuteri 
DSM 20016 5 4 4 4 5 3 23.7 39.373 380 
>gi|148531780|gb|ABQ83779.1| Peptidylprolyl isomerase [Lactobacillus reuteri DSM 20016 4 3 3 3 4 2 35.5 22.199 197 
>gi|183225758|dbj|BAG26275.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 [ 3 2 3 3 2 2 20.7 22.577 203 
>gi|183225128|dbj|BAG25645.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 3 1 0 2 0 0 12.1 35.441 297 
>gi|148530538|gb|ABQ82537.1| hypoxanthine phosphoribosyltransferase [Lactobacillus reuteri 
DSM 20016];> 5 3 3 2 2 2 31.1 20.464 180 
>gi|148531027|gb|ABQ83026.1| cytidylate kinase [Lactobacillus reuteri DSM 20016 4 2 1 1 3 3 24.1 25.015 228 
>gi|148531233|gb|ABQ83232.1| nucleotide deoxyribosyltransferase [Lactobacillus reuteri DSM 
20016];> 1 1 0 0 0 1 11.9 18.201 160 
>gi|148531479|gb|ABQ83478.1| tRNA/rRNA methyltransferase (SpoU) [Lactobacillus reuteri DSM 
20016];> 3 3 0 0 1 2 16.7 28.31 258 
>gi|148530337|gb|ABQ82336.1| glutamate-cysteine ligase [Lactobacillus reuteri DSM 20016 3 1 1 0 1 2 10.8 51.01 446 
>gi|183225058|dbj|BAG25575.1| phage major head protein [Lactobacillus reuteri JCM 1112];> 1 1 1 0 1 1 3.8 43.887 394 
>gi|227186252|gb|EEI66323.1| possible aspartate transaminase [Lactobacillus reuteri CF48-3A];>  6 6 0 2 0 0 24.3 42.745 395 
>gi|148531241|gb|ABQ83240.1| DSBA oxidoreductase [Lactobacillus reuteri DSM 20016];>J 2 2 0 1 0 0 16.3 24.566 215 
>gi|148530690|gb|ABQ82689.1| glucose-6-phosphate isomerase [Lactobacillus reuteri DSM 
20016];> 3 3 0 0 0 0 10.6 50.35 452 
>gi|148530481|gb|ABQ82480.1| methionyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 7 6 5 4 4 2 12.3 76.638 675 
>gi|148530860|gb|ABQ82859.1| cell division protein FtsA [Lactobacillus reuteri DSM 20016];> 2 1 2 1 1 1 5.3 50.485 457 
>gi|148531330|gb|ABQ83329.1| Peroxiredoxin [Lactobacillus reuteri DSM 20016];> 6 3 1 2 2 1 34.2 21.041 187 
>gi|148531472|gb|ABQ83471.1| transcription elongation factor GreA [Lactobacillus reuteri DSM 
20016];> 7 5 5 5 3 4 60.1 18.019 158 
>gi|148531067|gb|ABQ83066.1| prophage antirepressor [Lactobacillus reuteri DSM 20016];> 2 1 0 0 1 2 12.1 28.734 257 
>gi|148531094|gb|ABQ83093.1| hypothetical protein Lreu_0830 [Lactobacillus reuteri DSM 3 1 3 2 3 0 22.7 16.079 141 
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20016];> 
>gi|183225267|dbj|BAG25784.1| dextransucrase [Lactobacillus reuteri JCM 1112 1 1 1 1 1 1 1.1 167.91 1488 
>gi|148531941|gb|ABQ83940.1| porphobilinogen synthase [Lactobacillus reuteri DSM 20016 1 0 1 1 0 0 4.6 35.84 323 
>gi|148531613|gb|ABQ83612.1| hypothetical protein Lreu_1363 [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 1 2 13.8 19.693 189 
>gi|148530657|gb|ABQ82656.1| protein of unknown function UPF0052 and CofD [Lactobacillus 
reuteri DSM 20016];> 4 3 2 2 0 0 17.7 36.198 328 
>gi|148531444|gb|ABQ83443.1| protein of unknown function DUF322 [Lactobacillus reuteri DSM 
20016];> 5 4 4 2 1 2 40.7 15.835 145 
>gi|148531785|gb|ABQ83784.1| hypothetical protein Lreu_1539 [Lactobacillus reuteri DSM 
20016];> 4 3 2 3 1 0 39 16.827 146 
>gi|148531708|gb|ABQ83707.1| bacterial translation initiation factor 1 (bIF-1) [Lactobacillus 
reuteri DSM 20016];> 5 1 2 4 4 3 75 8.1615 72 
>gi|183226401|dbj|BAG26917.1| cell division initiation protein [Lactobacillus fermentum IFO 
3956];> 4 3 4 3 4 4 11.4 25.101 228 
>gi|148531846|gb|ABQ83845.1| tRNA/rRNA methyltransferase (SpoU) [Lactobacillus reuteri DSM 
20016];> 4 2 1 2 1 1 22.4 31.804 290 
>gi|148530684|gb|ABQ82683.1| Cof-like hydrolase [Lactobacillus reuteri DSM 20016];> 3 2 2 1 2 1 16.8 30.206 268 
>gi|227070209|gb|EEI08583.1| diaminopimelate decarboxylase [Lactobacillus reuteri MM2-3];>  5 5 0 1 1 1 13.6 48.355 441 
>gi|148531975|gb|ABQ83974.1| LSU ribosomal protein L29P [Lactobacillus reuteri DSM 20016];> 5 0 1 3 2 2 26.8 51.127 477 
>gi|148530611|gb|ABQ82610.1| peptidase M22, glycoprotease [Lactobacillus reuteri DSM 
20016];> 3 1 2 2 1 1 17 26.806 241 
>gi|148530405|gb|ABQ82404.1| acetolactate synthase, catabolic [Lactobacillus reuteri DSM 
20016 10 6 4 6 4 2 32.6 60.994 559 
>gi|148532050|gb|ABQ84049.1| hypothetical protein Lreu_1810 [Lactobacillus reuteri DSM 
20016];> 8 4 4 4 3 5 20.4 46.453 411 
>gi|148531719|gb|ABQ83718.1| LSU ribosomal protein L24P [Lactobacillus reuteri DSM 20016];> 2 2 1 1 1 1 10.8 10.975 102 
>gi|148530791|gb|ABQ82790.1| competence/damage-inducible protein cinA [Lactobacillus 
reuteri DSM 20016];> 1 0 0 0 1 1 4.8 45.373 415 
>gi|148530881|gb|ABQ82880.1| Tetrahydrodipicolinate succinyltransferase N-terminal domain 
protein [Lactobacillus reuteri DSM 20016];> 2 1 1 1 1 1 27.1 24.876 236 
>gi|148530680|gb|ABQ82679.1| glutamine--fructose-6-phosphate transaminase [Lactobacillus 
reuteri DSM 20016];> 10 4 3 4 6 1 30.7 66.611 606 
>gi|148530883|gb|ABQ82882.1| dihydrodipicolinate synthase [Lactobacillus reuteri DSM 20016];> 6 4 2 2 2 4 32.6 33.823 307 
>gi|148532020|gb|ABQ84019.1| PEBP family protein [Lactobacillus reuteri DSM 20016];> J 1 1 0 1 1 0 10.7 18.294 168 
>gi|148530788|gb|ABQ82787.1| peptidase M16 domain protein [Lactobacillus reuteri DSM 
20016];>  4 3 1 1 1 1 15.5 49.689 432 
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>gi|194453256|gb|EDX42154.1| Tetrahydrodipicolinate succinyltransferase domain protein 
[Lactobacillus reuteri 100-23];> 2 1 0 1 0 0 27.1 24.89 236 
>gi|148531434|gb|ABQ83433.1| guanylate kinase [Lactobacillus reuteri DSM 20016];> 2 2 2 2 2 2 10.7 23.546 206 
>gi|148531057|gb|ABQ83056.1| gluconate kinase, FGGY family [Lactobacillus reuteri DSM 
20016];>  8 3 5 7 5 3 30.8 55.417 509 
>gi|183224052|dbj|BAG24569.1| beta-phosphoglucomutase [Lactobacillus reuteri JCM 1112];> 7 1 5 1 2 2 44.4 24.587 225 
>gi|148530659|gb|ABQ82658.1| ATP-dependent Clp protease proteolytic subunit ClpP 
[Lactobacillus reuteri DSM 20016];> 4 2 3 3 4 2 44.7 21.433 197 
>gi|227185294|gb|EEI65365.1| HAD superfamily hydrolase [Lactobacillus reuteri CF48-3A];> 5 3 4 4 3 4 22.7 30.425 273 
>gi|148530442|gb|ABQ82441.1| triosephosphate isomerase [Lactobacillus reuteri DSM 20016];> 4 1 3 4 2 1 35.5 28.377 256 
>gi|148531423|gb|ABQ83422.1| LSU ribosomal protein L28P [Lactobacillus reuteri DSM 20016];> 3 3 3 3 3 3 31.1 6.9271 61 
>gi|227070541|gb|EEI08874.1| phosphoribosylaminoimidazole carboxylase [Lactobacillus reuteri 
MM2-3];> 7 4 6 2 2 2 32.8 42.428 384 
>gi|148532170|gb|ABQ84169.1| UDP-N-acetylmuramyl-tripeptide synthetase [Lactobacillus 
reuteri DSM 20016];> 5 3 2 4 1 1 14.5 57.457 516 
>gi|148530622|gb|ABQ82621.1| CoA-binding domain protein [Lactobacillus reuteri DSM 20016];> 4 2 0 1 2 3 29.9 23.939 214 
>gi|148531276|gb|ABQ83275.1| thiamine-phosphate diphosphorylase [Lactobacillus reuteri DSM 
20016];> 2 1 2 2 1 0 18.1 23.849 215 
>gi|337728189|emb|CCC03281.1| UDP-galactopyranose mutase [Lactobacillus reuteri ATCC 
53608] 5 5 3 3 3 2 16.7 43.523 372 
>gi|130893190|gb|ABO32597.1| ATP-dependent Clp protease ATP-binding subunit ClpC 
[Lactobacillus reuteri];> 7 3 5 4 6 6 12.5 92.89 830 
>gi|337728167|emb|CCC03258.1| putative cold shock protein [Lactobacillus reuteri ATCC 53608] 4 4 1 1 0 0 71.2 7.2839 66 
>gi|148530641|gb|ABQ82640.1| glycerol 3-phosphate dehydrogenase (NAD(P)+) [Lactobacillus 
reuteri DSM 20016 7 4 1 3 5 3 26 36.905 338 
>gi|148531418|gb|ABQ83417.1| acyl carrier protein [Lactobacillus reuteri DSM 20016];> 3 2 2 3 3 2 45.2 9.4942 84 
>gi|227070893|gb|EEI09216.1| DNA helicase [Lactobacillus reuteri MM2-3];> 6 5 3 3 2 3 10.2 90.014 775 
>gi|133930439|gb|ABO43791.1| 2-keto-4-pentenoate hydratase [Lactobacillus reuteri];> 2 2 0 1 1 1 9.5 29.068 263 
>gi|148530846|gb|ABQ82845.1| 6-phosphogluconolactonase [Lactobacillus reuteri DSM 20016 5 4 3 0 2 0 21.6 37.901 342 
>gi|227070638|gb|EEI08968.1| DNA-binding response regulator [Lactobacillus reuteri MM2-3];> 2 1 2 2 2 2 11.6 27.524 241 
>gi|148530493|gb|ABQ82492.1| hypothetical protein Lreu_0222 [Lactobacillus reuteri DSM 20016 3 2 2 3 3 3 24.1 25.919 245 
>gi|148530511|gb|ABQ82510.1| protein tyrosine phosphatase [Lactobacillus reuteri DSM 
20016];> 2 0 2 0 0 0 26.6 17.398 154 
>gi|148530787|gb|ABQ82786.1| peptidase M16 domain protein [Lactobacillus reuteri DSM 20016 3 1 2 2 0 2 13.3 47.131 415 
>gi|148531897|gb|ABQ83896.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016];> 3 1 3 3 3 1 15.7 35.791 332 
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>gi|148530924|gb|ABQ82923.1| GTP-binding protein Obg/CgtA [Lactobacillus reuteri DSM 
20016];> 10 5 5 6 3 2 28.8 47.975 438 
>gi|148530514|gb|ABQ82513.1| UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase 
[Lactobacillus reuteri DSM 20016];> 4 2 2 2 1 1 12.2 50.527 459 
>gi|148530344|gb|ABQ82343.1| guanosine monophosphate reductase [Lactobacillus reuteri DSM 
20016 3 2 2 1 2 2 15.1 35.96 324 
>gi|148531928|gb|ABQ83927.1| ybaK/ebsC protein [Lactobacillus reuteri DSM 20016 1 0 1 1 1 1 11.9 18.647 168 
>gi|148530723|gb|ABQ82722.1| translation factor SUA5 [Lactobacillus reuteri DSM 20016 3 1 0 2 2 1 12.6 37.261 342 
>gi|148531462|gb|ABQ83461.1| hypothetical protein Lreu_1204 [Lactobacillus reuteri DSM 
20016];> 3 2 2 2 2 3 69 6.3153 58 
>gi|148530724|gb|ABQ82723.1| serine hydroxymethyltransferase [Lactobacillus reuteri DSM 
20016 7 4 5 4 3 4 24.8 44.95 411 
>gi|148530416|gb|ABQ82415.1| formyltetrahydrofolate-dependent phosphoribosylglycinamide 
formyltransferase [Lactobacillus reuteri DSM 20016 2 0 2 1 2 0 35.3 21.163 190 
>gi|148531989|gb|ABQ83988.1| microcompartments protein [Lactobacillus reuteri DSM 20016];> 
reuteri DSM 20016];>gi|183225636|dbj|BAG26153.1| propanediol utilization protein PduA [Lacto 1 0 1 1 1 1 33.3 9.5708 93 
>gi|300379511|gb|ADK08388.1| OsmC family protein [Lactobacillus reuteri] 3 2 2 1 2 2 19.7 15.723 142 
>gi|148531530|gb|ABQ83529.1| malate dehydrogenase (NAD) [Lactobacillus reuteri DSM 
20016];> 6 5 3 4 4 4 29.5 33.353 312 
>gi|227071420|gb|EEI09725.1| FMN reductase [Lactobacillus reuteri MM2-3];> 3 3 3 3 3 3 13 26.152 238 
>gi|148530971|gb|ABQ82970.1| GrpE protein [Lactobacillus reuteri DSM 20016];> 2 1 1 2 2 2 11.6 21.43 190 
>gi|148531795|gb|ABQ83794.1| Esterase/lipase-like protein [Lactobacillus reuteri DSM 20016];> 4 2 4 1 2 2 29.8 26.628 238 
>gi|183225127|dbj|BAG25644.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  5 4 1 4 3 2 16.5 40.161 352 
>gi|148530605|gb|ABQ82604.1| Uroporphyrin-III C/tetrapyrrole (Corrin/Porphyrin) 
methyltransferase [Lactobacillus reuteri DSM 20016];> 2 1 0 0 1 0 14.6 32.603 288 
>gi|148531075|gb|ABQ83074.1| RecT protein [Lactobacillus reuteri DSM 20016 2 1 2 2 2 1 7.4 34.762 309 
>gi|148530868|gb|ABQ82867.1| NUDIX hydrolase [Lactobacillus reuteri DSM 20016];> 3 2 0 1 0 0 22.4 20.827 183 
>gi|148532082|gb|ABQ84081.1| D-Ala-D-Ala carboxypeptidase A, Serine peptidase, MEROPS 
family S11 [Lactobacillus reuteri DSM 20016];> 2 0 1 1 0 0 9.7 44.354 403 
>gi|148530602|gb|ABQ82601.1| protein of unknown function DUF970 [Lactobacillus reuteri DSM 
20016];> 1 0 1 1 1 0 15.9 11.874 107 
>gi|148530286|gb|ABQ82285.1| SSU ribosomal protein S18P [Lactobacillus reuteri DSM 20016];> 4 3 3 3 2 1 51.3 9.1536 78 
>gi|148530885|gb|ABQ82884.1| aminotransferase [Lactobacillus reuteri DSM 20016];> 1 1 1 1 1 1 4.6 42.991 394 
>gi|148531640|gb|ABQ83639.1| DEAD/DEAH box helicase domain protein [Lactobacillus reuteri 
DSM 20016];> 1 1 1 1 1 1 3 48.772 433 
>gi|148530810|gb|ABQ82809.1| glutamate racemase [Lactobacillus reuteri DSM 20016];> 2 2 1 1 0 1 15.7 28.92 267 
>gi|148530966|gb|ABQ82965.1| ribosome-binding factor A [Lactobacillus reuteri DSM 20016];> 3 2 2 1 2 2 16.8 13.412 119 
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>gi|148530664|gb|ABQ82663.1| RNAse R [Lactobacillus reuteri DSM 20016];> 6 5 4 4 5 4 9.4 91.867 801 
>gi|148532172|gb|ABQ84171.1| glucose inhibited division protein A [Lactobacillus reuteri DSM 
20016];> 4 3 4 3 4 3 7.9 71.918 647 
>gi|148531131|gb|ABQ83130.1| hypothetical protein Lreu_0867 [Lactobacillus reuteri DSM 
20016];> 5 3 3 2 5 2 69.2 10.576 91 
>gi|148530760|gb|ABQ82759.1| Glyoxalase/bleomycin resistance protein/dioxygenase 
[Lactobacillus reuteri DSM 20016 4 3 2 0 2 1 45.2 15.166 135 
>gi|148530279|gb|ABQ82278.1| DNA polymerase III, beta subunit [Lactobacillus reuteri DSM 
20016];> 7 5 4 5 3 4 26.3 41.831 380 
>gi|148531622|gb|ABQ83621.1| lipopolysaccharide biosynthesis protein [Lactobacillus reuteri 
DSM 20016];>r 2 2 1 1 1 1 15.3 22.766 209 
>gi|148530920|gb|ABQ82919.1| small GTP-binding protein [Lactobacillus reuteri DSM 20016];> 2 1 1 2 0 0 19.4 22.641 196 
>gi|148531473|gb|ABQ83472.1| uridine kinase [Lactobacillus reuteri DSM 20016 4 1 4 3 2 2 38.5 25.134 218 
>gi|148531188|gb|ABQ83187.1| putative RNA methylase [Lactobacillus reuteri DSM 20016  1 0 1 1 1 0 5 44.845 398 
>gi|148531409|gb|ABQ83408.1| tRNA (Guanine37-N(1)-) methyltransferase [Lactobacillus reuteri 
DSM 20016 2 2 0 1 0 0 7.9 28.476 252 
>gi|148530539|gb|ABQ82538.1| membrane protease FtsH catalytic subunit [Lactobacillus reuteri 
DSM 20016];>gi|148543505|ref|YP_001270875.1| ATP-dependent metalloprotease FtsH 
[Lactobacillus reuteri DSM 20016];>gi|194454716|gb|EDX43613.1| ATP-dependent metall 4 0 2 4 2 1 8.4 77.238 702 
>gi|148531585|gb|ABQ83584.1| ATPase AAA-2 domain protein [Lactobacillus reuteri DSM 
20016];> 7 2 2 1 2 4 15.8 81.867 734 
>gi|227070055|gb|EEI08433.1| GTP-binding protein EngA [Lactobacillus reuteri MM2-3];> 5 3 2 2 2 4 13.2 49.465 440 
>gi|227071710|gb|EEI10001.1| phosphoesterase [Lactobacillus reuteri MM2-3];> 5 4 3 2 2 3 12.6 37.97 342 
>gi|194453106|gb|EDX42004.1| Glycine hydroxymethyltransferase [Lactobacillus reuteri 100-
23];> 6 3 2 4 1 1 20.7 44.929 411 
>gi|148531144|gb|ABQ83143.1| GTP cyclohydrolase II [Lactobacillus reuteri DSM 20016 2 2 0 0 0 1 6.9 43.927 393 
>gi|148531658|gb|ABQ83657.1| nitroreductase [Lactobacillus reuteri DSM 20016];> 3 2 2 2 3 1 12.9 24.752 217 
>gi|300379499|gb|ADK08380.1| D-alanine-D-alanyl carrier protein ligase [Lactobacillus reuteri] 3 1 2 3 2 1 10.3 29.719 271 
>gi|227070071|gb|EEI08449.1| aldose 1-epimerase [Lactobacillus reuteri MM2-3 3 2 2 2 3 2 12.2 34.581 304 
>gi|148530714|gb|ABQ82713.1| arginine deiminase [Lactobacillus reuteri DSM 20016];> 6 2 5 4 4 2 22 46.242 410 
>gi|227070613|gb|EEI08943.1| possible asparagine synthase (glutamine-hydrolyzing) 
[Lactobacillus reuteri MM2-3 5 3 3 1 1 3 8.1 76.34 652 
>gi|148531438|gb|ABQ83437.1| hemolysin A [Lactobacillus reuteri DSM 20016];> 2 1 1 0 0 1 8.8 30.273 273 
>gi|227070057|gb|EEI08435.1| tetratricopeptide repeat family protein [Lactobacillus reuteri 
MM2-3];> 3 3 0 1 2 1 10.8 50.211 434 
>gi|183224279|dbj|BAG24796.1| putative lipase/esterase [Lactobacillus reuteri JCM 1112];> 4 3 1 1 2 1 15.4 33.174 292 
>gi|227070559|gb|EEI08890.1| possible gamma-glutamyl-gamma-aminobutyrate hydrolase 4 1 4 4 0 0 30.8 27.281 247 
 198 
 
[Lactobacillus reuteri MM2-3 
>gi|148531143|gb|ABQ83142.1| riboflavin synthase, alpha subunit [Lactobacillus reuteri DSM 
20016];>  2 1 2 1 1 1 12.5 21.593 200 
>gi|148531778|gb|ABQ83777.1| Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP(+)) 
[Lactobacillus reuteri DSM 20016];> 2 1 0 0 0 1 5.4 59.597 542 
>gi|148531335|gb|ABQ83334.1| SSU ribosomal protein S14P [Lactobacillus reuteri DSM 20016];> 5 5 3 4 3 3 32.6 10.399 89 
>gi|68160862|gb|AAY86877.1| unknown extracellular protein lr1434 [Lactobacillus reuteri 1 0 0 1 0 1 4.1 22.351 193 
>gi|148531828|gb|ABQ83827.1| quorum-sensing autoinducer 2 (AI-2), LuxS [Lactobacillus reuteri 
DSM 20016];> 4 2 3 2 2 2 33.5 17.695 158 
>gi|148532110|gb|ABQ84109.1| cytochrome b5 [Lactobacillus reuteri DSM 20016 1 0 0 1 1 1 34.7 8.1163 72 
>gi|148530983|gb|ABQ82982.1| [LSU ribosomal protein L11P]-lysine N-methyltransferase 
[Lactobacillus reuteri DSM 20016];> 2 1 0 0 0 1 12.5 34.966 319 
>gi|148531752|gb|ABQ83751.1| iron dependent repressor [Lactobacillus reuteri DSM 20016];> 1 1 0 1 1 1 5.4 25.242 224 
>gi|148531126|gb|ABQ83125.1| GCN5-related N-acetyltransferase [Lactobacillus reuteri DSM 
20016 1 1 1 1 0 1 6.8 20.109 177 
>gi|337729100|emb|CCC04223.1| glutamate racemase [Lactobacillus reuteri ATCC 53608] 2 2 0 0 0 0 15.7 28.972 267 
>gi|183225285|dbj|BAG25802.1| muramidase [Lactobacillus reuteri JCM 1112];> 2 1 0 2 0 1 9.8 55.89 492 
>gi|227071772|gb|EEI10061.1| transcription antitermination protein NusB [Lactobacillus reuteri 
MM2-3];> 4 2 2 3 1 2 39 16.148 141 
>gi|148531439|gb|ABQ83438.1| farnesyl-diphosphate synthase [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 4.5 31.64 290 
>gi|148531452|gb|ABQ83451.1| hypothetical protein Lreu_1194 [Lactobacillus reuteri DSM 
20016];> 3 3 1 1 0 0 23.2 19.53 168 
>gi|148530896|gb|ABQ82895.1| peptide deformylase [Lactobacillus reuteri DSM 20016 1 0 1 1 0 1 7 20.898 186 
>gi|148531404|gb|ABQ83403.1| protein of unknown function DUF1535 [Lactobacillus reuteri DSM 
20016];> 2 0 0 0 1 1 16.6 18.631 169 
>gi|148532093|gb|ABQ84092.1| transcriptional regulator, ArsR family [Lactobacillus reuteri DSM 
20016];> 2 0 2 2 2 2 29.8 12.182 104 
>gi|227070037|gb|EEI08415.1| S-adenosyl-L-methionine-dependent methyltransferase 
[Lactobacillus reuteri MM2-3];> 3 1 3 2 1 3 24.8 26.69 238 
>gi|183227291|dbj|BAG27807.1| glutamyl-tRNA amidotransferase subunit B [Lactobacillus 
fermentum IFO 3956];> 3 3 0 0 0 0 5.9 52.972 474 
>gi|183226941|dbj|BAG27457.1| glycerol kinase [Lactobacillus fermentum IFO 3956];> 2 2 2 2 2 2 2.4 55.633 503 
>gi|148531804|gb|ABQ83803.1| nitroreductase [Lactobacillus reuteri DSM 20016];> 2 2 1 1 0 0 13.4 28.863 253 
>gi|183224586|dbj|BAG25103.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 3 0 0 2 1 2 20 26.479 230 
>gi|227071080|gb|EEI09398.1| metallo-beta-lactamase [Lactobacillus reuteri MM2-3];> 2 1 1 0 0 0 7.3 70.828 628 
>gi|148531689|gb|ABQ83688.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C 1 1 0 1 0 0 13.3 11.572 105 
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[Lactobacillus reuteri DSM 20016];> 
>gi|148531635|gb|ABQ83634.1| methionine aminopeptidase, type I [Lactobacillus reuteri DSM 
20016];> 3 2 0 0 1 0 7.4 31.665 285 
>gi|148531871|gb|ABQ83870.1| CsbD family protein [Lactobacillus reuteri DSM 20016];> 1 0 1 1 1 1 18.5 7.1913 65 
>gi|148530789|gb|ABQ82788.1| Uncharacterized protein [Lactobacillus reuteri DSM 20016];> 2 1 1 0 0 0 7 38.296 345 
>gi|148530740|gb|ABQ82739.1| cell shape determining protein, MreB/Mrl family [Lactobacillus 
reuteri DSM 20016];> 4 2 1 1 1 3 10.9 35.48 330 
>gi|148530879|gb|ABQ82878.1| aspartate kinase [Lactobacillus reuteri DSM 20016];> 2 2 1 1 1 0 7.1 50.12 452 
>gi|227069946|gb|EEI08331.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3];> 3 2 1 1 1 0 16.6 19.78 175 
>gi|148530385|gb|ABQ82384.1| phosphopentomutase [Lactobacillus reuteri DSM 20016];> 1 1 0 0 1 1 4.8 44.002 397 
>gi|148531693|gb|ABQ83692.1| 5-(carboxyamino)imidazole ribonucleotide synthase 
[Lactobacillus reuteri DSM 20016];> 5 1 3 5 2 2 21.5 42.001 377 
>gi|183224803|dbj|BAG25320.1| hypothetical protein [Lactobacillus reuteri JCM 1112 2 1 2 0 0 0 11.6 40.672 371 
>gi|148531891|gb|ABQ83890.1| Ferritin, Dps family protein [Lactobacillus reuteri DSM 20016];> 2 1 0 2 0 0 20 18.223 155 
>gi|227071130|gb|EEI09446.1| TrmA family tRNA (uracil-5-)-methyltransferase [Lactobacillus 
reuteri MM2-3 3 3 1 1 1 1 7.5 53.815 480 
>gi|148532085|gb|ABQ84084.1| carbohydrate kinase, YjeF related protein [Lactobacillus reuteri 
DSM 20016];> 2 1 1 2 2 0 14.2 22.43 212 
>gi|148530310|gb|ABQ82309.1| pyrroline-5-carboxylate reductase [Lactobacillus reuteri DSM 
20016];> 3 2 1 0 2 0 18.1 29.38 270 
>gi|148530742|gb|ABQ82741.1| hypothetical protein Lreu_0473 [Lactobacillus reuteri DSM 
20016];> 3 2 2 2 2 2 56.8 8.7648 74 
>gi|148531987|gb|ABQ83986.1| Glycerol dehydratase [Lactobacillus reuteri DSM 20016];> 4 0 2 0 3 0 9.3 62.092 558 
>gi|227070920|gb|EEI09243.1| possible phosphatase [Lactobacillus reuteri MM2-3];> 1 1 0 1 1 1 6.9 24.08 218 
>gi|148530818|gb|ABQ82817.1| Xaa-Pro aminopeptidase, Metallo peptidase, MEROPS family 
M24B [Lactobacillus reuteri DSM 20016];>  4 2 1 1 2 0 19.8 40.615 369 
>gi|148531942|gb|ABQ83941.1| hydroxymethylbilane synthase [Lactobacillus reuteri DSM 
20016];> 2 0 2 1 1 1 8.9 33.658 305 
>gi|148530901|gb|ABQ82900.1| protein of unknown function UPF0223 [Lactobacillus reuteri DSM 
20016];> 2 0 0 0 2 1 28.4 11.867 102 
>gi|148530732|gb|ABQ82731.1| ATP synthase F0 subcomplex B subunit [Lactobacillus reuteri 
DSM 20016];> 3 2 1 0 0 1 20.3 19.254 172 
>gi|148530839|gb|ABQ82838.1| dipeptidase A, Cysteine peptidase, MEROPS family C69 
[Lactobacillus reuteri DSM 20016];> 3 0 0 1 2 0 7.4 51.591 458 
>gi|227070615|gb|EEI08945.1| tRNA modification GTPase TrmE [Lactobacillus reuteri MM2-3];>  1 0 0 1 1 1 3.6 52.527 477 
>gi|148531114|gb|ABQ83113.1| hypothetical protein Lreu_0850 [Lactobacillus reuteri DSM 
20016];> 2 0 0 1 0 1 22.2 10.169 90 
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>gi|148530807|gb|ABQ82806.1| MutS2 family protein [Lactobacillus reuteri DSM 20016];> 1 0 1 1 0 1 3.7 88.897 791 
>gi|148530576|gb|ABQ82575.1| RNA methyltransferase, TrmH family, group 3 [Lactobacillus 
reuteri DSM 20016];> 3 2 1 1 1 2 12.9 27.28 249 
>gi|148530520|gb|ABQ82519.1| DltD, C-terminal domain protein [Lactobacillus reuteri DSM 
20016];> 2 1 0 1 0 1 4.4 49.455 429 
>gi|148531488|gb|ABQ83487.1| protein of unknown function DUF177 [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 1 1 18.9 20.961 185 
>gi|183224273|dbj|BAG24790.1| transcription accessory protein [Lactobacillus reuteri JCM 1112 3 0 1 0 2 2 8.1 82.072 727 
>gi|148530907|gb|ABQ82906.1| Phosphopantetheine adenylyltransferase [Lactobacillus reuteri 
DSM 20016];> 3 1 1 1 1 1 43.9 19.361 173 
>gi|148531951|gb|ABQ83950.1| anaerobic cobaltochelatase [Lactobacillus reuteri DSM 20016];> 2 0 2 1 0 0 18.5 29.176 259 
>gi|15667450|dbj|BAB68226.1| putative autoaggregation-mediating protein [Enterococcus 
faecium] 2 1 1 0 1 1 12.4 23.402 210 
>gi|148531410|gb|ABQ83409.1| 16S rRNA processing protein RimM [Lactobacillus reuteri DSM 
20016];> 1 1 1 0 1 1 7.1 19.219 168 
>gi|148532087|gb|ABQ84086.1| histidyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 5 4 2 2 2 1 15.3 48.236 425 
>gi|148530614|gb|ABQ82613.1| pyrroline-5-carboxylate reductase [Lactobacillus reuteri DSM 
20016];> 4 3 2 1 1 1 21 26.78 257 
>gi|148530963|gb|ABQ82962.1| protein of unknown function DUF448 [Lactobacillus reuteri DSM 
20016 2 1 2 1 2 1 21 11.662 100 
>gi|148531021|gb|ABQ83020.1| condensin subunit ScpB [Lactobacillus reuteri DSM 20016];> 2 1 0 1 0 0 12.4 22.54 201 
>gi|148531915|gb|ABQ83914.1| hypothetical protein Lreu_1675 [Lactobacillus reuteri DSM 
20016];> 1 0 1 1 0 0 15.1 17.238 152 
>gi|194453122|gb|EDX42020.1| conserved hypothetical protein [Lactobacillus reuteri 100-23];> 3 2 1 1 2 2 55.4 8.7849 74 
>gi|148532109|gb|ABQ84108.1| cytochrome b5 [Lactobacillus reuteri DSM 20016];> 1 1 0 0 1 0 23.5 8.9459 81 
>gi|183224377|dbj|BAG24894.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  1 1 1 1 1 1 20.9 5.106 43 
>gi|148531981|gb|ABQ83980.1| microcompartments protein [Lactobacillus reuteri DSM 20016];> 2 2 2 2 2 2 43.8 9.7479 96 
>gi|227071654|gb|EEI09947.1| oxalyl-CoA decarboxylase [Lactobacillus reuteri MM2-3];>] 2 2 2 2 1 1 3.9 63.052 583 
>gi|148532091|gb|ABQ84090.1| transcriptional regulator, LacI family [Lactobacillus reuteri DSM 
20016];> 1 1 0 1 0 0 3.5 35.062 314 
>gi|148530327|gb|ABQ82326.1| Recombination helicase AddA [Lactobacillus reuteri DSM 
20016];> 2 0 0 0 0 2 2 159.71 1392 
>gi|148530541|gb|ABQ82540.1| tRNA-U20-dihydrouridine synthase [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 0 0 8.4 37.061 333 
>gi|227070201|gb|EEI08575.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3];> 3 1 1 1 1 3 37.6 13.567 117 
>gi|148531740|gb|ABQ83739.1| transcriptional regulator, TetR family [Lactobacillus reuteri DSM 
20016];> 1 0 1 1 1 1 15 22.79 200 
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>gi|273067912|gb|ACZ97545.1| methionyl-tRNA synthetase [Lactobacillus reuteri] 3 3 1 0 1 0 12.2 28.262 254 
>gi|148531115|gb|ABQ83114.1| hypothetical protein Lreu_0851 [Lactobacillus reuteri DSM 20016 2 0 0 2 0 2 21.1 10.116 90 
>gi|194454750|gb|EDX43647.1| hypothetical protein Lreu23DRAFT_5175 [Lactobacillus reuteri 
100-23];> 2 1 0 0 0 2 10.9 26.491 230 
>gi|148531041|gb|ABQ83040.1| Ras superfamily GTP-binding protein YlqF [Lactobacillus reuteri 
DSM 20016 1 0 0 0 1 1 4.1 32.562 290 
>gi|148531985|gb|ABQ83984.1| dehydratase, small subunit [Lactobacillus reuteri DSM 20016];> 1 1 1 1 1 1 9.3 19.319 172 
>gi|183224263|dbj|BAG24780.1| hypothetical protein [Lactobacillus reuteri JCM 1112  2 1 1 0 1 1 9.7 25.982 237 
>gi|148531756|gb|ABQ83755.1| UspA domain protein [Lactobacillus reuteri DSM 20016];> 1 1 0 1 1 1 7 17.57 158 
>gi|183224837|dbj|BAG25354.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 2 1 0 0 0 1 5.3 48.212 430 
>gi|183224293|dbj|BAG24810.1| 50S ribosomal protein L33 [Lactobacillus reuteri JCM 1112];>  1 0 0 1 1 0 20.4 5.8137 49 
>gi|148530735|gb|ABQ82734.1| ATP synthase F1 subcomplex gamma subunit [Lactobacillus 
reuteri DSM 20016];> 2 2 0 0 0 0 9.2 34.796 314 
>gi|148530858|gb|ABQ82857.1| UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-acetylglucosamine transferase [Lactobacillus reuteri DSM 
20016];>  1 1 0 0 1 0 8.4 40.606 370 
>gi|148532176|gb|ABQ84175.1| ribonuclease P protein component [Lactobacillus reuteri DSM 
20016];> 1 1 0 1 0 0 10.3 13.651 117 
>gi|183226906|dbj|BAG27422.1| NADH dehydrogenase [Lactobacillus fermentum IFO 3956];> 1 1 1 1 1 1 2.9 43.987 407 
>gi|148531170|gb|ABQ83169.1| LrgB family protein [Lactobacillus reuteri DSM 20016];> 2 2 1 0 2 0 15.9 26.306 246 
>gi|148531561|gb|ABQ83560.1| hypothetical protein Lreu_1303 [Lactobacillus reuteri DSM 
20016];> 2 2 0 1 1 1 49.1 6.3843 55 
>gi|148530753|gb|ABQ82752.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016];> 2 2 0 0 0 0 8.2 32.082 280 
>gi|148531976|gb|ABQ83975.1| ATP:cob(I)alamin adenosyltransferase [Lactobacillus reuteri DSM 
20016];> 3 1 3 1 2 3 21 16.903 157 
>gi|148531694|gb|ABQ83693.1| xanthine phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016];> 2 2 0 0 0 0 16.8 21.113 191 
>gi|183227494|dbj|BAG28010.1| ribonucleoside-diphosphate reductase alpha subunit 
[Lactobacillus fermentum IFO 3956];> 1 0 1 1 1 1 1.1 81.572 721 
>gi|227071855|gb|EEI10143.1| penicillin-binding protein [Lactobacillus reuteri MM2-3];> 1 0 0 0 1 1 1.7 76.108 699 
>gi|148531033|gb|ABQ83032.1| ABC transporter related [Lactobacillus reuteri DSM 20016];> 2 1 2 0 1 1 4.2 72.792 636 
>gi|148531690|gb|ABQ83689.1| CamS sex pheromone cAM373 family protein [Lactobacillus 
reuteri DSM 20016];> 3 2 0 1 0 1 10.8 40.775 371 
>gi|146749579|gb|ABQ44375.1| inosine-uridine nucleoside N-ribohydrolase [Lactobacillus 
reuteri];> 3 3 0 0 0 0 14.9 32.558 302 
>gi|194453331|gb|EDX42228.1| cell envelope-related transcriptional attenuator [Lactobacillus 1 1 1 1 1 1 4.2 38.126 334 
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reuteri 100-23];>  
>gi|194452845|gb|EDX41743.1| Cof-like hydrolase [Lactobacillus reuteri 100-23];> 1 1 1 1 1 0 5.1 30.945 272 
>gi|148531531|gb|ABQ83530.1| hypothetical protein Lreu_1273 [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 2 1 25.6 10.018 90 
>gi|148531691|gb|ABQ83690.1| DNA ligase, NAD-dependent [Lactobacillus reuteri DSM 20016 1 1 0 0 1 1 1.6 76.002 680 
>gi|148531361|gb|ABQ83360.1| hypothetical protein Lreu_1103 [Lactobacillus reuteri DSM 
20016];> 2 1 0 1 1 1 28.8 9.0878 80 
>gi|227185710|gb|EEI65781.1| hypothetical protein HMPREF0534_0888 [Lactobacillus reuteri 
CF48-3A];> 1 0 1 1 1 1 15 6.9798 60 
>gi|148530613|gb|ABQ82612.1| O-sialoglycoprotein endopeptidase [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 4.4 37.453 343 
>gi|183224190|dbj|BAG24707.1| DNA helicase [Lactobacillus reuteri JCM 1112];>  2 1 0 1 0 0 2.8 88.988 773 
>gi|148530894|gb|ABQ82893.1| protein of unknown function DUF1447 [Lactobacillus reuteri DSM 
20016];> 1 0 1 1 1 1 10 8.3122 70 
>gi|148531717|gb|ABQ83716.1| SSU ribosomal protein S14P [Lactobacillus reuteri DSM 20016 3 3 3 1 1 1 27.9 7.1065 61 
>gi|227185217|gb|EEI65288.1| cytochrome b5 [Lactobacillus reuteri CF48-3A];> 2 0 0 0 1 1 35.4 9.2174 82 
>gi|148531692|gb|ABQ83691.1| ATP-dependent DNA helicase PcrA [Lactobacillus reuteri DSM 
20016];> 2 2 2 2 1 2 2.9 86.29 757 
>gi|148530733|gb|ABQ82732.1| ATP synthase F1 subcomplex delta subunit [Lactobacillus reuteri 
DSM 20016];> 2 1 0 1 0 0 15.6 20.468 180 
>gi|148530347|gb|ABQ82346.1| Uracil phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016];> 1 0 0 1 1 0 6.7 20.252 179 
>gi|227071504|gb|EEI09804.1| glutamate-5-semialdehyde dehydrogenase [Lactobacillus reuteri 
MM2-3 4 4 0 1 0 0 9.9 45.499 416 
>gi|148531876|gb|ABQ83875.1| hypothetical protein Lreu_1635 [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 2.9 31.711 279 
>gi|148531498|gb|ABQ83497.1| LSU ribosomal protein L35P [Lactobacillus reuteri DSM 20016 2 2 0 1 0 0 20 7.615 65 
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>gi|296313256|gb|ACZ97544.2| D-alanine-D-alanine ligase [Lactobacillus reuteri] 5 4 3 3 4 3 20.9 33.684 301 
>gi|183227647|dbj|BAG28163.1| dehydrogenase [Lactobacillus fermentum IFO 3956];>] 10 9 8 8 8 9 30.1 35.835 336 
>gi|227070018|gb|EEI08398.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3];> 10 8 8 9 9 8 68.7 15.313 134 
>gi|183226184|dbj|BAG26700.1| phosphoglycerate kinase [Lactobacillus fermentum IFO 3956];> 11 8 8 10 7 7 21.2 42.696 401 
>gi|183225951|dbj|BAG26467.1| phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase [Lactobacillus fermentum IFO 3956 12 10 10 9 10 9 20.3 57.132 517 
>gi|183226186|dbj|BAG26702.1| enolase [Lactobacillus fermentum IFO 3956];> 12 11 11 11 12 10 38.2 47.79 440 
>gi|148531658|gb|ABQ83657.1| nitroreductase [Lactobacillus reuteri DSM 20016];> 12 7 9 9 12 10 68.2 24.752 217 
>gi|148530868|gb|ABQ82867.1| NUDIX hydrolase [Lactobacillus reuteri DSM 20016 12 9 8 9 9 12 76 20.827 183 
>gi|337728880|emb|CCC04000.1| hypothetical protein LRATCC53608_1247 [Lactobacillus reuteri 
ATCC 53608] 12 10 8 11 11 10 76.4 14.126 123 
>gi|183224883|dbj|BAG25400.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 13 9 10 11 12 13 65.2 20.834 181 
>gi|148530835|gb|ABQ82834.1| hypothetical protein Lreu_0566 [Lactobacillus reuteri DSM 
20016];> 14 12 12 11 9 10 77.9 18.628 163 
>gi|148531898|gb|ABQ83897.1| Inosine/uridine-preferring nucleoside hydrolase [Lactobacillus 
reuteri DSM 20016];> 14 11 11 10 12 13 81.9 34.905 320 
>gi|148530811|gb|ABQ82810.1| non-canonical purine NTP pyrophosphatase, rdgB/HAM1 family 
[Lactobacillus reuteri DSM 20016];> 14 12 11 12 10 12 83.6 21.286 195 
>gi|148531526|gb|ABQ83525.1| protein of unknown function DUF964 [Lactobacillus reuteri DSM 
20016];> 14 13 10 13 12 13 89.4 14.096 123 
>gi|148530453|gb|ABQ82452.1| 3-beta hydroxysteroid dehydrogenase/isomerase [Lactobacillus 
reuteri DSM 20016];> 15 14 15 15 15 14 69 31.632 284 
>gi|183225729|dbj|BAG26246.1| hypothetical protein [Lactobacillus reuteri JCM 1112  15 11 10 7 12 13 80.5 19.891 169 
>gi|148531716|gb|ABQ83715.1| SSU ribosomal protein S8P [Lactobacillus reuteri DSM 20016];> 15 11 13 12 12 13 87.1 14.536 132 
>gi|227071142|gb|EEI09458.1| acetoin dehydrogenase [Lactobacillus reuteri MM2-3];> 15 12 11 12 11 14 89.9 28.157 267 
>gi|337728896|emb|CCC04016.1| ribokinase [Lactobacillus reuteri ATCC 53608] 16 14 13 15 14 15 75.6 32.044 307 
>gi|148530952|gb|ABQ82951.1| uridylate kinase [Lactobacillus reuteri DSM 20016 16 11 13 12 15 13 76.7 25.876 240 
>gi|227071324|gb|EEI09633.1| heat shock protein Hsp33 [Lactobacillus reuteri MM2-3];> 17 13 13 11 14 11 64.1 35.232 323 
>gi|148532120|gb|ABQ84119.1| NAD-dependent epimerase/dehydratase [Lactobacillus reuteri 
DSM 20016];>  17 10 10 10 16 10 95.3 23.187 213 
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>gi|183227337|dbj|BAG27853.1| elongation factor G [Lactobacillus fermentum IFO 3956];> 18 14 15 14 15 14 34.3 76.351 694 
>gi|148532119|gb|ABQ84118.1| Bleomycin hydrolase [Lactobacillus reuteri DSM 20016 18 14 14 14 14 13 55.5 50.851 440 
>gi|227070209|gb|EEI08583.1| diaminopimelate decarboxylase [Lactobacillus reuteri MM2-3];>  18 9 5 11 12 14 59.4 48.355 441 
>gi|194453648|gb|EDX42545.1| glucokinase, ROK family [Lactobacillus reuteri 100-23 18 16 14 14 14 15 63.2 34.493 323 
>gi|148530668|gb|ABQ82667.1| phosphotransacetylase [Lactobacillus reuteri DSM 20016  18 17 17 16 14 13 75.9 34.699 324 
>gi|148530340|gb|ABQ82339.1| 2,5-didehydrogluconate reductase [Lactobacillus reuteri DSM 
20016];> 18 14 15 11 11 14 79.2 32.62 288 
>gi|227186201|gb|EEI66272.1| response regulator [Lactobacillus reuteri CF48-3A];> 18 15 14 11 14 11 79.3 26.602 237 
>gi|148531543|gb|ABQ83542.1| ribokinase [Lactobacillus reuteri DSM 20016 18 15 14 15 15 17 92.5 32.041 307 
>gi|148532092|gb|ABQ84091.1| Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 
[Lactobacillus reuteri DSM 20016];> 19 11 13 14 17 10 46.3 60.446 568 
>gi|148531464|gb|ABQ83463.1| glucokinase [Lactobacillus reuteri DSM 20016];> 19 18 15 14 16 17 63.2 34.42 323 
>gi|148530523|gb|ABQ82522.1| D-alanine-activating enzyme [Lactobacillus reuteri DSM 20016];> 19 15 17 15 16 16 66.7 55.989 508 
>gi|148530646|gb|ABQ82645.1| thioredoxin reductase [Lactobacillus reuteri DSM 20016];> 19 16 15 13 12 11 81 33.305 310 
>gi|148530593|gb|ABQ82592.1| ribonucleoside-diphosphate reductase class Ib beta subunit 
[Lactobacillus reuteri DSM 20016];> 20 16 15 16 16 20 81.1 39.248 339 
>gi|324978533|gb|EGC15482.1| cysteine--tRNA ligase [Lactobacillus reuteri MM4-1A];> 21 16 15 17 14 14 56.9 54.852 478 
>gi|183226438|dbj|BAG26954.1| elongation factor Tu [Lactobacillus fermentum IFO 3956];>  21 21 20 20 20 19 57.1 43.474 396 
>gi|148532080|gb|ABQ84079.1| glycerol 2-dehydrogenase (NAD+) [Lactobacillus reuteri DSM 
20016];> 21 19 19 18 17 18 69.4 40.698 373 
>gi|148530778|gb|ABQ82777.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016];> 21 17 18 15 20 17 74.8 44.031 404 
>gi|183225128|dbj|BAG25645.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 21 19 16 18 14 17 81.8 35.441 297 
>gi|68161011|gb|AAY86937.1| lr0280 [Lactobacillus reuteri] 22 14 10 18 10 18 70.7 36.729 331 
>gi|148530857|gb|ABQ82856.1| UDP-N-acetylmuramoylalanine--D-glutamate ligase [Lactobacillus 
reuteri DSM 20016];>. 22 16 14 15 15 18 74.6 50.332 456 
>gi|148531776|gb|ABQ83775.1| flavocytochrome c [Lactobacillus reuteri DSM 20016 22 18 15 14 19 19 76.9 50.13 464 
>gi|194452797|gb|EDX41695.1| Inorganic diphosphatase [Lactobacillus reuteri 100-23];>  22 21 17 19 17 18 77.2 34.18 311 
>gi|227071240|gb|EEI09554.1| possible glutathione-disulfide reductase [Lactobacillus reuteri 
MM2-3];> r 22 19 10 16 14 18 77.7 48.997 443 
>gi|148530995|gb|ABQ82994.1| Choloylglycine hydrolase [Lactobacillus reuteri DSM 20016];> 22 20 17 15 19 18 83.1 36.104 325 
>gi|148530419|gb|ABQ82418.1| phosphoglycerate mutase [Lactobacillus reuteri DSM 20016];> 22 17 21 22 21 21 87.3 26.121 228 
>gi|148530846|gb|ABQ82845.1| 6-phosphogluconolactonase [Lactobacillus reuteri DSM 20016];> 22 17 18 20 20 16 90.4 37.901 342 
>gi|148530724|gb|ABQ82723.1| serine hydroxymethyltransferase [Lactobacillus reuteri DSM 
20016];> 23 20 18 21 21 19 67.2 44.95 411 
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>gi|148530414|gb|ABQ82413.1| amidophosphoribosyltransferase [Lactobacillus reuteri DSM 
20016 23 16 22 21 19 9 67.4 52.984 484 
>gi|148530679|gb|ABQ82678.1| phosphoglucosamine mutase [Lactobacillus reuteri DSM 
20016];> 23 21 17 20 19 20 76.5 48.902 451 
>gi|148531050|gb|ABQ83049.1| Inorganic diphosphatase [Lactobacillus reuteri DSM 20016 23 21 18 20 19 19 77.8 34.194 311 
>gi|148531899|gb|ABQ83898.1| short-chain dehydrogenase/reductase SDR [Lactobacillus reuteri 
DSM 20016];> 23 17 20 18 15 17 78.5 26.924 251 
>gi|148530491|gb|ABQ82490.1| UDP-N-acetylglucosamine pyrophosphorylase [Lactobacillus 
reuteri DSM 20016];> 24 18 20 19 18 20 61.8 50.01 455 
>gi|148531554|gb|ABQ83553.1| methionine adenosyltransferase [Lactobacillus reuteri DSM 
20016];> 24 22 17 20 17 19 76.5 43.195 395 
>gi|148532032|gb|ABQ84031.1| cysteine synthase [Lactobacillus reuteri DSM 20016];> 24 20 18 19 16 18 87 32.241 307 
>gi|148530641|gb|ABQ82640.1| glycerol 3-phosphate dehydrogenase (NAD(P)+) [Lactobacillus 
reuteri DSM 20016];> G 24 18 20 17 17 18 88.8 36.905 338 
>gi|148530389|gb|ABQ82388.1| inosine-5-monophosphate dehydrogenase [Lactobacillus reuteri 
DSM 20016];> 24 21 19 22 21 23 92.6 39.373 380 
>gi|227185848|gb|EEI65919.1| acetate kinase [Lactobacillus reuteri CF48-3A];> 25 19 20 22 21 20 72.6 43.61 398 
>gi|148531549|gb|ABQ83548.1| peptidase V, Metallo peptidase, MEROPS family M20A 
[Lactobacillus reuteri DSM 20016];>  26 22 23 22 22 19 67.7 51.22 467 
>gi|183225183|dbj|BAG25700.1| ligase [Lactobacillus reuteri JCM 1112];> 26 21 16 21 23 23 69.2 49.294 441 
>gi|148532099|gb|ABQ84098.1| Alcohol dehydrogenase GroES domain protein [Lactobacillus 
reuteri DSM 20016];> 26 22 21 21 24 22 81.5 35.918 336 
>gi|148530695|gb|ABQ82694.1| ornithine carbamoyltransferase [Lactobacillus reuteri DSM 
20016];> L 26 20 19 18 23 21 83.3 37.559 335 
>gi|227185071|gb|EEI65142.1| elongation factor EF1B [Lactobacillus reuteri CF48-3A 26 22 20 20 22 20 85.2 31.961 291 
>gi|148530410|gb|ABQ82409.1| phosphoribosylaminoimidazole-succinocarboxamide synthase 
[Lactobacillus reuteri DSM 20016 26 22 20 17 18 14 86.2 27.308 239 
>gi|148531171|gb|ABQ83170.1| L-lactate dehydrogenase [Lactobacillus reuteri DSM 20016];> 26 21 20 20 23 22 87 35.005 324 
>gi|148530972|gb|ABQ82971.1| chaperone protein DnaK [Lactobacillus reuteri DSM 20016];> 27 18 18 14 18 23 61 67.211 621 
>gi|148530555|gb|ABQ82554.1| putative nicotinate phosphoribosyltransferase [Lactobacillus 
reuteri DSM 20016];> 27 21 20 21 21 22 66.6 55.609 488 
>gi|148531641|gb|ABQ83640.1| oxidoreductase domain protein [Lactobacillus reuteri DSM 
20016];>  27 25 20 18 20 21 70.8 38.272 339 
>gi|148531932|gb|ABQ83931.1| (R)-2-hydroxyisocaproate dehydrogenase [Lactobacillus reuteri 
DSM 20016];> 27 26 24 24 25 24 88 37.358 334 
>gi|148531688|gb|ABQ83687.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit A 
[Lactobacillus reuteri DSM 20016];>gi|148544654|ref|YP_001272024.1| aspartyl/glutamyl-tRNA 
amidotransferase subunit A [Lactobacillus reuteri DSM 20016];>gi|166989678|sp 28 19 18 23 23 22 77.8 53.009 490 
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>gi|148530951|gb|ABQ82950.1| translation elongation factor Ts (EF-Ts) [Lactobacillus reuteri DSM 
20016];> 29 26 24 23 26 23 85.2 31.962 291 
>gi|337728297|emb|CCC03392.1| alcohol dehydrogenase [Lactobacillus reuteri ATCC 53608 29 25 26 24 28 26 92.7 36.158 342 
>gi|227185611|gb|EEI65682.1| alcohol dehydrogenase [Lactobacillus reuteri CF48-3A];> 29 25 26 24 28 26 92.7 36.184 342 
>gi|148530918|gb|ABQ82917.1| trigger factor [Lactobacillus reuteri DSM 20016 30 21 15 26 17 25 69.5 48.747 436 
>gi|227186481|gb|EEI66552.1| D-alanine--D-alanine ligase [Lactobacillus reuteri CF48-3A 30 27 27 26 28 25 75.1 42.569 378 
>gi|183224464|dbj|BAG24981.1| D-alanine--D-alanine ligase [Lactobacillus reuteri JCM 1112];> 30 27 28 26 28 26 76.2 43.001 382 
>gi|148531929|gb|ABQ83928.1| dipeptidase A, Cysteine peptidase, MEROPS family C69 
[Lactobacillus reuteri DSM 20016 30 21 23 25 21 28 78.9 54.294 478 
>gi|337728095|emb|CCC03185.1| methionyl-tRNA synthase [Lactobacillus reuteri ATCC 53608] 31 22 18 26 17 28 56.1 76.572 675 
>gi|148531687|gb|ABQ83686.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B 
[Lactobacillus reuteri DSM 20016 31 17 22 24 25 27 75.7 53.424 474 
>gi|148530370|gb|ABQ82369.1| seryl-tRNA synthetase [Lactobacillus reuteri DSM 20016 31 24 20 25 24 27 79.1 49.29 435 
>gi|148530447|gb|ABQ82446.1| pyridine nucleotide-disulfide oxidoreductase dimerization region 
[Lactobacillus reuteri DSM 20016];> 31 28 26 28 27 30 79.8 49.944 451 
>gi|148531743|gb|ABQ83742.1| Alcohol dehydrogenase GroES domain protein [Lactobacillus 
reuteri DSM 20016 31 27 29 27 30 29 92.7 36.124 342 
>gi|227184598|gb|EEI64669.1| phosphoketolase [Lactobacillus reuteri CF48-3A];> 33 27 27 27 30 24 47.6 91.435 803 
>gi|148530959|gb|ABQ82958.1| prolyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 33 16 4 19 12 25 73.7 64.256 577 
>gi|183224383|dbj|BAG24900.1| enolase [Lactobacillus reuteri JCM 1112];> 33 29 28 29 31 29 75.7 49.951 457 
>gi|148530409|gb|ABQ82408.1| Adenylosuccinate lyase [Lactobacillus reuteri DSM 20016];> 33 27 28 27 28 28 82.8 49.454 431 
>gi|148530829|gb|ABQ82828.1| acetate kinase [Lactobacillus reuteri DSM 20016];> 33 24 26 28 28 26 88.9 43.595 398 
>gi|148531460|gb|ABQ83459.1| L-glutamine synthetase [Lactobacillus reuteri DSM 20016];> 33 31 28 30 32 29 89 50.835 447 
>gi|148531290|gb|ABQ83289.1| LPXTG-motif cell wall anchor domain [Lactobacillus reuteri DSM 
20016];> 34 24 29 24 28 28 62.4 80.889 752 
>gi|148530680|gb|ABQ82679.1| glutamine--fructose-6-phosphate transaminase [Lactobacillus 
reuteri DSM 20016];> 34 23 27 24 27 28 72.3 66.611 606 
>gi|148530917|gb|ABQ82916.1| translation elongation factor 1A (EF-1A/EF-Tu) [Lactobacillus 
reuteri DSM 20016];> 34 33 31 32 33 31 81.3 43.432 396 
>gi|148532037|gb|ABQ84036.1| Endothelin-converting protein 1 [Lactobacillus reuteri DSM 
20016];>  35 19 19 25 24 26 62.8 72.39 634 
>gi|227071557|gb|EEI09855.1| glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) 
[Lactobacillus reuteri MM2-3];> 35 34 34 33 35 33 91.6 37.062 345 
>gi|148531028|gb|ABQ83027.1| SSU ribosomal protein S1P [Lactobacillus reuteri DSM 
20016];>gi|148543994|ref|YP_001271364.1| 30S ribosomal protein S1 [Lactobacillus reuteri DSM 
20016];>gi|183224732|dbj|BAG25249.1| 30S ribosomal protein S1 [Lactobacillus reut 35 32 22 31 19 27 92.5 45.995 416 
>gi|148530903|gb|ABQ82902.1| GTP-binding protein TypA [Lactobacillus reuteri DSM 20016];> 36 29 29 32 33 31 63 68.827 614 
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>gi|183225744|dbj|BAG26261.1| threonyl-tRNA synthase [Lactobacillus reuteri JCM 1112];> 36 19 20 25 19 33 64.8 71.776 627 
>gi|337727906|emb|CCC02995.1| L-lactate dehydrogenase [Lactobacillus reuteri ATCC 53608] 37 30 30 31 30 30 90 34.069 319 
>gi|148530404|gb|ABQ82403.1| Formate-tetrahydrofolate ligase [Lactobacillus reuteri DSM 
20016];> 38 23 29 29 35 24 74.1 60.251 553 
>gi|227070122|gb|EEI08498.1| malate dehydrogenase (NAD) [Lactobacillus reuteri MM2-3];> 38 31 31 32 31 31 88.7 34.901 326 
>gi|148531006|gb|ABQ83005.1| glycyl-tRNA synthetase beta chain [Lactobacillus reuteri DSM 
20016 39 31 31 35 33 32 66.9 78.536 691 
>gi|148530481|gb|ABQ82480.1| methionyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 39 28 26 31 24 36 69.6 76.638 675 
>gi|227185690|gb|EEI65761.1| GMP synthase (glutamine-hydrolyzing) [Lactobacillus reuteri CF48-
3A];> 39 33 29 30 32 31 77.1 59.976 538 
>gi|148531553|gb|ABQ83552.1| leucyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 43 26 26 32 26 26 59.1 92.918 806 
>gi|148530331|gb|ABQ82330.1| maltose phosphorylase [Lactobacillus reuteri DSM 20016];> 43 27 31 31 37 30 62.3 86.744 750 
>gi|148531528|gb|ABQ83527.1| arginyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 43 32 28 36 40 38 80.1 63.878 562 
>gi|148530345|gb|ABQ82344.1| Adenylosuccinate synthetase [Lactobacillus reuteri DSM 20016];> 
s 43 39 41 39 38 37 83.1 47.725 432 
>gi|227071019|gb|EEI09341.1| bifunctional GMP synthase/glutamine amidotransferase protein 
[Lactobacillus reuteri MM2-3];> 43 35 31 33 35 35 85.7 59.912 538 
>gi|337729265|emb|CCC04392.1| phosphoglucomutase [Lactobacillus reuteri ATCC 53608] 44 35 37 35 36 32 82.8 63.747 574 
>gi|148530650|gb|ABQ82649.1| alpha-phosphoglucomutase [Lactobacillus reuteri DSM 20016];> 44 36 38 36 36 32 82.8 63.706 574 
>gi|227185787|gb|EEI65858.1| valyl-tRNA synthetase [Lactobacillus reuteri CF48-3A];> 45 36 34 33 32 30 53.9 104.65 907 
>gi|148530417|gb|ABQ82416.1| IMP cyclohydrolase [Lactobacillus reuteri DSM 20016];> 45 39 43 40 39 32 83.4 57.032 512 
>gi|194453154|gb|EDX42052.1| valyl-tRNA synthetase [Lactobacillus reuteri 100-23];> 47 39 35 34 32 31 56.8 102.19 884 
>gi|337729137|emb|CCC04260.1| valyl-tRNA synthase [Lactobacillus reuteri ATCC 53608] 47 38 35 34 33 31 57.2 102.21 884 
>gi|143798699|gb|ABF06644.2| sucrose phosphorylase [Lactobacillus reuteri];> 47 40 38 41 36 37 84.1 55.969 485 
>gi|148531459|gb|ABQ83458.1| glutamyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 47 38 36 39 37 42 84.2 58.349 501 
>gi|148530624|gb|ABQ82623.1| chaperonin GroEL [Lactobacillus reuteri DSM 20016];> 47 41 38 41 35 37 94.5 57.123 542 
>gi|337728521|emb|CCC03625.1| glucose-6-phosphate 1-dehydrogenase [Lactobacillus reuteri 
ATCC 53608] 48 43 45 44 44 43 87.2 56.355 493 
>gi|227070837|gb|EEI09162.1| glucose-6-phosphate 1-dehydrogenase [Lactobacillus reuteri 
MM2-3];> 49 46 47 46 46 46 86.7 56.713 496 
>gi|194454244|gb|EDX43141.1| glucose-6-phosphate 1-dehydrogenase [Lactobacillus reuteri 100-
23];> 49 45 47 45 45 45 87.2 56.374 493 
>gi|148531016|gb|ABQ83015.1| pyruvate kinase [Lactobacillus reuteri DSM 20016];> 50 45 46 46 44 45 78.9 51.825 473 
>gi|148532121|gb|ABQ84120.1| lysyl aminopeptidase, Metallo peptidase, MEROPS family M01 
[Lactobacillus reuteri DSM 20016];> 51 39 42 39 34 40 75.8 95.323 843 
>gi|183224518|dbj|BAG25035.1| alanyl-tRNA synthase [Lactobacillus reuteri JCM 1112];> 52 38 33 37 35 43 72.9 98.648 885 
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>gi|148530773|gb|ABQ82772.1| valyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 53 43 39 38 37 38 64.1 102.29 884 
>gi|148530866|gb|ABQ82865.1| Isoleucyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 56 36 30 42 45 47 73.5 109.95 960 
>gi|194453034|gb|EDX41932.1| Phosphoglycerate kinase [Lactobacillus reuteri 100-23];> 56 48 47 47 48 46 96 42.961 401 
>gi|337728440|emb|CCC03541.1| xylulose 5-phosphate phosphoketolase [Lactobacillus reuteri 
ATCC 53608] 57 48 43 47 51 42 78.2 91.372 803 
>gi|194454221|gb|EDX43118.1| Phosphoketolase [Lactobacillus reuteri 100-23];> 57 47 43 47 51 42 78.2 91.374 803 
>gi|183224381|dbj|BAG24898.1| phosphoglycerate kinase [Lactobacillus reuteri JCM 1112];> 57 49 48 48 50 48 96 42.96 401 
>gi|148531926|gb|ABQ83925.1| Phosphoketolase [Lactobacillus reuteri DSM 20016];> 58 48 45 47 51 45 79.2 91.403 803 
>gi|148531733|gb|ABQ83732.1| translation elongation factor 2 (EF-2/EF-G) [Lactobacillus reuteri 
DSM 20016];>  60 49 48 51 50 50 85.2 76.77 695 
>gi|337729321|emb|CCC04450.1| aldehyde-alcohol dehydrogenase [Lactobacillus reuteri ATCC 
53608];> 61 49 55 49 51 36 71 97.181 878 
>gi|337728522|emb|CCC03626.1| 6-phosphogluconate dehydrogenase [Lactobacillus reuteri ATCC 
53608];> 62 60 59 56 59 58 96.7 53.444 478 
>gi|183225653|dbj|BAG26170.1| 6-phosphogluconate dehydrogenase [Lactobacillus reuteri JCM 
1112];> 64 62 61 58 61 60 96.7 53.417 478 
>gi|148531571|gb|ABQ83570.1| hypothetical protein Lreu_1313 [Lactobacillus reuteri DSM 
20016];> 65 59 48 56 54 51 89.8 64.749 566 
>gi|148530592|gb|ABQ82591.1| alcohol dehydrogenase AdhE / acetaldehyde dehydrogenase 
[Lactobacillus reuteri DSM 20016 75 57 71 66 68 51 83.6 97.187 878 
>gi|148530322|gb|ABQ82321.1| ATPase AAA-2 domain protein [Lactobacillus reuteri DSM 
20016];> 86 80 68 51 71 63 85.1 82.305 745 
>gi|227070899|gb|EEI09222.1| D-lactate dehydrogenase [Lactobacillus reuteri MM2-3];> g 17 12 13 12 14 12 65.6 37.311 337 
>gi|148531037|gb|ABQ83036.1| degV family protein [Lactobacillus reuteri DSM 20016];> J 17 12 11 12 12 14 78.2 30.742 280 
>gi|227070649|gb|EEI08979.1| 1,3-propanediol dehydrogenase [Lactobacillus reuteri MM2-3];> 25 16 21 15 22 20 73.6 44.01 405 
>gi|148531009|gb|ABQ83008.1| aminotransferase [Lactobacillus reuteri DSM 20016];> 26 10 12 15 24 17 78.9 43.107 394 
>gi|130893244|gb|ABO32599.1| D-lactate dehydrogenase [Lactobacillus reuteri 13 12 12 10 11 10 37.8 40.533 362 
>gi|148530455|gb|ABQ82454.1| Substrate-binding region of ABC-type glycine betaine transport 
system [Lactobacillus reuteri DSM 20016];> 19 13 14 9 14 15 59.9 32.953 299 
>gi|269930626|gb|ACZ53583.1| phosphoketolase [Lactobacillus reuteri] 16 13 8 13 12 9 83.1 21.656 189 
>gi|148531057|gb|ABQ83056.1| gluconate kinase, FGGY family [Lactobacillus reuteri DSM 
20016];>  21 17 16 16 12 16 63.9 55.417 509 
>gi|148530556|gb|ABQ82555.1| NH(3)-dependent NAD(+) synthetase [Lactobacillus reuteri DSM 
20016];> 20 14 14 12 15 16 86.9 30.54 275 
>gi|183227581|dbj|BAG28097.1| 6-phosphogluconate dehydrogenase [Lactobacillus fermentum 
IFO 3956];> 12 12 11 11 11 10 22.8 53.488 479 
>gi|148530989|gb|ABQ82988.1| aspartyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];>; 11 5 2 5 7 7 21.2 68.43 600 
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>gi|148531795|gb|ABQ83794.1| Esterase/lipase-like protein [Lactobacillus reuteri DSM 20016];> 9 6 8 6 7 9 71.4 26.628 238 
>gi|183225853|dbj|BAG26369.1| ATP-dependent Clp protease ATP-binding subunit [Lactobacillus 
fermentum IFO 3956];> 9 9 6 5 9 6 10.9 76.678 697 
>gi|148530828|gb|ABQ82827.1| Adenine-specific DNA methylase-like protein [Lactobacillus 
reuteri DSM 20016];> 14 12 13 9 12 13 75.1 31.155 277 
>gi|146142505|gb|ABQ01722.1| fumarase [Lactobacillus reuteri];> 21 10 13 12 20 16 61.3 50.302 462 
>gi|148531824|gb|ABQ83823.1| translation elongation factor P (EF-P) [Lactobacillus reuteri DSM 
20016];> 11 8 9 8 10 8 55.7 20.518 185 
>gi|148530870|gb|ABQ82869.1| methylthioadenosine nucleosidase [Lactobacillus reuteri DSM 
20016];> 10 8 8 9 8 9 64.9 24.687 231 
>gi|227070039|gb|EEI08417.1| peptidase T [Lactobacillus reuteri MM2-3];> 18 15 9 12 11 11 52.5 46.484 419 
>gi|183226063|dbj|BAG26579.1| nicotinate phosphoribosyltransferase [Lactobacillus fermentum 
IFO 3956];> 6 6 4 6 5 5 14.6 55.469 486 
>gi|148530771|gb|ABQ82770.1| aminotransferase, class V [Lactobacillus reuteri DSM 20016];>  16 9 14 11 12 13 66.8 42.097 382 
>gi|148530760|gb|ABQ82759.1| Glyoxalase/bleomycin resistance protein/dioxygenase 
[Lactobacillus reuteri DSM 20016];> 7 5 7 5 5 4 51.1 15.166 135 
>gi|183224279|dbj|BAG24796.1| putative lipase/esterase [Lactobacillus reuteri JCM 1112];> 13 10 10 12 10 9 65.1 33.174 292 
>gi|183225901|dbj|BAG26417.1| inosine-5-monophosphate dehydrogenase [Lactobacillus 
fermentum IFO 3956];> 9 8 8 8 8 9 28.2 39.708 380 
>gi|148532158|gb|ABQ84157.1| hypoxanthine phosphoribosyltransferase [Lactobacillus reuteri 
DSM 20016];> 11 10 11 11 11 10 53.4 20.407 178 
>gi|148531690|gb|ABQ83689.1| CamS sex pheromone cAM373 family protein [Lactobacillus 
reuteri DSM 20016];> 5 3 3 3 3 5 19.9 40.775 371 
>gi|148530387|gb|ABQ82386.1| purine nucleoside phosphorylase [Lactobacillus reuteri DSM 
20016];> 13 9 12 11 12 11 66.5 25.751 236 
>gi|148531709|gb|ABQ83708.1| Adenylate kinase [Lactobacillus reuteri DSM 20016];> r 15 12 11 12 11 10 85.4 24.609 219 
>gi|148530564|gb|ABQ82563.1| cystathionine gamma-lyase [Lactobacillus reuteri DSM 20016];> 10 9 7 9 8 9 46.1 41.498 380 
>gi|148530578|gb|ABQ82577.1| transcription antitermination protein nusG [Lactobacillus reuteri 
DSM 20016 14 12 11 11 12 12 72.8 20.289 180 
>gi|148531828|gb|ABQ83827.1| quorum-sensing autoinducer 2 (AI-2), LuxS [Lactobacillus reuteri 
DSM 20016];> 16 11 13 12 11 13 91.1 17.695 158 
>gi|148530539|gb|ABQ82538.1| membrane protease FtsH catalytic subunit [Lactobacillus reuteri 
DSM 20016];> 22 17 17 15 13 16 37 77.238 702 
>gi|148530343|gb|ABQ82342.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016];> 14 10 10 13 12 12 64.1 49.604 449 
>gi|194453968|gb|EDX42865.1| Adenylate kinase [Lactobacillus reuteri 100-23];> 15 12 10 11 10 9 85.4 24.61 219 
>gi|148531330|gb|ABQ83329.1| Peroxiredoxin [Lactobacillus reuteri DSM 20016];> 14 10 8 8 10 9 92 21.041 187 
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>gi|337727893|emb|CCC02982.1| conjugated bile salt hydrolase [Lactobacillus reuteri ATCC 
53608] 15 13 11 12 15 12 60.3 36.06 325 
>gi|183226183|dbj|BAG26699.1| glyceraldehyde 3-phosphate dehydrogenase [Lactobacillus 
fermentum IFO 3956 10 8 7 7 9 8 34.1 36.208 337 
>gi|148530953|gb|ABQ82952.1| ribosome recycling factor [Lactobacillus reuteri DSM 20016];> 16 12 10 8 6 12 85.6 20.783 187 
>gi|148531713|gb|ABQ83712.1| SSU ribosomal protein S5P [Lactobacillus reuteri DSM 20016];> 16 13 15 14 13 12 81.1 17.646 169 
>gi|148532132|gb|ABQ84131.1| hypothetical protein Lreu_1894 [Lactobacillus reuteri DSM 
20016];> 6 5 3 3 4 2 53.3 13.741 120 
>gi|148531221|gb|ABQ83220.1| 1-deoxy-D-xylulose-5-phosphate synthase [Lactobacillus reuteri 
DSM 20016 19 10 11 10 11 10 41.6 65.608 591 
>gi|227071790|gb|EEI10079.1| ribulose-5-phosphate 3-epimerase [Lactobacillus reuteri MM2-3];> 14 8 10 11 13 11 55 25.102 231 
>gi|1667472|gb|AAB53259.1| chloramphenicol acetyltransferase-TC [Lactobacillus reuteri] 13 11 6 8 7 7 54.6 27.351 238 
>gi|148531415|gb|ABQ83414.1| signal recognition particle-docking protein FtsY [Lactobacillus 
reuteri DSM 20016];> 21 15 15 14 12 13 40.7 55.604 508 
>gi|148531196|gb|ABQ83195.1| degV family protein [Lactobacillus reuteri DSM 20016J 10 8 3 6 6 7 53.4 32.228 292 
>gi|148530696|gb|ABQ82695.1| carbamate kinase [Lactobacillus reuteri DSM 20016];> 16 13 13 10 11 9 76.5 33.008 310 
>gi|148531869|gb|ABQ83868.1| GTP-binding protein, HSR1-related [Lactobacillus reuteri DSM 
20016];>  18 15 12 12 12 14 52.2 47.758 425 
>gi|194454118|gb|EDX43015.1| quorum-sensing autoinducer 2 (AI-2), LuxS [Lactobacillus reuteri 
100-23];> 13 9 10 10 9 10 82.9 17.727 158 
>gi|227071698|gb|EEI09989.1| phosphoesterase [Lactobacillus reuteri MM2-3];> 8 7 6 7 8 7 55.1 19.857 176 
>gi|38018477|gb|AAR08285.1| GroEL [Lactobacillus reuteri DSM 20016] 8 7 8 8 6 6 59.5 18.192 168 
>gi|148530310|gb|ABQ82309.1| pyrroline-5-carboxylate reductase [Lactobacillus reuteri DSM 
20016];> 7 6 4 3 2 4 37.4 29.38 270 
>gi|112943316|gb|ABI26304.1| predicted flavoprotein [Lactobacillus reuteri];> 11 10 11 10 10 10 64.2 21.504 190 
>gi|148531889|gb|ABQ83888.1| prolinase, Serine peptidase, MEROPS family S33 [Lactobacillus 
reuteri DSM 20016];> 9 3 3 7 9 8 58.7 34.841 303 
>gi|148530865|gb|ABQ82864.1| DivIVA family protein [Lactobacillus reuteri DSM 20016];> 17 10 7 13 6 13 41.5 27.591 246 
>gi|148530569|gb|ABQ82568.1| ribose-5-phosphate isomerase [Lactobacillus reuteri DSM 
20016];> 15 12 13 12 11 12 80.2 25.036 227 
>gi|148532002|gb|ABQ84001.1| NrdI family protein [Lactobacillus reuteri DSM 20016];> 6 5 5 6 6 6 41.9 17.501 155 
>gi|148532070|gb|ABQ84069.1| histidyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 24 15 17 21 18 22 78.5 49.318 433 
>gi|148530878|gb|ABQ82877.1| diaminopimelate epimerase [Lactobacillus reuteri DSM 20016];> 11 8 6 4 9 7 59.5 36.381 333 
>gi|183225766|dbj|BAG26283.1| aspartate-ammonia ligase [Lactobacillus reuteri JCM 1112];> 18 10 6 13 15 15 62.2 39.72 339 
>gi|148531417|gb|ABQ83416.1| RNAse III [Lactobacillus reuteri DSM 20016];>. 16 12 7 11 13 13 87.6 26.606 233 
>gi|112943099|gb|ABI26296.1| single-stranded DNA-binding protein [Lactobacillus reuteri];> 7 6 5 7 6 6 38.5 20.605 187 
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>gi|227070727|gb|EEI09055.1| asparaginyl-tRNA synthetase [Lactobacillus reuteri MM2-3];>  5 1 1 2 2 5 14.7 52.076 448 
>gi|148530690|gb|ABQ82689.1| glucose-6-phosphate isomerase [Lactobacillus reuteri DSM 
20016];> 23 17 16 17 17 16 62.4 50.35 452 
>gi|194452927|gb|EDX41825.1| Cystathionine gamma-synthase [Lactobacillus reuteri 100-23];> 9 8 7 8 7 8 40.5 41.471 380 
>gi|194453139|gb|EDX42037.1| Glyoxalase/bleomycin resistance protein/dioxygenase 
[Lactobacillus reuteri 100-23];> 6 3 5 4 3 3 51.1 15.183 135 
>gi|148531521|gb|ABQ83520.1| histidine triad (HIT) protein [Lactobacillus reuteri DSM 20016];> 8 3 3 3 5 4 61.8 16.333 144 
>gi|148531583|gb|ABQ83582.1| Phosphotransferase system, phosphocarrier protein HPr 
[Lactobacillus reuteri DSM 20016 7 7 5 5 4 5 62.5 9.4076 88 
>gi|148530721|gb|ABQ82720.1| bacterial peptide chain release factor 1 (bRF-1) [Lactobacillus 
reuteri DSM 20016];> 7 5 4 3 3 7 27.6 41.287 362 
>gi|148531973|gb|ABQ83972.1| acetate kinase [Lactobacillus reuteri DSM 20016];> 9 3 3 5 7 6 36.8 43.802 394 
>gi|148530413|gb|ABQ82412.1| phosphoribosylformylglycinamidine synthase subunit II 
[Lactobacillus reuteri DSM 20016];> 17 5 9 11 13 8 37.2 80.944 742 
>gi|148531241|gb|ABQ83240.1| DSBA oxidoreductase [Lactobacillus reuteri DSM 20016];> J 7 7 1 4 4 5 41.9 24.566 215 
>gi|148530514|gb|ABQ82513.1| UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase 
[Lactobacillus reuteri DSM 20016];> 15 10 9 6 9 11 47.7 50.527 459 
>gi|148530755|gb|ABQ82754.1| UspA domain protein [Lactobacillus reuteri DSM 20016];> 9 7 4 9 7 7 48.1 18.017 162 
>gi|148530792|gb|ABQ82791.1| RecA protein [Lactobacillus reuteri DSM 20016];> 8 5 6 5 5 7 26.8 39.063 362 
>gi|148530415|gb|ABQ82414.1| phosphoribosylformylglycinamidine cyclo-ligase [Lactobacillus 
reuteri DSM 20016 R 19 15 16 12 17 6 81.7 36.975 345 
>gi|130893166|gb|ABO32596.1| ATP-dependent Clp protease ATP-binding subunit ClpX 
[Lactobacillus reuteri];> 16 7 4 9 8 14 52.6 45.969 416 
>gi|148530580|gb|ABQ82579.1| LSU ribosomal protein L1P [Lactobacillus reuteri DSM 20016];> 8 7 7 4 4 6 37.2 27.362 253 
>gi|227070541|gb|EEI08874.1| phosphoribosylaminoimidazole carboxylase [Lactobacillus reuteri 
MM2-3];> 18 10 15 10 12 12 72.9 42.428 384 
>gi|148531276|gb|ABQ83275.1| thiamine-phosphate diphosphorylase [Lactobacillus reuteri DSM 
20016];> 14 9 12 6 11 12 86.5 23.849 215 
>gi|148530601|gb|ABQ82600.1| thymidylate kinase [Lactobacillus reuteri DSM 20016];> 8 7 7 6 5 7 34.7 24.198 213 
>gi|148530538|gb|ABQ82537.1| hypoxanthine phosphoribosyltransferase [Lactobacillus reuteri 
DSM 20016];> 14 8 12 12 11 14 58.9 20.464 180 
>gi|148530877|gb|ABQ82876.1| ribose-phosphate pyrophosphokinase [Lactobacillus reuteri DSM 
20016];> 17 15 11 11 10 12 69.1 36.06 324 
>gi|148530808|gb|ABQ82807.1| thioredoxin [Lactobacillus reuteri DSM 20016];> 7 7 7 7 7 7 55.8 11.889 104 
>gi|148530568|gb|ABQ82567.1| aminopeptidase C, Cysteine peptidase, MEROPS family C01B 
[Lactobacillus reuteri DSM 20016];> 17 8 10 11 9 6 44.6 51.985 446 
>gi|148530279|gb|ABQ82278.1| DNA polymerase III, beta subunit [Lactobacillus reuteri DSM 14 13 14 11 12 12 49.7 41.831 380 
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20016];> 
>gi|148530965|gb|ABQ82964.1| bacterial translation initiation factor 2 (bIF-2) [Lactobacillus 
reuteri DSM 20016];> 9 7 6 5 8 5 19.5 83.537 752 
>gi|148531054|gb|ABQ83053.1| protein of unknown function DUF322 [Lactobacillus reuteri DSM 
20016];> 11 8 7 7 10 11 74 13.85 127 
>gi|227071794|gb|EEI10083.1| glycerone kinase [Lactobacillus reuteri MM2-3];> 12 5 7 6 6 7 32.2 62.132 575 
>gi|148531975|gb|ABQ83974.1| LSU ribosomal protein L29P [Lactobacillus reuteri DSM 20016];> 14 5 10 10 8 10 46.1 51.127 477 
>gi|183225457|dbj|BAG25974.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 6 5 6 5 5 3 40.2 20.101 179 
>gi|227070201|gb|EEI08575.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3];> 14 11 6 4 7 10 85.5 13.567 117 
>gi|337728945|emb|CCC04065.1| phosphoribosylformylglycinamidine synthase II [Lactobacillus 
reuteri ATCC 53608] 14 3 6 7 9 7 30.9 80.963 742 
>gi|148531012|gb|ABQ83011.1| protein of unknown function DUF34 [Lactobacillus reuteri DSM 
20016];> 6 4 5 5 3 5 23.4 30.534 274 
>gi|148531233|gb|ABQ83232.1| nucleotide deoxyribosyltransferase [Lactobacillus reuteri DSM 
20016];> 10 5 7 5 6 9 60.6 18.201 160 
>gi|148530418|gb|ABQ82417.1| phosphoribosylamine--glycine ligase [Lactobacillus reuteri DSM 
20016];> 13 3 9 11 11 1 46.5 45.76 419 
>gi|148530375|gb|ABQ82374.1| Inosine/uridine-preferring nucleoside hydrolase [Lactobacillus 
reuteri DSM 20016];> 12 6 8 8 8 10 62.3 32.573 302 
>gi|148531734|gb|ABQ83733.1| SSU ribosomal protein S7P [Lactobacillus reuteri DSM 20016];> 6 5 5 6 5 5 38.5 17.985 156 
>gi|183224027|dbj|BAG24544.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 10 7 9 6 7 5 45 20.228 180 
>gi|148531034|gb|ABQ83033.1| thymidylate synthase [Lactobacillus reuteri DSM 20016];>  9 6 8 8 6 9 27.2 36.982 320 
>gi|148530494|gb|ABQ82493.1| Cof-like hydrolase [Lactobacillus reuteri DSM 20016  9 8 7 6 3 5 32.2 30.465 273 
>gi|183225222|dbj|BAG25739.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 9 6 6 6 6 5 56.5 18.557 170 
>gi|148530832|gb|ABQ82831.1| HAD-superfamily subfamily IIA hydrolase like protein 
[Lactobacillus reuteri DSM 20016];> 9 6 3 4 6 7 42.6 28.505 256 
>gi|148530871|gb|ABQ82870.1| aminotransferase, class V [Lactobacillus reuteri DSM 20016];>  6 2 1 4 2 5 27.9 42.481 384 
>gi|148530787|gb|ABQ82786.1| peptidase M16 domain protein [Lactobacillus reuteri DSM 
20016];> 10 7 7 6 7 9 33 47.131 415 
>gi|148530492|gb|ABQ82491.1| ribose-phosphate pyrophosphokinase [Lactobacillus reuteri DSM 
20016];> 11 9 10 10 10 8 38.9 36.16 329 
>gi|148530623|gb|ABQ82622.1| chaperonin Cpn10 [Lactobacillus reuteri DSM 20016];> 8 6 5 6 8 6 71.3 10.149 94 
>gi|148531694|gb|ABQ83693.1| xanthine phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016];> 10 7 7 7 7 8 52.4 21.113 191 
>gi|112943728|gb|ABI26320.1| fructose-2,6-bisphosphatase [Lactobacillus reuteri];> 8 5 6 6 8 7 48.8 24.287 217 
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>gi|148530585|gb|ABQ82584.1| LSU ribosomal protein L12P [Lactobacillus reuteri DSM 20016];> 10 7 5 6 4 6 95 12.356 121 
>gi|148531033|gb|ABQ83032.1| ABC transporter related [Lactobacillus reuteri DSM 20016];> 16 6 10 10 10 6 32.2 72.792 636 
>gi|148531131|gb|ABQ83130.1| hypothetical protein Lreu_0867 [Lactobacillus reuteri DSM 
20016];> 11 11 9 8 10 9 63.7 10.576 91 
>gi|148530873|gb|ABQ82872.1| tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase 
[Lactobacillus reuteri DSM 20016];> 12 5 0 7 8 11 50.7 42.769 377 
>gi|148531941|gb|ABQ83940.1| porphobilinogen synthase [Lactobacillus reuteri DSM 20016];> 9 7 7 6 5 8 44 35.84 323 
>gi|148531141|gb|ABQ83140.1| Purine nucleosidase [Lactobacillus reuteri DSM 20016];> 10 8 5 6 7 5 67.8 34.734 314 
>gi|148530769|gb|ABQ82768.1| SSU ribosomal protein S4P [Lactobacillus reuteri DSM 20016];> 15 15 15 13 13 14 57.2 22.943 201 
>gi|183225185|dbj|BAG25702.1| thioredoxin [Lactobacillus reuteri JCM 1112];> 5 4 4 4 3 5 28.4 12.828 109 
>gi|148531891|gb|ABQ83890.1| Ferritin, Dps family protein [Lactobacillus reuteri DSM 20016];> 10 4 2 3 5 7 89 18.223 155 
>gi|148530571|gb|ABQ82570.1| deoxyuridine 5-triphosphate nucleotidohydrolase [Lactobacillus 
reuteri DSM 20016 8 4 6 6 7 7 44.9 20.3 178 
>gi|148531730|gb|ABQ83729.1| LSU ribosomal protein L3P [Lactobacillus reuteri DSM 20016];> 10 9 9 6 5 8 45.2 23.757 219 
>gi|148530714|gb|ABQ82713.1| arginine deiminase [Lactobacillus reuteri DSM 20016];> 19 14 9 11 15 18 64.9 46.242 410 
>gi|148531477|gb|ABQ83476.1| transcriptional regulator, HxlR family [Lactobacillus reuteri DSM 
20016];> 10 8 7 9 8 9 67.9 13.039 112 
>gi|148531718|gb|ABQ83717.1| LSU ribosomal protein L5P [Lactobacillus reuteri DSM 20016];> 10 5 8 8 5 10 60 20.171 180 
>gi|133930435|gb|ABO43789.1| DNA-binding protein [Lactobacillus reuteri];> 6 4 5 5 4 2 48.4 9.5238 91 
>gi|183225377|dbj|BAG25894.1| 50S ribosomal protein L18 [Lactobacillus reuteri JCM 1112];>  6 5 5 6 5 4 55.4 13.342 121 
>gi|183226422|dbj|BAG26938.1| GTP-binding protein [Lactobacillus fermentum IFO 3956];> 14 13 13 12 14 11 21.3 68.695 615 
>gi|148531329|gb|ABQ83328.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016];> 9 2 4 3 6 7 23.6 60.056 555 
>gi|148530659|gb|ABQ82658.1| ATP-dependent Clp protease proteolytic subunit ClpP 
[Lactobacillus reuteri DSM 20016];> 11 7 9 8 8 10 78.7 21.433 197 
>gi|148531780|gb|ABQ83779.1| Peptidylprolyl isomerase [Lactobacillus reuteri DSM 20016];> 9 6 5 6 7 8 58.9 22.199 197 
>gi|148531452|gb|ABQ83451.1| hypothetical protein Lreu_1194 [Lactobacillus reuteri DSM 
20016];> 8 7 8 5 6 6 51.8 19.53 168 
>gi|148530412|gb|ABQ82411.1| phosphoribosylformylglycinamidine synthase subunit I 
[Lactobacillus reuteri DSM 20016];> 9 6 7 8 8 5 73.9 24.732 226 
>gi|148530884|gb|ABQ82883.1| dihydrodipicolinate reductase [Lactobacillus reuteri DSM 
20016];> 8 4 2 5 4 3 50.6 27.932 259 
>gi|148531434|gb|ABQ83433.1| guanylate kinase [Lactobacillus reuteri DSM 20016 10 6 7 7 6 8 49 23.546 206 
>gi|148530584|gb|ABQ82583.1| LSU ribosomal protein L10P [Lactobacillus reuteri DSM 20016];> 5 3 3 3 2 3 39.2 18.139 166 
>gi|227070613|gb|EEI08943.1| possible asparagine synthase (glutamine-hydrolyzing) 
[Lactobacillus reuteri MM2-3];>gi|227186280|gb|EEI66351.1| possible asparagine synthase 14 10 11 8 7 4 25.9 76.34 652 
 214 
 
(glutamine-hydrolyzing) [Lactobacillus reuteri CF48-3A];>gi|227364300|ref|ZP_03848393. 
>gi|148532020|gb|ABQ84019.1| PEBP family protein [Lactobacillus reuteri DSM 20016];> J 6 3 5 3 5 3 37.5 18.294 168 
>gi|227071420|gb|EEI09725.1| FMN reductase [Lactobacillus reuteri MM2-3];> 6 3 4 4 4 2 24.8 26.152 238 
>gi|148531323|gb|ABQ83322.1| glycerol kinase [Lactobacillus reuteri DSM 20016 12 7 8 7 10 7 32.4 55.388 500 
>gi|227070129|gb|EEI08505.1| D-tyrosyl-tRNA(Tyr) deacylase [Lactobacillus reuteri MM2-3];>  5 4 4 4 3 4 53.5 17.733 159 
>gi|133930437|gb|ABO43790.1| cytosine deaminase [Lactobacillus reuteri];> 11 9 10 9 8 10 37.9 46.441 412 
>gi|148530405|gb|ABQ82404.1| acetolactate synthase, catabolic [Lactobacillus reuteri DSM 
20016];> 11 0 5 0 11 2 31.5 60.994 559 
>gi|148530924|gb|ABQ82923.1| GTP-binding protein Obg/CgtA [Lactobacillus reuteri DSM 
20016];> 17 13 10 8 9 13 48.2 47.975 438 
>gi|148530579|gb|ABQ82578.1| LSU ribosomal protein L11P [Lactobacillus reuteri DSM 20016];> 9 6 5 8 6 8 53.9 14.869 141 
>gi|148531486|gb|ABQ83485.1| two component transcriptional regulator, winged helix family 
[Lactobacillus reuteri DSM 20016];> 5 5 3 3 4 4 28.9 26.33 228 
>gi|183224837|dbj|BAG25354.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 7 4 7 3 4 3 25.3 48.212 430 
>gi|227070517|gb|EEI08850.1| deoxyribose-phosphate aldolase [Lactobacillus reuteri MM2-3];> 10 7 6 5 4 5 51.1 25.76 237 
>gi|148530821|gb|ABQ82820.1| protein of unknown function DUF28 [Lactobacillus reuteri DSM 
20016];> 11 9 8 7 6 7 63.3 27.161 248 
>gi|227071111|gb|EEI09429.1| Dyp family peroxidase family protein [Lactobacillus reuteri MM2-
3];>  11 7 7 5 10 6 40.1 36.463 317 
>gi|148531334|gb|ABQ83333.1| hypothetical protein Lreu_1076 [Lactobacillus reuteri DSM 
20016];> 1 1 1 0 0 0 9.7 17.798 154 
>gi|148531061|gb|ABQ83060.1| hypothetical protein Lreu_0797 [Lactobacillus reuteri DSM 
20016];> 4 3 1 1 0 3 27.4 31.07 285 
>gi|148531725|gb|ABQ83724.1| LSU ribosomal protein L22P [Lactobacillus reuteri DSM 20016];> 7 5 5 3 4 4 53 12.394 115 
>gi|148531458|gb|ABQ83457.1| aminotransferase [Lactobacillus reuteri DSM 20016];> 11 5 6 7 8 6 41 43.367 393 
>gi|148530344|gb|ABQ82343.1| guanosine monophosphate reductase [Lactobacillus reuteri DSM 
20016 11 6 5 7 7 9 48.5 35.96 324 
>gi|148530883|gb|ABQ82882.1| dihydrodipicolinate synthase [Lactobacillus reuteri DSM 20016];> 8 7 3 7 5 7 46.9 33.823 307 
>gi|148531980|gb|ABQ83979.1| Propanediol utilization protein [Lactobacillus reuteri DSM 
20016];> 7 2 4 3 3 6 33.6 23.962 214 
>gi|183225130|dbj|BAG25647.1| peptide methionine sulfoxide reductase [Lactobacillus reuteri 
JCM 1112];>  5 4 4 5 3 3 45.4 21.132 185 
>gi|148531027|gb|ABQ83026.1| cytidylate kinase [Lactobacillus reuteri DSM 20016];> 9 6 6 5 4 7 46.9 25.015 228 
>gi|133930513|gb|ABO43828.1| triosephosphate isomerase [Lactobacillus reuteri];> 12 10 7 9 7 8 64.4 29.214 264 
>gi|148530610|gb|ABQ82609.1| UDP-galactose 4-epimerase [Lactobacillus reuteri DSM 20016];> 16 11 12 7 12 4 81.3 36.598 331 
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>gi|227070968|gb|EEI09291.1| glutamate-1-semialdehyde 2,1-aminomutase [Lactobacillus reuteri 
MM2-3];> 12 10 7 5 5 8 53.7 48.026 443 
>gi|148531721|gb|ABQ83720.1| SSU ribosomal protein S17P [Lactobacillus reuteri DSM 20016];> 8 8 7 6 6 5 68.2 10.168 88 
>gi|183226317|dbj|BAG26833.1| valyl-tRNA synthase [Lactobacillus fermentum IFO 3956 13 12 9 9 7 5 15.8 101.85 884 
>gi|227070651|gb|EEI08981.1| rhodanese domain protein [Lactobacillus reuteri MM2-3];> 10 7 6 6 8 8 57.1 29.725 261 
>gi|148531143|gb|ABQ83142.1| riboflavin synthase, alpha subunit [Lactobacillus reuteri DSM 
20016];>  6 4 5 4 6 5 33 21.593 200 
>gi|183224298|dbj|BAG24815.1| aminotransferase [Lactobacillus reuteri JCM 1112  12 6 5 9 10 9 50.5 44.088 400 
>gi|148531444|gb|ABQ83443.1| protein of unknown function DUF322 [Lactobacillus reuteri DSM 
20016];> 6 2 4 3 4 3 48.3 15.835 145 
>gi|148531723|gb|ABQ83722.1| LSU ribosomal protein L16P [Lactobacillus reuteri DSM 20016];> 9 6 7 6 6 6 61.8 16.006 144 
>gi|148531005|gb|ABQ83004.1| glycyl-tRNA synthetase alpha chain [Lactobacillus reuteri DSM 
20016];> 14 12 7 7 10 10 56.7 37.843 328 
>gi|183224803|dbj|BAG25320.1| hypothetical protein [Lactobacillus reuteri JCM 1112];> 12 4 9 9 6 6 48 40.672 371 
>gi|148530530|gb|ABQ82529.1| Hydratase/decarboxylase [Lactobacillus reuteri DSM 20016];> 4 2 0 4 2 2 41.4 29.033 263 
>gi|148531715|gb|ABQ83714.1| LSU ribosomal protein L6P [Lactobacillus reuteri DSM 20016];> 13 7 6 11 6 10 44.4 19.635 178 
>gi|148530501|gb|ABQ82500.1| CTP synthase [Lactobacillus reuteri DSM 20016];> 7 4 3 3 5 4 20.6 59.6 534 
>gi|148530321|gb|ABQ82320.1| aromatic amino acid aminotransferase apoenzyme [Lactobacillus 
reuteri DSM 20016];> 11 9 4 8 6 9 42.5 42.52 395 
>gi|148531442|gb|ABQ83441.1| methenyltetrahydrofolate cyclohydrolase / 5,10-
methylenetetrahydrofolate dehydrogenase (NADP+) [Lactobacillus reuteri DSM 20016];> 10 6 7 6 6 3 45.5 30.424 286 
>gi|148530435|gb|ABQ82434.1| short-chain dehydrogenase/reductase SDR [Lactobacillus reuteri 
DSM 20016];> 11 8 4 3 4 9 61.8 26.39 246 
>gi|337728953|emb|CCC04073.1| acetolactate synthase [Lactobacillus reuteri ATCC 53608] 10 0 5 1 10 2 24.9 61.077 559 
>gi|227070793|gb|EEI09119.1| NADPH dehydrogenase [Lactobacillus reuteri MM2-3];> 4 1 2 0 3 1 26.1 26.711 230 
>gi|148530861|gb|ABQ82860.1| cell division protein FtsZ [Lactobacillus reuteri DSM 20016];> 12 8 7 8 9 10 42.2 44.45 415 
>gi|227184822|gb|EEI64893.1| possible 2-aminoadipate transaminase [Lactobacillus reuteri CF48-
3A];> 10 6 5 7 9 7 40.6 43.84 397 
>gi|148531693|gb|ABQ83692.1| 5-(carboxyamino)imidazole ribonucleotide synthase 
[Lactobacillus reuteri DSM 20016];> 13 8 8 8 10 11 57.6 42.001 377 
>gi|227185166|gb|EEI65237.1| aspartate semialdehyde dehydrogenase [Lactobacillus reuteri 
CF48-3A 6 0 2 1 6 2 29.3 38.935 358 
>gi|148531473|gb|ABQ83472.1| uridine kinase [Lactobacillus reuteri DSM 20016];> 7 3 7 5 6 7 40.4 25.134 218 
>gi|112943339|gb|ABI26305.1| sphingosine kinase [Lactobacillus reuteri 8 7 4 2 5 5 27.3 37.14 337 
>gi|227071141|gb|EEI09457.1| mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 
[Lactobacillus reuteri MM2-3];> 4 2 1 4 2 2 22.1 25.877 222 
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>gi|183225693|dbj|BAG26210.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 4 2 1 2 3 4 19.8 41.737 364 
>gi|148530734|gb|ABQ82733.1| ATP synthase F1 subcomplex alpha subunit [Lactobacillus reuteri 
DSM 20016];> 16 14 10 9 9 6 35.4 55.226 509 
>gi|148530542|gb|ABQ82541.1| lysyl-tRNA synthetase [Lactobacillus reuteri DSM 20016];> 14 7 1 9 8 13 31.7 58.296 508 
>gi|148531976|gb|ABQ83975.1| ATP:cob(I)alamin adenosyltransferase [Lactobacillus reuteri DSM 
20016];> 5 1 4 4 4 4 33.1 16.903 157 
>gi|148530651|gb|ABQ82650.1| hydrolase of HD superfamily-like protein [Lactobacillus reuteri 
DSM 20016];> 9 6 7 8 7 6 42.9 24.304 212 
>gi|148530744|gb|ABQ82743.1| glycine cleavage H-protein [Lactobacillus reuteri DSM 20016];> 6 3 2 4 3 6 75.3 10.641 97 
>gi|183225184|dbj|BAG25701.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 5 1 2 2 1 2 40.3 23.595 216 
>gi|148531499|gb|ABQ83498.1| bacterial translation initiation factor 3 (bIF-3) [Lactobacillus 
reuteri DSM 20016 i 4 3 3 2 3 4 31.2 19.487 170 
>gi|183225758|dbj|BAG26275.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 6 4 3 2 5 5 33 22.577 203 
>gi|148530319|gb|ABQ82318.1| OsmC family protein [Lactobacillus reuteri DSM 20016];> 8 6 8 5 6 6 45.1 15.724 142 
>gi|148531724|gb|ABQ83723.1| SSU ribosomal protein S3P [Lactobacillus reuteri DSM 20016];> 9 8 9 8 8 7 40.3 24.696 221 
>gi|148531729|gb|ABQ83728.1| LSU ribosomal protein L4P [Lactobacillus reuteri DSM 20016];> 6 6 6 4 4 5 41.1 22.29 207 
>gi|183224273|dbj|BAG24790.1| transcription accessory protein [Lactobacillus reuteri JCM 
1112];> 10 4 5 4 4 6 23.1 82.072 727 
>gi|148530614|gb|ABQ82613.1| pyrroline-5-carboxylate reductase [Lactobacillus reuteri DSM 
20016];> 8 6 5 3 5 4 46.7 26.78 257 
>gi|148530311|gb|ABQ82310.1| aldehyde dehydrogenase [Lactobacillus reuteri DSM 20016];> 7 3 6 3 3 0 22.3 50.505 457 
>gi|148531769|gb|ABQ83768.1| DJ-1 family protein [Lactobacillus reuteri DSM 20016];> 5 2 3 4 5 2 35.3 20.995 190 
>gi|148530379|gb|ABQ82378.1| chromosome segregation ATPase [Lactobacillus reuteri DSM 
20016];> 6 4 3 2 2 4 30.1 28.007 256 
>gi|227184876|gb|EEI64947.1| pyrroline-5-carboxylate reductase [Lactobacillus reuteri CF48-
3A];> 7 5 6 2 5 3 33.9 26.871 257 
>gi|148531565|gb|ABQ83564.1| heat shock protein Hsp20 [Lactobacillus reuteri DSM 20016 3 2 1 1 3 2 25.2 16.747 143 
>gi|148530950|gb|ABQ82949.1| SSU ribosomal protein S2P [Lactobacillus reuteri DSM 20016];> 10 7 6 9 4 9 36.3 29.657 262 
>gi|148531756|gb|ABQ83755.1| UspA domain protein [Lactobacillus reuteri DSM 20016];> 6 2 2 4 4 6 38 17.57 158 
>gi|227071504|gb|EEI09804.1| glutamate-5-semialdehyde dehydrogenase [Lactobacillus reuteri 
MM2-3 12 8 8 8 10 9 38.5 45.499 416 
>gi|148531915|gb|ABQ83914.1| hypothetical protein Lreu_1675 [Lactobacillus reuteri DSM 
20016];> 1 0 1 1 1 0 8.6 17.238 152 
>gi|183225283|dbj|BAG25800.1| putative autolysin [Lactobacillus reuteri JCM 1112 2 0 0 0 1 1 7.7 60.393 532 
 217 
 
>gi|148530881|gb|ABQ82880.1| Tetrahydrodipicolinate succinyltransferase N-terminal domain 
protein [Lactobacillus reuteri DSM 20016];> 5 3 2 2 3 5 38.6 24.876 236 
>gi|148531412|gb|ABQ83411.1| SSU ribosomal protein S16P [Lactobacillus reuteri DSM 20016];> 4 4 4 3 2 3 45.1 10.449 91 
>gi|194454489|gb|EDX43386.1| aminotransferase class I and II [Lactobacillus reuteri 100-23 8 6 2 5 3 6 32.4 42.531 395 
>gi|148530962|gb|ABQ82961.1| NusA antitermination factor [Lactobacillus reuteri DSM 20016];> 5 4 1 0 3 2 22.3 44.525 395 
>gi|148530371|gb|ABQ82370.1| amino acid ABC transporter membrane protein, PAAT family / 
amino acid ABC transporter substrate-binding protein, PAAT family [Lactobacillus reuteri DSM 
20016];>gi|148543337|ref|YP_001270707.1| polar amino acid ABC transporter i 2 1 0 1 0 1 6.6 53.65 487 
>gi|148531728|gb|ABQ83727.1| LSU ribosomal protein L23P [Lactobacillus reuteri DSM 20016];> 7 7 5 5 2 4 66.3 11.25 98 
>gi|148530842|gb|ABQ82841.1| NAD(+) kinase [Lactobacillus reuteri DSM 20016 6 4 6 3 5 6 24.8 30.666 270 
>gi|148530804|gb|ABQ82803.1| Holliday junction resolvase YqgF [Lactobacillus reuteri DSM 
20016];> 6 3 4 6 4 5 40.8 16.525 147 
>gi|148532168|gb|ABQ84167.1| signal peptidase I [Lactobacillus reuteri DSM 20016];> 3 1 2 2 2 2 18.4 22.703 201 
>gi|148532131|gb|ABQ84130.1| glutamine amidotransferase class-I [Lactobacillus reuteri DSM 
20016 4 3 3 3 4 3 31.8 25.353 223 
>gi|148530718|gb|ABQ82717.1| CobB/CobQ domain protein glutamine amidotransferase 
[Lactobacillus reuteri DSM 20016];> 3 3 1 0 0 2 21.3 26.134 235 
>gi|148530475|gb|ABQ82474.1| tryptophanyl-tRNA synthetase [Lactobacillus reuteri DSM 20016 10 4 2 5 9 8 47.9 38.062 340 
>gi|227071501|gb|EEI09801.1| LL-diaminopimelate aminotransferase [Lactobacillus reuteri MM2-
3];> 3 0 1 2 2 1 10.4 43.448 395 
>gi|148531738|gb|ABQ83737.1| DNA-directed RNA polymerase subunit beta [Lactobacillus reuteri 
DSM 20016];> 14 5 3 7 7 11 20.6 135.42 1211 
>gi|148531215|gb|ABQ83214.1| Glyoxalase/bleomycin resistance protein/dioxygenase 
[Lactobacillus reuteri DSM 20016];> 4 3 3 4 4 4 28.5 14.777 130 
>gi|148530964|gb|ABQ82963.1| LSU ribosomal protein L7AE [Lactobacillus reuteri DSM 20016];> 5 5 3 1 2 4 43.7 11.651 103 
>gi|183224121|dbj|BAG24638.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  9 3 8 6 6 6 54.3 24.277 219 
>gi|148530284|gb|ABQ82283.1| SSU ribosomal protein S6P [Lactobacillus reuteri DSM 20016];> 7 6 5 5 5 6 63.3 11.378 98 
>gi|148530288|gb|ABQ82287.1| LSU ribosomal protein L9P [Lactobacillus reuteri DSM 20016];> 7 3 5 2 4 3 37.3 16.692 150 
>gi|148531488|gb|ABQ83487.1| protein of unknown function DUF177 [Lactobacillus reuteri DSM 
20016];> 4 4 3 3 2 3 25.9 20.961 185 
>gi|183227420|dbj|BAG27936.1| autoinducer-2 production protein [Lactobacillus fermentum IFO 
3956];> 8 5 6 6 6 6 50 17.719 158 
>gi|148531987|gb|ABQ83986.1| Glycerol dehydratase [Lactobacillus reuteri DSM 20016];> 13 1 10 2 6 6 29 62.092 558 
>gi|148531286|gb|ABQ83285.1| Phosphoglycerate mutase [Lactobacillus reuteri DSM 20016];> 6 4 5 3 4 5 21.9 30.347 278 
>gi|148531703|gb|ABQ83702.1| LSU ribosomal protein L17P [Lactobacillus reuteri DSM 20016];> 4 4 2 2 2 3 32.3 14.201 127 
>gi|148530459|gb|ABQ82458.1| methionine-R-sulfoxide reductase [Lactobacillus reuteri DSM 
20016  7 4 5 4 5 4 54.9 16.101 142 
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>gi|148530385|gb|ABQ82384.1| phosphopentomutase [Lactobacillus reuteri DSM 20016];> 13 8 7 10 10 8 51.4 44.002 397 
>gi|183226446|dbj|BAG26962.1| GTP-binding protein [Lactobacillus fermentum IFO 3956];> 9 9 8 6 8 8 24.4 47.427 435 
>gi|148531540|gb|ABQ83539.1| hypothetical protein Lreu_1282 [Lactobacillus reuteri DSM 
20016];> 3 3 3 3 3 3 38 10.138 92 
>gi|148532166|gb|ABQ84165.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016];> 7 3 3 4 6 3 29.6 32.371 287 
>gi|148530541|gb|ABQ82540.1| tRNA-U20-dihydrouridine synthase [Lactobacillus reuteri DSM 
20016];> 10 4 1 3 4 4 52 37.061 333 
>gi|148530761|gb|ABQ82760.1| hypothetical protein Lreu_0492 [Lactobacillus reuteri DSM 
20016];> 3 2 2 2 2 3 16.6 27.759 247 
>gi|148530631|gb|ABQ82630.1| protein of unknown function UPF0029 [Lactobacillus reuteri DSM 
20016];> 5 4 3 2 3 2 29 23.548 210 
>gi|148530642|gb|ABQ82641.1| UDP-glucose pyrophosphorylase [Lactobacillus reuteri DSM 
20016];> 4 1 3 2 2 2 14.1 34.101 304 
>gi|148531708|gb|ABQ83707.1| bacterial translation initiation factor 1 (bIF-1) [Lactobacillus 
reuteri DSM 20016];> 6 4 3 2 3 5 55.6 8.1615 72 
>gi|148532063|gb|ABQ84062.1| thioredoxin [Lactobacillus reuteri DSM 20016 5 4 3 4 3 4 49.5 12.064 105 
>gi|148530691|gb|ABQ82690.1| hypothetical protein Lreu_0421 [Lactobacillus reuteri DSM 
20016];> 5 3 1 1 3 5 36.4 11.143 99 
>gi|183225646|dbj|BAG26163.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  2 0 0 0 0 2 13.5 19.84 178 
>gi|148530896|gb|ABQ82895.1| peptide deformylase [Lactobacillus reuteri DSM 20016];> 5 3 4 4 3 4 28.5 20.898 186 
>gi|227071772|gb|EEI10061.1| transcription antitermination protein NusB [Lactobacillus reuteri 
MM2-3 3 2 2 3 3 3 32.6 16.148 141 
>gi|148530837|gb|ABQ82836.1| Negative regulator of genetic competence [Lactobacillus reuteri 
DSM 20016];> 4 2 0 3 4 4 24.7 25.701 223 
>gi|148530983|gb|ABQ82982.1| [LSU ribosomal protein L11P]-lysine N-methyltransferase 
[Lactobacillus reuteri DSM 20016 11 6 7 7 7 9 73 34.966 319 
>gi|227070539|gb|EEI08872.1| acetolactate decarboxylase [Lactobacillus reuteri MM2-3];> 6 4 6 6 6 5 42.7 27.238 246 
>gi|148531705|gb|ABQ83704.1| SSU ribosomal protein S11P [Lactobacillus reuteri DSM 20016];> 3 3 2 2 2 2 22.5 13.759 129 
>gi|227070644|gb|EEI08974.1| phosphatidylglycerophosphatase [Lactobacillus reuteri MM2-3];> 9 6 8 5 7 5 56.2 18.978 169 
>gi|148531731|gb|ABQ83730.1| SSU ribosomal protein S10P [Lactobacillus reuteri DSM 20016];> 5 4 4 3 4 5 46.1 11.777 102 
>gi|148530997|gb|ABQ82996.1| argininosuccinate lyase [Lactobacillus reuteri DSM 20016];> 5 3 2 1 1 0 13 51.92 461 
>gi|148530860|gb|ABQ82859.1| cell division protein FtsA [Lactobacillus reuteri DSM 20016];> 4 3 4 3 3 4 9.2 50.485 457 
>gi|227071143|gb|EEI09459.1| ribosomal protein S9 [Lactobacillus reuteri MM2-3];> 7 7 6 6 5 7 33.1 14.494 133 
>gi|183224278|dbj|BAG24795.1| phosphoglycerate mutase [Lactobacillus reuteri JCM 1112 7 6 4 1 3 3 36.1 29.591 255 
>gi|148531843|gb|ABQ83842.1| Peptidoglycan-binding LysM [Lactobacillus reuteri DSM 20016];> 1 1 1 1 1 0 4.5 37.509 355 
>gi|148530634|gb|ABQ82633.1| SSU ribosomal protein S30P [Lactobacillus reuteri DSM 20016];> 4 3 2 3 4 3 35.7 21.144 182 
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>gi|148530681|gb|ABQ82680.1| hypothetical protein Lreu_0411 [Lactobacillus reuteri DSM 
20016];> 4 3 3 3 3 2 44.7 12.29 103 
>gi|148531711|gb|ABQ83710.1| LSU ribosomal protein L15P [Lactobacillus reuteri DSM 20016];> 6 6 5 5 4 5 31.9 15.447 144 
>gi|227071637|gb|EEI09931.1| uracil phosphoribosyltransferase [Lactobacillus reuteri MM2-3];> 5 3 3 5 4 4 27.1 24.512 221 
>gi|148530736|gb|ABQ82735.1| ATP synthase F1 subcomplex beta subunit [Lactobacillus reuteri 
DSM 20016];> 7 6 4 4 4 4 16.4 51.631 475 
>gi|148531735|gb|ABQ83734.1| SSU ribosomal protein S12P [Lactobacillus reuteri DSM 20016];> 3 3 2 2 2 2 19.4 15.503 139 
>gi|148531720|gb|ABQ83719.1| LSU ribosomal protein L14P [Lactobacillus reuteri DSM 20016];> 7 5 6 3 3 5 51.6 13.144 122 
>gi|148531538|gb|ABQ83537.1| dihydroneopterin aldolase [Lactobacillus reuteri DSM 20016];> 3 1 0 2 3 2 71.2 12.739 111 
>gi|148530994|gb|ABQ82993.1| GatB/Yqey domain protein [Lactobacillus reuteri DSM 20016];> 2 1 2 2 2 2 17.6 16.725 148 
>gi|148531536|gb|ABQ83535.1| GTP cyclohydrolase I [Lactobacillus reuteri DSM 20016];> 7 5 6 7 5 6 42.7 22.03 192 
>gi|148531841|gb|ABQ83840.1| GCN5-related N-acetyltransferase [Lactobacillus reuteri DSM 
20016];> 6 2 0 3 0 4 38.2 19.96 173 
>gi|148531888|gb|ABQ83887.1| dipeptidyl-peptidase IV, Serine peptidase, MEROPS family S15 
[Lactobacillus reuteri DSM 20016 3 0 0 0 3 0 5.8 90.378 800 
>gi|148531698|gb|ABQ83697.1| LSU ribosomal protein L13P [Lactobacillus reuteri DSM 20016];> 7 3 5 4 3 3 45.6 16.304 147 
>gi|337728903|emb|CCC04023.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608];> 7 3 4 4 3 4 28.3 30.777 286 
>gi|148531566|gb|ABQ83565.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016];> 8 6 3 6 4 4 45.4 30.851 282 
>gi|148531897|gb|ABQ83896.1| FAD-dependent pyridine nucleotide-disulfide oxidoreductase 
[Lactobacillus reuteri DSM 20016 8 7 3 6 4 6 45.2 35.791 332 
>gi|227185170|gb|EEI65241.1| amidohydrolase [Lactobacillus reuteri CF48-3A];> 5 2 2 5 3 3 23.5 42.662 383 
>gi|227070071|gb|EEI08449.1| aldose 1-epimerase [Lactobacillus reuteri MM2-3];> 7 4 4 5 4 5 45.7 34.581 304 
>gi|148532139|gb|ABQ84138.1| protein of unknown function DUF1002 [Lactobacillus reuteri DSM 
20016];> 8 2 4 3 3 6 20.7 35.908 333 
>gi|148530739|gb|ABQ82738.1| UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
[Lactobacillus reuteri DSM 20016];> 5 4 3 4 4 4 16.2 47.242 438 
>gi|148530367|gb|ABQ82366.1| NADPH-dependent FMN reductase [Lactobacillus reuteri DSM 
20016];> 7 5 1 4 3 6 27.4 45.674 416 
>gi|227070907|gb|EEI09230.1| possible Bis(5-nucleosyl)-tetraphosphatase (asymmetrical) 
[Lactobacillus reuteri MM2-3];> 3 1 3 1 2 2 23.2 19.718 168 
>gi|148531449|gb|ABQ83448.1| protein of unknown function DUF464 [Lactobacillus reuteri DSM 
20016];> 2 2 1 1 1 1 28 11.705 107 
>gi|148530526|gb|ABQ82525.1| alanine racemase [Lactobacillus reuteri DSM 20016];> 3 2 2 2 1 1 11.5 41.162 375 
>gi|148531531|gb|ABQ83530.1| hypothetical protein Lreu_1273 [Lactobacillus reuteri DSM 
20016];> 5 4 4 5 4 5 52.2 10.018 90 
>gi|148531352|gb|ABQ83351.1| N-acetylmuramoyl-L-alanine amidase, family 2 [Lactobacillus 3 0 1 3 3 2 10.8 44.687 399 
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reuteri DSM 20016];> 
>gi|148530885|gb|ABQ82884.1| aminotransferase [Lactobacillus reuteri DSM 20016 5 1 0 4 2 4 19.8 42.991 394 
>gi|148530622|gb|ABQ82621.1| CoA-binding domain protein [Lactobacillus reuteri DSM 20016];> 6 2 3 3 3 5 29.9 23.939 214 
>gi|148531448|gb|ABQ83447.1| LSU ribosomal protein L27P [Lactobacillus reuteri DSM 20016];> 5 5 4 4 4 4 50.5 9.9211 93 
>gi|148531151|gb|ABQ83150.1| 1,4-Dihydroxy-2-naphthoate synthase [Lactobacillus reuteri DSM 
20016];> 7 6 3 3 4 4 33.3 30.019 273 
>gi|336448856|gb|AEI57471.1| sensor histidine kinase [Lactobacillus reuteri SD2112];> 4 2 0 0 0 3 10.8 44.299 390 
>gi|148531917|gb|ABQ83916.1| lipoate-protein ligase [Lactobacillus reuteri DSM 20016];> 3 2 1 0 1 1 9.8 38.474 337 
>gi|148531212|gb|ABQ83211.1| protein of unknown function DUF21 [Lactobacillus reuteri DSM 
20016];> 3 2 1 1 3 2 7.1 52.119 453 
>gi|148531585|gb|ABQ83584.1| ATPase AAA-2 domain protein [Lactobacillus reuteri DSM 
20016];> 7 5 3 2 1 7 12.5 81.867 734 
>gi|148530478|gb|ABQ82477.1| hypothetical protein Lreu_0207 [Lactobacillus reuteri DSM 
20016];> 5 2 1 2 1 4 21.9 36.908 319 
>gi|337728714|emb|CCC03829.1| succinate-semialdehyde dehydrogenase [Lactobacillus reuteri 
ATCC 53608] 4 1 3 0 0 1 12.3 50.52 457 
>gi|148532165|gb|ABQ84164.1| Amidohydrolase 3 [Lactobacillus reuteri DSM 20016 2 1 1 0 1 0 8 57.42 522 
>gi|148530913|gb|ABQ82912.1| SSU ribosomal protein S20P [Lactobacillus reuteri DSM 20016];> 2 2 2 2 2 1 25 9.2436 84 
>gi|183225401|dbj|BAG25918.1| DNA-directed RNA polymerase beta subunit [Lactobacillus 
reuteri JCM 1112];> 10 4 0 6 3 9 11 135.36 1205 
>gi|148530653|gb|ABQ82652.1| Excinuclease ABC subunit B [Lactobacillus reuteri DSM 20016];> 5 3 2 5 1 0 12.9 79.421 690 
>gi|148531404|gb|ABQ83403.1| protein of unknown function DUF1535 [Lactobacillus reuteri DSM 
20016];> 2 1 0 1 2 2 7.7 18.631 169 
>gi|148530740|gb|ABQ82739.1| cell shape determining protein, MreB/Mrl family [Lactobacillus 
reuteri DSM 20016];> 6 2 2 3 4 4 25.2 35.48 330 
>gi|183225948|dbj|BAG26464.1| amidophosphoribosyltransferase [Lactobacillus fermentum IFO 
3956 3 3 3 3 3 2 9.2 53.518 487 
>gi|130893136|gb|ABO32595.1| D-lactate dehydrogenase [Lactobacillus reuteri];> 9 5 6 6 5 5 34.2 36.867 330 
>gi|148531986|gb|ABQ83985.1| dehydratase, medium subunit [Lactobacillus reuteri DSM 
20016];> 5 3 2 2 3 3 27.1 25.808 236 
>gi|148530742|gb|ABQ82741.1| hypothetical protein Lreu_0473 [Lactobacillus reuteri DSM 
20016];> 4 4 2 2 2 3 58.1 8.7648 74 
>gi|148531145|gb|ABQ83144.1| 6,7-dimethyl-8-ribityllumazine synthase [Lactobacillus reuteri 
DSM 20016 4 0 0 3 1 4 49.3 16.637 152 
>gi|183224141|dbj|BAG24658.1| tyrosyl-tRNA synthase [Lactobacillus reuteri JCM 1112];> 8 2 3 5 4 7 28.1 47.69 420 
>gi|148530599|gb|ABQ82598.1| DNA replication and repair protein RecR [Lactobacillus reuteri 
DSM 20016];> 7 3 5 1 6 4 39 22.089 200 
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>gi|183224612|dbj|BAG25129.1| myo-inositol-1(or 4)-monophosphatase [Lactobacillus reuteri 
JCM 1112];> 6 3 3 4 4 4 36 28.91 261 
>gi|148531752|gb|ABQ83751.1| iron dependent repressor [Lactobacillus reuteri DSM 20016];> 6 5 3 2 2 3 47.8 25.242 224 
>gi|148532003|gb|ABQ84002.1| 3-demethylubiquinone-9 3-methyltransferase [Lactobacillus 
reuteri DSM 20016];> 2 2 0 2 2 2 22.7 15.941 141 
>gi|148531643|gb|ABQ83642.1| conserved hypothetical protein 730 [Lactobacillus reuteri DSM 
20016 4 3 3 3 3 3 23.1 21.895 195 
>gi|148532146|gb|ABQ84145.1| hypothetical protein Lreu_1908 [Lactobacillus reuteri DSM 
20016];> 3 2 2 1 1 1 17.4 18.28 161 
>gi|148531438|gb|ABQ83437.1| hemolysin A [Lactobacillus reuteri DSM 20016];> 4 3 2 1 4 3 15 30.273 273 
>gi|148530817|gb|ABQ82816.1| hypothetical protein Lreu_0548 [Lactobacillus reuteri DSM 
20016];> 4 1 1 1 2 4 52.6 16.479 152 
>gi|148531846|gb|ABQ83845.1| tRNA/rRNA methyltransferase (SpoU) [Lactobacillus reuteri DSM 
20016];> 6 4 2 3 3 1 32.8 31.804 290 
>gi|227070920|gb|EEI09243.1| possible phosphatase [Lactobacillus reuteri MM2-3];> 5 5 4 4 4 4 26.6 24.08 218 
>gi|148530836|gb|ABQ82835.1| arsenate reductase-like protein [Lactobacillus reuteri DSM 
20016];> 4 2 0 1 0 4 29.3 15.539 133 
>gi|183227318|dbj|BAG27834.1| 30S ribosomal protein S5 [Lactobacillus fermentum IFO 3956 4 3 3 2 3 2 16.6 17.581 169 
>gi|337728855|emb|CCC03974.1| primosomal protein DnaI [Lactobacillus reuteri ATCC 53608 2 2 1 1 2 2 7.3 35.819 313 
>gi|183226170|dbj|BAG26686.1| phosphoglucomutase [Lactobacillus fermentum IFO 3956 6 5 5 6 4 4 8.9 63.671 574 
>gi|148532108|gb|ABQ84107.1| Methionine synthase, vitamin-B12 independent [Lactobacillus 
reuteri DSM 20016 7 5 1 1 0 3 28.8 42.352 378 
>gi|337728259|emb|CCC03354.1| DNA-directed RNA polymerase alpha subunit [Lactobacillus 
reuteri ATCC 53608 8 1 1 1 2 5 37.3 34.887 314 
>gi|148531689|gb|ABQ83688.1| aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C 
[Lactobacillus reuteri DSM 20016 4 3 1 2 2 1 51.4 11.572 105 
>gi|148530799|gb|ABQ82798.1| protein translocase subunit yajC [Lactobacillus reuteri DSM 
20016];> 3 0 1 1 3 2 22.1 16.384 154 
>gi|183227208|dbj|BAG27724.1| ATP-dependent Clp protease ATP-binding subunit [Lactobacillus 
fermentum IFO 3956 3 2 0 1 1 2 6.4 82.854 748 
>gi|148531956|gb|ABQ83955.1| precorrin-4 C11-methyltransferase [Lactobacillus reuteri DSM 
20016];> 6 1 3 2 5 2 33.6 27.872 253 
>gi|227071446|gb|EEI09749.1| possible acetyltransferase [Lactobacillus reuteri MM2-3];> 5 5 4 2 3 3 53.8 12.089 104 
>gi|148530788|gb|ABQ82787.1| peptidase M16 domain protein [Lactobacillus reuteri DSM 
20016];>  8 6 4 5 5 5 29.4 49.689 432 
>gi|60172697|gb|AAX14531.1| ABC-type cobalt transport system [Lactobacillus reuteri 1 0 0 1 0 1 13.6 12.127 110 
>gi|148531160|gb|ABQ83159.1| protein of unknown function DUF59 [Lactobacillus reuteri DSM 
20016 3 3 3 2 3 3 28.2 12.081 110 
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>gi|148530382|gb|ABQ82381.1| GTP-binding protein YchF [Lactobacillus reuteri DSM 20016];> 4 1 2 1 1 4 15.6 39.844 365 
>gi|148531350|gb|ABQ83349.1| hypothetical protein Lreu_1092 [Lactobacillus reuteri DSM 
20016];> 2 2 0 2 1 2 16.9 9.0102 77 
>gi|148530400|gb|ABQ82399.1| orotate phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016];> 2 0 0 1 1 2 10.8 23.434 213 
>gi|148530503|gb|ABQ82502.1| UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
[Lactobacillus reuteri DSM 20016];> 12 8 8 5 5 3 45.2 45.676 425 
>gi|194453840|gb|EDX42737.1| conserved hypothetical protein [Lactobacillus reuteri 100-23];> 3 3 2 2 3 2 12.7 28.451 245 
>gi|148530789|gb|ABQ82788.1| Uncharacterized protein [Lactobacillus reuteri DSM 20016];> 3 1 3 1 1 2 11.6 38.296 345 
>gi|148530810|gb|ABQ82809.1| glutamate racemase [Lactobacillus reuteri DSM 20016];> 3 2 2 1 3 2 20.6 28.92 267 
>gi|148531475|gb|ABQ83474.1| phenylalanyl-tRNA synthetase beta subunit [Lactobacillus reuteri 
DSM 20016 4 1 1 1 2 3 7.5 89.003 805 
>gi|148532009|gb|ABQ84008.1| UspA domain protein [Lactobacillus reuteri DSM 20016];>  2 1 2 2 1 1 15.6 17.199 154 
>gi|148531712|gb|ABQ83711.1| LSU ribosomal protein L30P [Lactobacillus reuteri DSM 20016];> 3 2 2 2 1 2 58.3 6.5566 60 
>gi|148531706|gb|ABQ83705.1| SSU ribosomal protein S13P [Lactobacillus reuteri DSM 20016];> 5 4 2 5 2 4 38 13.687 121 
>gi|183225952|dbj|BAG26468.1| phosphoribosylamine-glycine ligase [Lactobacillus fermentum 
IFO 3956];> 2 1 1 1 2 1 4.3 45.159 417 
>gi|148530853|gb|ABQ82852.1| S-adenosyl-methyltransferase MraW [Lactobacillus reuteri DSM 
20016 1 1 0 0 0 1 6 35.666 318 
>gi|148530901|gb|ABQ82900.1| protein of unknown function UPF0223 [Lactobacillus reuteri DSM 
20016];> 3 2 2 2 3 3 23.5 11.867 102 
>gi|148530553|gb|ABQ82552.1| aspartate racemase [Lactobacillus reuteri DSM 20016];> 8 2 1 0 8 0 53 26.763 236 
>gi|148530906|gb|ABQ82905.1| putative methyltransferase [Lactobacillus reuteri DSM 20016];> 5 3 0 2 2 4 28.3 20.85 187 
>gi|183227331|dbj|BAG27847.1| 30S ribosomal protein S19 [Lactobacillus fermentum IFO 3956];> 3 3 2 3 2 2 34.4 10.489 93 
>gi|148530907|gb|ABQ82906.1| Phosphopantetheine adenylyltransferase [Lactobacillus reuteri 
DSM 20016];> 5 5 5 5 4 3 27.2 19.361 173 
>gi|148530479|gb|ABQ82478.1| Silent information regulator protein Sir2 [Lactobacillus reuteri 
DSM 20016];> 8 5 3 4 3 5 47 26.454 232 
>gi|148531951|gb|ABQ83950.1| anaerobic cobaltochelatase [Lactobacillus reuteri DSM 20016];> 4 1 3 0 2 3 17 29.176 259 
>gi|148531918|gb|ABQ83917.1| UspA domain protein [Lactobacillus reuteri DSM 20016];> 3 1 3 2 2 1 18.7 17.168 155 
>gi|148531910|gb|ABQ83909.1| Alcohol dehydrogenase GroES domain protein [Lactobacillus 
reuteri DSM 20016  4 3 2 3 3 3 32.9 34.921 328 
>gi|148530411|gb|ABQ82410.1| phosphoribosylformylglycinamidine synthase, purS [Lactobacillus 
reuteri DSM 20016];> 2 1 0 2 0 0 32.9 9.3323 82 
>gi|148531126|gb|ABQ83125.1| GCN5-related N-acetyltransferase [Lactobacillus reuteri DSM 
20016];> 2 1 2 2 2 2 19.2 20.109 177 
>gi|148531274|gb|ABQ83273.1| Hydroxyethylthiazole kinase [Lactobacillus reuteri DSM 20016];> 3 2 2 3 3 2 18.2 29.028 269 
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>gi|227185635|gb|EEI65706.1| protein of hypothetical function DUF322 [Lactobacillus reuteri 
CF48-3A];>  3 3 2 3 3 3 10.7 13.014 122 
>gi|183225127|dbj|BAG25644.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  6 5 1 4 3 5 24.7 40.161 352 
>gi|112944062|gb|ABI26332.1| phosphoglycerate mutase [Lactobacillus reuteri];> 4 2 3 4 4 4 20.6 24.692 218 
>gi|227070057|gb|EEI08435.1| tetratricopeptide repeat family protein [Lactobacillus reuteri 
MM2-3];>  7 3 1 4 4 5 26 50.211 434 
>gi|148531988|gb|ABQ83987.1| microcompartments protein [Lactobacillus reuteri DSM 20016];> 4 0 3 1 0 1 32.4 24.945 238 
>gi|148530346|gb|ABQ82345.1| hypothetical protein Lreu_0070 [Lactobacillus reuteri DSM 
20016];> 2 2 0 1 1 0 12.3 29.491 261 
>gi|148531170|gb|ABQ83169.1| LrgB family protein [Lactobacillus reuteri DSM 20016];> 3 1 2 2 3 2 20.3 26.306 246 
>gi|148530942|gb|ABQ82941.1| hydroxymethylglutaryl-CoA synthase [Lactobacillus reuteri DSM 
20016 6 4 3 4 3 5 19.2 42.757 385 
>gi|148530993|gb|ABQ82992.1| SSU ribosomal protein S21P [Lactobacillus reuteri DSM 20016];> 2 2 2 2 2 2 30.2 7.7178 63 
>gi|148530848|gb|ABQ82847.1| RNA methyltransferase, TrmH family, group 2 [Lactobacillus 
reuteri DSM 20016];> 2 2 2 2 2 2 17.2 19.557 169 
>gi|227070559|gb|EEI08890.1| possible gamma-glutamyl-gamma-aminobutyrate hydrolase 
[Lactobacillus reuteri MM2-3];> 1 1 0 1 1 1 7.3 27.281 247 
>gi|148530473|gb|ABQ82472.1| nucleoside diphosphate kinase [Lactobacillus reuteri DSM 
20016];> 5 1 3 3 3 2 40.1 16.772 147 
>gi|148531727|gb|ABQ83726.1| LSU ribosomal protein L2P [Lactobacillus reuteri DSM 20016 6 2 2 2 4 2 27.8 30.47 281 
>gi|148530818|gb|ABQ82817.1| Xaa-Pro aminopeptidase, Metallo peptidase, MEROPS family 
M24B [Lactobacillus reuteri DSM 20016  7 4 3 5 5 2 32 40.615 369 
>gi|148530567|gb|ABQ82566.1| amino acid ABC transporter substrate-binding protein, PAAT 
family [Lactobacillus reuteri DSM 20016];> 3 3 0 0 1 0 12.9 28.516 263 
>gi|148531875|gb|ABQ83874.1| phage shock protein C, PspC [Lactobacillus reuteri DSM 20016];> 2 2 0 1 2 2 18.1 9.3228 83 
>gi|227185529|gb|EEI65600.1| translation factor SUA5 [Lactobacillus reuteri CF48-3A];> 2 0 1 1 2 1 7.9 38.904 354 
>gi|227070164|gb|EEI08539.1| protein of hypothetical function DUF896 [Lactobacillus reuteri 
MM2-3];> 5 2 1 2 4 2 61.6 10.422 86 
>gi|148531439|gb|ABQ83438.1| farnesyl-diphosphate synthase [Lactobacillus reuteri DSM 
20016];> 4 2 2 3 2 3 26.2 31.64 290 
>gi|194453403|gb|EDX42300.1| molybdenum cofactor synthesis domain protein [Lactobacillus 
reuteri 100-23];> 4 3 2 1 2 3 14.3 44.908 405 
>gi|148530805|gb|ABQ82804.1| protein of unknown function DUF1292 [Lactobacillus reuteri DSM 
20016];> 2 1 1 0 1 1 33.7 11.401 98 
>gi|194453194|gb|EDX42092.1| glutamate racemase [Lactobacillus reuteri 100-23];> 3 2 1 0 3 1 24.7 29 267 
>gi|148531492|gb|ABQ83491.1| metal dependent phosphohydrolase [Lactobacillus reuteri DSM 
20016];> 2 0 2 0 0 0 13.2 23.131 204 
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>gi|148531008|gb|ABQ83007.1| RNA polymerase, sigma 70 subunit, RpoD [Lactobacillus reuteri 
DSM 20016];> 6 4 1 2 2 4 18.9 43.385 380 
>gi|148530597|gb|ABQ82596.1| DNA polymerase III, subunits gamma and tau [Lactobacillus 
reuteri DSM 20016];> 3 2 0 0 1 0 7.9 68.85 611 
>gi|148530416|gb|ABQ82415.1| formyltetrahydrofolate-dependent phosphoribosylglycinamide 
formyltransferase [Lactobacillus reuteri DSM 20016];> 4 1 3 0 2 0 34.7 21.163 190 
>gi|148530327|gb|ABQ82326.1| Recombination helicase AddA [Lactobacillus reuteri DSM 
20016];> 4 0 0 0 2 4 5.2 159.71 1392 
>gi|148530604|gb|ABQ82603.1| protein of unknown function DUF972 [Lactobacillus reuteri DSM 
20016];> 2 2 2 2 2 2 12.9 13.587 116 
>gi|148531497|gb|ABQ83496.1| LSU ribosomal protein L20P [Lactobacillus reuteri DSM 20016];> r 4 4 4 4 4 4 27.4 13.515 117 
>gi|148530839|gb|ABQ82838.1| dipeptidase A, Cysteine peptidase, MEROPS family C69 
[Lactobacillus reuteri DSM 20016];> 2 1 2 2 2 2 6.1 51.591 458 
>gi|148530511|gb|ABQ82510.1| protein tyrosine phosphatase [Lactobacillus reuteri DSM 
20016];> 2 2 2 1 0 1 23.4 17.398 154 
>gi|148532023|gb|ABQ84022.1| hypothetical protein Lreu_1783 [Lactobacillus reuteri DSM 
20016];> 3 0 1 3 3 3 11.5 43.26 373 
>gi|227185295|gb|EEI65366.1| hypothetical extracellular protein [Lactobacillus reuteri CF48-3A];> 1 1 0 1 0 1 4.5 26.125 247 
>gi|148531416|gb|ABQ83415.1| condensin subunit Smc [Lactobacillus reuteri DSM 20016];> 2 0 0 1 1 2 2.7 135.2 1187 
>gi|148531410|gb|ABQ83409.1| 16S rRNA processing protein RimM [Lactobacillus reuteri DSM 
20016 5 3 3 3 3 3 32.1 19.219 168 
>gi|148531623|gb|ABQ83622.1| hypothetical protein Lreu_1373 [Lactobacillus reuteri DSM 
20016];> 2 0 0 0 2 0 7.8 46.111 398 
>gi|148531785|gb|ABQ83784.1| hypothetical protein Lreu_1539 [Lactobacillus reuteri DSM 20016 3 2 2 1 2 0 21.9 16.827 146 
>gi|148531533|gb|ABQ83532.1| Dihydropteroate synthase [Lactobacillus reuteri DSM 20016 5 0 1 1 4 2 19.4 43.584 387 
>gi|227071502|gb|EEI09802.1| cyanide hydratase [Lactobacillus reuteri MM2-3];> 1 1 0 0 0 1 6 30.185 266 
>gi|130893190|gb|ABO32597.1| ATP-dependent Clp protease ATP-binding subunit ClpC 
[Lactobacillus reuteri];> 5 0 2 3 1 2 6.1 92.89 830 
>gi|183224980|dbj|BAG25497.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 1 1 1 1 0 1 5.2 22.333 194 
>gi|148531472|gb|ABQ83471.1| transcription elongation factor GreA [Lactobacillus reuteri DSM 
20016];> 4 1 3 2 2 4 35.4 18.019 158 
>gi|148531003|gb|ABQ83002.1| GTP-binding protein Era [Lactobacillus reuteri DSM 20016];>  1 1 1 1 1 1 7 33.79 301 
>gi|148530525|gb|ABQ82524.1| holo-acyl-carrier-protein synthase [Lactobacillus reuteri DSM 
20016 3 1 1 2 1 2 56.7 13.167 120 
>gi|148531035|gb|ABQ83034.1| dihydrofolate reductase [Lactobacillus reuteri DSM 20016];>  2 1 2 2 1 2 13.6 18.66 162 
>gi|194453686|gb|EDX42583.1| ATP-cone domain protein [Lactobacillus reuteri 100-23];> 2 1 0 0 0 1 13.5 18.122 155 
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>gi|183225937|dbj|BAG26453.1| formate-tetrahydrofolate ligase [Lactobacillus fermentum IFO 
3956];> 2 2 2 1 2 1 2.5 59.287 553 
>gi|148531450|gb|ABQ83449.1| LSU ribosomal protein L21P [Lactobacillus reuteri DSM 20016];> 2 1 1 1 0 0 26.5 11.256 102 
>gi|148531622|gb|ABQ83621.1| lipopolysaccharide biosynthesis protein [Lactobacillus reuteri 
DSM 20016];> 3 1 2 2 1 2 18.2 22.766 209 
>gi|148530899|gb|ABQ82898.1| Dihydrolipoyllysine-residue succinyltransferase [Lactobacillus 
reuteri DSM 20016];> 2 1 0 1 0 1 5.2 48.372 444 
>gi|148531272|gb|ABQ83271.1| hypothetical protein Lreu_1011 [Lactobacillus reuteri DSM 
20016];> 2 1 1 0 2 0 4.5 72.576 629 
>gi|148531138|gb|ABQ83137.1| type I site-specific deoxyribonuclease, HsdR family [Lactobacillus 
reuteri DSM 20016 2 1 1 1 1 1 2.6 118.77 1041 
>gi|148531407|gb|ABQ83406.1| LSU ribosomal protein L19P [Lactobacillus reuteri DSM 20016];> 6 3 5 4 5 4 33.6 14.824 128 
>gi|148531298|gb|ABQ83297.1| hypothetical protein Lreu_1037 [Lactobacillus reuteri DSM 20016 2 0 2 0 1 1 5.2 69.932 630 
>gi|227186326|gb|EEI66397.1| conserved hypothetical protein [Lactobacillus reuteri CF48-3A];> 2 1 1 1 1 1 78.9 4.2448 38 
>gi|148530286|gb|ABQ82285.1| SSU ribosomal protein S18P [Lactobacillus reuteri DSM 20016];> 5 3 4 3 3 4 39.7 9.1536 78 
>gi|148530720|gb|ABQ82719.1| thymidine kinase [Lactobacillus reuteri DSM 20016 1 0 1 0 0 1 7.9 22.171 191 
>gi|148530635|gb|ABQ82634.1| protein translocase subunit secA [Lactobacillus reuteri DSM 
20016];>  5 3 4 3 2 2 5.1 90.351 787 
>gi|148531876|gb|ABQ83875.1| hypothetical protein Lreu_1635 [Lactobacillus reuteri DSM 20016 2 1 2 0 2 0 14.7 31.711 279 
>gi|148530347|gb|ABQ82346.1| Uracil phosphoribosyltransferase [Lactobacillus reuteri DSM 
20016];> 4 2 2 2 1 3 25.1 20.252 179 
>gi|183224052|dbj|BAG24569.1| beta-phosphoglucomutase [Lactobacillus reuteri JCM 1112];> 5 3 2 0 0 1 35.6 24.587 225 
>gi|148531763|gb|ABQ83762.1| hypothetical protein Lreu_1517 [Lactobacillus reuteri DSM 
20016];> 2 1 1 1 1 2 19.1 13.119 115 
>gi|148531954|gb|ABQ83953.1| precorrin-3 methyltransferase [Lactobacillus reuteri DSM 
20016];>  5 2 3 2 3 4 19.9 26.233 241 
>gi|148532142|gb|ABQ84141.1| Hydratase/decarboxylase [Lactobacillus reuteri DSM 20016];> 2 1 0 0 2 1 11.1 29.863 270 
>gi|148530374|gb|ABQ82373.1| Na+ dependent nucleoside transporter domain protein 
[Lactobacillus reuteri DSM 20016];> 3 0 2 2 1 2 8.2 44.04 403 
>gi|183224607|dbj|BAG25124.1| pyruvate dehydrogenase complex E1 component alpha subunit 
[Lactobacillus reuteri JCM 1112];> 3 3 3 2 1 1 15.4 41.361 371 
>gi|148530966|gb|ABQ82965.1| ribosome-binding factor A [Lactobacillus reuteri DSM 20016];> 2 2 2 2 1 2 19.3 13.412 119 
>gi|148531512|gb|ABQ83511.1| L-glutaminase [Lactobacillus reuteri DSM 20016];> 3 2 1 2 1 2 12.4 33.392 306 
>gi|227070371|gb|EEI08733.1| diaminohydroxyphosphoribosylaminopyrimidine deaminase / 5-
amino-6-(5-phosphoribosylamino)uracil reductase [Lactobacillus reuteri MM2-3];> 3 1 3 1 0 0 11 39.658 355 
>gi|148531144|gb|ABQ83143.1| GTP cyclohydrolase II [Lactobacillus reuteri DSM 20016];> 4 2 1 1 1 3 16 43.927 393 
>gi|112943293|gb|ABI26303.1| pyruvate/2-oxoglutarate dehydrogenase complex 4 4 2 1 2 1 11.6 50.725 475 
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dihydrolipoamide dehydrogenase (E3) component [Lactobacillus reuteri 
>gi|148531413|gb|ABQ83412.1| signal recognition particle subunit FFH/SRP54 (srp54) 
[Lactobacillus reuteri DSM 20016];> 5 4 2 2 1 0 10.2 54.114 481 
>gi|148531292|gb|ABQ83291.1| SMC domain protein [Lactobacillus reuteri DSM 20016];> 2 2 0 1 0 1 3.2 118.56 1033 
>gi|227071080|gb|EEI09398.1| metallo-beta-lactamase [Lactobacillus reuteri MM2-3];> 3 1 3 2 2 2 3.8 70.828 628 
>gi|148531719|gb|ABQ83718.1| LSU ribosomal protein L24P [Lactobacillus reuteri DSM 20016];> 2 2 1 1 1 2 10.8 10.975 102 
>gi|227070756|gb|EEI09083.1| ABC superfamily ATP binding cassette transporter, ABC/membrane 
protein [Lactobacillus reuteri MM2-3 1 1 0 1 0 0 1.7 72.445 666 
>gi|148530633|gb|ABQ82632.1| amidophosphoribosyltransferase-like protein [Lactobacillus 
reuteri DSM 20016];> 2 2 2 1 2 2 3.5 26.055 226 
>gi|183225571|dbj|BAG26088.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 6 4 1 1 3 3 28.1 27.624 249 
>gi|183224651|dbj|BAG25168.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];>  4 4 3 3 3 3 56 8.6646 75 
>gi|148530351|gb|ABQ82350.1| peptidase C26 [Lactobacillus reuteri DSM 20016];> 2 1 1 1 2 1 20.9 26.977 244 
>gi|148531602|gb|ABQ83601.1| bacterial peptide chain release factor 3 (bRF-3) [Lactobacillus 
reuteri DSM 20016  3 2 2 1 2 2 5.9 59.477 525 
>gi|148532084|gb|ABQ84083.1| ErfK/YbiS/YcfS/YnhG family protein [Lactobacillus reuteri DSM 
20016];> 1 1 1 0 1 1 6.4 24.726 218 
>gi|189485784|gb|AAU08014.2| inactive glucansucrase [Lactobacillus reuteri];> 1 0 0 1 1 0 0.6 179.41 1619 
>gi|148531187|gb|ABQ83186.1| NrdI family protein [Lactobacillus reuteri DSM 20016 2 0 0 0 2 2 17.1 18.082 158 
>gi|148530779|gb|ABQ82778.1| FolC bifunctional protein [Lactobacillus reuteri DSM 20016  2 0 1 0 2 0 8.9 47.999 437 
>gi|119390607|pdb|2NT8|A Chain A, Atp Bound At The Active Site Of A Pduo Type Atp:co(I) 
Rrinoid Adenosyltransferase From Lactobacillus Reuteri;> 3 2 3 1 2 2 13.5 25.598 223 
>gi|227070045|gb|EEI08423.1| possible reductase [Lactobacillus reuteri MM2-3];> 1 1 1 1 1 1 8 14.924 125 
>gi|227185113|gb|EEI65184.1| conserved hypothetical protein [Lactobacillus reuteri CF48-3A];> 3 2 3 1 1 2 38.8 8.7612 80 
>gi|148530703|gb|ABQ82702.1| hypothetical protein Lreu_0433 [Lactobacillus reuteri DSM 
20016];> 2 1 1 0 0 1 22.9 12.718 109 
>gi|148531183|gb|ABQ83182.1| penicillin-binding protein, 1A family [Lactobacillus reuteri DSM 
20016 4 2 0 1 0 1 6.2 82.075 754 
>gi|6707064|gb|AAF25576.1|AF120104_1 mucus binding protein precursor [Lactobacillus reuteri 
ATCC 53608 2 2 0 0 0 0 7.8 357.95 3269 
>gi|148530566|gb|ABQ82565.1| amino acid ABC transporter ATP-binding protein, PAAT family 
[Lactobacillus reuteri DSM 20016];> 1 1 0 0 0 1 6 27.538 249 
>gi|227186386|gb|EEI66457.1| ArsR family transcriptional regulator [Lactobacillus reuteri CF48-
3A];> 4 4 3 1 3 2 22.6 12.411 106 
>gi|148530664|gb|ABQ82663.1| RNAse R [Lactobacillus reuteri DSM 20016];> 3 1 0 0 0 3 4.6 91.867 801 
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>gi|148531240|gb|ABQ83239.1| Alpha/beta hydrolase fold-3 domain protein [Lactobacillus 
reuteri DSM 20016];> 4 4 3 2 4 2 16 34.992 312 
>gi|148531644|gb|ABQ83643.1| malate dehydrogenase (NAD) [Lactobacillus reuteri DSM 
20016];> 3 1 1 2 1 3 20.8 33.353 307 
>gi|148530504|gb|ABQ82503.1| LSU ribosomal protein L31P [Lactobacillus reuteri DSM 20016];> 1 1 1 1 0 1 17.3 9.123 81 
>gi|148531537|gb|ABQ83536.1| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
pyrophosphokinase [Lactobacillus reuteri DSM 20016  4 0 2 1 3 3 28.2 19.815 170 
>gi|183225679|dbj|BAG26196.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 2 0 0 0 1 1 12.9 18.055 170 
>gi|183224626|dbj|BAG25143.1| conserved hypothetical protein [Lactobacillus reuteri JCM 
1112];> 4 1 0 0 1 3 22.4 35.43 304 
>gi|148530719|gb|ABQ82718.1| domain of unknown function DUF1727 [Lactobacillus reuteri 
DSM 20016];> 2 2 1 2 2 2 5.6 50.191 445 
>gi|148530512|gb|ABQ82511.1| LemA family protein [Lactobacillus reuteri DSM 20016 4 1 1 1 3 2 22.2 21.33 189 
>gi|194454712|gb|EDX43609.1| Septum formation initiator [Lactobacillus reuteri 100-23];> 2 1 1 0 0 2 19.5 14.007 118 
>gi|183225630|dbj|BAG26147.1| propanediol dehydratase reactivation protein PduH 
[Lactobacillus reuteri JCM 1112];> 4 2 2 2 2 3 34.6 14.213 127 
>gi|183224761|dbj|BAG25278.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  1 0 0 1 0 0 4.9 21.003 184 
>gi|183225866|dbj|BAG26382.1| pyrimidine operon regulator [Lactobacillus fermentum IFO 
3956];> 3 1 1 2 0 2 19 20.167 179 
>gi|148531324|gb|ABQ83323.1| 4-oxalocrotonate tautomerase [Lactobacillus reuteri DSM 
20016];> 3 3 2 2 2 2 47.5 6.8159 61 
>gi|148531498|gb|ABQ83497.1| LSU ribosomal protein L35P [Lactobacillus reuteri DSM 20016];> 2 2 2 2 2 2 32.3 7.615 65 
>gi|194453567|gb|EDX42464.1| hypothetical protein Lreu23DRAFT_3980 [Lactobacillus reuteri 
100-23];> 1 1 0 1 1 1 1.1 96.477 880 
>gi|148530282|gb|ABQ82281.1| DNA gyrase subunit B [Lactobacillus reuteri DSM 20016];> 3 2 0 0 2 2 4.6 72.528 649 
>gi|148530732|gb|ABQ82731.1| ATP synthase F0 subcomplex B subunit [Lactobacillus reuteri 
DSM 20016 4 0 1 2 3 1 18 19.254 172 
>gi|148530621|gb|ABQ82620.1| ABC transporter related [Lactobacillus reuteri DSM 20016];> 2 0 1 1 0 0 5.3 73.56 645 
>gi|148532010|gb|ABQ84009.1| transcriptional regulator, AsnC family [Lactobacillus reuteri DSM 
20016];> 3 1 2 2 1 1 22.4 17.758 156 
>gi|148530673|gb|ABQ82672.1| UDP-N-acetylmuramate dehydrogenase [Lactobacillus reuteri 
DSM 20016];> 2 0 0 1 0 2 12.8 32.389 298 
>gi|194454703|gb|EDX43600.1| alanine racemase [Lactobacillus reuteri 100-23];> 2 1 1 0 0 1 8.3 41.257 375 
>gi|148530894|gb|ABQ82893.1| protein of unknown function DUF1447 [Lactobacillus reuteri DSM 
20016];> 3 2 1 2 3 2 21.4 8.3122 70 
>gi|227184517|gb|EEI64588.1| possible acetolactate decarboxylase [Lactobacillus reuteri CF48-
3A];> 3 3 2 2 2 2 9.3 27.057 246 
 228 
 
>gi|148530982|gb|ABQ82981.1| hypothetical protein Lreu_0717 [Lactobacillus reuteri DSM 
20016];> 2 1 1 2 2 2 22.3 13.889 112 
>gi|227071855|gb|EEI10143.1| penicillin-binding protein [Lactobacillus reuteri MM2-3];> 4 2 2 1 1 2 5.4 76.108 699 
>gi|148531436|gb|ABQ83435.1| DNA replication and repair protein RecN [Lactobacillus reuteri 
DSM 20016];> 2 1 2 2 0 0 4.5 62.895 559 
>gi|148530684|gb|ABQ82683.1| Cof-like hydrolase [Lactobacillus reuteri DSM 20016];> 2 2 1 0 1 1 7.8 30.206 268 
>gi|148532149|gb|ABQ84148.1| aminotransferase, class I and II [Lactobacillus reuteri DSM 
20016];> 3 1 1 1 2 1 13.2 43.732 386 
>gi|148531784|gb|ABQ83783.1| aldose 1-epimerase [Lactobacillus reuteri DSM 20016 2 1 2 0 1 0 14.2 37.927 345 
>gi|148530636|gb|ABQ82635.1| bacterial peptide chain release factor 2 (bRF-2) [Lactobacillus 
reuteri DSM 20016 3 2 1 2 1 1 15.4 37.463 332 
>gi|148531007|gb|ABQ83006.1| DNA primase [Lactobacillus reuteri DSM 20016 3 0 0 0 3 0 4.5 71.586 621 
>gi|227070716|gb|EEI09044.1| NAD-dependent epimerase/dehydratase [Lactobacillus reuteri 
MM2-3];> 2 2 0 0 1 0 11.2 27.234 242 
>gi|148531462|gb|ABQ83461.1| hypothetical protein Lreu_1204 [Lactobacillus reuteri DSM 20016 2 1 0 2 0 1 31 6.3153 58 
>gi|183227545|dbj|BAG28061.1| ribose 5-phosphate isomerase [Lactobacillus fermentum IFO 
3956];> 2 1 0 0 0 2 12.4 24.932 226 
>gi|133930415|gb|ABO43779.1| L-lactate dehydrogenase [Lactobacillus reuteri];> 5 1 1 2 3 3 16.3 33.427 312 
>gi|227070037|gb|EEI08415.1| S-adenosyl-L-methionine-dependent methyltransferase 
[Lactobacillus reuteri MM2-3];> 1 1 1 1 1 0 5.5 26.69 238 
>gi|148531530|gb|ABQ83529.1| malate dehydrogenase (NAD) [Lactobacillus reuteri DSM 20016 5 1 1 1 4 2 14.7 33.353 312 
>gi|148531744|gb|ABQ83743.1| Deoxyadenosine kinase [Lactobacillus reuteri DSM 20016 1 0 1 1 1 1 4.7 24.647 213 
>gi|148530796|gb|ABQ82795.1| Holliday junction DNA helicase subunit RuvA [Lactobacillus 
reuteri DSM 20016];> 2 0 0 0 2 0 18.1 22.298 199 
>gi|148531529|gb|ABQ83528.1| phosphomethylpyrimidine kinase [Lactobacillus reuteri DSM 
20016];> 3 3 1 1 0 2 15.9 29.317 271 
>gi|183226376|dbj|BAG26892.1| conserved hypothetical protein [Lactobacillus fermentum IFO 
3956];> 2 0 1 0 0 1 18.7 15.706 134 
>gi|148531904|gb|ABQ83903.1| hypothetical protein Lreu_1664 [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 8 12.648 113 
>gi|148532031|gb|ABQ84030.1| Homoserine O-succinyltransferase [Lactobacillus reuteri DSM 
20016];> 2 1 1 0 1 1 11.6 32.139 275 
>gi|183227422|dbj|BAG27938.1| aspartate-ammonia ligase [Lactobacillus fermentum IFO 3956];>  3 0 0 2 2 2 8.6 38.795 336 
>gi|183226154|dbj|BAG26670.1| peptide chain release factor 2 [Lactobacillus fermentum IFO 
3956];> 2 2 2 2 2 1 7 39.961 355 
>gi|183225888|dbj|BAG26404.1| tyrosyl-tRNA synthase [Lactobacillus fermentum IFO 3956];> 2 0 1 1 0 2 5.5 46.933 417 
>gi|183224304|dbj|BAG24821.1| hypothetical protein [Lactobacillus reuteri JCM 1112];>  3 2 1 1 1 0 27.1 11.379 96 
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>gi|227070646|gb|EEI08976.1| SPOUT methyltransferase superfamily protein [Lactobacillus 
reuteri MM2-3];> 2 1 2 2 2 2 10.4 19.733 173 
>gi|337729425|emb|CCC04555.1| conserved hypothetical protein [Lactobacillus reuteri ATCC 
53608] 2 1 1 1 1 2 9.4 26.142 223 
>gi|227070121|gb|EEI08497.1| possible malate dehydrogenase [Lactobacillus reuteri MM2-3];> 3 3 1 1 2 3 8.1 39.19 360 
>gi|148530588|gb|ABQ82587.1| large conductance mechanosensitive channel protein 
[Lactobacillus reuteri DSM 20016 3 2 2 1 1 1 21.1 13.773 123 
>gi|183225058|dbj|BAG25575.1| phage major head protein [Lactobacillus reuteri JCM 1112];> 1 1 0 0 1 0 3.8 43.887 394 
>gi|183225285|dbj|BAG25802.1| muramidase [Lactobacillus reuteri JCM 1112];> 4 2 2 3 3 3 14 55.89 492 
>gi|148530863|gb|ABQ82862.1| protein of unknown function YGGT [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 1 1 8.1 9.7797 86 
>gi|148531635|gb|ABQ83634.1| methionine aminopeptidase, type I [Lactobacillus reuteri DSM 
20016];> 2 0 1 0 1 0 7 31.665 285 
>gi|148531335|gb|ABQ83334.1| SSU ribosomal protein S14P [Lactobacillus reuteri DSM 20016];> 3 3 1 2 2 2 32.6 10.399 89 
>gi|183224586|dbj|BAG25103.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 3 1 1 0 0 1 12.6 26.479 230 
>gi|112944038|gb|ABI26331.1| folylpolyglutamate synthase [Lactobacillus reuteri];> 2 0 1 0 2 0 8.5 48.081 437 
>gi|337728982|emb|CCC04102.1| glucose-inhibited division protein B [Lactobacillus reuteri ATCC 
53608];> 2 1 0 1 2 1 16.6 26.683 241 
>gi|227185796|gb|EEI65867.1| rod shape-determining protein MreC [Lactobacillus reuteri CF48-
3A];> 1 1 1 0 0 1 4.1 31.961 291 
>gi|148531188|gb|ABQ83187.1| putative RNA methylase [Lactobacillus reuteri DSM 20016  1 1 1 1 0 0 5 44.845 398 
>gi|183224889|dbj|BAG25406.1| flavodoxin [Lactobacillus reuteri JCM 1112];> 2 1 0 0 1 2 10.5 19.402 172 
>gi|148532090|gb|ABQ84089.1| hypothetical protein Lreu_1851 [Lactobacillus reuteri DSM 
20016];> 1 1 1 1 0 1 26.2 7.0627 61 
>gi|148530594|gb|ABQ82593.1| ribonucleoside-diphosphate reductase class Ib alpha subunit 
[Lactobacillus reuteri DSM 20016];> 3 1 1 0 1 1 7.7 82.738 723 
>gi|183227462|dbj|BAG27978.1| cation-transporting ATPase [Lactobacillus fermentum IFO 3956 3 1 0 1 1 1 3 100.37 921 
>gi|148531079|gb|ABQ83078.1| hypothetical protein Lreu_0815 [Lactobacillus reuteri DSM 20016 1 1 0 1 0 0 9.8 14.305 123 
>gi|148530393|gb|ABQ82392.1| branched-chain amino acid transport [Lactobacillus reuteri DSM 
20016];>  1 1 0 1 0 1 8.8 12.954 114 
>gi|148531487|gb|ABQ83486.1| LSU ribosomal protein L32P [Lactobacillus reuteri DSM 20016 1 1 1 0 0 0 23.7 6.5727 59 
>gi|148531751|gb|ABQ83750.1| cold-shock DNA-binding protein family [Lactobacillus reuteri DSM 
20016];>  1 1 0 1 0 1 19.7 7.3269 66 
>gi|148531427|gb|ABQ83426.1| protein kinase [Lactobacillus reuteri DSM 20016];> 3 2 3 2 2 2 7.1 70.819 634 
>gi|183225432|dbj|BAG25949.1| conserved hypothetical protein [Lactobacillus reuteri JCM 1112 1 1 0 1 1 1 2.9 35.145 313 
>gi|148531205|gb|ABQ83204.1| 2,5-didehydrogluconate reductase [Lactobacillus reuteri DSM 
20016 3 0 2 0 1 0 12.7 34.433 300 
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>gi|227071659|gb|EEI09952.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3 2 0 1 0 0 2 10.4 19.844 173 
>gi|148530914|gb|ABQ82913.1| SSU ribosomal protein S15P [Lactobacillus reuteri DSM 20016 1 1 1 1 1 1 7.9 10.416 89 
>gi|227070978|gb|EEI09301.1| cobalt-precorrin-2 C(20)-methyltransferase [Lactobacillus reuteri 
MM2-3 1 0 1 0 1 1 6.7 26.806 240 
>gi|148531465|gb|ABQ83464.1| protein of unknown function DUF910 [Lactobacillus reuteri DSM 
20016 1 1 0 1 0 0 12.7 9.4478 79 
>gi|336448118|gb|AEI56733.1| P4 family prophage LambdaSa04 protein [Lactobacillus reuteri 
SD2112 2 1 1 1 1 2 1.7 85.238 751 
>gi|183226040|dbj|BAG26556.1| hypoxanthine-guanine phosphoribosyltransferase [Lactobacillus 
fermentum IFO 3956];> 2 0 1 2 1 1 9.3 20.442 182 
>gi|183226928|dbj|BAG27444.1| chorismate synthase [Lactobacillus fermentum IFO 3956];> 3 2 1 1 2 1 7.5 41.636 388 
>gi|148532169|gb|ABQ84168.1| ATP-grasp protein-like protein [Lactobacillus reuteri DSM 
20016];> 2 1 2 1 1 0 6.8 48.604 414 
>gi|148531424|gb|ABQ83423.1| thiamine diphosphokinase [Lactobacillus reuteri DSM 20016];> 1 0 0 0 1 1 8.3 24.536 216 
>gi|148531267|gb|ABQ83266.1| hypothetical protein Lreu_1006 [Lactobacillus reuteri DSM 
20016];> 2 2 0 0 1 0 14.7 16.149 143 
>gi|148531174|gb|ABQ83173.1| protein of unknown function DUF1440 [Lactobacillus reuteri DSM 
20016  1 1 0 1 1 1 7.2 18.375 166 
>gi|148530686|gb|ABQ82685.1| two component transcriptional regulator, winged helix family 
[Lactobacillus reuteri DSM 20016];> 2 1 1 1 1 2 11.7 27.76 239 
>gi|148531107|gb|ABQ83106.1| hypothetical protein Lreu_0843 [Lactobacillus reuteri DSM 
20016];> 1 1 1 0 0 0 4.2 23.788 215 
>gi|148531647|gb|ABQ83646.1| GCN5-related N-acetyltransferase [Lactobacillus reuteri DSM 
20016];> 3 2 3 2 2 1 21.9 17.195 151 
>gi|148531071|gb|ABQ83070.1| transcriptional regulator, XRE family [Lactobacillus reuteri DSM 
20016];> 3 0 2 2 1 2 28 9.7862 82 
>gi|227070084|gb|EEI08461.1| metal-dependent hydrolase [Lactobacillus reuteri MM2-3];> 2 2 1 1 1 1 10 18.134 160 
>gi|148531021|gb|ABQ83020.1| condensin subunit ScpB [Lactobacillus reuteri DSM 20016];> 2 0 0 0 0 2 11.4 22.54 201 
>gi|148531173|gb|ABQ83172.1| glycoside hydrolase, clan GH-D [Lactobacillus reuteri DSM 
20016];> 2 1 1 0 0 0 2.7 84.003 729 
>gi|148530329|gb|ABQ82328.1| acetyl-CoA acetyltransferase [Lactobacillus reuteri DSM 20016];> 4 2 3 0 0 2 14.3 41.055 392 
>gi|183224876|dbj|BAG25393.1| carbamoyl-phosphate synthase large subunit [Lactobacillus 
reuteri JCM 1112];> 2 0 0 0 2 1 3.3 92.789 825 
>gi|148532172|gb|ABQ84171.1| glucose inhibited division protein A [Lactobacillus reuteri DSM 
20016];> 2 1 0 0 0 2 4 71.918 647 
>gi|148531678|gb|ABQ83677.1| isochorismatase hydrolase [Lactobacillus reuteri DSM 20016];>  4 0 1 1 0 2 18.9 19.239 164 
>gi|227070750|gb|EEI09077.1| conserved hypothetical protein [Lactobacillus reuteri MM2-3];> 3 0 0 1 1 1 14.9 25.173 221 
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>gi|148530499|gb|ABQ82498.1| Domain of unknown function DUF1934 [Lactobacillus reuteri 
DSM 20016];> 2 0 2 0 0 1 18.2 15.33 132 
>gi|148530487|gb|ABQ82486.1| periplasmic solute binding protein [Lactobacillus reuteri DSM 
20016];> 2 2 1 0 0 0 7.3 34.078 303 
>gi|148532114|gb|ABQ84113.1| transcriptional regulator, HxlR family [Lactobacillus reuteri DSM 
20016];> 3 3 2 1 0 2 17.2 14.22 122 
>gi|183227079|dbj|BAG27595.1| hemolysin [Lactobacillus fermentum IFO 3956];> 2 1 1 1 1 2 4.1 29.737 271 
>gi|227185320|gb|EEI65391.1| 2-dehydropantoate 2-reductase [Lactobacillus reuteri CF48-3A];> 1 1 0 1 1 1 3.2 35.797 315 
>gi|148530753|gb|ABQ82752.1| aldo/keto reductase [Lactobacillus reuteri DSM 20016];> 3 2 0 0 2 1 11.1 32.082 280 
>gi|133930471|gb|ABO43807.1| Smf [Lactobacillus reuteri];>gi|148531043|gb|ABQ83042.1| 
DNA protecting protein DprA [Lactobacillus reuteri DSM 20016];> 2 2 1 1 0 0 5.5 31.8 291 
>gi|148531957|gb|ABQ83956.1| precorrin-6Y C5,15-methyltransferase (decarboxylating), CbiT 
subunit [Lactobacillus reuteri DSM 20016];> 2 0 1 0 0 1 9.2 20.387 184 
>gi|337729525|emb|CCC04656.1| putative replication initiator protein [Lactobacillus reuteri ATCC 
53608] 2 0 1 1 0 1 1.7 102.72 909 
>gi|148530648|gb|ABQ82647.1| amino acid ABC transporter substrate-binding protein, PAAT 
family [Lactobacillus reuteri DSM 20016];> 1 1 1 1 1 1 5.8 33.273 294 
>gi|183227290|dbj|BAG27806.1| conserved hypothetical protein [Lactobacillus fermentum IFO 
3956 2 1 0 2 1 2 6.3 36.249 335 
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Appendix 3 
List of publications 
Oral presentations 
22nd March 2012. Using SILAC to identify potential mucus binding proteins in 
Lactobacillus reuteri. Mass Spectacular JIC conference centre. 
24th March 2012. What are calories? Measuring calories in food Hands on 
demonstration. Science in Norwich. 
1st April 2010. How do gut microbes bind to mucus? SGM – Edinburgh. 
 
Poster presentations 
Jeffers F., Mulholland F., Etzold S., Roos S., MacKenzie D.A., and Juge N. Exploring 
molecular interactions of Lactobacillus reuteri with mucus by quantitative proteomics. 
Exploring Human Host-Microbiome Interactions in Health and Disease, Wellcome 
Trust, Genome Campus, Hinxton, Cambridge. 8th-10th May 2012. 
 
Jeffers F., MacKenzie D., and Juge N. How do gut microbes bind to mucus? SET for 
Britain, Houses of Parliament, London. 14th March 2011. 
 
Jeffers F,. Fuell C., MacKenzie D.A., Tailford L.E., Bongaerts R.J., and Juge N. Mucin-
lectin binding assessed by flow cytometry and mass spectrometry. RSC Carbohydrates 
in Dundee Conference 30th-31st August 2010. 
 
Jeffers F., MacKenzie D.A., Fuell C., Tailford L.E., Bongaerts R. and Juge N. Mucin – 
lectin interactions assessed by flow cytometry. RSC Carbohydrate Group Meeting: 
Sugars in Norwich, IFR, 15th-16th September 2009. 
 
Jeffers F., MacKenzie D.A., Fuell C., Tailford L.E. and Juge N. How do gut microbes 
bind to mucus. RSC Carbohydrate Group Meeting: Sugars in Norwich, IFR, 15th-16th 
September 2009. 
 
Jeffers F., MacKenzie D.A., Fuell C., Tailford L.E., Bongaerts R. and Juge N. How do 
commensal gut microbes bind to mucus? IFR Student Showcase May 2009. 
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Posters and conference talks (given by others) 
 
MacKenzie D.A., Crost E.H., Etzold S., Kober O., Jeffers F., Le Gall G., Fuell C., Tailford L.E. 
and Juge N. Investigating the role of mucins in the interaction between gut bacteria and the 
host. 8
th
 INRA-Rowett Symposium on Gut Microbiology, Gut Microbiota: Friend or Foe? 
Polydome Congress Centre, Clermont-Ferrand France 17
th
-20
th
 June 2012. 
 
Kober O., Schreiber O., Jeffers F., Wakenshaw L., Roos S., Holm L. and Juge N. Functional 
modulation of the rodent mucus layer by gut bacteria. Molecular mechanisms of inflammatory 
bowel disease, Biochemical Society, Durham 20
th
-22
nd
 March 2011. 
 
Kober O.K., Jeffers F., Hemmings A., Wakenshaw L., MacKenzie D.A. and Juge N. Functional 
modulation of the murine mucus layer by gut bacteria. British Society of Immunology Congress, 
Liverpool, 6
th
-10
th
 December 2010. 
 
MacKenzie D.A., Jeffers F., Tailford L.E., Parris A., Williams M.R., Hemmings A.M. and Juge N. 
Structural and functional analysis of a mucus-binding protein repeat: role in bacterial adhesion 
to mucus. BBSRC-INRA-WUR Workshop on Food and Gut Health, IFR, 6
th
-8
th
 October 2010. 
MacKenzie D.A., Jeffers F., Etzold S,. Kober O., Hemmings A. and Juge N. Structure and 
function of Lactobacillus reuteri mucus binding proteins in the maintenance of gut homeostasis. 
3
rd
 ASM Conference on Beneficial Microbes, Miami, Florida, USA. 25
th
-29
th
 October 2010. 
 
MacKenzie D.A., Jeffers F., Etzold S., Parris A., Fais M., Tailford L.E., Fairhurst S., Williams 
M.R., Field R., Hemmings A.M. and Juge N. Gut bacteria – host interaction: the role of mucus 
binding proteins. INRA-Rowett Symposium on Gut Microbiology, new insights into gut microbial 
ecosystems. Aberdeen Exhibition and Conference Centre 22
nd
-25
th
 June 2010. 
 
MacKenzie D.A., Jeffers F., Tailford L.E., Ruiz-Moyano S., Parris A., Williams M.R., Parker 
M.L., Hemmings A.M. and Juge N. Structural and functional analysis of a mucus-binding protein 
repeat: role in bacterial adhesion to mucus.4
th
 International Probiotic Conference, Kosice, 
Slovakia 15
th
-17
th
 June 2010. 
 
MacKenzie D.A., Jeffers F., Tailford L.E., Parris A., Williams M.R., Hemmings A.M. and Juge N. 
Structural and functional analysis of a mucus binding protein repeat:role in bacterial adhesion to 
mucus. Microbes in Norwich, JIC Conference Centre 27
th
 November 2009. 
 
Fuell C., MacKenzie D.A., Tailford L.E., Jeffers F. and Juge N. Mucin analysis by mass 
spectrometry. RSC Carbohydrate Group Meeting: Sugars in Norwich, IFR, 15
th
-16
th
 September 
2009. 
 
MacKenzie D.A., Jeffers F., Tailford L.E., Parris A., Williams M.R., Hemmings A.M. and Juge N. 
Structural and functional analysis of a mucus binding protein repeat:role in bacterial adhesion to 
mucus.RSC Carbohydrate Group Meeting: Sugars in Norwich, IFR, 15
th
-16
th
 September 2009. 
 
Fuell C., Jeffers F., MacKenzie D.A., Tailford L.E., Bongaerts R.J. and Juge N. Mucin-lectin 
binding assessed by flow cytometry and mass spectrometry. 15
th
 European Carbohydrate 
Symposium. 19
th
-24
th
 July 2009. 
 
Publication (with other projects) 
Jeffers F., Fuell C., Tailford L.E., MacKenzie D.A., Bongaerts R.J. and Juge N. Mucin-
lectin interactions assessed by flow cytometry. Carbohydrate Research (2010) 345, 
1486-1491. 
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